data_1khm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1khm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.2 mm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.7 mt -123.61 149.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 m -127.81 137.24 52.32 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -139.17 145.07 38.91 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.5 145.7 38.58 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.05 147.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -120.37 129.35 53.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.73 140.01 36.4 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.25 142.13 97.17 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 120.104 1.073 . . . . 0.0 110.876 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -48.64 -41.36 30.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 111.306 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.0 111.248 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.13 -23.45 51.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.578 -1.326 . . . . 0.0 108.308 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.77 90.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.786 0.803 . . . . 0.0 109.669 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -74.13 -33.87 63.69 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.43 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -67.46 -34.79 77.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.706 -1.246 . . . . 0.0 109.25 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.4 mt -78.82 -42.66 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 110.852 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.609 ' CD1' HH11 ' A' ' 59' ' ' ARG . 64.5 mt -69.35 -37.09 74.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.394 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.93 -171.33 42.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.96 -51.43 5.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.074 -1.251 . . . . 0.0 108.809 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 13.98 64.2 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.6 -4.48 14.15 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.688 -1.478 . . . . 0.0 109.578 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.0 mt-30 -42.69 -20.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.016 -1.285 . . . . 0.0 110.096 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 18.3 tpt180 -86.29 -39.42 16.53 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.158 -0.964 . . . . 0.0 110.862 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.34 -28.0 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.584 -1.322 . . . . 0.0 109.345 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -72.87 -49.05 32.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -56.26 -53.57 55.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.864 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 39' ' ' ILE . 96.4 mt -53.19 -31.56 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -62.88 -41.24 99.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.31 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.452 ' N ' ' ND1' ' A' ' 41' ' ' HIS . 3.6 m80 -81.28 -38.93 26.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.38 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -65.28 -41.94 93.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.436 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -87.08 -23.14 25.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.05 . . . . 0.0 110.609 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 0.6 71.05 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.69 160.66 21.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.846 -0.796 . . . . 0.0 110.114 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.7 m -108.67 139.91 42.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 47' ' ' ILE . 96.2 mt -137.3 137.57 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 109.966 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -123.21 127.41 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.0 mt -99.57 134.11 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.938 -1.101 . . . . 0.0 108.775 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.06 152.91 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 0.0 108.503 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.6 149.64 98.02 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 120.935 -1.103 . . . . 0.0 108.606 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 120.57 0.847 . . . . 0.0 111.718 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.844 0.83 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.609 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.6 mtt180 -119.28 137.87 53.39 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.34 144.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.408 -0.807 . . . . 0.0 110.347 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.03 144.31 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.749 -0.594 . . . . 0.0 110.324 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.5 m -117.7 122.1 42.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.624 . . . . 0.0 109.333 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.3 mt -102.3 133.61 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.9 . . . . 0.0 109.394 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 m -131.39 129.52 41.42 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.002 -1.061 . . . . 0.0 109.146 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.79 -173.62 37.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 p -70.58 158.54 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.91 -1.347 . . . . 0.0 109.493 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -45.08 49.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.255 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -67.25 -48.42 67.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.036 -1.04 . . . . 0.0 109.502 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.96 -35.51 69.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 108.822 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.26 -46.33 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 110.076 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.83 -43.19 94.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.79 -1.194 . . . . 0.0 109.23 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -62.26 -32.02 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -47.32 18.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.512 -0.743 . . . . 0.0 109.541 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.86 -37.75 74.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -70.61 -34.49 72.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.668 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.31 -20.19 60.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.804 -1.185 . . . . 0.0 108.902 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.82 -46.43 21.57 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.68 -37.38 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.38 -24.66 46.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.209 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -64.24 -37.59 88.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 117.725 -1.59 . . . . 0.0 107.177 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 t . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.892 -0.505 . . . . 0.0 109.723 179.929 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.7 mt -124.83 150.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.365 -0.834 . . . . 0.0 109.702 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -128.01 137.55 52.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.62 145.87 39.05 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -111.75 145.47 39.29 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.68 155.62 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -125.37 130.11 51.27 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.28 131.16 23.85 Favored Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.19 132.81 53.5 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 CA-C-N 120.383 1.172 . . . . 0.0 111.186 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -39.54 -41.1 0.96 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.491 -0.755 . . . . 0.0 111.666 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.43 -46.51 88.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.746 -1.221 . . . . 0.0 110.702 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.11 -20.09 57.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.53 -1.356 . . . . 0.0 108.052 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.39 85.29 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.85 0.833 . . . . 0.0 109.439 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.16 -27.9 61.06 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.8 p -73.86 -32.02 63.45 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.257 -0.902 . . . . 0.0 109.154 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.6 mt -88.98 -43.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.0 111.099 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.66 -35.2 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.882 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 -173.12 41.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -91.81 -2.03 57.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.943 -1.328 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -152.01 18.17 0.83 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.9 -9.87 10.49 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 32' ' ' GLY . 43.8 tt0 -36.24 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.707 -0.878 . . . . 0.0 111.004 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.8 tpp180 -88.19 -36.8 16.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.638 -1.289 . . . . 0.0 109.903 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.2 mm -73.05 -25.56 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.798 -1.189 . . . . 0.0 108.623 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -73.02 -49.95 25.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 108.837 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.53 -48.22 81.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.038 -1.039 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.62 -33.9 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.61 -54.75 43.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -70.81 -39.15 73.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.949 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -59.67 -46.04 90.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -86.5 -23.16 26.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 -0.98 85.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.46 163.13 17.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.966 . . . . 0.0 109.939 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 m -105.69 145.51 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.75 139.8 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.688 -1.257 . . . . 0.0 110.15 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.56 124.33 33.59 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.82 135.77 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 109.245 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.56 152.77 18.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.963 . . . . 0.0 108.81 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.48 153.46 94.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.002 -1.061 . . . . 0.0 108.721 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.495 1.574 0 C-N-CA 120.874 1.049 . . . . 0.0 112.486 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 6.1 p30 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.517 0.675 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -119.88 138.92 53.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 60' ' ' ILE . 82.6 mt -111.96 149.83 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.037 -1.04 . . . . 0.0 111.056 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 61' ' ' ILE . 77.4 mt -135.04 143.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.769 -0.582 . . . . 0.0 110.279 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.8 m -116.95 122.71 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -100.98 132.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -130.72 129.43 42.52 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.993 -1.067 . . . . 0.0 109.323 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -171.56 38.51 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.466 ' HG1' ' NE2' ' A' ' 69' ' ' GLN . 17.7 p -73.14 160.02 32.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.971 -1.311 . . . . 0.0 109.645 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -46.49 -47.25 19.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.22 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.52 -45.31 72.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -59.03 -36.98 75.9 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.906 -1.121 . . . . 0.0 108.787 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.1 -46.01 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.79 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -59.85 -43.44 94.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -61.17 -34.96 75.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 108.843 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.23 -45.76 46.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.448 -0.782 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.33 -47.35 85.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.366 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -61.32 -41.2 96.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.089 . . . . 0.0 109.943 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.59 -18.11 64.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.823 -1.173 . . . . 0.0 109.055 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 80' ' ' SER . 14.8 mt -83.67 -45.48 13.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 108.583 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -61.95 -38.83 89.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.688 . . . . 0.0 110.109 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -78.89 -22.53 45.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.411 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 98.8 p -63.36 -40.1 96.35 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.325 -179.703 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -124.12 149.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.295 -0.878 . . . . 0.0 109.662 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -128.13 137.61 52.17 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.42 145.34 38.77 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.95 145.62 38.05 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.57 151.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.5 m -124.11 129.42 50.83 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.99 134.61 26.08 Favored Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.37 146.16 52.74 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.26 1.129 . . . . 0.0 110.917 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HZ1' HH22 ' A' ' 26' ' ' ARG . 18.1 ttmm -52.23 -41.87 63.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.065 -1.022 . . . . 0.0 111.451 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.8 p-10 -63.23 -46.68 85.82 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.741 -1.224 . . . . 0.0 111.15 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 -24.16 59.78 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.536 -1.353 . . . . 0.0 108.332 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.52 83.65 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.641 0.734 . . . . 0.0 109.796 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.672 HH12 ' NH2' ' A' ' 59' ' ' ARG . 5.9 mtt-85 -74.37 -31.65 62.47 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.795 -0.762 . . . . 0.0 108.96 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -70.31 -39.07 75.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 109.327 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.5 mt -74.11 -44.76 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 110.743 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.491 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.3 mt -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.968 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.11 40.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -92.12 -40.53 10.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.334 . . . . 0.0 109.496 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -108.35 14.97 36.06 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 69.12 -5.79 4.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 32' ' ' GLY . 76.0 mt-30 -43.42 -23.79 0.08 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.989 -1.301 . . . . 0.0 110.206 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.1 tpp180 -81.6 -39.65 24.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.045 -1.034 . . . . 0.0 110.675 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -26.93 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 109.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.63 -43.3 72.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 0.0 109.045 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.42 -49.5 76.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.937 -1.102 . . . . 0.0 109.959 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -52.58 -33.84 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.99 -1.069 . . . . 0.0 109.935 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -66.66 -35.99 81.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.78 -36.61 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 110.358 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -74.53 -41.62 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.178 -0.951 . . . . 0.0 110.503 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 45' ' ' ALA . 6.2 p -87.1 -23.21 24.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 110.598 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.6 2.1 68.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.961 -2.056 . . . . 0.0 107.961 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.546 ' H ' ' HG ' ' A' ' 43' ' ' SER . . . -83.98 161.39 20.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.842 -0.799 . . . . 0.0 110.148 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.0 m -109.14 140.91 42.09 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.2 mt -138.03 136.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.819 -1.175 . . . . 0.0 109.974 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -121.14 127.51 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.76 132.29 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 0.0 108.484 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 60' ' ' ILE . 1.3 p30 -93.04 153.2 18.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.955 -1.09 . . . . 0.0 108.56 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -67.33 149.0 98.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 120.91 -1.119 . . . . 0.0 108.536 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.49 1.265 0 C-N-CA 120.423 0.749 . . . . 0.0 111.696 179.48 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.994 0.902 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.672 ' NH2' HH12 ' A' ' 26' ' ' ARG . 50.1 mtt180 -119.38 139.45 51.97 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 75.5 mt -111.07 141.07 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.348 -0.845 . . . . 0.0 110.518 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 61' ' ' ILE . 95.6 mt -122.41 144.98 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 110.393 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -117.78 123.53 46.21 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.68 132.6 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.424 -0.797 . . . . 0.0 109.547 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -129.58 130.07 45.22 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -173.67 38.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 p -73.63 160.45 31.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.293 . . . . 0.0 109.693 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.68 -47.1 20.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.588 -0.695 . . . . 0.0 110.017 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.9 -45.75 73.54 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.74 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.51 -38.65 81.51 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.813 -1.179 . . . . 0.0 109.183 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.32 -45.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.625 -0.672 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.36 -43.41 96.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.776 -1.202 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.54 -37.39 83.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 108.822 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.23 -46.79 48.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.716 . . . . 0.0 109.661 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -60.01 -46.63 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.243 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -61.59 -33.6 74.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.54 -24.28 58.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 108.93 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.77 -44.77 47.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 0.0 108.459 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -61.97 -38.58 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.728 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.85 -23.98 44.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -62.98 -37.86 88.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.987 -0.445 . . . . 0.0 109.85 -179.647 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.58 148.11 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -126.95 136.94 52.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.67 144.89 37.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.49 145.21 39.45 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.06 151.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 m -124.43 129.9 51.51 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.85 140.46 37.72 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.28 146.56 88.7 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 CA-C-N 120.131 1.083 . . . . 0.0 111.107 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -53.08 -41.05 64.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.999 -1.063 . . . . 0.0 111.463 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.78 -44.82 95.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.732 -1.23 . . . . 0.0 111.355 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.37 -23.04 50.87 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.57 -1.331 . . . . 0.0 108.135 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.9 89.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.739 0.78 . . . . 0.0 109.606 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.404 HH11 ' CG ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -74.7 -30.93 61.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.26 -32.23 69.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.867 -1.146 . . . . 0.0 109.286 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -82.42 -44.04 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.48 -35.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.787 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -173.36 41.07 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.73 2.0 56.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.001 -1.293 . . . . 0.0 109.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -156.01 19.58 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.08 -11.06 3.97 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 32' ' ' GLY . 59.5 mt-30 -36.26 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.708 -0.878 . . . . 0.0 110.683 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpp180 -85.13 -35.56 21.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.804 -1.185 . . . . 0.0 109.842 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -74.37 -26.45 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.961 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.7 -48.05 49.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.992 . . . . 0.0 108.912 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -57.16 -56.47 21.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.754 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 39' ' ' ILE . 88.7 mt -49.62 -32.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -62.16 -38.94 90.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -83.2 -39.37 21.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 110.602 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.8 -43.05 89.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.058 -1.026 . . . . 0.0 110.489 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 t -87.19 -23.55 24.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.191 -0.943 . . . . 0.0 110.692 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.67 1.67 72.69 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.92 161.96 19.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.852 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.48 140.72 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 47' ' ' ILE . 91.6 mt -137.22 137.25 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.641 -1.287 . . . . 0.0 109.999 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -124.12 129.88 51.61 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.82 128.8 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.998 -1.063 . . . . 0.0 108.556 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 60' ' ' ILE . 20.5 p-10 -87.83 156.67 19.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.885 -1.134 . . . . 0.0 108.968 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.9 151.62 96.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.949 -1.095 . . . . 0.0 108.506 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.493 1.454 0 C-N-CA 120.556 0.837 . . . . 0.0 111.858 179.821 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.889 0.852 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -114.39 138.46 50.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 76.4 mt -112.3 141.06 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.24 -0.913 . . . . 0.0 110.802 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -125.6 145.87 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.716 -0.615 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.5 m -118.16 122.66 43.59 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.6 mt -103.91 132.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.925 . . . . 0.0 109.471 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -131.43 129.78 41.66 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.988 -1.07 . . . . 0.0 109.278 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.23 -172.38 38.33 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.507 ' HG1' ' CD ' ' A' ' 69' ' ' GLN . 9.8 p -72.33 159.63 33.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.269 . . . . 0.0 109.519 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.96 -46.94 21.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -68.16 -47.04 69.1 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.507 ' CD ' ' HG1' ' A' ' 66' ' ' THR . 31.0 mt-30 -56.78 -34.45 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.885 -1.135 . . . . 0.0 109.369 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.9 mt -73.67 -45.35 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.499 -0.751 . . . . 0.0 110.45 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.33 -43.83 96.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.717 -1.239 . . . . 0.0 109.6 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.23 -32.65 72.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 108.856 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.14 -45.87 25.37 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.456 -0.778 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.63 -48.08 80.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.05 -39.89 91.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.037 -1.04 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.52 -25.63 65.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 0.0 108.959 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.4 -46.24 41.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.73 -38.48 88.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.537 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.418 HD21 ' N ' ' A' ' 79' ' ' ASN . 1.4 m-80 -78.58 -25.06 45.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 81' ' ' VAL . 89.1 p -62.36 -37.14 84.54 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' A' ' 80' ' ' SER . 34.8 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -123.84 149.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -0.875 . . . . 0.0 109.642 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 m -127.78 137.3 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -139.24 144.91 38.64 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.59 145.61 37.55 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.162 -0.962 . . . . 0.0 110.008 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.63 151.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.7 129.86 52.28 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.34 136.97 29.37 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.42 137.55 75.0 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 CA-C-N 120.114 1.076 . . . . 0.0 111.082 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -43.79 -40.68 4.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.274 -0.891 . . . . 0.0 111.448 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -46.73 84.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.699 -1.25 . . . . 0.0 111.399 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.435 ' O ' ' OG ' ' A' ' 27' ' ' SER . 74.3 mt -76.33 -19.46 58.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.375 -1.453 . . . . 0.0 108.069 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.82 88.93 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.721 0.772 . . . . 0.0 109.367 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 5.5 mtt-85 -74.57 -26.87 60.22 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 91.6 p -74.58 -28.84 61.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 109.386 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -88.28 -45.15 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.808 -1.183 . . . . 0.0 111.21 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.23 -34.7 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.91 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.05 -173.98 43.52 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -92.09 -4.97 53.65 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.997 -1.296 . . . . 0.0 109.554 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.1 1.41 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 77.34 -8.41 32.93 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLY . 12.2 pt20 -34.02 -29.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.952 -0.734 . . . . 0.0 111.235 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 mmt180 -85.88 -40.63 15.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.419 -1.426 . . . . 0.0 109.622 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -68.86 -26.62 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.009 -1.057 . . . . 0.0 109.202 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.86 -52.78 8.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.447 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -60.87 -47.8 84.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.05 . . . . 0.0 109.489 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.33 -36.01 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -55.87 -67.15 0.32 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.406 -0.809 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.78 -39.81 86.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -58.19 -45.97 86.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 110.128 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 p -86.77 -21.96 26.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.014 -1.054 . . . . 0.0 110.089 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.85 0.07 73.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.0 160.91 20.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.729 -0.865 . . . . 0.0 110.026 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.5 t -106.93 141.86 37.47 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 47' ' ' ILE . 96.1 mt -138.02 136.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.658 -1.276 . . . . 0.0 110.139 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.84 130.76 54.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.3 mt -101.01 134.16 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.644 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.28 150.48 20.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 108.598 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -66.86 149.85 98.13 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.899 -1.125 . . . . 0.0 108.437 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.491 1.354 0 CA-C-N 119.261 0.772 . . . . 0.0 111.442 179.455 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 26' ' ' ARG . 3.5 mtt-85 -116.87 140.53 49.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -111.93 141.63 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.288 -0.882 . . . . 0.0 110.718 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 61' ' ' ILE . 96.8 mt -125.25 144.4 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.696 -0.627 . . . . 0.0 110.47 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 m -117.57 122.3 43.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 mt -103.16 132.66 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -129.87 130.16 44.86 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.54 38.79 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.681 ' H ' HE21 ' A' ' 69' ' ' GLN . 21.1 p -73.49 160.42 31.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.29 . . . . 0.0 109.662 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -46.95 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.0 -47.02 69.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.681 HE21 ' H ' ' A' ' 66' ' ' THR . 24.8 mt-30 -58.07 -37.55 74.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.832 -1.167 . . . . 0.0 109.201 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.39 -45.8 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.621 -0.674 . . . . 0.0 110.316 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.01 -43.55 95.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.819 -1.176 . . . . 0.0 109.518 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -61.74 -33.12 73.5 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.19 -0.943 . . . . 0.0 108.75 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.12 -46.84 22.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.403 -0.811 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -58.36 -46.0 87.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -62.81 -37.06 85.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.062 . . . . 0.0 110.135 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.01 -17.71 62.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 108.971 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.34 -45.91 14.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 108.532 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.42 -38.24 88.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.621 -0.675 . . . . 0.0 110.273 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.71 -22.94 45.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 t -66.18 -36.35 82.86 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.06 -1.456 . . . . 0.0 107.369 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 110.201 -179.498 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -123.79 148.27 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.24 -0.913 . . . . 0.0 109.661 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -127.74 137.6 52.49 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.37 144.4 38.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.41 145.41 36.18 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.253 -0.904 . . . . 0.0 109.911 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.94 151.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -127.0 129.55 48.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.4 141.86 41.23 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.46 141.83 89.67 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 CA-C-N 120.287 1.138 . . . . 0.0 110.691 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -47.94 -41.15 24.16 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.897 -1.127 . . . . 0.0 111.451 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -61.75 -43.56 98.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.651 -1.281 . . . . 0.0 111.293 -178.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.92 -29.2 44.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.732 -1.23 . . . . 0.0 108.411 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -40.79 74.46 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.79 0.805 . . . . 0.0 109.311 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.78 -32.51 62.05 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.5 p -68.53 -25.24 64.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.959 -1.088 . . . . 0.0 109.046 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.55 -41.86 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.965 -1.085 . . . . 0.0 110.578 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.621 ' CD1' HH11 ' A' ' 59' ' ' ARG . 58.1 mt -68.12 -37.44 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.851 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.04 -173.72 39.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -91.27 -4.6 55.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.888 -1.36 . . . . 0.0 109.938 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.56 20.81 1.17 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.08 -11.4 2.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 32' ' ' GLY . 88.0 mt-30 -36.53 -27.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.737 -0.861 . . . . 0.0 110.624 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.6 tpp180 -86.17 -34.33 20.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.76 -1.213 . . . . 0.0 109.889 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -75.91 -27.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 109.172 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.29 -48.91 30.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -58.21 -55.13 38.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.574 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -50.41 -32.37 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 109.672 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -62.7 -37.81 87.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.045 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.79 -39.75 19.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 0.0 110.518 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.44 -41.61 93.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.984 -1.072 . . . . 0.0 110.333 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.527 ' HG ' ' CB ' ' A' ' 45' ' ' ALA . 3.0 p -86.96 -24.24 24.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.54 1.27 70.36 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.527 ' CB ' ' HG ' ' A' ' 43' ' ' SER . . . -84.12 161.06 20.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.765 -0.844 . . . . 0.0 110.041 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.8 t -108.46 139.35 43.33 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 47' ' ' ILE . 96.3 mt -136.76 136.75 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.822 -1.174 . . . . 0.0 109.981 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -122.28 128.83 51.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -99.05 135.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.119 . . . . 0.0 108.829 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.49 148.57 22.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.082 -1.011 . . . . 0.0 108.616 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 149.26 97.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.953 -1.092 . . . . 0.0 108.797 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.49 1.306 0 CA-C-N 119.391 0.818 . . . . 0.0 111.479 179.495 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.919 0.866 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.621 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.4 mtt180 -118.71 140.14 50.42 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -111.26 142.16 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.16 143.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.82 -0.55 . . . . 0.0 110.384 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.3 m -117.76 122.84 44.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 0.0 109.451 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.74 133.07 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 m -130.36 130.23 44.14 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.052 -1.03 . . . . 0.0 109.221 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.33 -172.71 38.49 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.471 ' HG1' ' CD ' ' A' ' 69' ' ' GLN . 15.1 p -72.65 159.55 33.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.024 -1.28 . . . . 0.0 109.725 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.94 19.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.102 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.24 -45.73 72.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.471 ' CD ' ' HG1' ' A' ' 66' ' ' THR . 78.8 mt-30 -58.84 -37.35 76.27 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.85 -1.156 . . . . 0.0 109.226 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.66 -45.6 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.774 . . . . 0.0 110.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -60.53 -43.08 97.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 0.0 109.363 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -62.64 -34.58 77.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.897 . . . . 0.0 108.657 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -46.01 31.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.76 -37.16 78.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 110.142 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.79 -35.33 72.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.589 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.85 -1.156 . . . . 0.0 108.885 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 80' ' ' SER . 16.3 mt -81.28 -45.31 16.42 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -61.81 -38.72 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.561 -0.712 . . . . 0.0 109.628 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -78.53 -24.69 45.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 83.6 p -62.14 -37.31 84.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.893 -179.955 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -123.6 148.61 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.569 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 m -127.31 136.96 52.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.38 144.92 38.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.92 148.77 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.45 129.68 52.29 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.97 136.51 28.95 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.3 137.64 80.7 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 CA-C-N 120.243 1.123 . . . . 0.0 110.995 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -43.36 -40.53 3.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 111.528 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -63.02 -46.5 87.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.72 -1.237 . . . . 0.0 111.178 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.42 -20.52 57.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.58 -1.325 . . . . 0.0 108.289 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.58 89.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.702 0.763 . . . . 0.0 109.881 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 59' ' ' ARG . 3.8 mtt-85 -74.41 -32.39 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.859 -0.737 . . . . 0.0 109.265 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -69.22 -32.53 71.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.71 -1.244 . . . . 0.0 109.267 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -80.02 -44.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.025 -1.047 . . . . 0.0 110.821 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CD1' HH11 ' A' ' 59' ' ' ARG . 54.5 mt -68.4 -36.39 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.941 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.88 -172.36 40.29 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -91.83 -24.26 19.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.992 -1.299 . . . . 0.0 109.765 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -127.41 18.26 6.09 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.12 -9.18 4.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 32' ' ' GLY . 36.9 mt-30 -38.93 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.991 . . . . 0.0 110.417 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 tpp180 -83.43 -37.68 22.9 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.977 -1.077 . . . . 0.0 110.244 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.0 -27.71 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.144 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.987 . . . . 0.0 109.076 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.44 -46.43 90.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 39' ' ' ILE . 97.1 mt -57.21 -33.44 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 0.0 110.078 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -67.35 -41.44 85.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.451 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 3.1 t-80 -78.44 -34.15 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.008 . . . . 0.0 110.221 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.27 -41.64 48.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.637 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -86.49 -23.55 25.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.939 -1.101 . . . . 0.0 110.449 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 0.69 71.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.62 161.26 20.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.738 -0.86 . . . . 0.0 109.926 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -109.1 140.05 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.44 137.34 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.728 -1.232 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -121.83 129.84 52.93 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.5 135.19 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.048 -1.033 . . . . 0.0 108.84 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -95.3 150.15 20.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 108.532 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' CD ' ' N ' ' A' ' 51' ' ' GLU . 3.4 mp0 -66.56 149.52 98.07 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.878 -1.138 . . . . 0.0 108.586 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-N 119.363 0.808 . . . . 0.0 111.44 179.482 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 122.037 0.922 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 26' ' ' ARG . 44.3 mtt180 -117.65 139.17 51.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -108.61 156.16 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.825 0.821 . . . . 0.0 110.541 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -138.94 142.63 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.752 -0.593 . . . . 0.0 110.07 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -116.65 123.08 46.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.695 -0.628 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.52 132.75 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.9 m -130.54 130.12 43.7 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.118 -0.989 . . . . 0.0 109.234 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.07 -173.13 39.23 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.8 p -73.49 160.23 32.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.046 -1.267 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -45.45 -48.77 13.8 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.397 0.618 . . . . 0.0 110.498 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.25 -45.43 73.24 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.946 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -58.54 -36.26 73.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 109.392 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.11 -45.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.251 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -60.62 -43.07 97.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.658 -1.276 . . . . 0.0 109.305 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.36 -36.63 82.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.59 49.42 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.517 -0.74 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.48 -45.05 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.924 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.5 mt -73.36 -16.0 61.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.867 -1.146 . . . . 0.0 108.998 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -83.36 -45.84 13.26 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.44 -38.2 88.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.78 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.3 -23.52 47.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -65.24 -35.41 80.96 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.953 -1.499 . . . . 0.0 107.392 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.661 -0.649 . . . . 0.0 110.179 -179.645 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.2 mt -125.31 151.47 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.341 -0.849 . . . . 0.0 109.931 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 t -129.69 142.25 50.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.254 -0.904 . . . . 0.0 108.988 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -143.24 146.75 33.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.98 146.94 39.43 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.57 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.2 150.97 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -130.44 82.28 2.05 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.56 149.61 75.17 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.01 169.13 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 119.418 0.828 . . . . 0.0 110.148 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -76.08 -42.33 47.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.565 -1.335 . . . . 0.0 110.949 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.06 -39.85 95.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.748 -1.22 . . . . 0.0 111.532 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.63 -27.66 40.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.779 -1.201 . . . . 0.0 108.638 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.64 77.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.826 0.822 . . . . 0.0 109.186 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.34 -33.81 63.25 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -67.9 -29.93 69.15 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.859 -1.15 . . . . 0.0 108.97 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -83.93 -42.99 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.926 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' CD1' HH11 ' A' ' 59' ' ' ARG . 56.4 mt -67.45 -36.24 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.961 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.02 -173.83 41.67 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' A' ' 31' ' ' LYS . 1.4 mptm? -91.74 -0.02 57.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.933 -1.333 . . . . 0.0 109.651 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.13 19.4 0.64 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.18 -11.52 4.9 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 32' ' ' GLY . 14.8 pt20 -34.99 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.858 -0.789 . . . . 0.0 111.011 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.3 tpp180 -84.31 -34.62 23.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.718 -1.239 . . . . 0.0 109.89 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -74.69 -26.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.935 -1.103 . . . . 0.0 108.882 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -71.57 -47.94 51.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 108.945 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -60.09 -49.57 77.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.14 -34.71 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.112 -0.992 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 110.036 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.49 -38.1 59.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.099 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.97 -43.42 98.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 110.086 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -86.86 -22.16 25.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.991 -1.068 . . . . 0.0 110.276 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 0.19 74.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.72 161.83 19.88 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.771 -0.841 . . . . 0.0 110.042 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -107.58 142.85 36.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 47' ' ' ILE . 96.6 mt -138.46 136.54 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.681 -1.262 . . . . 0.0 110.027 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -121.39 130.02 53.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.8 mt -100.47 135.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.894 -1.129 . . . . 0.0 108.808 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.29 150.39 20.33 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.17 150.46 95.5 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.905 -1.122 . . . . 0.0 108.504 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-N 119.167 0.738 . . . . 0.0 111.523 179.595 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' CD1' ' A' ' 29' ' ' ILE . 40.7 mtt180 -117.69 139.81 50.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -109.08 152.09 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.759 0.79 . . . . 0.0 110.793 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.97 142.47 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.771 -0.58 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.4 m -114.61 126.61 55.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.499 ' CD1' ' NE2' ' A' ' 74' ' ' GLN . 15.0 mt -107.36 130.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.396 -0.815 . . . . 0.0 109.397 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -128.63 131.11 48.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.17 -174.33 39.45 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 p -72.92 159.96 32.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.045 -1.268 . . . . 0.0 109.773 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.94 -47.41 21.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.4 -45.34 72.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -59.21 -36.22 75.0 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.904 -1.122 . . . . 0.0 109.235 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.1 mt -74.48 -45.28 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -43.22 96.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.708 -1.245 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.92 -31.86 71.37 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.57 -42.02 53.21 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.591 -0.693 . . . . 0.0 109.913 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.683 HE21 ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -57.79 -52.69 64.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 0.0 109.354 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.99 -38.73 70.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.96 -22.21 62.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.791 -1.193 . . . . 0.0 109.251 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' OG ' ' A' ' 80' ' ' SER . 18.9 mt -79.44 -45.54 19.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.0 108.222 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.24 -38.48 89.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.573 -0.704 . . . . 0.0 109.846 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.62 -24.17 45.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.42 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 78.9 p -63.72 -37.21 86.49 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.704 -0.623 . . . . 0.0 110.144 -179.391 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -125.08 149.85 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.3 -0.875 . . . . 0.0 109.879 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.3 t -129.08 142.1 51.0 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.011 0.91 . . . . 0.0 108.888 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -143.07 144.59 32.32 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -110.46 145.99 36.69 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.18 148.59 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -121.78 129.65 52.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 135.21 27.07 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.531 -0.731 . . . . 0.0 109.087 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.99 136.66 78.06 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.271 1.132 . . . . 0.0 111.335 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -43.16 -41.31 3.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.219 -0.925 . . . . 0.0 111.579 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -62.25 -46.19 89.96 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.74 -1.225 . . . . 0.0 111.054 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.31 -25.47 54.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.658 -1.276 . . . . 0.0 108.02 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.59 82.33 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.785 0.803 . . . . 0.0 109.321 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.84 -29.33 61.02 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -72.08 -30.25 64.93 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.062 -1.024 . . . . 0.0 109.052 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -86.97 -43.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.007 -1.058 . . . . 0.0 110.937 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.61 -35.59 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.728 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -175.35 43.13 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -91.59 -3.38 56.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -150.03 18.71 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.31 -10.43 6.21 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 32' ' ' GLY . 18.7 mm100 -36.25 -27.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.787 -0.831 . . . . 0.0 110.594 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.92 -35.7 20.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.937 -1.102 . . . . 0.0 109.856 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -76.19 -28.04 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.961 -1.087 . . . . 0.0 109.269 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.57 -48.8 37.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.966 -1.084 . . . . 0.0 109.307 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -57.38 -42.68 82.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.0 110.057 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.12 -32.72 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 110.114 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -65.76 -49.47 68.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.002 . . . . 0.0 109.952 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.56 ' N ' ' HD1' ' A' ' 41' ' ' HIS . 1.7 m80 -71.4 -32.27 68.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -42.7 42.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.373 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -86.58 -23.74 25.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.68 0.81 75.29 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.74 161.38 20.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.761 -0.847 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.9 140.51 42.28 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.88 137.76 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.689 -1.257 . . . . 0.0 110.013 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -122.82 129.45 51.71 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.4 mt -100.36 135.42 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 108.71 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.03 151.67 18.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.023 -1.048 . . . . 0.0 109.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.95 154.44 92.31 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.067 -1.02 . . . . 0.0 108.399 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.492 1.393 0 C-N-CA 120.477 0.785 . . . . 0.0 111.748 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -117.72 137.55 52.61 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.61 156.0 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.887 0.851 . . . . 0.0 111.078 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.74 142.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.139 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.8 m -116.21 123.96 49.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.643 -0.661 . . . . 0.0 109.287 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.17 -0.956 . . . . 0.0 109.572 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -130.35 130.24 44.18 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.098 -1.001 . . . . 0.0 109.06 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.46 -173.25 38.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.2 p -72.42 159.59 33.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.968 -1.313 . . . . 0.0 109.618 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.1 -46.97 23.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 110.162 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.12 -47.14 68.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 109.882 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.36 -36.51 71.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.79 -1.194 . . . . 0.0 109.111 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.26 -45.82 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.48 -42.75 96.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.818 -1.177 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -62.16 -37.74 86.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.305 -0.872 . . . . 0.0 108.875 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.92 -44.09 64.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.422 -0.798 . . . . 0.0 109.601 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -58.04 -48.93 78.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.024 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.64 -39.14 83.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.84 -18.3 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.861 -1.15 . . . . 0.0 109.194 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 ' O ' ' OG ' ' A' ' 80' ' ' SER . 16.6 mt -84.23 -45.91 12.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.11 -38.62 89.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.665 -0.647 . . . . 0.0 110.042 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -78.99 -23.59 44.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.925 -1.109 . . . . 0.0 109.89 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 81.1 p -61.94 -36.68 82.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.89 -0.506 . . . . 0.0 110.42 -179.686 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 mm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.93 149.22 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.293 -0.879 . . . . 0.0 109.682 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.4 m -127.94 137.5 52.29 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.91 146.17 38.9 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -112.02 145.97 38.72 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -126.77 155.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -126.44 130.27 50.35 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.21 133.26 24.77 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.94 136.09 74.6 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 CA-C-N 120.356 1.163 . . . . 0.0 111.265 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.46 -41.28 2.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 111.515 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.88 -46.33 88.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.651 -1.28 . . . . 0.0 111.187 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.435 ' O ' ' OG ' ' A' ' 27' ' ' SER . 10.8 mp -75.65 -19.8 58.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.491 -1.381 . . . . 0.0 108.109 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.43 85.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.34 -28.66 61.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 72.9 p -72.89 -30.71 64.16 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.121 -0.987 . . . . 0.0 109.178 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -89.06 -43.06 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 0.0 111.014 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.5 mt -69.13 -35.98 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.061 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -170.7 38.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.7 ttpp -91.76 -11.76 35.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.948 -1.325 . . . . 0.0 110.007 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -142.17 17.99 2.51 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.55 -9.64 14.76 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 5.7 tp-100 -36.07 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.707 -0.878 . . . . 0.0 111.137 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.1 tpp180 -85.95 -35.51 20.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.536 -1.352 . . . . 0.0 109.7 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -72.55 -23.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.81 -1.182 . . . . 0.0 108.414 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -73.19 -50.23 23.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -0.976 . . . . 0.0 109.004 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -57.25 -51.42 69.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.63 -33.5 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.566 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -58.8 -64.82 0.8 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -62.29 -39.3 92.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -61.14 -44.65 96.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.255 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 p -86.71 -22.93 25.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.976 -1.078 . . . . 0.0 110.433 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.71 0.55 74.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.65 19.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.803 -0.822 . . . . 0.0 110.025 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.0 t -107.23 141.57 38.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 47' ' ' ILE . 94.0 mt -137.09 138.33 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.57 -1.331 . . . . 0.0 110.265 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -124.83 129.87 51.28 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.68 136.23 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.059 . . . . 0.0 108.917 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.17 152.16 18.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -1.0 . . . . 0.0 109.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.568 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 4.0 pm0 -67.06 154.08 93.27 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 120.993 -1.067 . . . . 0.0 108.731 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo . . . . . 0 N--CA 1.494 1.549 0 C-N-CA 120.675 0.916 . . . . 0.0 112.341 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.96 138.35 52.23 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 60' ' ' ILE . 82.7 mt -111.66 147.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.196 -0.94 . . . . 0.0 110.752 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 61' ' ' ILE . 96.6 mt -132.55 144.04 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.858 -0.526 . . . . 0.0 110.445 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.9 m -118.02 122.29 42.82 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -102.22 133.33 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -131.17 129.67 42.04 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.999 -1.063 . . . . 0.0 109.145 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.62 -172.32 38.65 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 9.9 p -72.08 159.02 34.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.01 -1.288 . . . . 0.0 109.716 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -47.19 21.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.855 -0.528 . . . . 0.0 110.342 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -68.52 -45.55 71.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.806 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 35.3 mt-30 -58.24 -35.2 71.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.114 . . . . 0.0 109.32 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.9 mt -73.52 -45.59 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.467 -0.77 . . . . 0.0 110.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -60.47 -42.84 97.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.754 -1.216 . . . . 0.0 109.376 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.79 -36.18 80.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.79 57.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -58.45 -48.66 80.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 110.379 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.06 -41.84 93.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.955 -1.091 . . . . 0.0 109.932 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.56 -25.29 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.798 -1.189 . . . . 0.0 108.966 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.6 -45.55 44.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.65 -38.59 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.471 -0.768 . . . . 0.0 109.385 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -78.41 -24.24 46.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.342 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.4 p -63.22 -37.61 87.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.331 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.78 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.7 mt -123.29 148.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 m -127.51 137.34 52.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -138.96 144.49 39.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -110.3 145.78 36.83 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.196 -0.94 . . . . 0.0 110.239 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.08 148.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -121.49 129.87 53.2 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.86 138.73 33.23 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.557 -0.715 . . . . 0.0 109.183 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.22 147.21 67.34 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.032 1.047 . . . . 0.0 110.992 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -54.05 -41.86 68.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.996 -1.065 . . . . 0.0 111.271 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -62.25 -42.64 99.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.749 -1.219 . . . . 0.0 111.162 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' A' ' 27' ' ' SER . 27.2 mt -79.48 -26.68 41.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.63 -1.294 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -39.11 78.01 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.859 0.838 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.7 -30.51 61.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 88.4 p -70.67 -29.22 65.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.102 -0.999 . . . . 0.0 109.352 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.7 mt -86.65 -44.25 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.022 -1.049 . . . . 0.0 111.108 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.597 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.2 mt -64.86 -34.69 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.569 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -176.62 46.16 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -92.25 0.34 57.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.038 -1.272 . . . . 0.0 109.406 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.8 15.19 0.7 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 78.11 -8.02 40.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.1 mt-30 -34.57 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.943 -0.739 . . . . 0.0 111.023 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.5 mmp_? -87.05 -43.46 12.29 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.545 -1.347 . . . . 0.0 109.469 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.92 -26.46 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.077 -1.015 . . . . 0.0 108.951 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.75 -53.58 7.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' OE1' ' NH2' ' A' ' 35' ' ' ARG . 88.3 mt-30 -59.16 -52.48 65.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -52.93 -34.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.36 -47.71 84.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.389 -0.819 . . . . 0.0 110.576 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -75.07 -40.52 60.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.008 . . . . 0.0 110.746 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.93 -43.07 99.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 110.34 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -87.8 -22.92 24.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 110.632 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.73 0.6 74.86 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 160.74 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.768 -0.842 . . . . 0.0 110.194 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 t -108.09 142.8 37.72 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 47' ' ' ILE . 96.2 mt -138.51 136.88 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 110.301 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -122.06 128.54 51.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.1 mt -99.56 135.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 109.162 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -95.85 150.3 20.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.113 -0.992 . . . . 0.0 108.503 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.62 150.59 97.32 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.837 -1.164 . . . . 0.0 108.617 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.49 1.308 0 CA-C-N 119.133 0.726 . . . . 0.0 111.486 179.508 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.92 0.867 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.597 HH11 ' CD1' ' A' ' 29' ' ' ILE . 46.9 mtt180 -119.74 138.87 53.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -108.07 155.58 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.441 -0.787 . . . . 0.0 110.607 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -138.54 141.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.762 -0.586 . . . . 0.0 110.021 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -115.76 122.99 47.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -102.32 133.48 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -130.57 129.68 43.09 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.086 -1.009 . . . . 0.0 109.152 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.61 -174.1 38.94 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -72.39 159.66 33.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.954 -1.321 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.6 19.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.245 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -68.3 -45.96 71.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.274 -0.892 . . . . 0.0 109.946 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -58.35 -36.03 72.82 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.862 -1.149 . . . . 0.0 109.359 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.1 mt -71.91 -45.95 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.2 -43.59 95.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.768 -1.207 . . . . 0.0 109.663 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -60.98 -39.63 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.152 -0.968 . . . . 0.0 108.689 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.53 64.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.507 -0.746 . . . . 0.0 109.398 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.16 -49.86 74.63 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.494 -0.754 . . . . 0.0 110.319 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.53 -37.72 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.027 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.31 -19.78 63.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.791 -1.193 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.05 -46.24 15.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 108.624 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.45 -39.53 93.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.747 -0.595 . . . . 0.0 110.715 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -78.33 -22.34 48.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -65.25 -34.71 79.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.111 -1.436 . . . . 0.0 107.316 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.391 -0.818 . . . . 0.0 110.858 -178.682 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -123.44 150.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.308 -0.87 . . . . 0.0 109.368 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.19 138.05 53.61 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.47 144.17 37.88 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -110.87 146.32 36.71 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.27 152.77 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -126.4 129.6 49.09 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 140.15 36.43 Favored Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.76 150.76 68.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 CA-C-N 120.019 1.042 . . . . 0.0 110.665 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -56.48 -40.85 75.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.87 -1.143 . . . . 0.0 111.2 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.18 -45.4 91.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 111.552 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.88 -26.2 53.93 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.36 -1.462 . . . . 0.0 108.466 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.06 80.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.812 0.815 . . . . 0.0 109.514 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.45 -30.82 62.03 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.79 -34.3 71.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.081 -1.012 . . . . 0.0 109.147 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -82.11 -44.37 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 111.09 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.551 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.4 mt -67.1 -35.38 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.918 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.09 -175.67 41.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -91.23 -9.58 44.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.022 -1.281 . . . . 0.0 109.967 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -144.17 20.03 2.11 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 71.39 -11.6 2.95 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 32' ' ' GLY . 5.7 pt20 -35.54 -36.12 0.07 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.77 -0.841 . . . . 0.0 110.656 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -76.71 -33.35 58.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.949 -1.094 . . . . 0.0 110.213 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -77.01 -26.36 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.62 -1.3 . . . . 0.0 109.334 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.63 -46.22 66.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 109.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -59.99 -49.9 75.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.677 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.05 -33.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -61.23 -64.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.243 -0.91 . . . . 0.0 110.047 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -64.08 -38.81 92.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 110.231 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.37 -42.15 98.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.238 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 28.0 p -87.01 -22.49 25.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.931 -1.106 . . . . 0.0 110.383 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.08 0.25 69.54 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.82 160.87 21.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.857 -0.79 . . . . 0.0 110.116 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.55 139.79 41.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 47' ' ' ILE . 96.5 mt -137.44 137.22 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.669 -1.269 . . . . 0.0 109.935 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -122.83 126.87 48.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.98 135.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.873 -1.142 . . . . 0.0 108.528 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.42 148.18 23.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.151 -0.968 . . . . 0.0 108.593 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.19 149.17 97.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.899 -1.126 . . . . 0.0 108.761 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 C--N 1.313 -1.297 0 CA-C-N 119.344 0.802 . . . . 0.0 111.581 179.542 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 121.801 0.81 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.551 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.7 mtt180 -119.19 138.97 52.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 60' ' ' ILE . 84.2 mt -110.12 147.95 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.35 -0.844 . . . . 0.0 110.645 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 61' ' ' ILE . 90.2 mt -130.57 143.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.758 -0.589 . . . . 0.0 110.311 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.3 m -116.51 122.68 45.41 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.58 133.1 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 m -130.98 129.41 42.08 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.018 -1.051 . . . . 0.0 109.169 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.83 -173.94 39.94 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 159.41 34.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.12 -1.224 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -47.06 -47.04 22.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.717 -0.614 . . . . 0.0 110.451 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -68.5 -44.57 74.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.787 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 43' ' ' SER . 24.1 mm100 -59.54 -36.68 76.62 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.916 -1.115 . . . . 0.0 109.284 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -71.19 -45.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.124 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -60.36 -43.12 96.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.804 -1.185 . . . . 0.0 109.334 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.5 -37.15 84.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 108.628 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -46.64 48.94 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.525 -0.734 . . . . 0.0 109.491 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.54 -41.34 89.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -66.91 -36.39 82.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.15 -13.95 61.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 108.943 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.59 -45.16 12.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.971 . . . . 0.0 108.454 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.02 -38.45 88.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -79.14 -24.16 43.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 109.467 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.9 p -63.78 -38.58 91.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 -179.534 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.11 149.53 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -125.83 137.78 53.79 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.48 144.75 38.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -111.31 146.79 36.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -125.59 154.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 130.05 49.51 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.32 138.42 32.75 Favored Pre-proline 0 N--CA 1.506 2.338 0 O-C-N 121.514 -0.741 . . . . 0.0 109.23 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.88 175.05 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.114 1.076 . . . . 0.0 110.828 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.37 -39.27 39.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.584 -1.322 . . . . 0.0 110.534 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -63.41 -39.75 95.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -0.889 . . . . 0.0 111.457 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.423 ' O ' ' OG ' ' A' ' 27' ' ' SER . 11.2 mp -81.01 -28.66 35.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.439 -1.413 . . . . 0.0 108.311 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.039 0.923 . . . . 0.0 109.171 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -71.51 -30.87 66.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 94.0 p -72.28 -31.18 65.51 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.072 -1.017 . . . . 0.0 109.223 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -86.74 -44.27 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.146 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -67.21 -35.44 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.83 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.96 -173.61 41.56 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -91.67 0.55 57.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.046 -1.267 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.6 18.59 0.59 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.63 -10.35 6.95 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 32' ' ' GLY . 40.7 mt-30 -35.58 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.797 -0.825 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 tpt180 -85.68 -35.27 20.99 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.641 -1.287 . . . . 0.0 110.069 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -74.33 -27.38 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 109.019 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.62 -47.79 44.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.31 -46.49 88.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.039 -1.038 . . . . 0.0 110.031 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.92 -33.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -66.67 -40.18 88.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.015 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 41' ' ' HIS . 18.5 t-80 -77.51 -30.42 52.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 110.248 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 42' ' ' GLU . 2.2 tm-20 -79.12 -41.58 28.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -86.59 -23.68 25.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 110.48 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.52 0.6 73.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.46 161.15 20.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.681 -0.894 . . . . 0.0 110.053 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.6 m -108.79 140.07 42.73 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.76 137.5 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.775 -1.203 . . . . 0.0 110.024 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -122.3 129.26 52.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -99.68 135.15 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.884 -1.135 . . . . 0.0 108.676 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 10.0 m-20 -95.83 150.18 20.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.158 -0.964 . . . . 0.0 108.626 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -66.4 151.12 96.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.916 -1.115 . . . . 0.0 108.609 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 120.451 0.767 . . . . 0.0 111.705 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.794 0.807 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -116.66 138.74 51.22 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 60' ' ' ILE . 82.4 mt -112.4 147.24 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.193 -0.942 . . . . 0.0 110.962 -178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 61' ' ' ILE . 90.1 mt -132.22 143.26 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.836 -0.54 . . . . 0.0 110.218 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 m -116.43 124.36 49.81 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.0 mt -103.92 132.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -131.03 130.06 42.81 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.038 -1.039 . . . . 0.0 109.104 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.1 -173.27 38.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -72.12 159.27 34.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -47.46 -46.55 26.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.673 -0.642 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.08 -47.1 69.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 109.862 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 14.3 mp0 -57.91 -36.73 72.85 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.866 -1.146 . . . . 0.0 109.082 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.82 -45.79 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.511 -0.743 . . . . 0.0 110.019 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.66 -42.98 98.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.75 -1.219 . . . . 0.0 109.55 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.44 -38.37 89.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 108.817 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.1 -45.66 59.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.399 -0.813 . . . . 0.0 109.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.91 -41.24 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.134 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.84 -37.31 84.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 109.777 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -70.82 -26.69 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.799 -1.188 . . . . 0.0 108.836 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.78 -45.19 62.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -62.18 -38.89 90.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.39 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.38 -26.08 46.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.605 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 p -62.46 -36.66 83.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.177 -1.409 . . . . 0.0 107.244 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.077 0.465 . . . . 0.0 109.821 -179.812 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.64 149.46 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.352 -0.843 . . . . 0.0 109.792 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -127.1 137.66 53.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.8 145.34 38.06 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -110.95 144.74 39.55 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 109.938 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.88 149.04 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -122.24 129.62 52.41 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.92 138.99 33.79 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -56.87 146.12 80.58 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 CA-C-N 120.209 1.11 . . . . 0.0 110.918 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -52.7 -40.95 63.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.904 -1.122 . . . . 0.0 111.344 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -62.31 -44.25 96.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.807 -1.183 . . . . 0.0 111.231 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 27' ' ' SER . 32.6 mt -78.52 -26.73 45.87 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.622 -1.299 . . . . 0.0 108.209 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.45 79.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.83 0.824 . . . . 0.0 109.319 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -74.55 -30.09 61.61 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 96.8 p -71.12 -26.96 63.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.075 -1.016 . . . . 0.0 109.299 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -89.01 -43.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 110.999 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.596 ' CD1' HH11 ' A' ' 59' ' ' ARG . 52.4 mt -68.28 -36.01 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.707 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -172.72 40.37 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -91.65 -9.65 43.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 109.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -143.84 18.36 2.18 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.91 -10.44 9.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 32' ' ' GLY . 19.7 mm100 -35.61 -29.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.866 -0.785 . . . . 0.0 110.803 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.0 tpp180 -84.32 -37.15 21.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.643 -1.286 . . . . 0.0 109.743 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -72.3 -23.39 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.802 -1.186 . . . . 0.0 108.532 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -71.72 -48.14 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 108.939 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -59.11 -47.72 84.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.53 -33.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 40' ' ' ARG . 1.5 ttt-85 -57.88 -53.47 57.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.244 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.58 -39.57 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 0.0 110.357 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -59.07 -44.99 91.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.108 -0.995 . . . . 0.0 110.114 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t -86.93 -22.56 25.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 110.188 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.11 -0.16 80.41 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.03 162.82 18.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.707 -0.878 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.5 m -104.85 148.1 27.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -133.05 138.8 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.652 -1.28 . . . . 0.0 109.948 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.53 123.63 31.91 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.15 135.06 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 108.961 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.21 152.06 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.115 -0.991 . . . . 0.0 108.836 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' CD ' ' N ' ' A' ' 51' ' ' GLU . 3.2 mp0 -70.7 150.2 95.34 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 120.933 -1.105 . . . . 0.0 108.396 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.49 1.273 0 CA-C-N 119.442 0.837 . . . . 0.0 111.59 179.347 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 122.135 0.969 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.596 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.5 mtt180 -118.44 138.83 52.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 60' ' ' ILE . 83.7 mt -108.3 151.97 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.376 -0.828 . . . . 0.0 110.256 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -135.56 142.45 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.665 . . . . 0.0 110.123 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -116.48 121.12 40.89 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.717 -0.614 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.73 132.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.261 -0.899 . . . . 0.0 109.285 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -129.37 130.14 45.66 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.024 -1.047 . . . . 0.0 108.969 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.75 -172.34 38.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 p -73.26 160.0 32.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.001 -1.293 . . . . 0.0 109.619 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.14 -46.51 23.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.49 -45.22 72.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.254 -0.903 . . . . 0.0 109.857 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -59.16 -36.42 75.25 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.275 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 92.4 mt -72.33 -45.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.54 -0.725 . . . . 0.0 110.368 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.57 -42.95 97.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.753 -1.217 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.32 -31.63 71.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 109.005 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -43.14 36.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.502 -0.749 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.75 -48.23 75.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.177 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.21 -43.86 98.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -64.14 -24.58 67.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.905 -1.122 . . . . 0.0 109.084 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' OG ' ' A' ' 80' ' ' SER . 20.3 mt -76.87 -46.77 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 108.316 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.06 -38.57 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.55 -0.719 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.07 -25.45 47.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 109.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 77.9 p -62.79 -38.04 89.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.481 -1.387 . . . . 0.0 107.296 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.494 1.762 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.028 -179.611 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.38 148.54 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.286 -0.884 . . . . 0.0 109.53 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -126.7 137.75 53.31 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.45 144.48 38.05 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.13 146.6 36.54 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.178 -0.951 . . . . 0.0 110.302 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.39 150.79 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -124.86 130.08 51.67 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.68 138.0 31.6 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 22' ' ' LYS . 2.5 Cg_endo -57.91 134.69 64.11 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 CA-C-N 120.158 1.092 . . . . 0.0 110.384 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 21' ' ' PRO . 28.7 ttmt -39.07 -40.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.454 -0.779 . . . . 0.0 111.112 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.89 -40.2 96.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.985 -1.072 . . . . 0.0 110.868 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.59 -26.74 50.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.661 -1.274 . . . . 0.0 108.696 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.32 79.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.774 0.797 . . . . 0.0 109.479 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -76.59 -29.11 56.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.4 p -73.59 -24.77 60.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.862 -1.149 . . . . 0.0 109.05 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -95.47 -42.6 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.961 -1.087 . . . . 0.0 110.609 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.25 -35.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.84 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.25 -172.04 39.28 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -91.57 -14.16 30.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.294 . . . . 0.0 109.957 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -139.04 18.51 3.13 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.96 -10.21 7.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.729 -1.748 . . . . 0.0 108.729 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 32' ' ' GLY . 70.2 mt-30 -36.03 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.777 -0.837 . . . . 0.0 110.673 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.53 -36.06 20.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.764 -1.21 . . . . 0.0 109.961 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -73.46 -24.48 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -73.04 -47.8 41.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.078 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.11 -50.24 74.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.048 -1.032 . . . . 0.0 109.867 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.4 -31.79 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.79 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -61.1 -65.12 0.74 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.43 ' HD1' ' H ' ' A' ' 41' ' ' HIS . 22.3 m80 -64.9 -36.73 85.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.326 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.33 -42.95 92.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.056 -1.028 . . . . 0.0 110.199 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -86.99 -22.94 25.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.354 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.99 0.83 70.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.49 161.44 20.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -108.82 138.11 45.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 47' ' ' ILE . 96.2 mt -136.38 137.88 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.816 -1.178 . . . . 0.0 109.891 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -123.09 128.28 49.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.85 135.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 108.541 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.57 151.59 19.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.037 -1.039 . . . . 0.0 108.939 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.02 155.38 87.25 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.342 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 N--CA 1.492 1.404 0 C-N-CA 120.624 0.883 . . . . 0.0 111.933 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 121.59 0.709 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -119.41 137.37 53.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.17 153.79 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.3 -0.875 . . . . 0.0 111.052 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.92 141.93 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.765 -0.585 . . . . 0.0 110.184 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -115.91 123.96 49.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.636 -0.665 . . . . 0.0 109.341 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -104.07 132.19 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.74 46.49 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.114 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.54 38.63 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 66' ' ' THR . 7.4 p -74.72 161.69 29.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.995 -1.297 . . . . 0.0 109.532 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.8 -47.48 30.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -0.754 . . . . 0.0 110.449 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.85 -49.44 62.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.07 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.66 -36.68 69.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.854 -1.154 . . . . 0.0 109.212 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.8 mt -70.46 -45.54 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -60.7 -42.87 98.04 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.694 -1.254 . . . . 0.0 109.445 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.37 -37.94 87.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.276 -0.89 . . . . 0.0 108.784 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 -45.1 62.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.438 -0.789 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.83 -49.06 79.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.913 . . . . 0.0 109.966 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -59.39 -41.11 88.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.803 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.424 ' O ' ' OG ' ' A' ' 80' ' ' SER . 25.7 mt -67.01 -25.9 66.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 108.947 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.01 -44.37 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.883 -1.135 . . . . 0.0 108.34 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -62.0 -38.89 90.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.581 -0.7 . . . . 0.0 109.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -78.57 -23.82 45.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.874 -1.141 . . . . 0.0 109.618 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.487 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 25.5 m -63.69 -36.46 83.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.252 -1.53 . . . . 0.0 107.013 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.791 -0.568 . . . . 0.0 109.872 179.806 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.1 mt -125.2 150.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.314 -0.866 . . . . 0.0 109.706 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 t -127.48 148.17 50.31 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -148.44 142.04 25.47 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -108.22 145.45 34.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.03 154.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -126.48 129.65 49.09 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.5 136.14 28.23 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.74 139.27 84.6 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 CA-C-N 120.16 1.093 . . . . 0.0 111.1 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -44.42 -40.02 5.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 0.0 111.252 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -63.24 -47.1 83.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.725 -1.235 . . . . 0.0 111.116 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.4 mt -76.86 -21.67 54.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.349 -1.469 . . . . 0.0 108.348 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.36 90.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.865 0.84 . . . . 0.0 109.443 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -75.42 -28.58 59.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.1 p -74.05 -32.73 63.43 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.191 -0.943 . . . . 0.0 108.881 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -86.84 -44.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.667 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.1 mt -69.92 -35.98 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.018 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.89 -170.14 41.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -92.26 -47.2 7.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.18 -1.188 . . . . 0.0 109.421 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.67 13.21 59.54 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 67.12 -1.64 6.09 Favored Glycine 0 N--CA 1.493 2.455 0 O-C-N 120.882 -1.364 . . . . 0.0 109.812 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.7 mt-30 -45.93 -16.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 119.316 1.558 . . . . 0.0 109.862 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -82.95 -38.82 22.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.907 -1.121 . . . . 0.0 110.864 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.05 -18.98 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.139 -1.601 . . . . 0.0 109.155 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -73.75 -50.43 20.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.393 -0.817 . . . . 0.0 109.088 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.18 -48.54 81.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.545 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.4 mt -58.45 -34.74 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.62 -59.51 5.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -67.78 -37.59 82.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.86 -44.47 93.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -0.985 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -86.6 -23.07 25.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 110.301 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.04 0.54 76.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.28 18.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.762 -0.846 . . . . 0.0 109.876 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -108.04 141.36 39.82 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.3 mt -134.2 137.22 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.765 -1.209 . . . . 0.0 110.214 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -122.77 127.41 49.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.1 134.43 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.021 -1.049 . . . . 0.0 108.584 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.9 149.48 21.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.133 -0.98 . . . . 0.0 108.559 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.92 149.22 97.8 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 120.827 -1.171 . . . . 0.0 108.568 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.49 1.305 0 CA-C-N 119.213 0.754 . . . . 0.0 111.446 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.079 0.942 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -117.47 140.22 49.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.59 144.21 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.381 -0.824 . . . . 0.0 110.785 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.422 HD11 HG22 ' A' ' 61' ' ' ILE . 96.2 mt -127.44 143.8 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.768 -0.583 . . . . 0.0 110.342 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.4 m -117.94 120.75 38.77 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.725 -0.609 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.09 133.13 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -129.33 130.59 46.29 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.06 -1.025 . . . . 0.0 109.19 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.56 -172.61 38.67 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 p -73.71 160.77 31.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.058 -1.26 . . . . 0.0 109.522 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -46.84 -46.96 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -67.74 -45.88 73.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -59.93 -38.91 83.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.786 -1.196 . . . . 0.0 109.26 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.81 -45.61 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.733 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -60.7 -43.34 97.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.801 -1.187 . . . . 0.0 109.375 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -61.43 -40.17 93.45 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.4 -46.4 64.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.493 -0.754 . . . . 0.0 109.417 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -57.41 -52.61 64.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 109.945 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 63.7 t80 -57.31 -40.51 78.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.035 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.92 -27.67 66.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.863 -1.148 . . . . 0.0 108.975 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -74.74 -45.94 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.058 . . . . 0.0 108.433 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -61.28 -39.35 90.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.667 -0.645 . . . . 0.0 109.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 10.0 m-80 -78.38 -23.79 46.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.9 p -63.07 -34.54 77.8 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.595 . . . . 0.0 110.474 -179.251 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 150.49 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 109.485 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 m -126.85 136.64 52.62 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.0 144.91 39.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.8 146.16 36.88 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.256 -0.902 . . . . 0.0 110.064 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.17 153.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -124.2 129.64 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.43 136.55 28.79 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 121.466 -0.771 . . . . 0.0 109.25 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.35 139.25 85.77 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.082 1.065 . . . . 0.0 110.954 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -44.26 -40.07 4.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.184 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.39 -46.58 85.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.824 -1.172 . . . . 0.0 111.43 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 27' ' ' SER . 74.3 mt -76.84 -22.99 52.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.311 -1.493 . . . . 0.0 108.251 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.95 -38.23 85.17 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.831 0.824 . . . . 0.0 109.14 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.38 -27.25 59.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 92.9 p -74.54 -31.57 62.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.065 -1.022 . . . . 0.0 109.254 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.8 mt -83.89 -45.95 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 110.972 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.75 -34.28 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.798 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.52 -176.22 44.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -91.93 5.0 51.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 109.676 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -157.55 17.35 0.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.28 -9.49 13.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' GLY . 62.0 mt-30 -34.65 -28.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.95 -0.735 . . . . 0.0 111.015 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.4 mmt180 -86.33 -40.16 15.74 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.484 -1.385 . . . . 0.0 109.617 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.1 mm -69.85 -27.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.047 . . . . 0.0 109.295 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -77.4 -53.55 7.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.68 -48.11 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.08 -34.5 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -59.26 -74.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -53.06 -34.8 58.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.471 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.06 -44.14 80.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.419 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -86.42 -24.57 25.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 0.0 110.538 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.77 -3.92 83.96 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.06 162.64 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -1.056 . . . . 0.0 110.098 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.4 m -107.01 142.62 36.35 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 47' ' ' ILE . 96.8 mt -138.06 136.78 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.665 -1.272 . . . . 0.0 110.04 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -123.0 127.29 48.61 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -98.03 135.07 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.94 -1.1 . . . . 0.0 108.636 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.69 151.27 19.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.094 -1.004 . . . . 0.0 108.766 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 4.0 mp0 -67.78 149.37 98.28 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 120.996 -1.065 . . . . 0.0 108.46 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.314 -1.239 0 CA-C-N 119.445 0.837 . . . . 0.0 111.431 179.403 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.928 0.87 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -120.63 140.47 51.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.3 140.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.437 -0.79 . . . . 0.0 111.239 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 61' ' ' ILE . 92.8 mt -120.92 144.73 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.665 -0.647 . . . . 0.0 110.239 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.8 m -117.31 125.12 50.54 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.81 131.31 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.16 -0.963 . . . . 0.0 109.624 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -129.19 130.73 46.7 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.088 -1.008 . . . . 0.0 109.024 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.57 -174.42 38.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 p -73.24 160.22 32.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.266 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -46.72 24.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.383 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 m-20 -68.15 -46.85 69.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.925 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -58.28 -37.33 74.8 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.898 -1.126 . . . . 0.0 109.293 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.2 mt -70.84 -45.76 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.504 -0.747 . . . . 0.0 110.212 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.2 -43.18 96.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.792 -1.193 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.16 -35.24 78.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 108.757 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.37 35.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.533 -0.729 . . . . 0.0 109.55 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.15 -47.09 84.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.268 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -61.52 -35.27 77.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.013 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.36 -26.93 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.82 -1.175 . . . . 0.0 109.02 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.33 -46.03 57.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.086 -1.009 . . . . 0.0 108.317 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -61.39 -37.64 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.446 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.85 -24.15 44.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -64.07 -40.11 95.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.933 -179.596 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -123.98 148.85 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -127.55 137.34 52.58 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.04 144.01 38.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.49 144.89 37.13 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.208 -0.933 . . . . 0.0 109.942 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.13 153.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.82 129.89 50.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.0 137.39 30.03 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.485 -0.759 . . . . 0.0 108.957 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.81 144.61 93.22 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.158 1.092 . . . . 0.0 110.958 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -50.94 -41.37 58.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 111.339 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -45.38 92.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.74 -1.225 . . . . 0.0 111.42 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.78 -25.71 53.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.448 -1.407 . . . . 0.0 108.175 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.26 79.83 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.735 0.779 . . . . 0.0 109.4 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.7 -30.11 61.43 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -71.41 -33.25 69.27 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.935 -1.103 . . . . 0.0 109.243 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.15 -45.13 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 111.016 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.21 -35.06 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.877 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 -171.9 39.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -91.79 -4.26 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.329 . . . . 0.0 109.771 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.87 19.58 1.11 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.32 -10.61 6.01 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 32' ' ' GLY . 35.3 tt0 -36.57 -26.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.792 -0.828 . . . . 0.0 111.109 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.2 tpp180 -87.12 -37.48 17.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.733 -1.229 . . . . 0.0 109.777 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.41 -23.92 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.744 -1.222 . . . . 0.0 108.571 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -72.78 -49.33 31.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.63 -47.96 80.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.706 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.06 -32.81 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.04 -47.19 86.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.109 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -80.22 -39.47 29.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.112 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.39 -44.28 97.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.016 -1.053 . . . . 0.0 110.188 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -87.14 -22.33 25.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.079 -1.013 . . . . 0.0 110.217 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.18 79.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.79 162.63 18.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.772 -0.84 . . . . 0.0 109.848 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 m -105.35 146.97 28.68 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mm -132.45 138.21 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.605 -1.309 . . . . 0.0 109.955 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -126.6 124.72 40.59 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -101.66 132.98 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 108.787 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.61 150.83 19.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.006 -1.059 . . . . 0.0 108.487 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -66.21 150.15 97.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.969 -1.082 . . . . 0.0 108.455 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.49 1.286 0 C-N-CA 120.38 0.72 . . . . 0.0 111.687 179.627 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.96 0.886 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.495 HH11 ' CG ' ' A' ' 59' ' ' ARG . 5.1 mtt-85 -118.05 139.52 51.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -111.54 141.89 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.314 -0.866 . . . . 0.0 110.845 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 61' ' ' ILE . 92.8 mt -124.96 143.71 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.752 -0.593 . . . . 0.0 110.484 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -118.59 118.38 31.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.718 -0.614 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -96.37 134.31 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -131.74 129.04 40.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 -171.95 37.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.435 ' H ' ' HG1' ' A' ' 66' ' ' THR . 7.8 p -71.71 159.31 34.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.049 -1.265 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -46.26 46.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.675 . . . . 0.0 110.273 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -66.94 -46.53 74.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.08 -1.013 . . . . 0.0 109.494 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -57.99 -32.81 68.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.0 -1.062 . . . . 0.0 109.001 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.46 -45.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.503 -0.748 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -44.01 93.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.664 -1.272 . . . . 0.0 109.518 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -61.14 -34.1 74.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.072 -1.017 . . . . 0.0 108.729 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.55 -47.13 28.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.528 -0.732 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -58.44 -47.68 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 110.345 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 79' ' ' ASN . 56.9 t80 -61.14 -38.15 85.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.794 -1.191 . . . . 0.0 108.95 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.2 mt -74.38 -46.25 41.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 0.0 108.364 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.46 -38.54 87.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 8.5 m-80 -78.53 -23.89 46.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.569 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 81' ' ' VAL . 92.9 p -63.99 -40.28 96.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.6 ' N ' ' HG ' ' A' ' 80' ' ' SER . 5.2 t . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.775 -0.578 . . . . 0.0 110.007 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.97 149.97 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 109.858 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -128.72 143.56 50.96 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -144.7 144.38 31.19 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -109.82 145.53 36.57 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.293 -0.879 . . . . 0.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.3 148.96 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -124.71 129.6 50.8 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.18 142.7 43.41 Favored Pre-proline 0 N--CA 1.506 2.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.65 146.8 63.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 120.485 1.209 . . . . 0.0 110.605 178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -52.31 -40.28 61.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 111.168 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.21 -42.45 99.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.699 -1.25 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' O ' ' OG ' ' A' ' 27' ' ' SER . 11.1 mp -79.8 -32.1 40.79 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.71 -1.244 . . . . 0.0 108.439 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.27 68.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.794 0.807 . . . . 0.0 109.305 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.99 -33.12 63.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 98.4 p -67.59 -27.87 67.28 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.936 -1.102 . . . . 0.0 108.948 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -85.33 -42.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.83 -37.37 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.748 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.64 -174.07 40.87 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.53 -8.31 47.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.955 -1.321 . . . . 0.0 109.831 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -145.2 20.11 1.92 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.33 -11.13 4.21 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 32' ' ' GLY . 74.1 mt-30 -36.34 -27.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.824 -0.809 . . . . 0.0 110.609 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.5 tpt180 -86.75 -35.48 19.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.818 -1.176 . . . . 0.0 109.77 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.3 mm -75.06 -26.55 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.078 . . . . 0.0 108.878 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -73.29 -48.27 35.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.164 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.52 -51.03 71.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 39' ' ' ILE . 95.9 mt -56.59 -32.98 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.044 -1.035 . . . . 0.0 109.734 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -59.51 -51.2 70.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.0 110.179 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -75.56 -38.45 59.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.32 -44.43 96.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.992 . . . . 0.0 110.194 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -86.76 -23.46 25.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.394 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.56 0.04 78.03 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.35 19.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.713 -0.875 . . . . 0.0 109.939 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -107.25 141.79 38.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 47' ' ' ILE . 96.5 mt -138.69 136.81 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.634 -1.291 . . . . 0.0 109.822 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -124.12 129.4 50.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -101.08 132.75 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.886 -1.134 . . . . 0.0 108.382 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -92.06 153.43 19.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 108.949 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.57 153.56 95.62 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 120.952 -1.093 . . . . 0.0 108.113 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 C--N 1.311 -1.407 0 CA-C-N 119.42 0.829 . . . . 0.0 111.17 179.57 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -116.28 139.78 50.01 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.12 140.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -125.1 144.22 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.785 -0.572 . . . . 0.0 110.632 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.86 46.93 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.652 -0.655 . . . . 0.0 109.352 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.48 132.62 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -0.81 . . . . 0.0 109.528 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -130.47 130.49 44.29 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.994 -1.066 . . . . 0.0 109.203 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.89 38.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.2 p -73.22 160.25 32.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.051 -1.264 . . . . 0.0 109.844 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -45.41 -48.88 13.6 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.381 0.61 . . . . 0.0 110.562 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.937 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.37 -36.66 73.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.792 -1.192 . . . . 0.0 109.356 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -72.08 -45.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 110.354 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -60.76 -42.77 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.758 -1.214 . . . . 0.0 109.422 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -62.16 -34.52 76.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.807 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.36 45.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.46 -0.775 . . . . 0.0 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.34 -48.58 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.95 -40.08 87.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 80' ' ' SER . 23.6 mt -68.02 -30.27 69.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.801 -1.187 . . . . 0.0 109.02 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.64 -45.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.973 -1.079 . . . . 0.0 108.276 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.06 -39.43 92.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.593 -0.692 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 HD21 ' N ' ' A' ' 79' ' ' ASN . 1.1 m-80 -77.97 -25.49 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 0.0 109.872 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 22.9 m -61.93 -34.37 75.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.772 -0.58 . . . . 0.0 110.122 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -123.06 150.8 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 109.335 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 m -126.91 136.41 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -139.66 145.59 38.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -110.19 145.36 37.4 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.112 -0.993 . . . . 0.0 109.925 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.11 148.52 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -122.72 129.89 52.31 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 140.6 37.91 Favored Pre-proline 0 N--CA 1.503 2.223 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.58 144.2 97.56 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.04 1.05 . . . . 0.0 110.86 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.03 -41.09 46.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.934 -1.104 . . . . 0.0 111.35 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -62.15 -45.82 91.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.651 -1.281 . . . . 0.0 111.12 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -76.88 -24.36 52.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.501 -1.374 . . . . 0.0 108.597 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.12 90.15 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.864 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -73.97 -33.68 63.96 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.388 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -68.2 -34.02 75.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.782 -1.199 . . . . 0.0 109.266 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -77.43 -44.85 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.147 -0.971 . . . . 0.0 110.991 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.22 -36.09 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.811 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.11 -171.96 39.42 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -91.74 -0.57 57.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.935 -1.333 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -153.52 19.1 0.69 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 73.48 -11.66 5.23 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 32' ' ' GLY . 4.8 pt20 -34.54 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.75 . . . . 0.0 111.19 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -82.43 -34.4 28.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.695 -1.253 . . . . 0.0 109.557 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -73.63 -25.03 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.971 -1.081 . . . . 0.0 108.815 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -72.26 -46.62 55.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.359 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -60.07 -47.29 86.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.81 -33.69 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.174 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.79 -43.58 83.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.039 -1.038 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -77.16 -32.94 56.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.095 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.38 -41.99 46.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 110.359 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 p -86.71 -23.38 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.079 -1.013 . . . . 0.0 110.53 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.17 71.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 161.06 20.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.86 -0.788 . . . . 0.0 110.161 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.4 m -108.42 138.55 44.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.9 mt -137.43 137.02 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.722 -1.237 . . . . 0.0 109.919 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -122.84 129.11 51.27 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.9 mt -100.91 132.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.855 -1.153 . . . . 0.0 108.528 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 18.5 p-10 -91.93 154.32 18.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 108.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 51' ' ' GLU . 9.7 mp0 -67.8 149.51 98.22 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 120.817 -1.177 . . . . 0.0 108.502 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 CA-C-N 119.298 0.785 . . . . 0.0 111.711 179.554 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.701 0.762 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -116.26 136.21 53.21 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 78.1 mt -109.65 147.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.162 -0.961 . . . . 0.0 110.414 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.85 143.75 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.811 -0.555 . . . . 0.0 110.334 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -117.13 123.76 47.52 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.04 132.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.295 -0.878 . . . . 0.0 109.582 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.3 m -129.71 130.73 45.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.994 -1.066 . . . . 0.0 109.102 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.13 -172.73 38.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -72.84 160.03 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.608 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.05 -46.84 22.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 110.151 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.97 -47.38 68.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -56.97 -35.79 69.55 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.903 -1.123 . . . . 0.0 109.198 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.41 -45.45 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.595 -0.691 . . . . 0.0 110.28 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.23 -42.61 98.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.893 -1.129 . . . . 0.0 109.584 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.41 -36.77 83.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.85 61.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.427 -0.796 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -59.49 -48.5 81.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.56 -35.97 75.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 80' ' ' SER . 24.2 mt -72.61 -28.85 63.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.774 -1.204 . . . . 0.0 109.095 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.7 -44.83 66.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.121 -0.987 . . . . 0.0 108.422 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.22 -38.87 90.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -0.757 . . . . 0.0 109.845 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -24.4 46.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 109.749 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.477 ' HG ' HH12 ' A' ' 35' ' ' ARG . 20.8 m -64.27 -34.4 78.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.109 -1.437 . . . . 0.0 107.377 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.74 -0.6 . . . . 0.0 109.822 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 4' ' ' ASN . 52.5 p 51.04 69.94 2.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.0 109.533 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.17 33.83 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.0 1.133 . . . . 0.0 111.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 2' ' ' SER . 9.2 m120 -154.06 69.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.333 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.3 m -164.06 103.16 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 64.1 t80 54.06 -176.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.568 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.552 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 76.17 -12.13 10.31 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER 46.83 28.0 0.77 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.631 -0.923 . . . . 0.0 109.727 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.536 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.4 mt 46.2 43.0 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.53 -32.88 0.84 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 170.67 162.75 23.54 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.17 165.97 18.06 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 118.355 1.077 . . . . 0.0 112.192 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.26 142.45 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.7 mt -123.61 149.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 m -127.81 137.24 52.32 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -139.17 145.07 38.91 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.5 145.7 38.58 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.05 147.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -120.37 129.35 53.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.73 140.01 36.4 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.25 142.13 97.17 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 120.104 1.073 . . . . 0.0 110.876 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -48.64 -41.36 30.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 111.306 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.0 111.248 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.13 -23.45 51.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.578 -1.326 . . . . 0.0 108.308 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.77 90.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.786 0.803 . . . . 0.0 109.669 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -74.13 -33.87 63.69 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.43 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -67.46 -34.79 77.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.706 -1.246 . . . . 0.0 109.25 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.4 mt -78.82 -42.66 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 110.852 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.609 ' CD1' HH11 ' A' ' 59' ' ' ARG . 64.5 mt -69.35 -37.09 74.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.394 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.93 -171.33 42.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.96 -51.43 5.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.074 -1.251 . . . . 0.0 108.809 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 13.98 64.2 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.6 -4.48 14.15 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.688 -1.478 . . . . 0.0 109.578 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.0 mt-30 -42.69 -20.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.016 -1.285 . . . . 0.0 110.096 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 18.3 tpt180 -86.29 -39.42 16.53 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.158 -0.964 . . . . 0.0 110.862 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.34 -28.0 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.584 -1.322 . . . . 0.0 109.345 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -72.87 -49.05 32.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -56.26 -53.57 55.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.864 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 39' ' ' ILE . 96.4 mt -53.19 -31.56 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -62.88 -41.24 99.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.31 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.452 ' N ' ' ND1' ' A' ' 41' ' ' HIS . 3.6 m80 -81.28 -38.93 26.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.38 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -65.28 -41.94 93.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.436 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -87.08 -23.14 25.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.05 . . . . 0.0 110.609 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 0.6 71.05 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.69 160.66 21.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.846 -0.796 . . . . 0.0 110.114 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.7 m -108.67 139.91 42.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 47' ' ' ILE . 96.2 mt -137.3 137.57 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 109.966 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -123.21 127.41 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.0 mt -99.57 134.11 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.938 -1.101 . . . . 0.0 108.775 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.06 152.91 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 0.0 108.503 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.6 149.64 98.02 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 120.935 -1.103 . . . . 0.0 108.606 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -61.01 143.33 99.27 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 120.57 0.847 . . . . 0.0 111.718 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.8 mt -82.75 119.43 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.266 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -49.83 129.91 20.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.88 29.29 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -153.43 123.74 7.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.53 50.25 1.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -140.07 154.11 46.97 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.844 0.83 . . . . 0.0 110.099 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.609 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.6 mtt180 -119.28 137.87 53.39 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.34 144.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.408 -0.807 . . . . 0.0 110.347 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.03 144.31 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.749 -0.594 . . . . 0.0 110.324 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.5 m -117.7 122.1 42.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.624 . . . . 0.0 109.333 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.3 mt -102.3 133.61 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.9 . . . . 0.0 109.394 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 m -131.39 129.52 41.42 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.002 -1.061 . . . . 0.0 109.146 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.79 -173.62 37.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 p -70.58 158.54 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.91 -1.347 . . . . 0.0 109.493 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -45.08 49.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.255 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -67.25 -48.42 67.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.036 -1.04 . . . . 0.0 109.502 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.96 -35.51 69.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 108.822 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.26 -46.33 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 110.076 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.83 -43.19 94.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.79 -1.194 . . . . 0.0 109.23 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -62.26 -32.02 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -47.32 18.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.512 -0.743 . . . . 0.0 109.541 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.86 -37.75 74.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -70.61 -34.49 72.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.668 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.31 -20.19 60.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.804 -1.185 . . . . 0.0 108.902 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.82 -46.43 21.57 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.68 -37.38 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.38 -24.66 46.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.209 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -64.24 -37.59 88.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 117.725 -1.59 . . . . 0.0 107.177 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.2 t -41.65 -49.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.892 -0.505 . . . . 0.0 109.723 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.55 ' C ' ' H ' ' A' ' 84' ' ' TYR . 49.6 mttm -48.85 -21.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.701 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' SER . 59.7 tt0 -55.84 -10.1 0.69 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.492 -1.38 . . . . 0.0 107.859 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.55 ' H ' ' C ' ' A' ' 82' ' ' LYS . 84.3 t80 -66.63 55.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.795 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . 5.6 p 63.54 8.27 3.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.98 -66.92 1.98 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' PHE . 16.2 mtpp -73.58 111.09 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.139 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 93.3 m-85 51.32 98.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.41 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -68.53 -43.64 31.45 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.259 -1.142 . . . . 0.0 110.269 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 2' ' ' SER . 3.9 Cg_exo -67.29 -167.32 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.765 0.977 . . . . 0.0 112.071 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.73 110.26 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -165.56 53.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.406 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.48 ' C ' ' H ' ' A' ' 8' ' ' ASP . 44.2 p90 -66.35 -1.68 3.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.63 -12.64 0.66 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 6' ' ' TYR . 27.0 t70 49.91 60.33 3.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.402 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.0 OUTLIER 46.35 46.13 13.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.05 -41.98 0.36 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.41 162.33 23.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -65.18 171.67 8.67 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 118.423 1.111 . . . . 0.0 112.26 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.57 141.18 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.249 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.7 mt -124.83 150.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.365 -0.834 . . . . 0.0 109.702 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -128.01 137.55 52.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.62 145.87 39.05 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -111.75 145.47 39.29 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.68 155.62 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -125.37 130.11 51.27 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.28 131.16 23.85 Favored Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.19 132.81 53.5 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 CA-C-N 120.383 1.172 . . . . 0.0 111.186 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -39.54 -41.1 0.96 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.491 -0.755 . . . . 0.0 111.666 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.43 -46.51 88.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.746 -1.221 . . . . 0.0 110.702 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.11 -20.09 57.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.53 -1.356 . . . . 0.0 108.052 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.39 85.29 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.85 0.833 . . . . 0.0 109.439 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.16 -27.9 61.06 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.8 p -73.86 -32.02 63.45 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.257 -0.902 . . . . 0.0 109.154 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.6 mt -88.98 -43.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.0 111.099 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.66 -35.2 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.882 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 -173.12 41.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -91.81 -2.03 57.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.943 -1.328 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -152.01 18.17 0.83 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.9 -9.87 10.49 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 32' ' ' GLY . 43.8 tt0 -36.24 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.707 -0.878 . . . . 0.0 111.004 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.629 HH21 HE22 ' A' ' 83' ' ' GLN . 11.8 tpp180 -88.19 -36.8 16.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.638 -1.289 . . . . 0.0 109.903 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.2 mm -73.05 -25.56 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.798 -1.189 . . . . 0.0 108.623 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -73.02 -49.95 25.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 108.837 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.53 -48.22 81.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.038 -1.039 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.62 -33.9 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.61 -54.75 43.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -70.81 -39.15 73.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.949 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -59.67 -46.04 90.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -86.5 -23.16 26.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 -0.98 85.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.46 163.13 17.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.966 . . . . 0.0 109.939 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 m -105.69 145.51 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.75 139.8 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.688 -1.257 . . . . 0.0 110.15 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.56 124.33 33.59 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.82 135.77 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 109.245 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.56 152.77 18.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.963 . . . . 0.0 108.81 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.48 153.46 94.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.002 -1.061 . . . . 0.0 108.721 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.44 157.05 56.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.874 1.049 . . . . 0.0 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.0 mt -103.11 170.68 7.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.522 -0.736 . . . . 0.0 109.146 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.3 141.61 28.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.088 -1.008 . . . . 0.0 109.45 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.26 21.74 64.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 m -163.81 94.89 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -1.155 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.2 pm0 -73.03 52.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.566 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 6.1 p30 -120.45 158.35 27.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.517 0.675 . . . . 0.0 109.27 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -119.88 138.92 53.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 60' ' ' ILE . 82.6 mt -111.96 149.83 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.037 -1.04 . . . . 0.0 111.056 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 61' ' ' ILE . 77.4 mt -135.04 143.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.769 -0.582 . . . . 0.0 110.279 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.8 m -116.95 122.71 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -100.98 132.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -130.72 129.43 42.52 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.993 -1.067 . . . . 0.0 109.323 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -171.56 38.51 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.466 ' HG1' ' NE2' ' A' ' 69' ' ' GLN . 17.7 p -73.14 160.02 32.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.971 -1.311 . . . . 0.0 109.645 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -46.49 -47.25 19.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.22 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.52 -45.31 72.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -59.03 -36.98 75.9 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.906 -1.121 . . . . 0.0 108.787 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.1 -46.01 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.79 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -59.85 -43.44 94.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -61.17 -34.96 75.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 108.843 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.23 -45.76 46.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.448 -0.782 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.33 -47.35 85.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.366 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -61.32 -41.2 96.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.089 . . . . 0.0 109.943 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.59 -18.11 64.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.823 -1.173 . . . . 0.0 109.055 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' A' ' 80' ' ' SER . 14.8 mt -83.67 -45.48 13.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 108.583 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -61.95 -38.83 89.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.688 . . . . 0.0 110.109 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -78.89 -22.53 45.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.411 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 98.8 p -63.36 -40.1 96.35 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.5 t -42.13 -52.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.325 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 84' ' ' TYR . 41.2 mttp -46.93 -21.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.889 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.629 HE22 HH21 ' A' ' 35' ' ' ARG . 50.1 tt0 -57.95 -10.72 1.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.599 -1.313 . . . . 0.0 107.555 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.508 ' H ' ' C ' ' A' ' 82' ' ' LYS . 85.4 t80 -65.81 60.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.35 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 83' ' ' GLN . 23.9 p 54.4 8.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -70.31 -55.14 9.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' PHE . 16.2 mtpp -78.14 104.86 8.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 109.326 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 87' ' ' LYS . 45.6 t80 56.39 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.46 179.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m 52.25 70.76 1.72 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.39 -166.56 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.064 1.176 . . . . 0.0 111.892 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m120 52.44 51.86 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.6 p -73.7 144.32 45.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 8' ' ' ASP . 25.1 m-85 55.42 22.25 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.74 13.41 2.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER 52.19 91.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 0.0 109.417 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.3 -23.15 57.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.343 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.57 38.31 80.43 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.55 164.89 15.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.03 156.15 64.27 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.895 1.063 . . . . 0.0 112.297 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.22 140.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -124.12 149.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.295 -0.878 . . . . 0.0 109.662 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -128.13 137.61 52.17 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.42 145.34 38.77 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.95 145.62 38.05 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.57 151.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.5 m -124.11 129.42 50.83 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.99 134.61 26.08 Favored Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.37 146.16 52.74 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.26 1.129 . . . . 0.0 110.917 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HZ1' HH22 ' A' ' 26' ' ' ARG . 18.1 ttmm -52.23 -41.87 63.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.065 -1.022 . . . . 0.0 111.451 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.8 p-10 -63.23 -46.68 85.82 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.741 -1.224 . . . . 0.0 111.15 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 -24.16 59.78 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.536 -1.353 . . . . 0.0 108.332 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.52 83.65 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.641 0.734 . . . . 0.0 109.796 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.672 HH12 ' NH2' ' A' ' 59' ' ' ARG . 5.9 mtt-85 -74.37 -31.65 62.47 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.795 -0.762 . . . . 0.0 108.96 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -70.31 -39.07 75.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 109.327 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.5 mt -74.11 -44.76 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 110.743 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.491 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.3 mt -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.968 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.11 40.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -92.12 -40.53 10.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.334 . . . . 0.0 109.496 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -108.35 14.97 36.06 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 69.12 -5.79 4.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 32' ' ' GLY . 76.0 mt-30 -43.42 -23.79 0.08 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.989 -1.301 . . . . 0.0 110.206 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.1 tpp180 -81.6 -39.65 24.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.045 -1.034 . . . . 0.0 110.675 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -26.93 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 109.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.63 -43.3 72.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 0.0 109.045 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.42 -49.5 76.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.937 -1.102 . . . . 0.0 109.959 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -52.58 -33.84 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.99 -1.069 . . . . 0.0 109.935 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -66.66 -35.99 81.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.78 -36.61 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 110.358 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -74.53 -41.62 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.178 -0.951 . . . . 0.0 110.503 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.546 ' HG ' ' H ' ' A' ' 45' ' ' ALA . 6.2 p -87.1 -23.21 24.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 110.598 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.6 2.1 68.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.961 -2.056 . . . . 0.0 107.961 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.546 ' H ' ' HG ' ' A' ' 43' ' ' SER . . . -83.98 161.39 20.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.842 -0.799 . . . . 0.0 110.148 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.0 m -109.14 140.91 42.09 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.2 mt -138.03 136.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.819 -1.175 . . . . 0.0 109.974 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -121.14 127.51 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.76 132.29 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 0.0 108.484 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 60' ' ' ILE . 1.3 p30 -93.04 153.2 18.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.955 -1.09 . . . . 0.0 108.56 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -67.33 149.0 98.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 120.91 -1.119 . . . . 0.0 108.536 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.22 142.54 98.48 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 120.423 0.749 . . . . 0.0 111.696 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 mt -82.2 132.49 35.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -57.05 129.45 41.8 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 109.475 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.32 35.06 8.22 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 58' ' ' ASP . 51.0 m -163.96 102.23 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -1.109 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 6.0 mp0 -70.21 49.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 109.35 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 56' ' ' SER . 5.5 m-20 -141.12 154.01 45.69 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.994 0.902 . . . . 0.0 110.191 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.672 ' NH2' HH12 ' A' ' 26' ' ' ARG . 50.1 mtt180 -119.38 139.45 51.97 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 75.5 mt -111.07 141.07 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.348 -0.845 . . . . 0.0 110.518 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 61' ' ' ILE . 95.6 mt -122.41 144.98 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 110.393 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -117.78 123.53 46.21 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.68 132.6 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.424 -0.797 . . . . 0.0 109.547 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -129.58 130.07 45.22 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -173.67 38.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 p -73.63 160.45 31.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.293 . . . . 0.0 109.693 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.68 -47.1 20.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.588 -0.695 . . . . 0.0 110.017 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.9 -45.75 73.54 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.74 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.51 -38.65 81.51 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.813 -1.179 . . . . 0.0 109.183 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.32 -45.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.625 -0.672 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.36 -43.41 96.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.776 -1.202 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.54 -37.39 83.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 108.822 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.23 -46.79 48.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.716 . . . . 0.0 109.661 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -60.01 -46.63 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.243 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -61.59 -33.6 74.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.54 -24.28 58.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 108.93 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.77 -44.77 47.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 0.0 108.459 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -61.97 -38.58 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.728 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.85 -23.98 44.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -62.98 -37.86 88.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 84' ' ' TYR . 19.6 t -42.46 -49.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.987 -0.445 . . . . 0.0 109.85 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 84' ' ' TYR . 2.6 mptm? -48.06 -22.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 109.468 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' SER . 55.1 tt0 -59.93 -13.67 12.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.541 -1.349 . . . . 0.0 107.401 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 82' ' ' LYS . 91.2 t80 -53.8 86.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER 69.46 10.08 7.54 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.06 160.52 29.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -55.62 143.95 28.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.375 -1.074 . . . . 0.0 108.466 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' LYS . 84.2 m-85 52.51 101.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.479 -0.763 . . . . 0.0 109.511 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.427 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.43 162.26 4.15 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 108.92 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.06 -69.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.996 1.13 . . . . 0.0 111.858 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 51.71 51.17 17.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.9 p -168.7 146.64 3.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 62.4 t80 -165.33 42.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . -65.84 4.24 2.45 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 6' ' ' TYR . 20.8 t0 58.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -1.041 . . . . 0.0 109.749 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' GLY . 31.0 mt -134.12 90.94 2.74 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.2 -18.65 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . -178.52 165.07 34.05 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.54 145.49 87.48 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 120.982 1.121 . . . . 0.0 112.064 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -74.6 140.85 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.912 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.58 148.11 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -126.95 136.94 52.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.67 144.89 37.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.49 145.21 39.45 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.06 151.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 m -124.43 129.9 51.51 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.85 140.46 37.72 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.28 146.56 88.7 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 CA-C-N 120.131 1.083 . . . . 0.0 111.107 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -53.08 -41.05 64.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.999 -1.063 . . . . 0.0 111.463 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.78 -44.82 95.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.732 -1.23 . . . . 0.0 111.355 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.37 -23.04 50.87 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.57 -1.331 . . . . 0.0 108.135 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.9 89.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.739 0.78 . . . . 0.0 109.606 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.404 HH11 ' CG ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -74.7 -30.93 61.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.26 -32.23 69.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.867 -1.146 . . . . 0.0 109.286 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -82.42 -44.04 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.48 -35.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.787 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -173.36 41.07 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.73 2.0 56.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.001 -1.293 . . . . 0.0 109.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -156.01 19.58 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.08 -11.06 3.97 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 32' ' ' GLY . 59.5 mt-30 -36.26 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.708 -0.878 . . . . 0.0 110.683 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpp180 -85.13 -35.56 21.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.804 -1.185 . . . . 0.0 109.842 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -74.37 -26.45 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.961 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.7 -48.05 49.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.992 . . . . 0.0 108.912 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -57.16 -56.47 21.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.754 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 39' ' ' ILE . 88.7 mt -49.62 -32.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -62.16 -38.94 90.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -83.2 -39.37 21.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 110.602 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.8 -43.05 89.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.058 -1.026 . . . . 0.0 110.489 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 t -87.19 -23.55 24.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.191 -0.943 . . . . 0.0 110.692 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.67 1.67 72.69 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.92 161.96 19.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.852 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.48 140.72 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 47' ' ' ILE . 91.6 mt -137.22 137.25 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.641 -1.287 . . . . 0.0 109.999 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -124.12 129.88 51.61 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.82 128.8 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.998 -1.063 . . . . 0.0 108.556 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 60' ' ' ILE . 20.5 p-10 -87.83 156.67 19.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.885 -1.134 . . . . 0.0 108.968 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.9 151.62 96.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.949 -1.095 . . . . 0.0 108.506 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.2 143.14 93.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.556 0.837 . . . . 0.0 111.858 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.7 mt -80.38 141.66 35.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.285 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -70.64 134.84 47.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.341 -0.85 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.01 -2.7 76.12 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.3 t -110.39 -178.95 3.63 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.467 -1.019 . . . . 0.0 109.661 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -144.02 31.07 1.27 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -135.11 159.81 40.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.889 0.852 . . . . 0.0 110.596 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -114.39 138.46 50.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 76.4 mt -112.3 141.06 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.24 -0.913 . . . . 0.0 110.802 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -125.6 145.87 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.716 -0.615 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.5 m -118.16 122.66 43.59 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.6 mt -103.91 132.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.925 . . . . 0.0 109.471 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -131.43 129.78 41.66 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.988 -1.07 . . . . 0.0 109.278 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.23 -172.38 38.33 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.507 ' HG1' ' CD ' ' A' ' 69' ' ' GLN . 9.8 p -72.33 159.63 33.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.269 . . . . 0.0 109.519 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.96 -46.94 21.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -68.16 -47.04 69.1 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.507 ' CD ' ' HG1' ' A' ' 66' ' ' THR . 31.0 mt-30 -56.78 -34.45 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.885 -1.135 . . . . 0.0 109.369 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.9 mt -73.67 -45.35 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.499 -0.751 . . . . 0.0 110.45 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.33 -43.83 96.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.717 -1.239 . . . . 0.0 109.6 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.23 -32.65 72.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 108.856 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.14 -45.87 25.37 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.456 -0.778 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.63 -48.08 80.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.05 -39.89 91.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.037 -1.04 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.52 -25.63 65.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 0.0 108.959 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.4 -46.24 41.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.73 -38.48 88.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.537 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 79' ' ' ASN . 1.4 m-80 -78.58 -25.06 45.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.548 ' HG ' ' N ' ' A' ' 81' ' ' VAL . 89.1 p -62.36 -37.14 84.54 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.548 ' N ' ' HG ' ' A' ' 80' ' ' SER . 34.8 t -42.06 -48.37 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.513 ' C ' ' H ' ' A' ' 84' ' ' TYR . 39.0 pttt -50.07 -21.09 1.13 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.044 -1.035 . . . . 0.0 110.25 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.51 ' C ' ' H ' ' A' ' 85' ' ' SER . 42.7 tt0 -57.68 -10.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 107.577 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 82' ' ' LYS . 76.3 t80 -69.34 42.77 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.026 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 83' ' ' GLN . 8.4 p 59.02 7.58 0.84 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.364 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -71.0 -54.98 8.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -125.23 43.07 3.14 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.581 -0.952 . . . . 0.0 108.907 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 65.5 t80 -171.67 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.531 -0.73 . . . . 0.0 109.403 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 p90 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.469 -179.83 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.65 162.2 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -1.171 . . . . 0.0 108.966 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.78 159.82 23.45 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.974 1.116 . . . . 0.0 111.915 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 1.8 m120 -55.75 135.86 51.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.2 m -155.84 -11.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ASP . 31.9 p90 -172.0 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 9' ' ' LEU . . . -67.37 68.62 0.24 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.396 -2.281 . . . . 0.0 107.396 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' TYR . 26.5 t0 -45.49 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.928 . . . . 0.0 110.26 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLY . 14.3 mt -89.02 51.99 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 108.762 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 38.86 96.3 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.27 162.18 23.18 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -63.75 166.01 16.98 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 118.289 1.045 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -82.97 141.37 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.022 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -123.84 149.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -0.875 . . . . 0.0 109.642 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 m -127.78 137.3 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -139.24 144.91 38.64 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.59 145.61 37.55 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.162 -0.962 . . . . 0.0 110.008 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.63 151.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.7 129.86 52.28 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.34 136.97 29.37 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.42 137.55 75.0 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 CA-C-N 120.114 1.076 . . . . 0.0 111.082 178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -43.79 -40.68 4.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.274 -0.891 . . . . 0.0 111.448 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -46.73 84.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.699 -1.25 . . . . 0.0 111.399 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.435 ' O ' ' OG ' ' A' ' 27' ' ' SER . 74.3 mt -76.33 -19.46 58.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.375 -1.453 . . . . 0.0 108.069 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.82 88.93 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.721 0.772 . . . . 0.0 109.367 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 5.5 mtt-85 -74.57 -26.87 60.22 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 91.6 p -74.58 -28.84 61.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 109.386 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -88.28 -45.15 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.808 -1.183 . . . . 0.0 111.21 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.23 -34.7 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.91 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.05 -173.98 43.52 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -92.09 -4.97 53.65 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.997 -1.296 . . . . 0.0 109.554 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.1 1.41 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 77.34 -8.41 32.93 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLY . 12.2 pt20 -34.02 -29.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.952 -0.734 . . . . 0.0 111.235 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 mmt180 -85.88 -40.63 15.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.419 -1.426 . . . . 0.0 109.622 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -68.86 -26.62 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.009 -1.057 . . . . 0.0 109.202 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.86 -52.78 8.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.447 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -60.87 -47.8 84.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.05 . . . . 0.0 109.489 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.33 -36.01 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -55.87 -67.15 0.32 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.406 -0.809 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.78 -39.81 86.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -58.19 -45.97 86.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 110.128 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 p -86.77 -21.96 26.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.014 -1.054 . . . . 0.0 110.089 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.85 0.07 73.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.0 160.91 20.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.729 -0.865 . . . . 0.0 110.026 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.5 t -106.93 141.86 37.47 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 47' ' ' ILE . 96.1 mt -138.02 136.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.658 -1.276 . . . . 0.0 110.139 -178.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.84 130.76 54.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.3 mt -101.01 134.16 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.644 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.28 150.48 20.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 108.598 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -66.86 149.85 98.13 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.899 -1.125 . . . . 0.0 108.437 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.98 141.6 89.83 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 119.261 0.772 . . . . 0.0 111.442 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -77.47 117.86 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.008 . . . . 0.0 109.317 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 5.6 mp0 -52.95 131.23 35.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.404 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.4 48.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.5 t -130.46 -170.4 2.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.488 -1.007 . . . . 0.0 109.295 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -144.63 33.58 1.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -138.15 157.67 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 110.706 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 26' ' ' ARG . 3.5 mtt-85 -116.87 140.53 49.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -111.93 141.63 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.288 -0.882 . . . . 0.0 110.718 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 61' ' ' ILE . 96.8 mt -125.25 144.4 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.696 -0.627 . . . . 0.0 110.47 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 m -117.57 122.3 43.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 mt -103.16 132.66 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -129.87 130.16 44.86 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.54 38.79 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.681 ' H ' HE21 ' A' ' 69' ' ' GLN . 21.1 p -73.49 160.42 31.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.29 . . . . 0.0 109.662 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -46.95 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.0 -47.02 69.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.681 HE21 ' H ' ' A' ' 66' ' ' THR . 24.8 mt-30 -58.07 -37.55 74.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.832 -1.167 . . . . 0.0 109.201 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.39 -45.8 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.621 -0.674 . . . . 0.0 110.316 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.01 -43.55 95.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.819 -1.176 . . . . 0.0 109.518 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -61.74 -33.12 73.5 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.19 -0.943 . . . . 0.0 108.75 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.12 -46.84 22.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.403 -0.811 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -58.36 -46.0 87.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -62.81 -37.06 85.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.062 . . . . 0.0 110.135 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.01 -17.71 62.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 108.971 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.34 -45.91 14.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 108.532 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.42 -38.24 88.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.621 -0.675 . . . . 0.0 110.273 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.71 -22.94 45.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 t -66.18 -36.35 82.86 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.06 -1.456 . . . . 0.0 107.369 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.4 t -48.59 -43.26 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 110.201 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.526 ' C ' ' H ' ' A' ' 84' ' ' TYR . 80.8 mttt -53.79 -22.36 9.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.284 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.474 ' NE2' ' NH1' ' A' ' 35' ' ' ARG . 53.5 mt-30 -57.91 -10.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.279 -1.513 . . . . 0.0 107.636 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' H ' ' C ' ' A' ' 82' ' ' LYS . 88.1 t80 -71.3 63.7 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m 52.37 10.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.272 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -67.86 -65.9 2.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 16.6 mtpp -81.6 29.06 0.38 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -1.142 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 72.9 m-85 -162.0 40.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.6 t80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.414 -179.716 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.409 ' H1 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.485 ' OG ' ' ND2' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -173.73 162.17 3.17 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 108.944 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.05 -36.39 96.52 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 120.928 1.085 . . . . 0.0 111.856 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.678 ' H ' HD21 ' A' ' 4' ' ' ASN . 0.8 OUTLIER -51.4 134.92 28.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.507 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -168.99 150.34 4.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.261 -0.899 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 50.98 22.0 1.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . -60.15 -10.37 15.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 7' ' ' GLY . 19.8 t0 60.48 143.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 11' ' ' GLY . 46.2 mt -96.54 -15.96 21.35 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.256 -0.903 . . . . 0.0 109.252 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.93 -10.02 3.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 161.75 167.63 22.48 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.3 141.66 76.1 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.077 1.184 . . . . 0.0 112.255 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -80.95 141.64 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 108.932 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -123.79 148.27 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.24 -0.913 . . . . 0.0 109.661 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -127.74 137.6 52.49 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.37 144.4 38.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.41 145.41 36.18 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.253 -0.904 . . . . 0.0 109.911 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.94 151.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -127.0 129.55 48.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.4 141.86 41.23 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.46 141.83 89.67 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 CA-C-N 120.287 1.138 . . . . 0.0 110.691 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -47.94 -41.15 24.16 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.897 -1.127 . . . . 0.0 111.451 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -61.75 -43.56 98.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.651 -1.281 . . . . 0.0 111.293 -178.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -78.92 -29.2 44.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.732 -1.23 . . . . 0.0 108.411 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -40.79 74.46 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.79 0.805 . . . . 0.0 109.311 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.78 -32.51 62.05 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.5 p -68.53 -25.24 64.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.959 -1.088 . . . . 0.0 109.046 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.55 -41.86 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.965 -1.085 . . . . 0.0 110.578 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.621 ' CD1' HH11 ' A' ' 59' ' ' ARG . 58.1 mt -68.12 -37.44 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.851 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.04 -173.72 39.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -91.27 -4.6 55.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.888 -1.36 . . . . 0.0 109.938 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.56 20.81 1.17 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.08 -11.4 2.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.526 ' H ' ' C ' ' A' ' 32' ' ' GLY . 88.0 mt-30 -36.53 -27.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.737 -0.861 . . . . 0.0 110.624 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.6 tpp180 -86.17 -34.33 20.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.76 -1.213 . . . . 0.0 109.889 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -75.91 -27.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 109.172 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.29 -48.91 30.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -58.21 -55.13 38.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.574 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -50.41 -32.37 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 109.672 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -62.7 -37.81 87.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.045 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.79 -39.75 19.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 0.0 110.518 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.44 -41.61 93.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.984 -1.072 . . . . 0.0 110.333 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.527 ' HG ' ' CB ' ' A' ' 45' ' ' ALA . 3.0 p -86.96 -24.24 24.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -178.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.54 1.27 70.36 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.527 ' CB ' ' HG ' ' A' ' 43' ' ' SER . . . -84.12 161.06 20.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.765 -0.844 . . . . 0.0 110.041 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.8 t -108.46 139.35 43.33 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 47' ' ' ILE . 96.3 mt -136.76 136.75 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.822 -1.174 . . . . 0.0 109.981 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -122.28 128.83 51.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -99.05 135.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.119 . . . . 0.0 108.829 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.49 148.57 22.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.082 -1.011 . . . . 0.0 108.616 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 149.26 97.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.953 -1.092 . . . . 0.0 108.797 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.28 143.0 93.38 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.391 0.818 . . . . 0.0 111.479 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.83 133.56 39.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.07 -1.019 . . . . 0.0 109.507 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.29 134.95 57.01 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.14 39.41 7.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -159.99 174.87 13.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -1.119 . . . . 0.0 109.223 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -138.02 44.01 2.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 0.0 108.966 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -140.56 154.34 46.47 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.919 0.866 . . . . 0.0 109.831 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.621 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.4 mtt180 -118.71 140.14 50.42 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -111.26 142.16 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.16 143.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.82 -0.55 . . . . 0.0 110.384 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.3 m -117.76 122.84 44.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 0.0 109.451 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.74 133.07 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 m -130.36 130.23 44.14 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.052 -1.03 . . . . 0.0 109.221 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.33 -172.71 38.49 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.471 ' HG1' ' CD ' ' A' ' 69' ' ' GLN . 15.1 p -72.65 159.55 33.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.024 -1.28 . . . . 0.0 109.725 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.94 19.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.102 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.24 -45.73 72.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.471 ' CD ' ' HG1' ' A' ' 66' ' ' THR . 78.8 mt-30 -58.84 -37.35 76.27 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.85 -1.156 . . . . 0.0 109.226 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.66 -45.6 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.774 . . . . 0.0 110.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -60.53 -43.08 97.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 0.0 109.363 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -62.64 -34.58 77.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.897 . . . . 0.0 108.657 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -46.01 31.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.76 -37.16 78.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 110.142 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.79 -35.33 72.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.589 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.85 -1.156 . . . . 0.0 108.885 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.417 ' O ' ' OG ' ' A' ' 80' ' ' SER . 16.3 mt -81.28 -45.31 16.42 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -61.81 -38.72 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.561 -0.712 . . . . 0.0 109.628 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -78.53 -24.69 45.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 83.6 p -62.14 -37.31 84.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.6 t -41.56 -50.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.893 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 84' ' ' TYR . 79.5 mttt -48.09 -22.55 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.609 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -58.44 -12.53 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.496 ' H ' ' C ' ' A' ' 82' ' ' LYS . 74.9 t80 -55.08 -59.38 4.83 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.929 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.1 p -171.57 58.66 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -135.74 -72.03 0.07 OUTLIER Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -81.87 18.3 1.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 108.571 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 86' ' ' GLY . 93.6 t80 -178.03 81.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.424 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 2' ' ' SER . 53.9 p 50.32 71.64 1.49 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -1.163 . . . . 0.0 109.546 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.64 -46.49 6.89 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.122 1.215 . . . . 0.0 111.992 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -66.4 135.61 54.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 7' ' ' GLY . 42.3 t -158.54 169.57 24.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 8' ' ' ASP . 87.8 m-85 -74.79 33.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.892 . . . . 0.0 109.606 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -70.17 49.37 0.72 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.483 ' N ' ' O ' ' A' ' 6' ' ' TYR . 7.3 p-10 -42.92 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.908 -0.76 . . . . 0.0 110.216 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.517 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.2 mt -75.36 -21.5 58.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.204 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 -40.54 0.44 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.517 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.12 165.71 28.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.84 150.13 89.12 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.972 1.114 . . . . 0.0 112.195 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -81.4 141.34 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.091 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -123.6 148.61 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.569 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 m -127.31 136.96 52.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.38 144.92 38.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.92 148.77 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.45 129.68 52.29 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.97 136.51 28.95 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.3 137.64 80.7 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 CA-C-N 120.243 1.123 . . . . 0.0 110.995 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -43.36 -40.53 3.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 111.528 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -63.02 -46.5 87.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.72 -1.237 . . . . 0.0 111.178 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.42 -20.52 57.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.58 -1.325 . . . . 0.0 108.289 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.58 89.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.702 0.763 . . . . 0.0 109.881 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 59' ' ' ARG . 3.8 mtt-85 -74.41 -32.39 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.859 -0.737 . . . . 0.0 109.265 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -69.22 -32.53 71.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.71 -1.244 . . . . 0.0 109.267 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -80.02 -44.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.025 -1.047 . . . . 0.0 110.821 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.517 ' CD1' HH11 ' A' ' 59' ' ' ARG . 54.5 mt -68.4 -36.39 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.941 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.88 -172.36 40.29 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -91.83 -24.26 19.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.992 -1.299 . . . . 0.0 109.765 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -127.41 18.26 6.09 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.12 -9.18 4.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.482 ' H ' ' C ' ' A' ' 32' ' ' GLY . 36.9 mt-30 -38.93 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.991 . . . . 0.0 110.417 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 tpp180 -83.43 -37.68 22.9 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.977 -1.077 . . . . 0.0 110.244 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.0 -27.71 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.144 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.987 . . . . 0.0 109.076 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.44 -46.43 90.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 39' ' ' ILE . 97.1 mt -57.21 -33.44 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 0.0 110.078 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -67.35 -41.44 85.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.451 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 3.1 t-80 -78.44 -34.15 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.008 . . . . 0.0 110.221 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.27 -41.64 48.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.637 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -86.49 -23.55 25.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.939 -1.101 . . . . 0.0 110.449 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 0.69 71.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.62 161.26 20.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.738 -0.86 . . . . 0.0 109.926 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -109.1 140.05 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.44 137.34 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.728 -1.232 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -121.83 129.84 52.93 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.5 135.19 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.048 -1.033 . . . . 0.0 108.84 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -95.3 150.15 20.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 108.532 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.4 mp0 -66.56 149.52 98.07 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.878 -1.138 . . . . 0.0 108.586 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -61.69 141.49 90.99 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 119.363 0.808 . . . . 0.0 111.44 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.0 mt -76.38 117.73 18.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 109.4 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 13.6 mp0 -49.35 133.8 19.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.335 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.88 28.62 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.609 ' HG ' ' H ' ' A' ' 57' ' ' GLU . 26.9 t -139.49 -175.98 4.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.462 -1.023 . . . . 0.0 109.232 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.609 ' H ' ' HG ' ' A' ' 56' ' ' SER . 11.8 mp0 -142.46 34.8 1.47 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -143.65 157.1 44.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.037 0.922 . . . . 0.0 111.033 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 26' ' ' ARG . 44.3 mtt180 -117.65 139.17 51.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -108.61 156.16 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.825 0.821 . . . . 0.0 110.541 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -138.94 142.63 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.752 -0.593 . . . . 0.0 110.07 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -116.65 123.08 46.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.695 -0.628 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.52 132.75 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.9 m -130.54 130.12 43.7 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.118 -0.989 . . . . 0.0 109.234 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.07 -173.13 39.23 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.8 p -73.49 160.23 32.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.046 -1.267 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -45.45 -48.77 13.8 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.397 0.618 . . . . 0.0 110.498 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.25 -45.43 73.24 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.946 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -58.54 -36.26 73.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 109.392 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.11 -45.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.251 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -60.62 -43.07 97.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.658 -1.276 . . . . 0.0 109.305 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.36 -36.63 82.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.59 49.42 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.517 -0.74 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.48 -45.05 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.924 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.5 mt -73.36 -16.0 61.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.867 -1.146 . . . . 0.0 108.998 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -83.36 -45.84 13.26 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.44 -38.2 88.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.78 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.3 -23.52 47.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -65.24 -35.41 80.96 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.953 -1.499 . . . . 0.0 107.392 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.0 t -42.36 -54.24 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.661 -0.649 . . . . 0.0 110.179 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 84' ' ' TYR . 5.5 mptp? -45.0 -24.61 0.24 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 110.077 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' SER . 34.5 tt0 -55.66 -13.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.409 -1.432 . . . . 0.0 107.574 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 82' ' ' LYS . 88.3 t80 -58.34 81.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER 82.68 53.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.275 0.559 . . . . 0.0 109.737 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.85 -35.24 0.49 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.549 ' C ' ' H ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -158.36 -167.49 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 108.798 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' H ' ' CD ' ' A' ' 87' ' ' LYS . 73.4 t80 -52.56 -7.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 109.673 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' H ' ' C ' ' A' ' 87' ' ' LYS . 73.9 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.376 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.6 p -168.16 71.26 0.86 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -1.216 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.51 -42.13 35.57 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.12 1.213 . . . . 0.0 112.016 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 6' ' ' TYR . 17.3 t30 -167.94 13.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 7' ' ' GLY . 8.2 m -71.37 12.54 0.32 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' C ' ' H ' ' A' ' 8' ' ' ASP . 57.2 t80 -73.68 35.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -65.31 4.28 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 6' ' ' TYR . 36.6 m-20 53.04 67.78 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -1.154 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.534 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.4 mt -82.95 44.11 0.9 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.23 -34.76 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 168.96 162.08 20.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -65.63 166.67 19.23 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.32 1.06 . . . . 0.0 112.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mm -87.19 140.46 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 109.154 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.2 mt -125.31 151.47 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.341 -0.849 . . . . 0.0 109.931 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 t -129.69 142.25 50.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.254 -0.904 . . . . 0.0 108.988 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -143.24 146.75 33.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.98 146.94 39.43 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.57 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.2 150.97 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -130.44 82.28 2.05 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.56 149.61 75.17 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -57.01 169.13 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 119.418 0.828 . . . . 0.0 110.148 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -76.08 -42.33 47.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.565 -1.335 . . . . 0.0 110.949 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.06 -39.85 95.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.748 -1.22 . . . . 0.0 111.532 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.9 mt -79.63 -27.66 40.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.779 -1.201 . . . . 0.0 108.638 179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.64 77.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.826 0.822 . . . . 0.0 109.186 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.34 -33.81 63.25 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -67.9 -29.93 69.15 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.859 -1.15 . . . . 0.0 108.97 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -83.93 -42.99 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.926 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' CD1' HH11 ' A' ' 59' ' ' ARG . 56.4 mt -67.45 -36.24 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.961 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.02 -173.83 41.67 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 31' ' ' LYS . 1.4 mptm? -91.74 -0.02 57.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.933 -1.333 . . . . 0.0 109.651 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.502 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.13 19.4 0.64 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.18 -11.52 4.9 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 32' ' ' GLY . 14.8 pt20 -34.99 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.858 -0.789 . . . . 0.0 111.011 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.3 tpp180 -84.31 -34.62 23.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.718 -1.239 . . . . 0.0 109.89 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -74.69 -26.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.935 -1.103 . . . . 0.0 108.882 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -71.57 -47.94 51.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 108.945 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -60.09 -49.57 77.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.14 -34.71 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.112 -0.992 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 110.036 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.49 -38.1 59.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.099 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.97 -43.42 98.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 110.086 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -86.86 -22.16 25.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.991 -1.068 . . . . 0.0 110.276 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 0.19 74.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.72 161.83 19.88 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.771 -0.841 . . . . 0.0 110.042 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -107.58 142.85 36.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 47' ' ' ILE . 96.6 mt -138.46 136.54 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.681 -1.262 . . . . 0.0 110.027 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -121.39 130.02 53.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.8 mt -100.47 135.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.894 -1.129 . . . . 0.0 108.808 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.29 150.39 20.33 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.17 150.46 95.5 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.905 -1.122 . . . . 0.0 108.504 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.25 142.27 97.82 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 CA-C-N 119.167 0.738 . . . . 0.0 111.523 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.68 130.81 35.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.938 . . . . 0.0 109.422 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 3.0 mp0 -63.14 133.16 53.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.15 19.03 34.57 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -153.1 142.81 21.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -1.079 . . . . 0.0 109.243 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.3 pm0 -102.87 51.64 0.8 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.503 -0.748 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -143.99 154.54 43.38 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.669 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' CD1' ' A' ' 29' ' ' ILE . 40.7 mtt180 -117.69 139.81 50.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -109.08 152.09 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.759 0.79 . . . . 0.0 110.793 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.97 142.47 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.771 -0.58 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.4 m -114.61 126.61 55.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.499 ' CD1' ' NE2' ' A' ' 74' ' ' GLN . 15.0 mt -107.36 130.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.396 -0.815 . . . . 0.0 109.397 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -128.63 131.11 48.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.17 -174.33 39.45 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 p -72.92 159.96 32.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.045 -1.268 . . . . 0.0 109.773 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.94 -47.41 21.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.4 -45.34 72.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -59.21 -36.22 75.0 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.904 -1.122 . . . . 0.0 109.235 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.1 mt -74.48 -45.28 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -43.22 96.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.708 -1.245 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.92 -31.86 71.37 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.57 -42.02 53.21 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.591 -0.693 . . . . 0.0 109.913 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.683 ' N ' HE21 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -57.79 -52.69 64.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 0.0 109.354 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.99 -38.73 70.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.96 -22.21 62.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.791 -1.193 . . . . 0.0 109.251 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' O ' ' OG ' ' A' ' 80' ' ' SER . 18.9 mt -79.44 -45.54 19.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.0 108.222 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.24 -38.48 89.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.573 -0.704 . . . . 0.0 109.846 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.62 -24.17 45.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' ' 83' ' ' GLN . 78.9 p -63.72 -37.21 86.49 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.11 -40.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.704 -0.623 . . . . 0.0 110.144 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 84' ' ' TYR . 85.3 mttt -56.89 -24.86 55.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.951 -1.093 . . . . 0.0 110.531 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.519 ' N ' ' OE1' ' A' ' 83' ' ' GLN . 9.7 mp0 -57.76 -11.24 2.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.116 -1.615 . . . . 0.0 107.363 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' A' ' 86' ' ' GLY . 85.0 t80 -68.97 55.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.032 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 83' ' ' GLN . 7.4 m 56.8 4.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -64.91 -78.6 0.2 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 6.6 ptmm? -59.55 120.11 8.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -1.15 . . . . 0.0 109.226 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 50.95 91.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.447 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m 52.45 71.54 1.43 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.201 -1.176 . . . . 0.0 109.559 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.71 102.93 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.18 1.253 . . . . 0.0 111.97 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -165.64 79.97 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 m 51.46 68.06 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 69.5 t80 -64.43 -176.89 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.586 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 69.84 0.55 26.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' GLY . 5.1 m-20 52.91 82.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.47 -1.018 . . . . 0.0 109.484 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 mt 45.58 58.1 4.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.58 27.11 17.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' GLY . . . 79.98 163.24 27.27 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -64.63 166.46 17.74 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.956 1.104 . . . . 0.0 112.227 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.96 141.9 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 109.096 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -125.08 149.85 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.3 -0.875 . . . . 0.0 109.879 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.3 t -129.08 142.1 51.0 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.011 0.91 . . . . 0.0 108.888 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -143.07 144.59 32.32 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -110.46 145.99 36.69 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.18 148.59 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -121.78 129.65 52.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 135.21 27.07 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.531 -0.731 . . . . 0.0 109.087 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.99 136.66 78.06 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.271 1.132 . . . . 0.0 111.335 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -43.16 -41.31 3.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.219 -0.925 . . . . 0.0 111.579 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -62.25 -46.19 89.96 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.74 -1.225 . . . . 0.0 111.054 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.31 -25.47 54.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.658 -1.276 . . . . 0.0 108.02 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.59 82.33 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.785 0.803 . . . . 0.0 109.321 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.84 -29.33 61.02 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -72.08 -30.25 64.93 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.062 -1.024 . . . . 0.0 109.052 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -86.97 -43.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.007 -1.058 . . . . 0.0 110.937 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.61 -35.59 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.728 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -175.35 43.13 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -91.59 -3.38 56.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -150.03 18.71 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.31 -10.43 6.21 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.489 ' H ' ' C ' ' A' ' 32' ' ' GLY . 18.7 mm100 -36.25 -27.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.787 -0.831 . . . . 0.0 110.594 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.92 -35.7 20.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.937 -1.102 . . . . 0.0 109.856 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -76.19 -28.04 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.961 -1.087 . . . . 0.0 109.269 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.57 -48.8 37.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.966 -1.084 . . . . 0.0 109.307 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -57.38 -42.68 82.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.0 110.057 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.12 -32.72 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 110.114 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -65.76 -49.47 68.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.002 . . . . 0.0 109.952 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.56 ' HD1' ' N ' ' A' ' 41' ' ' HIS . 1.7 m80 -71.4 -32.27 68.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -42.7 42.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.373 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -86.58 -23.74 25.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.68 0.81 75.29 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.74 161.38 20.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.761 -0.847 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.9 140.51 42.28 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.88 137.76 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.689 -1.257 . . . . 0.0 110.013 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -122.82 129.45 51.71 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 68.4 mt -100.36 135.42 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 108.71 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.03 151.67 18.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.023 -1.048 . . . . 0.0 109.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.95 154.44 92.31 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.067 -1.02 . . . . 0.0 108.399 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -64.69 141.99 74.93 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.477 0.785 . . . . 0.0 111.748 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.2 mt -79.92 118.94 22.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.282 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -55.77 114.64 1.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.411 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.07 -17.0 5.2 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.0 t -122.51 -170.25 2.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.435 -1.038 . . . . 0.0 109.687 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.47 37.85 1.69 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.68 157.77 36.48 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -117.72 137.55 52.61 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.61 156.0 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.887 0.851 . . . . 0.0 111.078 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.74 142.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.139 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.8 m -116.21 123.96 49.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.643 -0.661 . . . . 0.0 109.287 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.17 -0.956 . . . . 0.0 109.572 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -130.35 130.24 44.18 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.098 -1.001 . . . . 0.0 109.06 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.46 -173.25 38.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.2 p -72.42 159.59 33.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.968 -1.313 . . . . 0.0 109.618 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.1 -46.97 23.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 110.162 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.12 -47.14 68.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 109.882 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.36 -36.51 71.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.79 -1.194 . . . . 0.0 109.111 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.26 -45.82 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.48 -42.75 96.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.818 -1.177 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -62.16 -37.74 86.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.305 -0.872 . . . . 0.0 108.875 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.92 -44.09 64.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.422 -0.798 . . . . 0.0 109.601 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -58.04 -48.93 78.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.024 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.64 -39.14 83.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.84 -18.3 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.861 -1.15 . . . . 0.0 109.194 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 ' O ' ' OG ' ' A' ' 80' ' ' SER . 16.6 mt -84.23 -45.91 12.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 108.392 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.11 -38.62 89.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.665 -0.647 . . . . 0.0 110.042 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -78.99 -23.59 44.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.925 -1.109 . . . . 0.0 109.89 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 81.1 p -61.94 -36.68 82.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' A' ' 84' ' ' TYR . 7.9 t -49.92 -51.12 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.89 -0.506 . . . . 0.0 110.42 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 84' ' ' TYR . 36.2 mttm -47.85 -25.51 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.804 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.572 ' O ' ' N ' ' A' ' 85' ' ' SER . 48.5 tt0 -61.72 -10.75 9.45 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.473 -1.392 . . . . 0.0 107.694 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' VAL . 89.2 t80 -44.76 88.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.5 p 52.45 32.43 11.33 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 61.43 150.23 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.86 57.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.134 . . . . 0.0 109.038 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 86' ' ' GLY . 61.9 t80 -172.26 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' OXT' ' CD1' ' A' ' 89' ' ' PHE . 54.1 t80 . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.505 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -168.78 71.22 0.76 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.21 -1.171 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.94 101.49 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.064 1.176 . . . . 0.0 111.934 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.456 ' CG ' ' H ' ' A' ' 5' ' ' SER . 50.9 t30 -168.29 176.15 6.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 10.5 m 54.83 9.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASP . 58.7 t80 -72.23 6.86 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . -69.04 62.39 0.52 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' TYR . 5.2 m-20 -40.89 130.54 2.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.885 -0.774 . . . . 0.0 110.367 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER 53.32 29.81 9.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.237 -0.915 . . . . 0.0 108.73 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' GLY . . . 75.54 -37.72 1.2 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 176.06 164.52 30.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.83 164.12 25.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.862 1.041 . . . . 0.0 112.02 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.62 142.9 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.377 -0.827 . . . . 0.0 109.156 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.93 149.22 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.293 -0.879 . . . . 0.0 109.682 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.4 m -127.94 137.5 52.29 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.91 146.17 38.9 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -112.02 145.97 38.72 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -126.77 155.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -126.44 130.27 50.35 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.21 133.26 24.77 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.94 136.09 74.6 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 CA-C-N 120.356 1.163 . . . . 0.0 111.265 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -42.46 -41.28 2.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 111.515 -178.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.88 -46.33 88.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.651 -1.28 . . . . 0.0 111.187 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.435 ' O ' ' OG ' ' A' ' 27' ' ' SER . 10.8 mp -75.65 -19.8 58.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.491 -1.381 . . . . 0.0 108.109 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.43 85.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.34 -28.66 61.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 72.9 p -72.89 -30.71 64.16 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.121 -0.987 . . . . 0.0 109.178 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -89.06 -43.06 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 0.0 111.014 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.5 mt -69.13 -35.98 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.061 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -170.7 38.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.7 ttpp -91.76 -11.76 35.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.948 -1.325 . . . . 0.0 110.007 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -142.17 17.99 2.51 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.55 -9.64 14.76 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 5.7 tp-100 -36.07 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.707 -0.878 . . . . 0.0 111.137 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.672 HH21 ' NE2' ' A' ' 83' ' ' GLN . 12.1 tpp180 -85.95 -35.51 20.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.536 -1.352 . . . . 0.0 109.7 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -72.55 -23.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.81 -1.182 . . . . 0.0 108.414 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -73.19 -50.23 23.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -0.976 . . . . 0.0 109.004 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -57.25 -51.42 69.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.63 -33.5 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.566 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -58.8 -64.82 0.8 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -62.29 -39.3 92.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -61.14 -44.65 96.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.255 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 p -86.71 -22.93 25.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.976 -1.078 . . . . 0.0 110.433 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.71 0.55 74.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.65 19.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.803 -0.822 . . . . 0.0 110.025 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.0 t -107.23 141.57 38.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 47' ' ' ILE . 94.0 mt -137.09 138.33 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.57 -1.331 . . . . 0.0 110.265 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -124.83 129.87 51.28 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.68 136.23 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.059 . . . . 0.0 108.917 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.17 152.16 18.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -1.0 . . . . 0.0 109.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.568 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 pm0 -67.06 154.08 93.27 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 120.993 -1.067 . . . . 0.0 108.731 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.64 151.0 85.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.675 0.916 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.62 169.22 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.308 -0.87 . . . . 0.0 109.11 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.55 141.78 29.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.03 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 37.85 47.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 58' ' ' ASP . 26.0 t -174.07 90.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.164 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 11.3 mp0 -68.66 55.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' SER . 1.8 m-20 -126.39 154.46 43.56 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.96 138.35 52.23 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.418 HG22 HD11 ' A' ' 60' ' ' ILE . 82.7 mt -111.66 147.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.196 -0.94 . . . . 0.0 110.752 -178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 61' ' ' ILE . 96.6 mt -132.55 144.04 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.858 -0.526 . . . . 0.0 110.445 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.9 m -118.02 122.29 42.82 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -102.22 133.33 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -131.17 129.67 42.04 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.999 -1.063 . . . . 0.0 109.145 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.62 -172.32 38.65 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 9.9 p -72.08 159.02 34.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.01 -1.288 . . . . 0.0 109.716 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -47.19 21.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.855 -0.528 . . . . 0.0 110.342 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -68.52 -45.55 71.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.806 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' OE1' ' OG1' ' A' ' 66' ' ' THR . 35.3 mt-30 -58.24 -35.2 71.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.114 . . . . 0.0 109.32 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.9 mt -73.52 -45.59 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.467 -0.77 . . . . 0.0 110.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -60.47 -42.84 97.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.754 -1.216 . . . . 0.0 109.376 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.79 -36.18 80.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.79 57.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -58.45 -48.66 80.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 110.379 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.06 -41.84 93.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.955 -1.091 . . . . 0.0 109.932 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.56 -25.29 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.798 -1.189 . . . . 0.0 108.966 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.6 -45.55 44.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.65 -38.59 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.471 -0.768 . . . . 0.0 109.385 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -78.41 -24.24 46.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.342 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.4 p -63.22 -37.61 87.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.331 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 84' ' ' TYR . 22.9 t -41.26 -50.72 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' GLY . 2.6 mptm? -47.64 -22.39 0.5 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.424 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.672 ' NE2' HH21 ' A' ' 35' ' ' ARG . 53.4 tt0 -61.58 -14.66 32.0 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 81' ' ' VAL . 91.1 t80 -53.81 85.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.782 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.0 t 65.46 33.24 8.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 108.891 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . 87.25 163.99 39.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 4.5 mtmm -76.1 31.8 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -1.124 . . . . 0.0 108.726 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.533 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 68.6 m-85 -162.38 92.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.9 t80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.362 -179.847 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.592 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -68.09 -44.02 37.37 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 110.282 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 2' ' ' SER . 3.3 Cg_exo -66.97 -176.79 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 120.81 1.007 . . . . 0.0 112.03 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.23 85.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 76.2 p -170.3 107.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -165.47 -4.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.83 -28.51 11.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 173.01 123.99 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' GLY . 19.0 mt -68.25 49.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . -55.45 87.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 137.58 -74.3 0.41 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -45.71 117.58 1.85 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.936 1.09 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.46 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.537 -0.727 . . . . 0.0 109.26 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.7 mt -123.29 148.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 m -127.51 137.34 52.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -138.96 144.49 39.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -110.3 145.78 36.83 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.196 -0.94 . . . . 0.0 110.239 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.08 148.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -121.49 129.87 53.2 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.86 138.73 33.23 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.557 -0.715 . . . . 0.0 109.183 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -56.22 147.21 67.34 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.032 1.047 . . . . 0.0 110.992 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -54.05 -41.86 68.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.996 -1.065 . . . . 0.0 111.271 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -62.25 -42.64 99.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.749 -1.219 . . . . 0.0 111.162 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' A' ' 27' ' ' SER . 27.2 mt -79.48 -26.68 41.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.63 -1.294 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -39.11 78.01 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.859 0.838 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.7 -30.51 61.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 88.4 p -70.67 -29.22 65.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.102 -0.999 . . . . 0.0 109.352 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.7 mt -86.65 -44.25 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.022 -1.049 . . . . 0.0 111.108 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.597 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.2 mt -64.86 -34.69 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.569 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -176.62 46.16 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -92.25 0.34 57.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.038 -1.272 . . . . 0.0 109.406 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.8 15.19 0.7 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 78.11 -8.02 40.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.1 mt-30 -34.57 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.943 -0.739 . . . . 0.0 111.023 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.5 mmp_? -87.05 -43.46 12.29 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.545 -1.347 . . . . 0.0 109.469 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.92 -26.46 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.077 -1.015 . . . . 0.0 108.951 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.75 -53.58 7.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' OE1' ' NH2' ' A' ' 35' ' ' ARG . 88.3 mt-30 -59.16 -52.48 65.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -52.93 -34.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.36 -47.71 84.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.389 -0.819 . . . . 0.0 110.576 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -75.07 -40.52 60.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.008 . . . . 0.0 110.746 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.93 -43.07 99.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 110.34 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -87.8 -22.92 24.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 110.632 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.73 0.6 74.86 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 160.74 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.768 -0.842 . . . . 0.0 110.194 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 t -108.09 142.8 37.72 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 47' ' ' ILE . 96.2 mt -138.51 136.88 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 110.301 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -122.06 128.54 51.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.1 mt -99.56 135.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 109.162 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -95.85 150.3 20.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.113 -0.992 . . . . 0.0 108.503 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.62 150.59 97.32 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.837 -1.164 . . . . 0.0 108.617 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.79 143.18 91.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 CA-C-N 119.133 0.726 . . . . 0.0 111.486 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.6 mt -77.39 119.93 21.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.048 -1.032 . . . . 0.0 109.368 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 55' ' ' GLY . 3.2 tm-20 -49.26 137.95 13.36 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.417 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 54' ' ' GLU . . . 86.98 33.82 11.73 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.0 t -155.62 -176.24 5.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -142.92 40.51 1.52 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.403 -0.811 . . . . 0.0 108.962 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.73 154.49 47.45 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.92 0.867 . . . . 0.0 110.102 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.597 HH11 ' CD1' ' A' ' 29' ' ' ILE . 46.9 mtt180 -119.74 138.87 53.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -108.07 155.58 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.441 -0.787 . . . . 0.0 110.607 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -138.54 141.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.762 -0.586 . . . . 0.0 110.021 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -115.76 122.99 47.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -102.32 133.48 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -130.57 129.68 43.09 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.086 -1.009 . . . . 0.0 109.152 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.61 -174.1 38.94 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -72.39 159.66 33.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.954 -1.321 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.6 19.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.245 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -68.3 -45.96 71.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.274 -0.892 . . . . 0.0 109.946 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -58.35 -36.03 72.82 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.862 -1.149 . . . . 0.0 109.359 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.1 mt -71.91 -45.95 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.2 -43.59 95.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.768 -1.207 . . . . 0.0 109.663 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -60.98 -39.63 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.152 -0.968 . . . . 0.0 108.689 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.53 64.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.507 -0.746 . . . . 0.0 109.398 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.16 -49.86 74.63 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.494 -0.754 . . . . 0.0 110.319 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.53 -37.72 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.027 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.31 -19.78 63.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.791 -1.193 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.7 mt -81.05 -46.24 15.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 108.624 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.45 -39.53 93.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.747 -0.595 . . . . 0.0 110.715 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -78.33 -22.34 48.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -65.25 -34.71 79.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.111 -1.436 . . . . 0.0 107.316 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.17 -40.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -0.818 . . . . 0.0 110.858 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -56.83 -32.0 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.999 -1.063 . . . . 0.0 111.018 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.02 -21.16 11.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.37 -1.456 . . . . 0.0 108.014 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -100.48 84.93 2.85 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.448 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 85' ' ' SER . 24.9 p 56.91 77.24 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.548 -0.72 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.511 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -152.57 -70.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 12.9 mtpp -81.88 20.71 0.93 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 96.9 m-85 -161.73 -122.15 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.287 179.481 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 53.3 p 50.48 71.17 1.63 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.231 -1.158 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.44 140.26 52.0 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.095 1.197 . . . . 0.0 111.917 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 1.0 OUTLIER -55.38 131.2 45.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -95.15 58.79 2.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.209 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 75.9 t80 -170.28 3.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.31 -41.03 39.08 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 14.6 t70 -176.34 177.98 1.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.522 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 4.0 mm? -93.78 66.14 3.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 108.414 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.49 45.8 22.92 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.58 165.87 25.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.52 163.56 23.62 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.857 1.038 . . . . 0.0 112.265 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -80.3 144.8 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.067 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -123.44 150.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.308 -0.87 . . . . 0.0 109.368 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.19 138.05 53.61 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.47 144.17 37.88 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -110.87 146.32 36.71 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.27 152.77 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -126.4 129.6 49.09 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 140.15 36.43 Favored Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.76 150.76 68.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 CA-C-N 120.019 1.042 . . . . 0.0 110.665 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -56.48 -40.85 75.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.87 -1.143 . . . . 0.0 111.2 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.18 -45.4 91.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 111.552 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.88 -26.2 53.93 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.36 -1.462 . . . . 0.0 108.466 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.06 80.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.812 0.815 . . . . 0.0 109.514 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.45 -30.82 62.03 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.79 -34.3 71.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.081 -1.012 . . . . 0.0 109.147 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -82.11 -44.37 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 111.09 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.551 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.4 mt -67.1 -35.38 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.918 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.09 -175.67 41.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -91.23 -9.58 44.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.022 -1.281 . . . . 0.0 109.967 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -144.17 20.03 2.11 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 71.39 -11.6 2.95 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.522 ' H ' ' C ' ' A' ' 32' ' ' GLY . 5.7 pt20 -35.54 -36.12 0.07 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.77 -0.841 . . . . 0.0 110.656 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -76.71 -33.35 58.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.949 -1.094 . . . . 0.0 110.213 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -77.01 -26.36 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.62 -1.3 . . . . 0.0 109.334 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.63 -46.22 66.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 109.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -59.99 -49.9 75.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.677 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.05 -33.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -61.23 -64.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.243 -0.91 . . . . 0.0 110.047 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -64.08 -38.81 92.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 110.231 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.37 -42.15 98.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.238 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 28.0 p -87.01 -22.49 25.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.931 -1.106 . . . . 0.0 110.383 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.08 0.25 69.54 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.82 160.87 21.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.857 -0.79 . . . . 0.0 110.116 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.55 139.79 41.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 47' ' ' ILE . 96.5 mt -137.44 137.22 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.669 -1.269 . . . . 0.0 109.935 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -122.83 126.87 48.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.98 135.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.873 -1.142 . . . . 0.0 108.528 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.42 148.18 23.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.151 -0.968 . . . . 0.0 108.593 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.19 149.17 97.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.899 -1.126 . . . . 0.0 108.761 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -61.54 141.81 92.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 CA-C-N 119.344 0.802 . . . . 0.0 111.581 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.5 mt -76.09 122.65 24.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -50.41 140.06 14.3 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.208 -0.932 . . . . 0.0 109.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.63 32.22 19.4 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -157.99 173.29 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -1.148 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -133.88 42.18 2.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.455 -0.778 . . . . 0.0 109.194 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.38 154.59 49.97 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.801 0.81 . . . . 0.0 109.775 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.551 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.7 mtt180 -119.19 138.97 52.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 60' ' ' ILE . 84.2 mt -110.12 147.95 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.35 -0.844 . . . . 0.0 110.645 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 61' ' ' ILE . 90.2 mt -130.57 143.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.758 -0.589 . . . . 0.0 110.311 -179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.3 m -116.51 122.68 45.41 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.58 133.1 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 m -130.98 129.41 42.08 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.018 -1.051 . . . . 0.0 109.169 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.83 -173.94 39.94 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 159.41 34.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.12 -1.224 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -47.06 -47.04 22.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.717 -0.614 . . . . 0.0 110.451 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -68.5 -44.57 74.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.787 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 43' ' ' SER . 24.1 mm100 -59.54 -36.68 76.62 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.916 -1.115 . . . . 0.0 109.284 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -71.19 -45.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.124 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -60.36 -43.12 96.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.804 -1.185 . . . . 0.0 109.334 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.5 -37.15 84.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 108.628 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -46.64 48.94 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.525 -0.734 . . . . 0.0 109.491 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.54 -41.34 89.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -66.91 -36.39 82.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.15 -13.95 61.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 108.943 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.59 -45.16 12.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.971 . . . . 0.0 108.454 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.02 -38.45 88.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -79.14 -24.16 43.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 109.467 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.9 p -63.78 -38.58 91.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 22.1 t -40.19 -46.44 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.497 ' C ' ' H ' ' A' ' 84' ' ' TYR . 16.5 pttm -50.56 -19.49 0.91 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.876 -1.14 . . . . 0.0 109.903 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.45 ' C ' ' H ' ' A' ' 85' ' ' SER . 52.1 tp60 -56.88 -12.38 1.93 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 79.9 t80 -71.16 45.34 0.09 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.977 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 83' ' ' GLN . 4.0 m 57.31 6.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.318 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.496 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -66.45 -45.67 83.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -133.67 44.05 2.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 108.876 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 81.2 t80 -173.3 58.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 109.248 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.449 -179.78 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.7 m -166.04 71.38 1.22 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.257 -1.143 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -61.28 129.44 28.38 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.094 1.196 . . . . 0.0 111.964 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -170.82 147.11 2.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.078 -1.014 . . . . 0.0 109.523 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 7' ' ' GLY . 78.2 p -171.03 70.49 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -73.04 11.07 0.76 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 109.669 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -49.72 -46.67 38.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER 169.73 15.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' GLY . 17.5 mt 43.6 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.834 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLY . . . -57.19 82.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 56.79 164.62 0.05 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.58 160.77 46.52 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 120.921 1.081 . . . . 0.0 112.017 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.59 140.92 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.069 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.11 149.53 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -125.83 137.78 53.79 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.48 144.75 38.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -111.31 146.79 36.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -125.59 154.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 130.05 49.51 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.32 138.42 32.75 Favored Pre-proline 0 N--CA 1.506 2.338 0 O-C-N 121.514 -0.741 . . . . 0.0 109.23 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.88 175.05 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.114 1.076 . . . . 0.0 110.828 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.37 -39.27 39.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.584 -1.322 . . . . 0.0 110.534 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -63.41 -39.75 95.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -0.889 . . . . 0.0 111.457 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.423 ' O ' ' OG ' ' A' ' 27' ' ' SER . 11.2 mp -81.01 -28.66 35.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.439 -1.413 . . . . 0.0 108.311 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.039 0.923 . . . . 0.0 109.171 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -71.51 -30.87 66.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 94.0 p -72.28 -31.18 65.51 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.072 -1.017 . . . . 0.0 109.223 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -86.74 -44.27 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.146 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -67.21 -35.44 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.83 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.96 -173.61 41.56 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -91.67 0.55 57.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.046 -1.267 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.6 18.59 0.59 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.63 -10.35 6.95 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 32' ' ' GLY . 40.7 mt-30 -35.58 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.797 -0.825 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 tpt180 -85.68 -35.27 20.99 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.641 -1.287 . . . . 0.0 110.069 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -74.33 -27.38 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 109.019 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.62 -47.79 44.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.31 -46.49 88.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.039 -1.038 . . . . 0.0 110.031 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.92 -33.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -66.67 -40.18 88.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.015 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 18.5 t-80 -77.51 -30.42 52.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 110.248 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 42' ' ' GLU . 2.2 tm-20 -79.12 -41.58 28.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -86.59 -23.68 25.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 110.48 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.52 0.6 73.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.46 161.15 20.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.681 -0.894 . . . . 0.0 110.053 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.6 m -108.79 140.07 42.73 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.76 137.5 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.775 -1.203 . . . . 0.0 110.024 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -122.3 129.26 52.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -99.68 135.15 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.884 -1.135 . . . . 0.0 108.676 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 10.0 m-20 -95.83 150.18 20.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.158 -0.964 . . . . 0.0 108.626 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -66.4 151.12 96.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.916 -1.115 . . . . 0.0 108.609 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.01 142.18 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 120.451 0.767 . . . . 0.0 111.705 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.0 mt -79.71 137.37 37.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.41 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.32 134.51 50.42 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.3 -0.875 . . . . 0.0 109.695 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.24 -6.6 63.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.4 t -110.03 -169.15 1.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.367 -1.078 . . . . 0.0 109.58 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.58 38.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.68 162.79 34.55 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.794 0.807 . . . . 0.0 110.8 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -116.66 138.74 51.22 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 60' ' ' ILE . 82.4 mt -112.4 147.24 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.193 -0.942 . . . . 0.0 110.962 -178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 61' ' ' ILE . 90.1 mt -132.22 143.26 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.836 -0.54 . . . . 0.0 110.218 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 m -116.43 124.36 49.81 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.0 mt -103.92 132.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -131.03 130.06 42.81 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.038 -1.039 . . . . 0.0 109.104 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.1 -173.27 38.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -72.12 159.27 34.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -47.46 -46.55 26.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.673 -0.642 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.08 -47.1 69.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 109.862 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 14.3 mp0 -57.91 -36.73 72.85 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.866 -1.146 . . . . 0.0 109.082 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.82 -45.79 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.511 -0.743 . . . . 0.0 110.019 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.66 -42.98 98.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.75 -1.219 . . . . 0.0 109.55 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.44 -38.37 89.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 108.817 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.1 -45.66 59.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.399 -0.813 . . . . 0.0 109.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.91 -41.24 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.134 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.84 -37.31 84.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 109.777 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -70.82 -26.69 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.799 -1.188 . . . . 0.0 108.836 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.78 -45.19 62.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -62.18 -38.89 90.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.39 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.38 -26.08 46.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.605 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 p -62.46 -36.66 83.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.177 -1.409 . . . . 0.0 107.244 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.1 t -40.87 -44.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.077 0.465 . . . . 0.0 109.821 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' TYR . 39.3 pttt -52.54 -21.12 3.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.462 ' C ' ' H ' ' A' ' 85' ' ' SER . 57.1 tt0 -58.62 -9.28 1.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.579 -1.325 . . . . 0.0 107.628 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' LYS . 68.0 t80 -67.29 47.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.998 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 83' ' ' GLN . 11.4 p 57.3 6.59 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.325 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -72.97 -71.42 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -107.28 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.45 -1.03 . . . . 0.0 109.136 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 67.5 t80 -172.17 45.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.512 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m -165.37 71.77 1.37 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.258 -1.143 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' ASN . 3.4 Cg_exo -65.67 -176.06 0.52 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.102 1.201 . . . . 0.0 111.985 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' SER . 8.5 m120 54.21 101.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.647 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' ASN . 8.3 t 55.82 105.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.632 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -59.9 150.55 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.904 . . . . 0.0 109.11 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.45 2.5 80.07 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLY . 3.2 p30 40.93 -159.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 122.227 -0.572 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.97 68.1 1.68 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.873 . . . . 0.0 109.136 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.83 44.24 61.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.44 161.99 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.39 141.95 63.92 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 118.475 1.138 . . . . 0.0 112.072 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.27 139.49 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 108.862 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.64 149.46 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.352 -0.843 . . . . 0.0 109.792 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -127.1 137.66 53.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.8 145.34 38.06 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -110.95 144.74 39.55 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 109.938 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.88 149.04 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -122.24 129.62 52.41 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.92 138.99 33.79 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -56.87 146.12 80.58 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 CA-C-N 120.209 1.11 . . . . 0.0 110.918 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -52.7 -40.95 63.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.904 -1.122 . . . . 0.0 111.344 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -62.31 -44.25 96.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.807 -1.183 . . . . 0.0 111.231 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 27' ' ' SER . 32.6 mt -78.52 -26.73 45.87 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.622 -1.299 . . . . 0.0 108.209 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.45 79.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.83 0.824 . . . . 0.0 109.319 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -74.55 -30.09 61.61 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 96.8 p -71.12 -26.96 63.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.075 -1.016 . . . . 0.0 109.299 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -89.01 -43.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 110.999 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.596 ' CD1' HH11 ' A' ' 59' ' ' ARG . 52.4 mt -68.28 -36.01 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.707 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -172.72 40.37 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -91.65 -9.65 43.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 109.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -143.84 18.36 2.18 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.91 -10.44 9.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 32' ' ' GLY . 19.7 mm100 -35.61 -29.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.866 -0.785 . . . . 0.0 110.803 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.0 tpp180 -84.32 -37.15 21.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.643 -1.286 . . . . 0.0 109.743 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -72.3 -23.39 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.802 -1.186 . . . . 0.0 108.532 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -71.72 -48.14 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 108.939 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -59.11 -47.72 84.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.53 -33.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.504 HH11 ' CG ' ' A' ' 40' ' ' ARG . 1.5 ttt-85 -57.88 -53.47 57.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.244 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.58 -39.57 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 0.0 110.357 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -59.07 -44.99 91.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.108 -0.995 . . . . 0.0 110.114 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t -86.93 -22.56 25.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 110.188 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.11 -0.16 80.41 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.03 162.82 18.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.707 -0.878 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.5 m -104.85 148.1 27.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -133.05 138.8 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.652 -1.28 . . . . 0.0 109.948 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.53 123.63 31.91 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.15 135.06 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 108.961 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.21 152.06 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.115 -0.991 . . . . 0.0 108.836 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 3.2 mp0 -70.7 150.2 95.34 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 120.933 -1.105 . . . . 0.0 108.396 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.49 139.62 65.39 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 CA-C-N 119.442 0.837 . . . . 0.0 111.59 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 56' ' ' SER . 15.3 mt -70.96 178.67 3.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.054 -1.029 . . . . 0.0 108.755 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.511 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 11.6 mp0 -58.17 129.53 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.9 62.69 5.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 58' ' ' ASP . 4.6 m -121.73 100.84 7.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.531 -0.982 . . . . 0.0 109.523 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -77.88 26.98 0.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 108.7 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 56' ' ' SER . 3.7 m-20 -142.27 155.06 45.2 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.135 0.969 . . . . 0.0 110.287 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.596 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.5 mtt180 -118.44 138.83 52.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 60' ' ' ILE . 83.7 mt -108.3 151.97 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.376 -0.828 . . . . 0.0 110.256 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -135.56 142.45 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.665 . . . . 0.0 110.123 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -116.48 121.12 40.89 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.717 -0.614 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.73 132.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.261 -0.899 . . . . 0.0 109.285 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -129.37 130.14 45.66 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.024 -1.047 . . . . 0.0 108.969 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.75 -172.34 38.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 p -73.26 160.0 32.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.001 -1.293 . . . . 0.0 109.619 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.14 -46.51 23.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.49 -45.22 72.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.254 -0.903 . . . . 0.0 109.857 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -59.16 -36.42 75.25 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.275 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 92.4 mt -72.33 -45.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.54 -0.725 . . . . 0.0 110.368 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.57 -42.95 97.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.753 -1.217 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.32 -31.63 71.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 109.005 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -43.14 36.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.502 -0.749 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.75 -48.23 75.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.177 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.21 -43.86 98.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -64.14 -24.58 67.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.905 -1.122 . . . . 0.0 109.084 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.407 ' O ' ' OG ' ' A' ' 80' ' ' SER . 20.3 mt -76.87 -46.77 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 108.316 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.06 -38.57 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.55 -0.719 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.07 -25.45 47.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 109.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 77' ' ' LEU . 77.9 p -62.79 -38.04 89.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.481 -1.387 . . . . 0.0 107.296 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.86 -50.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.028 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -48.17 -21.92 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.661 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -60.74 -24.69 65.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.669 -1.269 . . . . 0.0 107.737 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.46 ' CD2' ' OG ' ' A' ' 85' ' ' SER . 85.6 t80 -48.42 -36.04 13.99 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.857 0.836 . . . . 0.0 108.815 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.8 m -168.53 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.25 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 85' ' ' SER . 9.5 mttp -59.01 99.93 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 53.1 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.886 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.531 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.31 161.85 60.68 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.158 -1.201 . . . . 0.0 109.026 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.7 148.18 83.95 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.005 1.137 . . . . 0.0 111.904 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -171.17 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.0 p -169.96 146.22 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' C ' ' H ' ' A' ' 8' ' ' ASP . 53.5 p90 -164.33 149.29 10.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . 74.97 -0.33 58.5 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.256 -2.338 . . . . 0.0 107.256 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 10' ' ' GLY . 36.5 t70 55.13 167.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 122.055 -0.673 . . . . 0.0 109.638 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 mt 47.76 12.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.695 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 47.1 64.07 2.94 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.04 170.48 0.1 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -59.61 135.42 64.17 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.156 1.237 . . . . 0.0 112.369 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -82.83 144.42 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.38 148.54 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.286 -0.884 . . . . 0.0 109.53 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -126.7 137.75 53.31 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.45 144.48 38.05 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.13 146.6 36.54 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.178 -0.951 . . . . 0.0 110.302 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.39 150.79 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -124.86 130.08 51.67 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.68 138.0 31.6 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 22' ' ' LYS . 2.5 Cg_endo -57.91 134.69 64.11 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 CA-C-N 120.158 1.092 . . . . 0.0 110.384 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 21' ' ' PRO . 28.7 ttmt -39.07 -40.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.454 -0.779 . . . . 0.0 111.112 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.89 -40.2 96.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.985 -1.072 . . . . 0.0 110.868 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -77.59 -26.74 50.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.661 -1.274 . . . . 0.0 108.696 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.32 79.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.774 0.797 . . . . 0.0 109.479 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -76.59 -29.11 56.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.4 p -73.59 -24.77 60.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.862 -1.149 . . . . 0.0 109.05 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -95.47 -42.6 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.961 -1.087 . . . . 0.0 110.609 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.25 -35.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.84 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.25 -172.04 39.28 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -91.57 -14.16 30.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.294 . . . . 0.0 109.957 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -139.04 18.51 3.13 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.96 -10.21 7.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.729 -1.748 . . . . 0.0 108.729 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 32' ' ' GLY . 70.2 mt-30 -36.03 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.777 -0.837 . . . . 0.0 110.673 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.531 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.53 -36.06 20.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.764 -1.21 . . . . 0.0 109.961 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -73.46 -24.48 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -73.04 -47.8 41.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.078 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.11 -50.24 74.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.048 -1.032 . . . . 0.0 109.867 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.4 -31.79 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.79 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -61.1 -65.12 0.74 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.43 ' H ' ' HD1' ' A' ' 41' ' ' HIS . 22.3 m80 -64.9 -36.73 85.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.326 -179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.33 -42.95 92.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.056 -1.028 . . . . 0.0 110.199 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -86.99 -22.94 25.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.354 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.99 0.83 70.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.49 161.44 20.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -108.82 138.11 45.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 47' ' ' ILE . 96.2 mt -136.38 137.88 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.816 -1.178 . . . . 0.0 109.891 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -123.09 128.28 49.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.8 mt -99.85 135.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 108.541 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.57 151.59 19.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.037 -1.039 . . . . 0.0 108.939 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.02 155.38 87.25 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.342 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.95 143.02 77.77 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 120.624 0.883 . . . . 0.0 111.933 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.3 mt -83.14 119.88 25.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.48 128.67 20.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.62 20.58 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -158.04 128.06 6.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -1.109 . . . . 0.0 109.386 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -92.55 48.08 1.35 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -131.82 154.31 49.26 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.59 0.709 . . . . 0.0 109.655 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 -119.41 137.37 53.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.17 153.79 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.3 -0.875 . . . . 0.0 111.052 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.92 141.93 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.765 -0.585 . . . . 0.0 110.184 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -115.91 123.96 49.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.636 -0.665 . . . . 0.0 109.341 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -104.07 132.19 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.74 46.49 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.114 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.54 38.63 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.447 ' H ' ' HG1' ' A' ' 66' ' ' THR . 7.4 p -74.72 161.69 29.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.995 -1.297 . . . . 0.0 109.532 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.8 -47.48 30.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -0.754 . . . . 0.0 110.449 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.85 -49.44 62.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.07 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.66 -36.68 69.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.854 -1.154 . . . . 0.0 109.212 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.8 mt -70.46 -45.54 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -60.7 -42.87 98.04 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.694 -1.254 . . . . 0.0 109.445 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.37 -37.94 87.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.276 -0.89 . . . . 0.0 108.784 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 -45.1 62.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.438 -0.789 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.83 -49.06 79.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.913 . . . . 0.0 109.966 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -59.39 -41.11 88.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.803 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.424 ' O ' ' OG ' ' A' ' 80' ' ' SER . 25.7 mt -67.01 -25.9 66.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 108.947 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.01 -44.37 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.883 -1.135 . . . . 0.0 108.34 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -62.0 -38.89 90.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.581 -0.7 . . . . 0.0 109.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -78.57 -23.82 45.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.874 -1.141 . . . . 0.0 109.618 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.487 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 25.5 m -63.69 -36.46 83.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.252 -1.53 . . . . 0.0 107.013 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -41.18 -44.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.791 -0.568 . . . . 0.0 109.872 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 84' ' ' TYR . 14.3 mptt -55.74 -21.92 21.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.995 -1.065 . . . . 0.0 110.12 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -57.22 -11.72 1.89 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.304 -1.497 . . . . 0.0 107.51 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.508 ' H ' ' C ' ' A' ' 82' ' ' LYS . 80.5 t80 -58.15 -31.83 67.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.4 p -175.71 -144.37 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 57.2 -82.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 85' ' ' SER . 15.2 mtpp -63.66 76.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -1.146 . . . . 0.0 108.36 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' GLY . 5.7 t80 71.18 107.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.438 -179.584 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 174.79 -63.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.171 -1.193 . . . . 0.0 110.088 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 2' ' ' SER . 3.7 Cg_exo -48.92 168.1 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 CA-C-N 119.371 0.811 . . . . 0.0 112.145 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 2' ' ' SER . 20.7 m120 -157.26 57.05 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 p -62.5 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 8' ' ' ASP . 62.6 t80 51.96 36.71 19.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.928 . . . . 0.0 109.567 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 4.82 3.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 19.0 t70 54.4 -161.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 109.15 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 32.6 mt -123.07 83.48 2.13 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -42.38 95.11 0.01 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 74.81 163.45 10.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.61 164.71 22.84 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.053 1.168 . . . . 0.0 112.169 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.75 142.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.1 mt -125.2 150.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.314 -0.866 . . . . 0.0 109.706 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 t -127.48 148.17 50.31 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -148.44 142.04 25.47 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -108.22 145.45 34.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.03 154.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -126.48 129.65 49.09 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.5 136.14 28.23 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.74 139.27 84.6 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 CA-C-N 120.16 1.093 . . . . 0.0 111.1 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -44.42 -40.02 5.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 0.0 111.252 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -63.24 -47.1 83.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.725 -1.235 . . . . 0.0 111.116 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.4 mt -76.86 -21.67 54.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.349 -1.469 . . . . 0.0 108.348 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.36 90.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.865 0.84 . . . . 0.0 109.443 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -75.42 -28.58 59.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.1 p -74.05 -32.73 63.43 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.191 -0.943 . . . . 0.0 108.881 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -86.84 -44.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.667 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.1 mt -69.92 -35.98 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.018 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.89 -170.14 41.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -92.26 -47.2 7.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.18 -1.188 . . . . 0.0 109.421 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.67 13.21 59.54 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 67.12 -1.64 6.09 Favored Glycine 0 N--CA 1.493 2.455 0 O-C-N 120.882 -1.364 . . . . 0.0 109.812 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.7 mt-30 -45.93 -16.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 119.316 1.558 . . . . 0.0 109.862 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -82.95 -38.82 22.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.907 -1.121 . . . . 0.0 110.864 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 tp -74.05 -18.98 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.139 -1.601 . . . . 0.0 109.155 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -73.75 -50.43 20.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.393 -0.817 . . . . 0.0 109.088 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.18 -48.54 81.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.545 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.4 mt -58.45 -34.74 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.62 -59.51 5.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -67.78 -37.59 82.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.86 -44.47 93.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -0.985 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -86.6 -23.07 25.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 110.301 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.04 0.54 76.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.28 18.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.762 -0.846 . . . . 0.0 109.876 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -108.04 141.36 39.82 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 98.3 mt -134.2 137.22 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.765 -1.209 . . . . 0.0 110.214 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -122.77 127.41 49.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.1 134.43 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.021 -1.049 . . . . 0.0 108.584 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.9 149.48 21.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.133 -0.98 . . . . 0.0 108.559 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.92 149.22 97.8 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 120.827 -1.171 . . . . 0.0 108.568 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.52 143.96 93.81 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 119.213 0.754 . . . . 0.0 111.446 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -77.67 121.61 24.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.063 -1.023 . . . . 0.0 109.225 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.74 135.04 47.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.1 14.24 54.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.6 t -129.66 -164.48 1.41 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.528 -0.984 . . . . 0.0 109.384 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -153.48 34.76 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.89 156.78 44.98 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.079 0.942 . . . . 0.0 110.641 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -117.47 140.22 49.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.59 144.21 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.381 -0.824 . . . . 0.0 110.785 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 61' ' ' ILE . 96.2 mt -127.44 143.8 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.768 -0.583 . . . . 0.0 110.342 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.4 m -117.94 120.75 38.77 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.725 -0.609 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.09 133.13 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -129.33 130.59 46.29 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.06 -1.025 . . . . 0.0 109.19 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.56 -172.61 38.67 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 p -73.71 160.77 31.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.058 -1.26 . . . . 0.0 109.522 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -46.84 -46.96 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.448 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -67.74 -45.88 73.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -59.93 -38.91 83.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.786 -1.196 . . . . 0.0 109.26 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.81 -45.61 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.733 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -60.7 -43.34 97.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.801 -1.187 . . . . 0.0 109.375 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -61.43 -40.17 93.45 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.4 -46.4 64.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.493 -0.754 . . . . 0.0 109.417 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -57.41 -52.61 64.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 109.945 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 63.7 t80 -57.31 -40.51 78.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.035 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.92 -27.67 66.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.863 -1.148 . . . . 0.0 108.975 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -74.74 -45.94 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.058 . . . . 0.0 108.433 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -61.28 -39.35 90.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.667 -0.645 . . . . 0.0 109.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 10.0 m-80 -78.38 -23.79 46.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.9 p -63.07 -34.54 77.8 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 83' ' ' GLN . 48.6 t -46.07 -54.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.595 . . . . 0.0 110.474 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.542 ' C ' ' H ' ' A' ' 84' ' ' TYR . 13.2 pttm -45.03 -21.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.06 -1.025 . . . . 0.0 111.019 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 85' ' ' SER . 54.8 tp60 -59.04 -7.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.379 -1.451 . . . . 0.0 107.929 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.542 ' H ' ' C ' ' A' ' 82' ' ' LYS . 77.5 t80 -66.14 50.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.336 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.453 ' N ' ' O ' ' A' ' 83' ' ' GLN . 26.2 p 48.97 14.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -69.4 -51.08 28.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.2 mtpp -98.7 118.72 36.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 87' ' ' LYS . 28.9 t80 57.56 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.326 -0.859 . . . . 0.0 109.324 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.471 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -168.23 71.08 0.84 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.239 -1.154 . . . . 0.0 109.627 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.47 -58.09 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.079 1.186 . . . . 0.0 112.008 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -165.56 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 86.7 t80 -69.39 -179.52 1.68 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.442 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.609 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 55.44 8.13 1.67 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' A' ' 6' ' ' TYR . 5.4 p-10 41.59 54.34 3.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.813 -0.816 . . . . 0.0 110.165 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 11' ' ' GLY . 23.0 mt -75.26 -16.57 60.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.91 -35.26 0.74 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.92 169.36 34.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.73 163.19 22.41 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.106 1.204 . . . . 0.0 112.11 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.31 143.27 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 150.49 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 109.485 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 m -126.85 136.64 52.62 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.0 144.91 39.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.8 146.16 36.88 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.256 -0.902 . . . . 0.0 110.064 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.17 153.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -124.2 129.64 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.43 136.55 28.79 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 121.466 -0.771 . . . . 0.0 109.25 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.35 139.25 85.77 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.082 1.065 . . . . 0.0 110.954 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -44.26 -40.07 4.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.184 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.39 -46.58 85.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.824 -1.172 . . . . 0.0 111.43 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 27' ' ' SER . 74.3 mt -76.84 -22.99 52.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.311 -1.493 . . . . 0.0 108.251 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.95 -38.23 85.17 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.831 0.824 . . . . 0.0 109.14 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.38 -27.25 59.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 92.9 p -74.54 -31.57 62.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.065 -1.022 . . . . 0.0 109.254 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.8 mt -83.89 -45.95 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 110.972 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.75 -34.28 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.798 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.52 -176.22 44.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -91.93 5.0 51.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 109.676 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -157.55 17.35 0.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.28 -9.49 13.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' GLY . 62.0 mt-30 -34.65 -28.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.95 -0.735 . . . . 0.0 111.015 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.4 mmt180 -86.33 -40.16 15.74 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.484 -1.385 . . . . 0.0 109.617 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.1 mm -69.85 -27.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.047 . . . . 0.0 109.295 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -77.4 -53.55 7.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.68 -48.11 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.08 -34.5 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -59.26 -74.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -53.06 -34.8 58.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.471 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.06 -44.14 80.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.419 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -86.42 -24.57 25.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 0.0 110.538 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.77 -3.92 83.96 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.06 162.64 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -1.056 . . . . 0.0 110.098 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.4 m -107.01 142.62 36.35 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 47' ' ' ILE . 96.8 mt -138.06 136.78 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.665 -1.272 . . . . 0.0 110.04 -178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -123.0 127.29 48.61 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -98.03 135.07 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.94 -1.1 . . . . 0.0 108.636 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.69 151.27 19.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.094 -1.004 . . . . 0.0 108.766 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 4.0 mp0 -67.78 149.37 98.28 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 120.996 -1.065 . . . . 0.0 108.46 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.14 141.37 88.18 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 CA-C-N 119.445 0.837 . . . . 0.0 111.431 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.2 mt -74.83 134.54 41.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.078 -1.014 . . . . 0.0 109.377 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.02 144.37 55.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.9 36.85 27.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 42.4 t -155.08 -164.94 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.482 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.404 ' N ' ' OG ' ' A' ' 56' ' ' SER . 4.7 pt-20 -155.22 35.4 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 108.846 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -137.37 155.59 49.21 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.928 0.87 . . . . 0.0 110.239 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -120.63 140.47 51.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.3 140.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.437 -0.79 . . . . 0.0 111.239 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 61' ' ' ILE . 92.8 mt -120.92 144.73 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.665 -0.647 . . . . 0.0 110.239 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.8 m -117.31 125.12 50.54 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.81 131.31 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.16 -0.963 . . . . 0.0 109.624 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -129.19 130.73 46.7 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.088 -1.008 . . . . 0.0 109.024 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.57 -174.42 38.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 p -73.24 160.22 32.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.266 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -46.72 24.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.383 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 2.5 m-20 -68.15 -46.85 69.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.925 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -58.28 -37.33 74.8 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.898 -1.126 . . . . 0.0 109.293 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.2 mt -70.84 -45.76 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.504 -0.747 . . . . 0.0 110.212 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.2 -43.18 96.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.792 -1.193 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.16 -35.24 78.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 108.757 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.37 35.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.533 -0.729 . . . . 0.0 109.55 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.15 -47.09 84.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.268 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -61.52 -35.27 77.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.013 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.36 -26.93 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.82 -1.175 . . . . 0.0 109.02 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.33 -46.03 57.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.086 -1.009 . . . . 0.0 108.317 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -61.39 -37.64 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.446 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.85 -24.15 44.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -64.07 -40.11 95.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.9 t -41.69 -47.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.933 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.505 ' C ' ' H ' ' A' ' 84' ' ' TYR . 54.8 mttm -49.71 -21.22 1.0 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.004 -1.06 . . . . 0.0 109.609 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -57.63 -11.47 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.569 -1.332 . . . . 0.0 107.481 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 82' ' ' LYS . 91.2 t80 -53.54 -58.82 5.81 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.798 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.7 p -169.84 57.72 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -133.21 -63.79 0.08 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 mtpp -80.78 17.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 108.537 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' H ' ' C ' ' A' ' 86' ' ' GLY . 24.9 t80 175.61 107.73 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.469 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t -169.38 71.47 0.69 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.136 . . . . 0.0 109.566 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.39 -49.64 1.74 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.023 1.149 . . . . 0.0 111.865 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -167.3 148.49 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 136.96 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.502 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 53.94 12.82 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.656 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.48 -50.95 34.05 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 10.2 t70 -174.82 -164.96 0.18 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.863 -0.787 . . . . 0.0 109.372 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.526 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 16.9 mt 49.95 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.29 -15.86 0.15 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 169.44 166.41 28.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.25 136.23 46.58 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.003 1.135 . . . . 0.0 112.134 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mm -75.46 141.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -123.98 148.85 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -127.55 137.34 52.58 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.04 144.01 38.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.49 144.89 37.13 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.208 -0.933 . . . . 0.0 109.942 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.13 153.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.82 129.89 50.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.0 137.39 30.03 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.485 -0.759 . . . . 0.0 108.957 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.81 144.61 93.22 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.158 1.092 . . . . 0.0 110.958 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -50.94 -41.37 58.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 111.339 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -45.38 92.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.74 -1.225 . . . . 0.0 111.42 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.78 -25.71 53.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.448 -1.407 . . . . 0.0 108.175 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.26 79.83 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.735 0.779 . . . . 0.0 109.4 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.7 -30.11 61.43 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -71.41 -33.25 69.27 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.935 -1.103 . . . . 0.0 109.243 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.15 -45.13 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 111.016 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.21 -35.06 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.877 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 -171.9 39.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -91.79 -4.26 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.329 . . . . 0.0 109.771 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.87 19.58 1.11 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.32 -10.61 6.01 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 32' ' ' GLY . 35.3 tt0 -36.57 -26.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.792 -0.828 . . . . 0.0 111.109 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.2 tpp180 -87.12 -37.48 17.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.733 -1.229 . . . . 0.0 109.777 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.41 -23.92 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.744 -1.222 . . . . 0.0 108.571 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -72.78 -49.33 31.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.63 -47.96 80.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.706 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.06 -32.81 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.04 -47.19 86.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.109 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -80.22 -39.47 29.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.112 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.39 -44.28 97.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.016 -1.053 . . . . 0.0 110.188 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -87.14 -22.33 25.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.079 -1.013 . . . . 0.0 110.217 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.18 79.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.79 162.63 18.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.772 -0.84 . . . . 0.0 109.848 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 m -105.35 146.97 28.68 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mm -132.45 138.21 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.605 -1.309 . . . . 0.0 109.955 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -126.6 124.72 40.59 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -101.66 132.98 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 108.787 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.61 150.83 19.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.006 -1.059 . . . . 0.0 108.487 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -66.21 150.15 97.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.969 -1.082 . . . . 0.0 108.455 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -60.37 141.91 96.82 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 120.38 0.72 . . . . 0.0 111.687 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -82.52 147.17 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.382 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.42 126.61 29.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.2 -0.937 . . . . 0.0 109.417 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.415 ' O ' ' OG ' ' A' ' 56' ' ' SER . . . 89.36 37.53 7.04 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 55' ' ' GLY . 68.9 m -167.08 102.21 0.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.144 . . . . 0.0 109.492 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 9.3 mp0 -73.43 50.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -136.41 154.61 50.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.96 0.886 . . . . 0.0 110.009 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.495 HH11 ' CG ' ' A' ' 59' ' ' ARG . 5.1 mtt-85 -118.05 139.52 51.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -111.54 141.89 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.314 -0.866 . . . . 0.0 110.845 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 61' ' ' ILE . 92.8 mt -124.96 143.71 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.752 -0.593 . . . . 0.0 110.484 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -118.59 118.38 31.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.718 -0.614 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -96.37 134.31 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -131.74 129.04 40.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 -171.95 37.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.435 ' H ' ' HG1' ' A' ' 66' ' ' THR . 7.8 p -71.71 159.31 34.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.049 -1.265 . . . . 0.0 109.536 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -46.26 46.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.675 . . . . 0.0 110.273 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -66.94 -46.53 74.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.08 -1.013 . . . . 0.0 109.494 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -57.99 -32.81 68.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.0 -1.062 . . . . 0.0 109.001 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.46 -45.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.503 -0.748 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -44.01 93.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.664 -1.272 . . . . 0.0 109.518 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -61.14 -34.1 74.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.072 -1.017 . . . . 0.0 108.729 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.55 -47.13 28.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.528 -0.732 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -58.44 -47.68 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 110.345 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 79' ' ' ASN . 56.9 t80 -61.14 -38.15 85.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.794 -1.191 . . . . 0.0 108.95 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.2 mt -74.38 -46.25 41.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 0.0 108.364 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.46 -38.54 87.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 8.5 m-80 -78.53 -23.89 46.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.569 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 81' ' ' VAL . 92.9 p -63.99 -40.28 96.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.6 ' N ' ' HG ' ' A' ' 80' ' ' SER . 5.2 t -44.41 -43.65 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.775 -0.578 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 84' ' ' TYR . 49.5 mttp -54.5 -23.92 18.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.01 -1.056 . . . . 0.0 110.361 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -58.87 -12.17 4.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.245 -1.535 . . . . 0.0 107.304 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 82' ' ' LYS . 85.5 t80 -54.55 -64.14 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.053 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 85' ' ' SER . 24.7 p -172.06 59.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.67 -65.88 0.07 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -86.01 23.61 1.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 108.757 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 65.9 t80 -174.52 46.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' OXT' ' CD1' ' A' ' 89' ' ' PHE . 39.4 t80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -171.53 162.63 4.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 0.0 109.045 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.81 8.28 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 120.972 1.115 . . . . 0.0 111.944 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 2' ' ' SER . 19.5 t30 -158.76 125.49 4.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.0 t -171.83 57.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 77.3 t80 -167.96 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.24 -6.4 4.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 6' ' ' TYR . 28.3 m-20 53.38 -145.45 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -1.149 . . . . 0.0 109.428 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.25 -10.56 59.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.259 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.42 59.22 10.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.65 169.16 13.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -64.0 156.0 61.2 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.124 1.216 . . . . 0.0 112.23 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.15 142.73 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.079 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.97 149.97 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 109.858 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -128.72 143.56 50.96 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -144.7 144.38 31.19 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -109.82 145.53 36.57 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.293 -0.879 . . . . 0.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.3 148.96 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -124.71 129.6 50.8 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.18 142.7 43.41 Favored Pre-proline 0 N--CA 1.506 2.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.65 146.8 63.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 120.485 1.209 . . . . 0.0 110.605 178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -52.31 -40.28 61.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 111.168 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.21 -42.45 99.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.699 -1.25 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' O ' ' OG ' ' A' ' 27' ' ' SER . 11.1 mp -79.8 -32.1 40.79 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.71 -1.244 . . . . 0.0 108.439 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.27 68.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.794 0.807 . . . . 0.0 109.305 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.99 -33.12 63.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 24' ' ' LEU . 98.4 p -67.59 -27.87 67.28 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.936 -1.102 . . . . 0.0 108.948 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -85.33 -42.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.83 -37.37 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.748 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.64 -174.07 40.87 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.53 -8.31 47.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.955 -1.321 . . . . 0.0 109.831 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -145.2 20.11 1.92 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.33 -11.13 4.21 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.518 ' H ' ' C ' ' A' ' 32' ' ' GLY . 74.1 mt-30 -36.34 -27.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.824 -0.809 . . . . 0.0 110.609 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.5 tpt180 -86.75 -35.48 19.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.818 -1.176 . . . . 0.0 109.77 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.3 mm -75.06 -26.55 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.078 . . . . 0.0 108.878 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -73.29 -48.27 35.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.164 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.52 -51.03 71.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 39' ' ' ILE . 95.9 mt -56.59 -32.98 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.044 -1.035 . . . . 0.0 109.734 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -59.51 -51.2 70.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.0 110.179 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -75.56 -38.45 59.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.32 -44.43 96.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.992 . . . . 0.0 110.194 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -86.76 -23.46 25.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.394 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.56 0.04 78.03 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.35 19.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.713 -0.875 . . . . 0.0 109.939 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -107.25 141.79 38.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 47' ' ' ILE . 96.5 mt -138.69 136.81 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.634 -1.291 . . . . 0.0 109.822 -178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -124.12 129.4 50.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -101.08 132.75 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.886 -1.134 . . . . 0.0 108.382 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -92.06 153.43 19.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 108.949 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.57 153.56 95.62 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 120.952 -1.093 . . . . 0.0 108.113 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.76 138.95 60.68 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 CA-C-N 119.42 0.829 . . . . 0.0 111.17 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.18 127.58 33.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.017 . . . . 0.0 109.52 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -46.87 141.56 3.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.384 -0.823 . . . . 0.0 109.571 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.95 22.63 63.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -150.08 177.47 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -1.035 . . . . 0.0 109.52 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -139.33 -31.92 0.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.534 -0.729 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.98 156.63 5.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.945 -1.097 . . . . 0.0 109.058 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 -116.28 139.78 50.01 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.12 140.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -125.1 144.22 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.785 -0.572 . . . . 0.0 110.632 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.86 46.93 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.652 -0.655 . . . . 0.0 109.352 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.48 132.62 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -0.81 . . . . 0.0 109.528 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -130.47 130.49 44.29 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.994 -1.066 . . . . 0.0 109.203 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.89 38.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.2 p -73.22 160.25 32.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.051 -1.264 . . . . 0.0 109.844 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -45.41 -48.88 13.6 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.381 0.61 . . . . 0.0 110.562 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.937 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.37 -36.66 73.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.792 -1.192 . . . . 0.0 109.356 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -72.08 -45.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 110.354 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -60.76 -42.77 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.758 -1.214 . . . . 0.0 109.422 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -62.16 -34.52 76.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.807 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.36 45.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.46 -0.775 . . . . 0.0 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.34 -48.58 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.95 -40.08 87.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.432 ' O ' ' OG ' ' A' ' 80' ' ' SER . 23.6 mt -68.02 -30.27 69.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.801 -1.187 . . . . 0.0 109.02 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.64 -45.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.973 -1.079 . . . . 0.0 108.276 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.06 -39.43 92.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.593 -0.692 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 HD21 ' N ' ' A' ' 79' ' ' ASN . 1.1 m-80 -77.97 -25.49 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 0.0 109.872 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 76' ' ' LEU . 22.9 m -61.93 -34.37 75.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 45.3 t -44.44 -52.82 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.772 -0.58 . . . . 0.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.519 ' C ' ' H ' ' A' ' 84' ' ' TYR . 37.6 pttt -46.38 -23.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 85' ' ' SER . 65.4 tt0 -58.32 -10.74 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.477 -1.389 . . . . 0.0 107.429 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 82' ' ' LYS . 91.3 t80 -59.64 82.67 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.738 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.1 m 67.37 40.96 2.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 61.43 149.93 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 20.3 ttpt -68.27 48.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -1.207 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 86' ' ' GLY . 87.8 m-85 -156.61 42.49 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.429 -179.766 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m -165.04 71.16 1.42 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.229 -1.159 . . . . 0.0 109.521 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 5' ' ' SER . 5.1 Cg_exo -64.43 -15.2 48.53 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.088 1.192 . . . . 0.0 112.023 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' SER . 12.9 m120 -61.67 1.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.633 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 3' ' ' PRO . 8.8 t 55.05 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 8' ' ' ASP . 90.8 t80 -61.71 -3.72 1.19 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -61.94 -0.52 2.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 6' ' ' TYR . 17.7 m-20 52.59 90.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -1.094 . . . . 0.0 109.559 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.86 -7.67 59.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.354 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 11' ' ' GLY . . . 59.51 79.08 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 57.41 164.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -64.32 160.42 39.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.065 1.176 . . . . 0.0 112.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.88 139.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -123.06 150.8 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 109.335 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 m -126.91 136.41 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -139.66 145.59 38.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -110.19 145.36 37.4 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.112 -0.993 . . . . 0.0 109.925 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.11 148.52 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -122.72 129.89 52.31 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 140.6 37.91 Favored Pre-proline 0 N--CA 1.503 2.223 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.58 144.2 97.56 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.04 1.05 . . . . 0.0 110.86 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.03 -41.09 46.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.934 -1.104 . . . . 0.0 111.35 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -62.15 -45.82 91.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.651 -1.281 . . . . 0.0 111.12 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -76.88 -24.36 52.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.501 -1.374 . . . . 0.0 108.597 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.12 90.15 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.864 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -73.97 -33.68 63.96 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.388 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -68.2 -34.02 75.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.782 -1.199 . . . . 0.0 109.266 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -77.43 -44.85 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.147 -0.971 . . . . 0.0 110.991 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.22 -36.09 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.811 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.11 -171.96 39.42 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -91.74 -0.57 57.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.935 -1.333 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.496 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -153.52 19.1 0.69 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 73.48 -11.66 5.23 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.496 ' H ' ' C ' ' A' ' 32' ' ' GLY . 4.8 pt20 -34.54 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.75 . . . . 0.0 111.19 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.547 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -82.43 -34.4 28.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.695 -1.253 . . . . 0.0 109.557 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -73.63 -25.03 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.971 -1.081 . . . . 0.0 108.815 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -72.26 -46.62 55.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.359 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -60.07 -47.29 86.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.81 -33.69 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.174 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.79 -43.58 83.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.039 -1.038 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -77.16 -32.94 56.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.095 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.38 -41.99 46.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 110.359 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 p -86.71 -23.38 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.079 -1.013 . . . . 0.0 110.53 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.17 71.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 161.06 20.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.86 -0.788 . . . . 0.0 110.161 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.4 m -108.42 138.55 44.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.9 mt -137.43 137.02 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.722 -1.237 . . . . 0.0 109.919 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -122.84 129.11 51.27 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.9 mt -100.91 132.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.855 -1.153 . . . . 0.0 108.528 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 18.5 p-10 -91.93 154.32 18.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 108.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' N ' ' CD ' ' A' ' 51' ' ' GLU . 9.7 mp0 -67.8 149.51 98.22 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 120.817 -1.177 . . . . 0.0 108.502 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.66 141.7 97.51 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 119.298 0.785 . . . . 0.0 111.711 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 55' ' ' GLY . 36.8 mt -80.54 113.87 19.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.768 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -45.92 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . 143.53 -16.39 2.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 58' ' ' ASP . 49.9 m -124.47 123.48 40.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.171 -1.193 . . . . 0.0 109.891 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.4 pm0 -79.55 44.03 0.59 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 108.877 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 56' ' ' SER . 70.3 m-20 -132.07 156.64 45.94 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.701 0.762 . . . . 0.0 109.93 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -116.26 136.21 53.21 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 78.1 mt -109.65 147.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.162 -0.961 . . . . 0.0 110.414 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.85 143.75 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.811 -0.555 . . . . 0.0 110.334 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -117.13 123.76 47.52 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.04 132.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.295 -0.878 . . . . 0.0 109.582 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.3 m -129.71 130.73 45.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.994 -1.066 . . . . 0.0 109.102 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.13 -172.73 38.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -72.84 160.03 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.608 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.05 -46.84 22.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 110.151 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.97 -47.38 68.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -56.97 -35.79 69.55 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.903 -1.123 . . . . 0.0 109.198 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.41 -45.45 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.595 -0.691 . . . . 0.0 110.28 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.23 -42.61 98.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.893 -1.129 . . . . 0.0 109.584 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.41 -36.77 83.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.85 61.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.427 -0.796 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -59.49 -48.5 81.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.56 -35.97 75.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' A' ' 80' ' ' SER . 24.2 mt -72.61 -28.85 63.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.774 -1.204 . . . . 0.0 109.095 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.7 -44.83 66.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.121 -0.987 . . . . 0.0 108.422 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.22 -38.87 90.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -0.757 . . . . 0.0 109.845 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -24.4 46.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 109.749 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.477 ' HG ' HH12 ' A' ' 35' ' ' ARG . 20.8 m -64.27 -34.4 78.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.109 -1.437 . . . . 0.0 107.377 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.7 t -42.97 -46.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.74 -0.6 . . . . 0.0 109.822 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.539 ' C ' ' H ' ' A' ' 84' ' ' TYR . 31.3 mttm -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.594 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.492 ' O ' ' N ' ' A' ' 85' ' ' SER . 34.2 tp60 -57.1 -10.33 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.471 -1.393 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.539 ' H ' ' C ' ' A' ' 82' ' ' LYS . 83.4 t80 -65.41 63.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.123 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 83' ' ' GLN . 20.6 p 55.71 5.84 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -69.14 -50.33 34.5 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 88' ' ' PHE . 15.6 mtpp -84.97 114.06 21.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.368 -1.078 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 75.7 m-85 51.11 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.518 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.2 mm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.7 mt -123.61 149.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 m -127.81 137.24 52.32 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -139.17 145.07 38.91 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.5 145.7 38.58 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.05 147.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -120.37 129.35 53.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.73 140.01 36.4 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.25 142.13 97.17 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 120.104 1.073 . . . . 0.0 110.876 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -48.64 -41.36 30.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 111.306 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.0 111.248 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.13 -23.45 51.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.578 -1.326 . . . . 0.0 108.308 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.77 90.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.786 0.803 . . . . 0.0 109.669 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -74.13 -33.87 63.69 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.43 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -67.46 -34.79 77.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.706 -1.246 . . . . 0.0 109.25 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 81' ' ' VAL . 88.4 mt -78.82 -42.66 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 110.852 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.62 ' CD1' HH11 ' A' ' 59' ' ' ARG . 64.5 mt -69.35 -37.09 74.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.394 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.93 -171.33 42.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.96 -51.43 5.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.074 -1.251 . . . . 0.0 108.809 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 13.98 64.2 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.6 -4.48 14.15 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.688 -1.478 . . . . 0.0 109.578 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.0 mt-30 -42.69 -20.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.016 -1.285 . . . . 0.0 110.096 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 18.3 tpt180 -86.29 -39.42 16.53 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.158 -0.964 . . . . 0.0 110.862 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.34 -28.0 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.584 -1.322 . . . . 0.0 109.345 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -72.87 -49.05 32.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -56.26 -53.57 55.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.864 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.19 -31.56 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -62.88 -41.24 99.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.31 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 3.6 m80 -81.28 -38.93 26.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.38 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -65.28 -41.94 93.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.436 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -87.08 -23.14 25.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.05 . . . . 0.0 110.609 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 0.6 71.05 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.69 160.66 21.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.846 -0.796 . . . . 0.0 110.114 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.7 m -108.67 139.91 42.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.3 137.57 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 109.966 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -123.21 127.41 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.0 mt -99.57 134.11 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.938 -1.101 . . . . 0.0 108.775 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.06 152.91 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 0.0 108.503 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.6 149.64 98.02 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 120.935 -1.103 . . . . 0.0 108.606 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 120.57 0.847 . . . . 0.0 111.718 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.844 0.83 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.62 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.6 mtt180 -119.28 137.87 53.39 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.34 144.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.408 -0.807 . . . . 0.0 110.347 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.03 144.31 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.749 -0.594 . . . . 0.0 110.324 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.5 m -117.7 122.1 42.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.624 . . . . 0.0 109.333 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.3 mt -102.3 133.61 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.9 . . . . 0.0 109.394 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 m -131.39 129.52 41.42 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.002 -1.061 . . . . 0.0 109.146 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.79 -173.62 37.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 p -70.58 158.54 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.91 -1.347 . . . . 0.0 109.493 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -45.08 49.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.255 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -67.25 -48.42 67.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.036 -1.04 . . . . 0.0 109.502 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.96 -35.51 69.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 108.822 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.26 -46.33 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 110.076 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.83 -43.19 94.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.79 -1.194 . . . . 0.0 109.23 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -62.26 -32.02 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -47.32 18.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.512 -0.743 . . . . 0.0 109.541 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.86 -37.75 74.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -70.61 -34.49 72.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.668 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.31 -20.19 60.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.804 -1.185 . . . . 0.0 108.902 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.82 -46.43 21.57 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -62.68 -37.38 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.38 -24.66 46.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.209 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -64.24 -37.59 88.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 117.725 -1.59 . . . . 0.0 107.177 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 28' ' ' ILE . 18.2 t . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.892 -0.505 . . . . 0.0 109.723 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.7 mt -124.83 150.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.365 -0.834 . . . . 0.0 109.702 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -128.01 137.55 52.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.62 145.87 39.05 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -111.75 145.47 39.29 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.68 155.62 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -125.37 130.11 51.27 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.28 131.16 23.85 Favored Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.19 132.81 53.5 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 CA-C-N 120.383 1.172 . . . . 0.0 111.186 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -39.54 -41.1 0.96 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.491 -0.755 . . . . 0.0 111.666 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.43 -46.51 88.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.746 -1.221 . . . . 0.0 110.702 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -76.11 -20.09 57.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.53 -1.356 . . . . 0.0 108.052 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.39 85.29 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.85 0.833 . . . . 0.0 109.439 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.16 -27.9 61.06 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.8 p -73.86 -32.02 63.45 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.257 -0.902 . . . . 0.0 109.154 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.6 mt -88.98 -43.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.0 111.099 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.66 -35.2 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.882 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 -173.12 41.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -91.81 -2.03 57.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.943 -1.328 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -152.01 18.17 0.83 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.9 -9.87 10.49 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.8 tt0 -36.24 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.707 -0.878 . . . . 0.0 111.004 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.8 tpp180 -88.19 -36.8 16.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.638 -1.289 . . . . 0.0 109.903 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.2 mm -73.05 -25.56 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.798 -1.189 . . . . 0.0 108.623 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -73.02 -49.95 25.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 108.837 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.53 -48.22 81.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.038 -1.039 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.62 -33.9 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.61 -54.75 43.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -70.81 -39.15 73.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.949 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -59.67 -46.04 90.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -86.5 -23.16 26.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 -0.98 85.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.46 163.13 17.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.966 . . . . 0.0 109.939 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 m -105.69 145.51 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.75 139.8 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.688 -1.257 . . . . 0.0 110.15 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.56 124.33 33.59 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.82 135.77 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 109.245 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.56 152.77 18.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.963 . . . . 0.0 108.81 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.48 153.46 94.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.002 -1.061 . . . . 0.0 108.721 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.495 1.574 0 C-N-CA 120.874 1.049 . . . . 0.0 112.486 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 6.1 p30 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.517 0.675 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -119.88 138.92 53.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.6 mt -111.96 149.83 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.037 -1.04 . . . . 0.0 111.056 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.4 mt -135.04 143.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.769 -0.582 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.8 m -116.95 122.71 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -100.98 132.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -130.72 129.43 42.52 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.993 -1.067 . . . . 0.0 109.323 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -171.56 38.51 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.456 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 17.7 p -73.14 160.02 32.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.971 -1.311 . . . . 0.0 109.645 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.49 -47.25 19.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.22 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.52 -45.31 72.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -59.03 -36.98 75.9 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.906 -1.121 . . . . 0.0 108.787 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.1 -46.01 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.79 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.85 -43.44 94.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -61.17 -34.96 75.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 108.843 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.23 -45.76 46.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.448 -0.782 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.33 -47.35 85.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.366 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -61.32 -41.2 96.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.089 . . . . 0.0 109.943 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.59 -18.11 64.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.823 -1.173 . . . . 0.0 109.055 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -45.48 13.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 108.583 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -61.95 -38.83 89.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.688 . . . . 0.0 110.109 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -78.89 -22.53 45.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.411 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 98.8 p -63.36 -40.1 96.35 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.592 HG13 HD23 ' A' ' 24' ' ' LEU . 19.5 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.325 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -124.12 149.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.295 -0.878 . . . . 0.0 109.662 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -128.13 137.61 52.17 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.42 145.34 38.77 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.95 145.62 38.05 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.57 151.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.5 m -124.11 129.42 50.83 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.99 134.61 26.08 Favored Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.37 146.16 52.74 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.26 1.129 . . . . 0.0 110.917 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.23 -41.87 63.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.065 -1.022 . . . . 0.0 111.451 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.8 p-10 -63.23 -46.68 85.82 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.741 -1.224 . . . . 0.0 111.15 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 -24.16 59.78 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.536 -1.353 . . . . 0.0 108.332 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.52 83.65 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.641 0.734 . . . . 0.0 109.796 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.689 HH12 ' NH2' ' A' ' 59' ' ' ARG . 5.9 mtt-85 -74.37 -31.65 62.47 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.795 -0.762 . . . . 0.0 108.96 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -70.31 -39.07 75.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 109.327 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.5 mt -74.11 -44.76 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 110.743 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.3 mt -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.968 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.11 40.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -92.12 -40.53 10.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.334 . . . . 0.0 109.496 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.35 14.97 36.06 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 69.12 -5.79 4.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -43.42 -23.79 0.08 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.989 -1.301 . . . . 0.0 110.206 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.1 tpp180 -81.6 -39.65 24.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.045 -1.034 . . . . 0.0 110.675 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -26.93 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 109.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.63 -43.3 72.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 0.0 109.045 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.42 -49.5 76.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.937 -1.102 . . . . 0.0 109.959 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -52.58 -33.84 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.99 -1.069 . . . . 0.0 109.935 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -66.66 -35.99 81.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.78 -36.61 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 110.358 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -74.53 -41.62 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.178 -0.951 . . . . 0.0 110.503 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -87.1 -23.21 24.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 110.598 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.6 2.1 68.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.961 -2.056 . . . . 0.0 107.961 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.98 161.39 20.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.842 -0.799 . . . . 0.0 110.148 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.0 m -109.14 140.91 42.09 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.2 mt -138.03 136.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.819 -1.175 . . . . 0.0 109.974 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -121.14 127.51 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.76 132.29 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 0.0 108.484 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 60' ' ' ILE . 1.3 p30 -93.04 153.2 18.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.955 -1.09 . . . . 0.0 108.56 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -67.33 149.0 98.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 120.91 -1.119 . . . . 0.0 108.536 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.49 1.265 0 C-N-CA 120.423 0.749 . . . . 0.0 111.696 179.48 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.994 0.902 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.689 ' NH2' HH12 ' A' ' 26' ' ' ARG . 50.1 mtt180 -119.38 139.45 51.97 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 75.5 mt -111.07 141.07 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.348 -0.845 . . . . 0.0 110.518 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -122.41 144.98 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 110.393 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -117.78 123.53 46.21 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.68 132.6 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.424 -0.797 . . . . 0.0 109.547 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -129.58 130.07 45.22 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -173.67 38.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 p -73.63 160.45 31.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.293 . . . . 0.0 109.693 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -47.1 20.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.588 -0.695 . . . . 0.0 110.017 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.9 -45.75 73.54 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.74 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.51 -38.65 81.51 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.813 -1.179 . . . . 0.0 109.183 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.32 -45.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.625 -0.672 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.36 -43.41 96.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.776 -1.202 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.54 -37.39 83.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 108.822 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.23 -46.79 48.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.716 . . . . 0.0 109.661 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -60.01 -46.63 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.243 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -61.59 -33.6 74.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.54 -24.28 58.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 108.93 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.77 -44.77 47.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 0.0 108.459 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -61.97 -38.58 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.728 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.85 -23.98 44.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -62.98 -37.86 88.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.987 -0.445 . . . . 0.0 109.85 -179.647 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.58 148.11 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -126.95 136.94 52.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.67 144.89 37.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.49 145.21 39.45 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.06 151.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 m -124.43 129.9 51.51 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.85 140.46 37.72 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.28 146.56 88.7 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 CA-C-N 120.131 1.083 . . . . 0.0 111.107 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -53.08 -41.05 64.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.999 -1.063 . . . . 0.0 111.463 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.78 -44.82 95.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.732 -1.23 . . . . 0.0 111.355 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.37 -23.04 50.87 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.57 -1.331 . . . . 0.0 108.135 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.9 89.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.739 0.78 . . . . 0.0 109.606 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.413 HH11 ' CG ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -74.7 -30.93 61.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.26 -32.23 69.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.867 -1.146 . . . . 0.0 109.286 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -82.42 -44.04 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.48 -35.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.787 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -173.36 41.07 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.73 2.0 56.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.001 -1.293 . . . . 0.0 109.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -156.01 19.58 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.08 -11.06 3.97 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 32' ' ' GLY . 59.5 mt-30 -36.26 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.708 -0.878 . . . . 0.0 110.683 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpp180 -85.13 -35.56 21.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.804 -1.185 . . . . 0.0 109.842 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -74.37 -26.45 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.961 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.7 -48.05 49.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.992 . . . . 0.0 108.912 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.16 -56.47 21.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.754 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.62 -32.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -62.16 -38.94 90.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -83.2 -39.37 21.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 110.602 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.8 -43.05 89.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.058 -1.026 . . . . 0.0 110.489 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 t -87.19 -23.55 24.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.191 -0.943 . . . . 0.0 110.692 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.67 1.67 72.69 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.92 161.96 19.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.852 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.48 140.72 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.6 mt -137.22 137.25 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.641 -1.287 . . . . 0.0 109.999 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -124.12 129.88 51.61 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.82 128.8 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.998 -1.063 . . . . 0.0 108.556 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 60' ' ' ILE . 20.5 p-10 -87.83 156.67 19.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.885 -1.134 . . . . 0.0 108.968 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.9 151.62 96.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.949 -1.095 . . . . 0.0 108.506 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.493 1.454 0 C-N-CA 120.556 0.837 . . . . 0.0 111.858 179.821 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.889 0.852 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -114.39 138.46 50.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 76.4 mt -112.3 141.06 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.24 -0.913 . . . . 0.0 110.802 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -125.6 145.87 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.716 -0.615 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.5 m -118.16 122.66 43.59 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.6 mt -103.91 132.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.925 . . . . 0.0 109.471 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -131.43 129.78 41.66 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.988 -1.07 . . . . 0.0 109.278 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.23 -172.38 38.33 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 p -72.33 159.63 33.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.269 . . . . 0.0 109.519 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -46.96 -46.94 21.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -68.16 -47.04 69.1 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -56.78 -34.45 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.885 -1.135 . . . . 0.0 109.369 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.9 mt -73.67 -45.35 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.499 -0.751 . . . . 0.0 110.45 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -60.33 -43.83 96.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.717 -1.239 . . . . 0.0 109.6 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.23 -32.65 72.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 108.856 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.14 -45.87 25.37 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.456 -0.778 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.63 -48.08 80.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.05 -39.89 91.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.037 -1.04 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.52 -25.63 65.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 0.0 108.959 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.4 -46.24 41.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.73 -38.48 88.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.537 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -78.58 -25.06 45.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 89.1 p -62.36 -37.14 84.54 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -123.84 149.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -0.875 . . . . 0.0 109.642 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 m -127.78 137.3 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -139.24 144.91 38.64 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -110.59 145.61 37.55 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.162 -0.962 . . . . 0.0 110.008 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.63 151.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.7 129.86 52.28 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.34 136.97 29.37 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 24' ' ' LEU . 1.1 Cg_endo -60.42 137.55 75.0 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 CA-C-N 120.114 1.076 . . . . 0.0 111.082 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -43.79 -40.68 4.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.274 -0.891 . . . . 0.0 111.448 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -46.73 84.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.699 -1.25 . . . . 0.0 111.399 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 21' ' ' PRO . 74.3 mt -76.33 -19.46 58.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.375 -1.453 . . . . 0.0 108.069 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.82 88.93 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.721 0.772 . . . . 0.0 109.367 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 5.5 mtt-85 -74.57 -26.87 60.22 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.6 p -74.58 -28.84 61.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -88.28 -45.15 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.808 -1.183 . . . . 0.0 111.21 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.23 -34.7 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.91 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.05 -173.98 43.52 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -92.09 -4.97 53.65 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.997 -1.296 . . . . 0.0 109.554 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.1 1.41 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 77.34 -8.41 32.93 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLY . 12.2 pt20 -34.02 -29.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.952 -0.734 . . . . 0.0 111.235 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 mmt180 -85.88 -40.63 15.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.419 -1.426 . . . . 0.0 109.622 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -68.86 -26.62 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.009 -1.057 . . . . 0.0 109.202 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.86 -52.78 8.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.447 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -60.87 -47.8 84.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.05 . . . . 0.0 109.489 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.33 -36.01 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -55.87 -67.15 0.32 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.406 -0.809 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.78 -39.81 86.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -58.19 -45.97 86.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 110.128 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 p -86.77 -21.96 26.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.014 -1.054 . . . . 0.0 110.089 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.85 0.07 73.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.0 160.91 20.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.729 -0.865 . . . . 0.0 110.026 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.5 t -106.93 141.86 37.47 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.02 136.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.658 -1.276 . . . . 0.0 110.139 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.84 130.76 54.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.3 mt -101.01 134.16 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.644 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.28 150.48 20.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 108.598 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -66.86 149.85 98.13 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.899 -1.125 . . . . 0.0 108.437 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.491 1.354 0 CA-C-N 119.261 0.772 . . . . 0.0 111.442 179.455 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 26' ' ' ARG . 3.5 mtt-85 -116.87 140.53 49.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -111.93 141.63 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.288 -0.882 . . . . 0.0 110.718 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.25 144.4 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.696 -0.627 . . . . 0.0 110.47 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 m -117.57 122.3 43.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 mt -103.16 132.66 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -129.87 130.16 44.86 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.54 38.79 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 p -73.49 160.42 31.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.29 . . . . 0.0 109.662 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.14 -46.95 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.0 -47.02 69.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.07 -37.55 74.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.832 -1.167 . . . . 0.0 109.201 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.39 -45.8 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.621 -0.674 . . . . 0.0 110.316 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.01 -43.55 95.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.819 -1.176 . . . . 0.0 109.518 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -61.74 -33.12 73.5 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.19 -0.943 . . . . 0.0 108.75 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.12 -46.84 22.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.403 -0.811 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -58.36 -46.0 87.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -62.81 -37.06 85.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.062 . . . . 0.0 110.135 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.01 -17.71 62.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 108.971 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.34 -45.91 14.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 108.532 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.42 -38.24 88.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.621 -0.675 . . . . 0.0 110.273 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.71 -22.94 45.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 t -66.18 -36.35 82.86 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.06 -1.456 . . . . 0.0 107.369 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 81' ' ' VAL . 4.4 t . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 110.201 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -123.79 148.27 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.24 -0.913 . . . . 0.0 109.661 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -127.74 137.6 52.49 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.37 144.4 38.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.41 145.41 36.18 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.253 -0.904 . . . . 0.0 109.911 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.94 151.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -127.0 129.55 48.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.534 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.4 141.86 41.23 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.46 141.83 89.67 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 CA-C-N 120.287 1.138 . . . . 0.0 110.691 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -47.94 -41.15 24.16 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.897 -1.127 . . . . 0.0 111.451 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -61.75 -43.56 98.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.651 -1.281 . . . . 0.0 111.293 -178.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -78.92 -29.2 44.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.732 -1.23 . . . . 0.0 108.411 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -40.79 74.46 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.79 0.805 . . . . 0.0 109.311 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.78 -32.51 62.05 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.5 p -68.53 -25.24 64.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.959 -1.088 . . . . 0.0 109.046 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.55 -41.86 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.965 -1.085 . . . . 0.0 110.578 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.63 ' CD1' HH11 ' A' ' 59' ' ' ARG . 58.1 mt -68.12 -37.44 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.851 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.04 -173.72 39.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -91.27 -4.6 55.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.888 -1.36 . . . . 0.0 109.938 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.56 20.81 1.17 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.08 -11.4 2.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 32' ' ' GLY . 88.0 mt-30 -36.53 -27.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.737 -0.861 . . . . 0.0 110.624 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.6 tpp180 -86.17 -34.33 20.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.76 -1.213 . . . . 0.0 109.889 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -75.91 -27.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 109.172 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.29 -48.91 30.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -58.21 -55.13 38.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.574 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -50.41 -32.37 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 109.672 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -62.7 -37.81 87.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.045 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.79 -39.75 19.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 0.0 110.518 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.44 -41.61 93.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.984 -1.072 . . . . 0.0 110.333 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -86.96 -24.24 24.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.54 1.27 70.36 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.12 161.06 20.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.765 -0.844 . . . . 0.0 110.041 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.8 t -108.46 139.35 43.33 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.3 mt -136.76 136.75 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.822 -1.174 . . . . 0.0 109.981 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -122.28 128.83 51.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -99.05 135.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.119 . . . . 0.0 108.829 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.49 148.57 22.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.082 -1.011 . . . . 0.0 108.616 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 149.26 97.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.953 -1.092 . . . . 0.0 108.797 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.49 1.306 0 CA-C-N 119.391 0.818 . . . . 0.0 111.479 179.495 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.919 0.866 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.63 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.4 mtt180 -118.71 140.14 50.42 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -111.26 142.16 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.16 143.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.82 -0.55 . . . . 0.0 110.384 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.3 m -117.76 122.84 44.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 0.0 109.451 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.74 133.07 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 m -130.36 130.23 44.14 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.052 -1.03 . . . . 0.0 109.221 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.33 -172.71 38.49 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 p -72.65 159.55 33.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.024 -1.28 . . . . 0.0 109.725 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -46.59 -46.94 19.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.102 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.24 -45.73 72.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -58.84 -37.35 76.27 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.85 -1.156 . . . . 0.0 109.226 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.66 -45.6 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.774 . . . . 0.0 110.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.53 -43.08 97.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 0.0 109.363 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -62.64 -34.58 77.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.897 . . . . 0.0 108.657 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -46.01 31.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.76 -37.16 78.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 110.142 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.79 -35.33 72.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.589 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.85 -1.156 . . . . 0.0 108.885 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -81.28 -45.31 16.42 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.81 -38.72 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.561 -0.712 . . . . 0.0 109.628 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -78.53 -24.69 45.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.6 p -62.14 -37.31 84.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HD23 ' A' ' 24' ' ' LEU . 39.6 t . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.893 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -123.6 148.61 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.569 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 m -127.31 136.96 52.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.38 144.92 38.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.92 148.77 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.45 129.68 52.29 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.97 136.51 28.95 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.3 137.64 80.7 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 CA-C-N 120.243 1.123 . . . . 0.0 110.995 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -43.36 -40.53 3.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 111.528 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -63.02 -46.5 87.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.72 -1.237 . . . . 0.0 111.178 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.42 -20.52 57.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.58 -1.325 . . . . 0.0 108.289 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.58 89.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.702 0.763 . . . . 0.0 109.881 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 59' ' ' ARG . 3.8 mtt-85 -74.41 -32.39 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.859 -0.737 . . . . 0.0 109.265 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -69.22 -32.53 71.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.71 -1.244 . . . . 0.0 109.267 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -80.02 -44.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.025 -1.047 . . . . 0.0 110.821 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.526 ' CD1' HH11 ' A' ' 59' ' ' ARG . 54.5 mt -68.4 -36.39 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.941 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.88 -172.36 40.29 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -91.83 -24.26 19.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.992 -1.299 . . . . 0.0 109.765 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -127.41 18.26 6.09 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.12 -9.18 4.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' GLY . 36.9 mt-30 -38.93 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.991 . . . . 0.0 110.417 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 tpp180 -83.43 -37.68 22.9 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.977 -1.077 . . . . 0.0 110.244 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.0 -27.71 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.144 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.987 . . . . 0.0 109.076 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.44 -46.43 90.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.21 -33.44 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 0.0 110.078 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -67.35 -41.44 85.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HD1' ' C ' ' A' ' 41' ' ' HIS . 3.1 t-80 -78.44 -34.15 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.008 . . . . 0.0 110.221 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.27 -41.64 48.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.637 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -86.49 -23.55 25.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.939 -1.101 . . . . 0.0 110.449 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 0.69 71.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.62 161.26 20.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.738 -0.86 . . . . 0.0 109.926 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -109.1 140.05 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.44 137.34 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.728 -1.232 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -121.83 129.84 52.93 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.5 135.19 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.048 -1.033 . . . . 0.0 108.84 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -95.3 150.15 20.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 108.532 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 3.4 mp0 -66.56 149.52 98.07 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.878 -1.138 . . . . 0.0 108.586 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-N 119.363 0.808 . . . . 0.0 111.44 179.482 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 122.037 0.922 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 26' ' ' ARG . 44.3 mtt180 -117.65 139.17 51.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -108.61 156.16 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.825 0.821 . . . . 0.0 110.541 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -138.94 142.63 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.752 -0.593 . . . . 0.0 110.07 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -116.65 123.08 46.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.695 -0.628 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.52 132.75 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.9 m -130.54 130.12 43.7 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.118 -0.989 . . . . 0.0 109.234 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.07 -173.13 39.23 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.8 p -73.49 160.23 32.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.046 -1.267 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -45.45 -48.77 13.8 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.397 0.618 . . . . 0.0 110.498 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.25 -45.43 73.24 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.946 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -58.54 -36.26 73.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 109.392 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.11 -45.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.251 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -60.62 -43.07 97.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.658 -1.276 . . . . 0.0 109.305 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.36 -36.63 82.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.59 49.42 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.517 -0.74 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.48 -45.05 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.924 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.5 mt -73.36 -16.0 61.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.867 -1.146 . . . . 0.0 108.998 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -83.36 -45.84 13.26 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.44 -38.2 88.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.78 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.3 -23.52 47.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -65.24 -35.41 80.96 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.953 -1.499 . . . . 0.0 107.392 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 81' ' ' VAL . 25.0 t . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.661 -0.649 . . . . 0.0 110.179 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.2 mt -125.31 151.47 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.341 -0.849 . . . . 0.0 109.931 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 t -129.69 142.25 50.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.254 -0.904 . . . . 0.0 108.988 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -143.24 146.75 33.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.98 146.94 39.43 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.57 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.2 150.97 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -130.44 82.28 2.05 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.56 149.61 75.17 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -57.01 169.13 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 119.418 0.828 . . . . 0.0 110.148 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -76.08 -42.33 47.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.565 -1.335 . . . . 0.0 110.949 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.06 -39.85 95.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.748 -1.22 . . . . 0.0 111.532 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 21' ' ' PRO . 21.9 mt -79.63 -27.66 40.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.779 -1.201 . . . . 0.0 108.638 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' PRO . . . -58.19 -38.64 77.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.826 0.822 . . . . 0.0 109.186 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.34 -33.81 63.25 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -67.9 -29.93 69.15 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.859 -1.15 . . . . 0.0 108.97 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -83.93 -42.99 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.926 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' CD1' HH11 ' A' ' 59' ' ' ARG . 56.4 mt -67.45 -36.24 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.961 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.02 -173.83 41.67 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' A' ' 31' ' ' LYS . 1.4 mptm? -91.74 -0.02 57.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.933 -1.333 . . . . 0.0 109.651 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.13 19.4 0.64 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.18 -11.52 4.9 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 32' ' ' GLY . 14.8 pt20 -34.99 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.858 -0.789 . . . . 0.0 111.011 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.3 tpp180 -84.31 -34.62 23.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.718 -1.239 . . . . 0.0 109.89 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -74.69 -26.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.935 -1.103 . . . . 0.0 108.882 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -71.57 -47.94 51.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 108.945 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -60.09 -49.57 77.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.14 -34.71 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.112 -0.992 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 110.036 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.49 -38.1 59.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.099 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.97 -43.42 98.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 110.086 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -86.86 -22.16 25.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.991 -1.068 . . . . 0.0 110.276 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 0.19 74.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.72 161.83 19.88 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.771 -0.841 . . . . 0.0 110.042 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -107.58 142.85 36.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -138.46 136.54 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.681 -1.262 . . . . 0.0 110.027 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -121.39 130.02 53.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.8 mt -100.47 135.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.894 -1.129 . . . . 0.0 108.808 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.29 150.39 20.33 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.17 150.46 95.5 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.905 -1.122 . . . . 0.0 108.504 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-N 119.167 0.738 . . . . 0.0 111.523 179.595 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' CD1' ' A' ' 29' ' ' ILE . 40.7 mtt180 -117.69 139.81 50.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -109.08 152.09 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.759 0.79 . . . . 0.0 110.793 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.97 142.47 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.771 -0.58 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.4 m -114.61 126.61 55.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mt -107.36 130.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.396 -0.815 . . . . 0.0 109.397 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -128.63 131.11 48.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.17 -174.33 39.45 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 p -72.92 159.96 32.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.045 -1.268 . . . . 0.0 109.773 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.94 -47.41 21.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.4 -45.34 72.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -59.21 -36.22 75.0 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.904 -1.122 . . . . 0.0 109.235 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.697 ' CG2' HE22 ' A' ' 74' ' ' GLN . 86.1 mt -74.48 -45.28 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 110.454 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -60.36 -43.22 96.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.708 -1.245 . . . . 0.0 109.188 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.92 -31.86 71.37 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.57 -42.02 53.21 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.591 -0.693 . . . . 0.0 109.913 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.697 HE22 ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -57.79 -52.69 64.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 0.0 109.354 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.99 -38.73 70.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.96 -22.21 62.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.791 -1.193 . . . . 0.0 109.251 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.9 mt -79.44 -45.54 19.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.0 108.222 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.24 -38.48 89.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.573 -0.704 . . . . 0.0 109.846 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.62 -24.17 45.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -63.72 -37.21 86.49 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.423 ' CG1' HD13 ' A' ' 24' ' ' LEU . 3.5 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.704 -0.623 . . . . 0.0 110.144 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -125.08 149.85 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.3 -0.875 . . . . 0.0 109.879 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.3 t -129.08 142.1 51.0 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.011 0.91 . . . . 0.0 108.888 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -143.07 144.59 32.32 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -110.46 145.99 36.69 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.18 148.59 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -121.78 129.65 52.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 135.21 27.07 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.531 -0.731 . . . . 0.0 109.087 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.99 136.66 78.06 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.271 1.132 . . . . 0.0 111.335 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -43.16 -41.31 3.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.219 -0.925 . . . . 0.0 111.579 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -62.25 -46.19 89.96 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.74 -1.225 . . . . 0.0 111.054 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.31 -25.47 54.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.658 -1.276 . . . . 0.0 108.02 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.59 82.33 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.785 0.803 . . . . 0.0 109.321 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.84 -29.33 61.02 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -72.08 -30.25 64.93 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.062 -1.024 . . . . 0.0 109.052 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -86.97 -43.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.007 -1.058 . . . . 0.0 110.937 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.61 -35.59 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.728 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -175.35 43.13 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -91.59 -3.38 56.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -150.03 18.71 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.31 -10.43 6.21 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 32' ' ' GLY . 18.7 mm100 -36.25 -27.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.787 -0.831 . . . . 0.0 110.594 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.92 -35.7 20.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.937 -1.102 . . . . 0.0 109.856 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -76.19 -28.04 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.961 -1.087 . . . . 0.0 109.269 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.57 -48.8 37.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.966 -1.084 . . . . 0.0 109.307 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -57.38 -42.68 82.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.0 110.057 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.12 -32.72 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 110.114 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -65.76 -49.47 68.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.002 . . . . 0.0 109.952 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 1.7 m80 -71.4 -32.27 68.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -42.7 42.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.373 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -86.58 -23.74 25.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.68 0.81 75.29 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.74 161.38 20.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.761 -0.847 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.9 140.51 42.28 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.88 137.76 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.689 -1.257 . . . . 0.0 110.013 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -122.82 129.45 51.71 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG21 ' NH2' ' A' ' 59' ' ' ARG . 68.4 mt -100.36 135.42 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 108.71 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.03 151.67 18.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.023 -1.048 . . . . 0.0 109.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.95 154.44 92.31 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.067 -1.02 . . . . 0.0 108.399 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.492 1.393 0 C-N-CA 120.477 0.785 . . . . 0.0 111.748 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.8 mmm180 -117.72 137.55 52.61 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.61 156.0 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.887 0.851 . . . . 0.0 111.078 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.74 142.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.139 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.8 m -116.21 123.96 49.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.643 -0.661 . . . . 0.0 109.287 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.17 -0.956 . . . . 0.0 109.572 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -130.35 130.24 44.18 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.098 -1.001 . . . . 0.0 109.06 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.46 -173.25 38.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.2 p -72.42 159.59 33.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.968 -1.313 . . . . 0.0 109.618 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -47.1 -46.97 23.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 110.162 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.12 -47.14 68.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 109.882 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.36 -36.51 71.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.79 -1.194 . . . . 0.0 109.111 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.26 -45.82 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -60.48 -42.75 96.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.818 -1.177 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -62.16 -37.74 86.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.305 -0.872 . . . . 0.0 108.875 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.92 -44.09 64.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.422 -0.798 . . . . 0.0 109.601 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -58.04 -48.93 78.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.024 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.64 -39.14 83.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.84 -18.3 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.861 -1.15 . . . . 0.0 109.194 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -45.91 12.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 108.392 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.11 -38.62 89.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.665 -0.647 . . . . 0.0 110.042 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.99 -23.59 44.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.925 -1.109 . . . . 0.0 109.89 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.1 p -61.94 -36.68 82.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.89 -0.506 . . . . 0.0 110.42 -179.686 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 mm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.93 149.22 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.293 -0.879 . . . . 0.0 109.682 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.4 m -127.94 137.5 52.29 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.91 146.17 38.9 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -112.02 145.97 38.72 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -126.77 155.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -126.44 130.27 50.35 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -126.21 133.26 24.77 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.94 136.09 74.6 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 CA-C-N 120.356 1.163 . . . . 0.0 111.265 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -42.46 -41.28 2.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 111.515 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.88 -46.33 88.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.651 -1.28 . . . . 0.0 111.187 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 HG13 ' A' ' 81' ' ' VAL . 10.8 mp -75.65 -19.8 58.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.491 -1.381 . . . . 0.0 108.109 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.43 85.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.34 -28.66 61.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.9 p -72.89 -30.71 64.16 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.121 -0.987 . . . . 0.0 109.178 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -89.06 -43.06 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 0.0 111.014 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.5 mt -69.13 -35.98 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.061 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -170.7 38.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 15.7 ttpp -91.76 -11.76 35.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.948 -1.325 . . . . 0.0 110.007 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.17 17.99 2.51 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.55 -9.64 14.76 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 5.7 tp-100 -36.07 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.707 -0.878 . . . . 0.0 111.137 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.1 tpp180 -85.95 -35.51 20.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.536 -1.352 . . . . 0.0 109.7 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -72.55 -23.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.81 -1.182 . . . . 0.0 108.414 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -73.19 -50.23 23.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -0.976 . . . . 0.0 109.004 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -57.25 -51.42 69.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.63 -33.5 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.566 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -58.8 -64.82 0.8 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -62.29 -39.3 92.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -61.14 -44.65 96.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.255 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 p -86.71 -22.93 25.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.976 -1.078 . . . . 0.0 110.433 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.71 0.55 74.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.65 19.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.803 -0.822 . . . . 0.0 110.025 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.0 t -107.23 141.57 38.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.0 mt -137.09 138.33 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.57 -1.331 . . . . 0.0 110.265 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -124.83 129.87 51.28 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.68 136.23 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.059 . . . . 0.0 108.917 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.17 152.16 18.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -1.0 . . . . 0.0 109.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.642 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 pm0 -67.06 154.08 93.27 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 120.993 -1.067 . . . . 0.0 108.731 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo . . . . . 0 N--CA 1.494 1.549 0 C-N-CA 120.675 0.916 . . . . 0.0 112.341 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.96 138.35 52.23 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -111.66 147.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.196 -0.94 . . . . 0.0 110.752 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 20' ' ' ILE . 96.6 mt -132.55 144.04 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.858 -0.526 . . . . 0.0 110.445 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.9 m -118.02 122.29 42.82 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -102.22 133.33 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -131.17 129.67 42.04 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.999 -1.063 . . . . 0.0 109.145 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.62 -172.32 38.65 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -72.08 159.02 34.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.01 -1.288 . . . . 0.0 109.716 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -47.19 21.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.855 -0.528 . . . . 0.0 110.342 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -68.52 -45.55 71.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.806 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -58.24 -35.2 71.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.114 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.9 mt -73.52 -45.59 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.467 -0.77 . . . . 0.0 110.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -60.47 -42.84 97.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.754 -1.216 . . . . 0.0 109.376 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.79 -36.18 80.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.79 57.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -58.45 -48.66 80.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 110.379 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.06 -41.84 93.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.955 -1.091 . . . . 0.0 109.932 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.56 -25.29 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.798 -1.189 . . . . 0.0 108.966 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.6 -45.55 44.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.65 -38.59 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.471 -0.768 . . . . 0.0 109.385 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -78.41 -24.24 46.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.342 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.4 p -63.22 -37.61 87.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.331 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 HD23 ' A' ' 24' ' ' LEU . 22.9 t . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.7 mt -123.29 148.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 m -127.51 137.34 52.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -138.96 144.49 39.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -110.3 145.78 36.83 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.196 -0.94 . . . . 0.0 110.239 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.08 148.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -121.49 129.87 53.2 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.86 138.73 33.23 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.557 -0.715 . . . . 0.0 109.183 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -56.22 147.21 67.34 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.032 1.047 . . . . 0.0 110.992 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -54.05 -41.86 68.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.996 -1.065 . . . . 0.0 111.271 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -62.25 -42.64 99.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.749 -1.219 . . . . 0.0 111.162 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.488 HD13 ' CG1' ' A' ' 81' ' ' VAL . 27.2 mt -79.48 -26.68 41.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.63 -1.294 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -39.11 78.01 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.859 0.838 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.7 -30.51 61.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.4 p -70.67 -29.22 65.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.102 -0.999 . . . . 0.0 109.352 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.7 mt -86.65 -44.25 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.022 -1.049 . . . . 0.0 111.108 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.2 mt -64.86 -34.69 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.569 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -176.62 46.16 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -92.25 0.34 57.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.038 -1.272 . . . . 0.0 109.406 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.8 15.19 0.7 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 78.11 -8.02 40.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.1 mt-30 -34.57 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.943 -0.739 . . . . 0.0 111.023 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.5 mmp_? -87.05 -43.46 12.29 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.545 -1.347 . . . . 0.0 109.469 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.92 -26.46 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.077 -1.015 . . . . 0.0 108.951 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.75 -53.58 7.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' OE1' ' NH2' ' A' ' 35' ' ' ARG . 88.3 mt-30 -59.16 -52.48 65.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -52.93 -34.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.36 -47.71 84.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.389 -0.819 . . . . 0.0 110.576 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -75.07 -40.52 60.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.008 . . . . 0.0 110.746 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.93 -43.07 99.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 110.34 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -87.8 -22.92 24.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 110.632 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.73 0.6 74.86 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 160.74 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.768 -0.842 . . . . 0.0 110.194 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 t -108.09 142.8 37.72 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -138.51 136.88 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 110.301 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -122.06 128.54 51.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.1 mt -99.56 135.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 109.162 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -95.85 150.3 20.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.113 -0.992 . . . . 0.0 108.503 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.62 150.59 97.32 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.837 -1.164 . . . . 0.0 108.617 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.49 1.308 0 CA-C-N 119.133 0.726 . . . . 0.0 111.486 179.508 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.92 0.867 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 46.9 mtt180 -119.74 138.87 53.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -108.07 155.58 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.441 -0.787 . . . . 0.0 110.607 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -138.54 141.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.762 -0.586 . . . . 0.0 110.021 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -115.76 122.99 47.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -102.32 133.48 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -130.57 129.68 43.09 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.086 -1.009 . . . . 0.0 109.152 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.61 -174.1 38.94 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -72.39 159.66 33.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.954 -1.321 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -46.59 -46.6 19.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.245 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -68.3 -45.96 71.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.274 -0.892 . . . . 0.0 109.946 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -58.35 -36.03 72.82 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.862 -1.149 . . . . 0.0 109.359 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.1 mt -71.91 -45.95 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.2 -43.59 95.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.768 -1.207 . . . . 0.0 109.663 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -60.98 -39.63 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.152 -0.968 . . . . 0.0 108.689 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.53 64.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.507 -0.746 . . . . 0.0 109.398 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.16 -49.86 74.63 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.494 -0.754 . . . . 0.0 110.319 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.53 -37.72 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.027 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.31 -19.78 63.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.791 -1.193 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 81' ' ' VAL . 13.7 mt -81.05 -46.24 15.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 108.624 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.45 -39.53 93.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.747 -0.595 . . . . 0.0 110.715 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -78.33 -22.34 48.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -65.25 -34.71 79.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.111 -1.436 . . . . 0.0 107.316 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.488 ' CG1' HD13 ' A' ' 24' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.391 -0.818 . . . . 0.0 110.858 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -123.44 150.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.308 -0.87 . . . . 0.0 109.368 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.19 138.05 53.61 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.47 144.17 37.88 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -110.87 146.32 36.71 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.27 152.77 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -126.4 129.6 49.09 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 140.15 36.43 Favored Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.76 150.76 68.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 CA-C-N 120.019 1.042 . . . . 0.0 110.665 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -56.48 -40.85 75.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.87 -1.143 . . . . 0.0 111.2 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.18 -45.4 91.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 111.552 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.88 -26.2 53.93 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.36 -1.462 . . . . 0.0 108.466 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.06 80.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.812 0.815 . . . . 0.0 109.514 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.45 -30.82 62.03 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.79 -34.3 71.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.081 -1.012 . . . . 0.0 109.147 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -82.11 -44.37 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 111.09 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.562 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.4 mt -67.1 -35.38 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.918 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.09 -175.67 41.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -91.23 -9.58 44.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.022 -1.281 . . . . 0.0 109.967 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -144.17 20.03 2.11 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 71.39 -11.6 2.95 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 32' ' ' GLY . 5.7 pt20 -35.54 -36.12 0.07 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.77 -0.841 . . . . 0.0 110.656 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -76.71 -33.35 58.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.949 -1.094 . . . . 0.0 110.213 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -77.01 -26.36 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.62 -1.3 . . . . 0.0 109.334 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.63 -46.22 66.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 109.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.99 -49.9 75.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.677 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.05 -33.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -61.23 -64.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.243 -0.91 . . . . 0.0 110.047 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -64.08 -38.81 92.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 110.231 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.37 -42.15 98.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.238 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 28.0 p -87.01 -22.49 25.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.931 -1.106 . . . . 0.0 110.383 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.08 0.25 69.54 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.82 160.87 21.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.857 -0.79 . . . . 0.0 110.116 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.55 139.79 41.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.44 137.22 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.669 -1.269 . . . . 0.0 109.935 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -122.83 126.87 48.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.98 135.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.873 -1.142 . . . . 0.0 108.528 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.42 148.18 23.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.151 -0.968 . . . . 0.0 108.593 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.19 149.17 97.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.899 -1.126 . . . . 0.0 108.761 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 C--N 1.313 -1.297 0 CA-C-N 119.344 0.802 . . . . 0.0 111.581 179.542 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 121.801 0.81 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.562 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.7 mtt180 -119.19 138.97 52.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.2 mt -110.12 147.95 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.35 -0.844 . . . . 0.0 110.645 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -130.57 143.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.758 -0.589 . . . . 0.0 110.311 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.3 m -116.51 122.68 45.41 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.58 133.1 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 m -130.98 129.41 42.08 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.018 -1.051 . . . . 0.0 109.169 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.83 -173.94 39.94 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 159.41 34.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.12 -1.224 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -47.04 22.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.717 -0.614 . . . . 0.0 110.451 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -68.5 -44.57 74.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.787 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 43' ' ' SER . 24.1 mm100 -59.54 -36.68 76.62 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.916 -1.115 . . . . 0.0 109.284 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -71.19 -45.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.124 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.36 -43.12 96.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.804 -1.185 . . . . 0.0 109.334 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.5 -37.15 84.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 108.628 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -46.64 48.94 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.525 -0.734 . . . . 0.0 109.491 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.54 -41.34 89.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -66.91 -36.39 82.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.15 -13.95 61.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 108.943 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.59 -45.16 12.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.971 . . . . 0.0 108.454 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.02 -38.45 88.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -79.14 -24.16 43.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 109.467 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.9 p -63.78 -38.58 91.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 81' ' ' VAL . 22.1 t . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.11 149.53 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -125.83 137.78 53.79 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.48 144.75 38.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -111.31 146.79 36.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -125.59 154.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 130.05 49.51 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.32 138.42 32.75 Favored Pre-proline 0 N--CA 1.506 2.338 0 O-C-N 121.514 -0.741 . . . . 0.0 109.23 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.88 175.05 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.114 1.076 . . . . 0.0 110.828 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.37 -39.27 39.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.584 -1.322 . . . . 0.0 110.534 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -63.41 -39.75 95.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -0.889 . . . . 0.0 111.457 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 24' ' ' LEU . 11.2 mp -81.01 -28.66 35.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.439 -1.413 . . . . 0.0 108.311 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.039 0.923 . . . . 0.0 109.171 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -71.51 -30.87 66.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.0 p -72.28 -31.18 65.51 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.072 -1.017 . . . . 0.0 109.223 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -86.74 -44.27 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.146 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -67.21 -35.44 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.83 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.96 -173.61 41.56 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -91.67 0.55 57.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.046 -1.267 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.6 18.59 0.59 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.63 -10.35 6.95 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 33' ' ' GLY . 40.7 mt-30 -35.58 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.797 -0.825 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 tpt180 -85.68 -35.27 20.99 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.641 -1.287 . . . . 0.0 110.069 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -74.33 -27.38 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 109.019 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.62 -47.79 44.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.31 -46.49 88.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.039 -1.038 . . . . 0.0 110.031 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.92 -33.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -66.67 -40.18 88.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.015 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 41' ' ' HIS . 18.5 t-80 -77.51 -30.42 52.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 110.248 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 2.2 tm-20 -79.12 -41.58 28.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -86.59 -23.68 25.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 110.48 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.52 0.6 73.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.46 161.15 20.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.681 -0.894 . . . . 0.0 110.053 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.6 m -108.79 140.07 42.73 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.76 137.5 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.775 -1.203 . . . . 0.0 110.024 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -122.3 129.26 52.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -99.68 135.15 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.884 -1.135 . . . . 0.0 108.676 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 10.0 m-20 -95.83 150.18 20.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.158 -0.964 . . . . 0.0 108.626 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -66.4 151.12 96.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.916 -1.115 . . . . 0.0 108.609 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 120.451 0.767 . . . . 0.0 111.705 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.794 0.807 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -116.66 138.74 51.22 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.4 mt -112.4 147.24 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.193 -0.942 . . . . 0.0 110.962 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.1 mt -132.22 143.26 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.836 -0.54 . . . . 0.0 110.218 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 m -116.43 124.36 49.81 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.0 mt -103.92 132.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -131.03 130.06 42.81 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.038 -1.039 . . . . 0.0 109.104 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.1 -173.27 38.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -72.12 159.27 34.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.46 -46.55 26.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.673 -0.642 . . . . 0.0 110.392 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.08 -47.1 69.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 109.862 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 14.3 mp0 -57.91 -36.73 72.85 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.866 -1.146 . . . . 0.0 109.082 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.82 -45.79 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.511 -0.743 . . . . 0.0 110.019 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.66 -42.98 98.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.75 -1.219 . . . . 0.0 109.55 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.44 -38.37 89.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 108.817 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.1 -45.66 59.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.399 -0.813 . . . . 0.0 109.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.91 -41.24 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.134 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.492 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 57.1 t80 -66.84 -37.31 84.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 109.777 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -70.82 -26.69 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.799 -1.188 . . . . 0.0 108.836 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.78 -45.19 62.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.18 -38.89 90.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.39 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 18.2 m-20 -78.38 -26.08 46.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.605 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 p -62.46 -36.66 83.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.177 -1.409 . . . . 0.0 107.244 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.077 0.465 . . . . 0.0 109.821 -179.812 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.64 149.46 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.352 -0.843 . . . . 0.0 109.792 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -127.1 137.66 53.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.8 145.34 38.06 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -110.95 144.74 39.55 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 109.938 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.88 149.04 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -122.24 129.62 52.41 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.92 138.99 33.79 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -56.87 146.12 80.58 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 CA-C-N 120.209 1.11 . . . . 0.0 110.918 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -52.7 -40.95 63.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.904 -1.122 . . . . 0.0 111.344 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -62.31 -44.25 96.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.807 -1.183 . . . . 0.0 111.231 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 mt -78.52 -26.73 45.87 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.622 -1.299 . . . . 0.0 108.209 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.45 79.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.83 0.824 . . . . 0.0 109.319 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -74.55 -30.09 61.61 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.8 p -71.12 -26.96 63.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.075 -1.016 . . . . 0.0 109.299 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -89.01 -43.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 110.999 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 52.4 mt -68.28 -36.01 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.707 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -172.72 40.37 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -91.65 -9.65 43.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 109.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -143.84 18.36 2.18 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.91 -10.44 9.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.583 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 19.7 mm100 -35.61 -29.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.866 -0.785 . . . . 0.0 110.803 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.0 tpp180 -84.32 -37.15 21.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.643 -1.286 . . . . 0.0 109.743 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -72.3 -23.39 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.802 -1.186 . . . . 0.0 108.532 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -71.72 -48.14 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 108.939 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 34' ' ' GLN . 0.8 OUTLIER -59.11 -47.72 84.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.53 -33.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.519 HH11 ' CG ' ' A' ' 40' ' ' ARG . 1.5 ttt-85 -57.88 -53.47 57.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.244 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.58 -39.57 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 0.0 110.357 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -59.07 -44.99 91.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.108 -0.995 . . . . 0.0 110.114 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t -86.93 -22.56 25.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 110.188 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.11 -0.16 80.41 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.03 162.82 18.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.707 -0.878 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.5 m -104.85 148.1 27.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -133.05 138.8 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.652 -1.28 . . . . 0.0 109.948 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.53 123.63 31.91 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.15 135.06 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 108.961 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.21 152.06 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.115 -0.991 . . . . 0.0 108.836 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 3.2 mp0 -70.7 150.2 95.34 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 120.933 -1.105 . . . . 0.0 108.396 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.49 1.273 0 CA-C-N 119.442 0.837 . . . . 0.0 111.59 179.347 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 122.135 0.969 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.5 mtt180 -118.44 138.83 52.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -108.3 151.97 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.376 -0.828 . . . . 0.0 110.256 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -135.56 142.45 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.665 . . . . 0.0 110.123 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -116.48 121.12 40.89 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.717 -0.614 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.73 132.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.261 -0.899 . . . . 0.0 109.285 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -129.37 130.14 45.66 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.024 -1.047 . . . . 0.0 108.969 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.75 -172.34 38.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 p -73.26 160.0 32.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.001 -1.293 . . . . 0.0 109.619 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.14 -46.51 23.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.49 -45.22 72.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.254 -0.903 . . . . 0.0 109.857 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -59.16 -36.42 75.25 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.275 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 92.4 mt -72.33 -45.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.54 -0.725 . . . . 0.0 110.368 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.57 -42.95 97.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.753 -1.217 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.32 -31.63 71.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 109.005 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -43.14 36.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.502 -0.749 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.75 -48.23 75.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.177 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.21 -43.86 98.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -64.14 -24.58 67.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.905 -1.122 . . . . 0.0 109.084 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.87 -46.77 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 108.316 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.06 -38.57 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.55 -0.719 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.07 -25.45 47.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 109.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.9 p -62.79 -38.04 89.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.481 -1.387 . . . . 0.0 107.296 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.494 1.762 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.028 -179.611 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.38 148.54 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.286 -0.884 . . . . 0.0 109.53 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -126.7 137.75 53.31 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.45 144.48 38.05 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.13 146.6 36.54 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.178 -0.951 . . . . 0.0 110.302 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.39 150.79 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -124.86 130.08 51.67 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.68 138.0 31.6 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 22' ' ' LYS . 2.5 Cg_endo -57.91 134.69 64.11 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 CA-C-N 120.158 1.092 . . . . 0.0 110.384 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 21' ' ' PRO . 28.7 ttmt -39.07 -40.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.454 -0.779 . . . . 0.0 111.112 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.89 -40.2 96.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.985 -1.072 . . . . 0.0 110.868 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 81' ' ' VAL . 4.0 mm? -77.59 -26.74 50.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.661 -1.274 . . . . 0.0 108.696 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.32 79.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.774 0.797 . . . . 0.0 109.479 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -76.59 -29.11 56.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.4 p -73.59 -24.77 60.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.862 -1.149 . . . . 0.0 109.05 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -95.47 -42.6 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.961 -1.087 . . . . 0.0 110.609 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.25 -35.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.84 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.25 -172.04 39.28 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -91.57 -14.16 30.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.294 . . . . 0.0 109.957 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -139.04 18.51 3.13 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.96 -10.21 7.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.729 -1.748 . . . . 0.0 108.729 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' GLY . 70.2 mt-30 -36.03 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.777 -0.837 . . . . 0.0 110.673 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.53 -36.06 20.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.764 -1.21 . . . . 0.0 109.961 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -73.46 -24.48 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -73.04 -47.8 41.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.078 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.11 -50.24 74.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.048 -1.032 . . . . 0.0 109.867 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.4 -31.79 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.79 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -61.1 -65.12 0.74 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -64.9 -36.73 85.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.33 -42.95 92.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.056 -1.028 . . . . 0.0 110.199 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -86.99 -22.94 25.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.354 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.99 0.83 70.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.49 161.44 20.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -108.82 138.11 45.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.38 137.88 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.816 -1.178 . . . . 0.0 109.891 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -123.09 128.28 49.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.448 HG21 ' NH2' ' A' ' 59' ' ' ARG . 66.8 mt -99.85 135.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 108.541 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.57 151.59 19.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.037 -1.039 . . . . 0.0 108.939 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.02 155.38 87.25 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.342 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 N--CA 1.492 1.404 0 C-N-CA 120.624 0.883 . . . . 0.0 111.933 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 121.59 0.709 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.3 mmm180 -119.41 137.37 53.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.17 153.79 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.3 -0.875 . . . . 0.0 111.052 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.92 141.93 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.765 -0.585 . . . . 0.0 110.184 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -115.91 123.96 49.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.636 -0.665 . . . . 0.0 109.341 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -104.07 132.19 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.74 46.49 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.114 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.54 38.63 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -74.72 161.69 29.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.995 -1.297 . . . . 0.0 109.532 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -47.48 30.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -0.754 . . . . 0.0 110.449 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.85 -49.44 62.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.07 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.66 -36.68 69.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.854 -1.154 . . . . 0.0 109.212 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.8 mt -70.46 -45.54 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.7 -42.87 98.04 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.694 -1.254 . . . . 0.0 109.445 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.37 -37.94 87.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.276 -0.89 . . . . 0.0 108.784 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 -45.1 62.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.438 -0.789 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -58.83 -49.06 79.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.913 . . . . 0.0 109.966 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -59.39 -41.11 88.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.803 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.01 -25.9 66.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 108.947 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.01 -44.37 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.883 -1.135 . . . . 0.0 108.34 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -62.0 -38.89 90.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.581 -0.7 . . . . 0.0 109.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -78.57 -23.82 45.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.874 -1.141 . . . . 0.0 109.618 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.487 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 25.5 m -63.69 -36.46 83.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.252 -1.53 . . . . 0.0 107.013 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 24' ' ' LEU . 24.6 t . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.791 -0.568 . . . . 0.0 109.872 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.1 mt -125.2 150.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.314 -0.866 . . . . 0.0 109.706 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 t -127.48 148.17 50.31 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -148.44 142.04 25.47 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -108.22 145.45 34.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.03 154.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -126.48 129.65 49.09 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.5 136.14 28.23 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.74 139.27 84.6 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 CA-C-N 120.16 1.093 . . . . 0.0 111.1 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -44.42 -40.02 5.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 0.0 111.252 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -63.24 -47.1 83.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.725 -1.235 . . . . 0.0 111.116 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.4 mt -76.86 -21.67 54.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.349 -1.469 . . . . 0.0 108.348 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.36 90.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.865 0.84 . . . . 0.0 109.443 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -75.42 -28.58 59.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.1 p -74.05 -32.73 63.43 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.191 -0.943 . . . . 0.0 108.881 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -86.84 -44.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.667 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CD1' HH11 ' A' ' 59' ' ' ARG . 68.1 mt -69.92 -35.98 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.018 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.89 -170.14 41.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -92.26 -47.2 7.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.18 -1.188 . . . . 0.0 109.421 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.67 13.21 59.54 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 67.12 -1.64 6.09 Favored Glycine 0 N--CA 1.493 2.455 0 O-C-N 120.882 -1.364 . . . . 0.0 109.812 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.7 mt-30 -45.93 -16.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 119.316 1.558 . . . . 0.0 109.862 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -82.95 -38.82 22.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.907 -1.121 . . . . 0.0 110.864 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 HD13 ' A' ' 47' ' ' ILE . 9.6 tp -74.05 -18.98 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.139 -1.601 . . . . 0.0 109.155 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -73.75 -50.43 20.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.393 -0.817 . . . . 0.0 109.088 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.18 -48.54 81.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.545 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.4 mt -58.45 -34.74 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.62 -59.51 5.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -67.78 -37.59 82.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.86 -44.47 93.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -0.985 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -86.6 -23.07 25.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 110.301 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.04 0.54 76.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.28 18.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.762 -0.846 . . . . 0.0 109.876 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -108.04 141.36 39.82 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.475 HD13 HD11 ' A' ' 36' ' ' ILE . 98.3 mt -134.2 137.22 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.765 -1.209 . . . . 0.0 110.214 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -122.77 127.41 49.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.1 134.43 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.021 -1.049 . . . . 0.0 108.584 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.9 149.48 21.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.133 -0.98 . . . . 0.0 108.559 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.92 149.22 97.8 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 120.827 -1.171 . . . . 0.0 108.568 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.49 1.305 0 CA-C-N 119.213 0.754 . . . . 0.0 111.446 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.079 0.942 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.405 HH11 ' CD1' ' A' ' 29' ' ' ILE . 45.5 mtt180 -117.47 140.22 49.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.59 144.21 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.381 -0.824 . . . . 0.0 110.785 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.44 143.8 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.768 -0.583 . . . . 0.0 110.342 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.4 m -117.94 120.75 38.77 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.725 -0.609 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.09 133.13 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -129.33 130.59 46.29 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.06 -1.025 . . . . 0.0 109.19 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.56 -172.61 38.67 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 p -73.71 160.77 31.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.058 -1.26 . . . . 0.0 109.522 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -46.96 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -67.74 -45.88 73.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -59.93 -38.91 83.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.786 -1.196 . . . . 0.0 109.26 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.81 -45.61 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.733 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.7 -43.34 97.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.801 -1.187 . . . . 0.0 109.375 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -61.43 -40.17 93.45 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.4 -46.4 64.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.493 -0.754 . . . . 0.0 109.417 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -57.41 -52.61 64.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 109.945 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 63.7 t80 -57.31 -40.51 78.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.035 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.92 -27.67 66.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.863 -1.148 . . . . 0.0 108.975 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -74.74 -45.94 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.058 . . . . 0.0 108.433 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -61.28 -39.35 90.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.667 -0.645 . . . . 0.0 109.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 10.0 m-80 -78.38 -23.79 46.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.9 p -63.07 -34.54 77.8 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.595 . . . . 0.0 110.474 -179.251 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 150.49 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 109.485 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 m -126.85 136.64 52.62 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.0 144.91 39.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.8 146.16 36.88 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.256 -0.902 . . . . 0.0 110.064 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.17 153.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -124.2 129.64 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.43 136.55 28.79 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 121.466 -0.771 . . . . 0.0 109.25 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.35 139.25 85.77 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.082 1.065 . . . . 0.0 110.954 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -44.26 -40.07 4.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.184 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.39 -46.58 85.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.824 -1.172 . . . . 0.0 111.43 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.84 -22.99 52.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.311 -1.493 . . . . 0.0 108.251 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.95 -38.23 85.17 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.831 0.824 . . . . 0.0 109.14 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.38 -27.25 59.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.9 p -74.54 -31.57 62.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.065 -1.022 . . . . 0.0 109.254 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.8 mt -83.89 -45.95 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 110.972 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.75 -34.28 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.798 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.52 -176.22 44.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -91.93 5.0 51.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 109.676 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -157.55 17.35 0.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.28 -9.49 13.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 62.0 mt-30 -34.65 -28.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.95 -0.735 . . . . 0.0 111.015 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.4 mmt180 -86.33 -40.16 15.74 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.484 -1.385 . . . . 0.0 109.617 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.1 mm -69.85 -27.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.047 . . . . 0.0 109.295 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -77.4 -53.55 7.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.68 -48.11 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.08 -34.5 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -59.26 -74.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -53.06 -34.8 58.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.471 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.06 -44.14 80.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.419 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -86.42 -24.57 25.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 0.0 110.538 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.77 -3.92 83.96 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.06 162.64 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -1.056 . . . . 0.0 110.098 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.4 m -107.01 142.62 36.35 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -138.06 136.78 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.665 -1.272 . . . . 0.0 110.04 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -123.0 127.29 48.61 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -98.03 135.07 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.94 -1.1 . . . . 0.0 108.636 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.69 151.27 19.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.094 -1.004 . . . . 0.0 108.766 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 mp0 -67.78 149.37 98.28 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 120.996 -1.065 . . . . 0.0 108.46 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.314 -1.239 0 CA-C-N 119.445 0.837 . . . . 0.0 111.431 179.403 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.928 0.87 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -120.63 140.47 51.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.3 140.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.437 -0.79 . . . . 0.0 111.239 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -120.92 144.73 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.665 -0.647 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.8 m -117.31 125.12 50.54 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.81 131.31 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.16 -0.963 . . . . 0.0 109.624 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -129.19 130.73 46.7 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.088 -1.008 . . . . 0.0 109.024 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.57 -174.42 38.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 p -73.24 160.22 32.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.266 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.25 -46.72 24.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.383 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 2.5 m-20 -68.15 -46.85 69.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.925 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -58.28 -37.33 74.8 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.898 -1.126 . . . . 0.0 109.293 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.2 mt -70.84 -45.76 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.504 -0.747 . . . . 0.0 110.212 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -60.2 -43.18 96.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.792 -1.193 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.16 -35.24 78.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 108.757 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.37 35.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.533 -0.729 . . . . 0.0 109.55 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.15 -47.09 84.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.268 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -61.52 -35.27 77.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.013 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.36 -26.93 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.82 -1.175 . . . . 0.0 109.02 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.33 -46.03 57.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.086 -1.009 . . . . 0.0 108.317 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -61.39 -37.64 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.446 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.85 -24.15 44.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -64.07 -40.11 95.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 81' ' ' VAL . 11.9 t . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.933 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -123.98 148.85 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -127.55 137.34 52.58 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.04 144.01 38.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.49 144.89 37.13 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.208 -0.933 . . . . 0.0 109.942 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.13 153.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.82 129.89 50.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.0 137.39 30.03 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.485 -0.759 . . . . 0.0 108.957 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.81 144.61 93.22 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.158 1.092 . . . . 0.0 110.958 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -50.94 -41.37 58.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 111.339 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -45.38 92.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.74 -1.225 . . . . 0.0 111.42 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.78 -25.71 53.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.448 -1.407 . . . . 0.0 108.175 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.26 79.83 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.735 0.779 . . . . 0.0 109.4 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.7 -30.11 61.43 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -71.41 -33.25 69.27 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.935 -1.103 . . . . 0.0 109.243 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.15 -45.13 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 111.016 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.21 -35.06 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.877 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 -171.9 39.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -91.79 -4.26 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.329 . . . . 0.0 109.771 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.87 19.58 1.11 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.32 -10.61 6.01 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 32' ' ' GLY . 35.3 tt0 -36.57 -26.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.792 -0.828 . . . . 0.0 111.109 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.2 tpp180 -87.12 -37.48 17.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.733 -1.229 . . . . 0.0 109.777 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.41 -23.92 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.744 -1.222 . . . . 0.0 108.571 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -72.78 -49.33 31.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.63 -47.96 80.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.706 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.06 -32.81 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.04 -47.19 86.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.109 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -80.22 -39.47 29.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.112 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.39 -44.28 97.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.016 -1.053 . . . . 0.0 110.188 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -87.14 -22.33 25.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.079 -1.013 . . . . 0.0 110.217 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.18 79.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.79 162.63 18.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.772 -0.84 . . . . 0.0 109.848 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 m -105.35 146.97 28.68 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mm -132.45 138.21 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.605 -1.309 . . . . 0.0 109.955 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -126.6 124.72 40.59 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -101.66 132.98 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 108.787 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.61 150.83 19.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.006 -1.059 . . . . 0.0 108.487 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -66.21 150.15 97.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.969 -1.082 . . . . 0.0 108.455 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.49 1.286 0 C-N-CA 120.38 0.72 . . . . 0.0 111.687 179.627 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.96 0.886 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.512 HH11 ' CG ' ' A' ' 59' ' ' ARG . 5.1 mtt-85 -118.05 139.52 51.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -111.54 141.89 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.314 -0.866 . . . . 0.0 110.845 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -124.96 143.71 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.752 -0.593 . . . . 0.0 110.484 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -118.59 118.38 31.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.718 -0.614 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -96.37 134.31 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -131.74 129.04 40.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 -171.95 37.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 p -71.71 159.31 34.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.049 -1.265 . . . . 0.0 109.536 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -46.26 46.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.675 . . . . 0.0 110.273 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -66.94 -46.53 74.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.08 -1.013 . . . . 0.0 109.494 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -57.99 -32.81 68.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.0 -1.062 . . . . 0.0 109.001 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.46 -45.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.503 -0.748 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -44.01 93.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.664 -1.272 . . . . 0.0 109.518 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -61.14 -34.1 74.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.072 -1.017 . . . . 0.0 108.729 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.55 -47.13 28.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.528 -0.732 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -58.44 -47.68 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 110.345 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 79' ' ' ASN . 56.9 t80 -61.14 -38.15 85.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.794 -1.191 . . . . 0.0 108.95 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.2 mt -74.38 -46.25 41.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 0.0 108.364 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.46 -38.54 87.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 8.5 m-80 -78.53 -23.89 46.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.569 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.9 p -63.99 -40.28 96.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 81' ' ' VAL . 5.2 t . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.775 -0.578 . . . . 0.0 110.007 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.97 149.97 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 109.858 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -128.72 143.56 50.96 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -144.7 144.38 31.19 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -109.82 145.53 36.57 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.293 -0.879 . . . . 0.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.3 148.96 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -124.71 129.6 50.8 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.622 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -126.18 142.7 43.41 Favored Pre-proline 0 N--CA 1.506 2.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.65 146.8 63.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 120.485 1.209 . . . . 0.0 110.605 178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -52.31 -40.28 61.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 111.168 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.21 -42.45 99.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.699 -1.25 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -79.8 -32.1 40.79 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.71 -1.244 . . . . 0.0 108.439 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.27 68.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.794 0.807 . . . . 0.0 109.305 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.99 -33.12 63.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.4 p -67.59 -27.87 67.28 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.936 -1.102 . . . . 0.0 108.948 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -85.33 -42.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.83 -37.37 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.748 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.64 -174.07 40.87 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.53 -8.31 47.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.955 -1.321 . . . . 0.0 109.831 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -145.2 20.11 1.92 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.33 -11.13 4.21 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 32' ' ' GLY . 74.1 mt-30 -36.34 -27.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.824 -0.809 . . . . 0.0 110.609 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.5 tpt180 -86.75 -35.48 19.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.818 -1.176 . . . . 0.0 109.77 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.3 mm -75.06 -26.55 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.078 . . . . 0.0 108.878 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -73.29 -48.27 35.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.164 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.52 -51.03 71.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.59 -32.98 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.044 -1.035 . . . . 0.0 109.734 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -59.51 -51.2 70.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.0 110.179 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -75.56 -38.45 59.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.32 -44.43 96.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.992 . . . . 0.0 110.194 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -86.76 -23.46 25.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.394 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.56 0.04 78.03 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.35 19.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.713 -0.875 . . . . 0.0 109.939 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -107.25 141.79 38.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -138.69 136.81 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.634 -1.291 . . . . 0.0 109.822 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -124.12 129.4 50.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -101.08 132.75 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.886 -1.134 . . . . 0.0 108.382 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -92.06 153.43 19.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 108.949 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.57 153.56 95.62 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 120.952 -1.093 . . . . 0.0 108.113 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 C--N 1.311 -1.407 0 CA-C-N 119.42 0.829 . . . . 0.0 111.17 179.57 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.5 tpp180 -116.28 139.78 50.01 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.12 140.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -125.1 144.22 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.785 -0.572 . . . . 0.0 110.632 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.86 46.93 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.652 -0.655 . . . . 0.0 109.352 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.48 132.62 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -0.81 . . . . 0.0 109.528 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -130.47 130.49 44.29 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.994 -1.066 . . . . 0.0 109.203 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.89 38.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.2 p -73.22 160.25 32.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.051 -1.264 . . . . 0.0 109.844 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.41 -48.88 13.6 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.381 0.61 . . . . 0.0 110.562 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.937 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.37 -36.66 73.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.792 -1.192 . . . . 0.0 109.356 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -72.08 -45.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 110.354 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -60.76 -42.77 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.758 -1.214 . . . . 0.0 109.422 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -62.16 -34.52 76.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.807 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.36 45.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.46 -0.775 . . . . 0.0 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.34 -48.58 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.95 -40.08 87.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.6 mt -68.02 -30.27 69.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.801 -1.187 . . . . 0.0 109.02 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.64 -45.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.973 -1.079 . . . . 0.0 108.276 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.06 -39.43 92.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.593 -0.692 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.97 -25.49 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 0.0 109.872 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.9 m -61.93 -34.37 75.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG13 HD23 ' A' ' 24' ' ' LEU . 45.3 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.772 -0.58 . . . . 0.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -123.06 150.8 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 109.335 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 m -126.91 136.41 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -139.66 145.59 38.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -110.19 145.36 37.4 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.112 -0.993 . . . . 0.0 109.925 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.11 148.52 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -122.72 129.89 52.31 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 140.6 37.91 Favored Pre-proline 0 N--CA 1.503 2.223 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.58 144.2 97.56 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.04 1.05 . . . . 0.0 110.86 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.03 -41.09 46.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.934 -1.104 . . . . 0.0 111.35 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -62.15 -45.82 91.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.651 -1.281 . . . . 0.0 111.12 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -76.88 -24.36 52.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.501 -1.374 . . . . 0.0 108.597 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.12 90.15 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.864 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -73.97 -33.68 63.96 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.388 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -68.2 -34.02 75.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.782 -1.199 . . . . 0.0 109.266 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -77.43 -44.85 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.147 -0.971 . . . . 0.0 110.991 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.22 -36.09 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.811 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.11 -171.96 39.42 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -91.74 -0.57 57.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.935 -1.333 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -153.52 19.1 0.69 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 73.48 -11.66 5.23 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 32' ' ' GLY . 28.0 pt20 -34.54 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.75 . . . . 0.0 111.19 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -82.43 -34.4 28.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.695 -1.253 . . . . 0.0 109.557 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -73.63 -25.03 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.971 -1.081 . . . . 0.0 108.815 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -72.26 -46.62 55.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.359 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -60.07 -47.29 86.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.81 -33.69 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.174 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.79 -43.58 83.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.039 -1.038 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -77.16 -32.94 56.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.095 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.38 -41.99 46.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 110.359 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 p -86.71 -23.38 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.079 -1.013 . . . . 0.0 110.53 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.17 71.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 161.06 20.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.86 -0.788 . . . . 0.0 110.161 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.4 m -108.42 138.55 44.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.9 mt -137.43 137.02 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.722 -1.237 . . . . 0.0 109.919 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -122.84 129.11 51.27 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.9 mt -100.91 132.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.855 -1.153 . . . . 0.0 108.528 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 18.5 p-10 -91.93 154.32 18.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 108.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 9.7 mp0 -67.8 149.51 98.22 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 120.817 -1.177 . . . . 0.0 108.502 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 CA-C-N 119.298 0.785 . . . . 0.0 111.711 179.554 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.701 0.762 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -116.26 136.21 53.21 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 78.1 mt -109.65 147.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.162 -0.961 . . . . 0.0 110.414 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.85 143.75 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.811 -0.555 . . . . 0.0 110.334 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -117.13 123.76 47.52 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.04 132.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.295 -0.878 . . . . 0.0 109.582 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.3 m -129.71 130.73 45.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.994 -1.066 . . . . 0.0 109.102 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.13 -172.73 38.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -72.84 160.03 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.608 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.05 -46.84 22.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 110.151 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.97 -47.38 68.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -56.97 -35.79 69.55 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.903 -1.123 . . . . 0.0 109.198 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.41 -45.45 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.595 -0.691 . . . . 0.0 110.28 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.23 -42.61 98.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.893 -1.129 . . . . 0.0 109.584 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.41 -36.77 83.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.85 61.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.427 -0.796 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -59.49 -48.5 81.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.56 -35.97 75.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.61 -28.85 63.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.774 -1.204 . . . . 0.0 109.095 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.7 -44.83 66.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.121 -0.987 . . . . 0.0 108.422 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.22 -38.87 90.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -0.757 . . . . 0.0 109.845 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -24.4 46.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 109.749 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.452 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 20.8 m -64.27 -34.4 78.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.109 -1.437 . . . . 0.0 107.377 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.74 -0.6 . . . . 0.0 109.822 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' ASN . 52.5 p 51.04 69.94 2.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.0 109.533 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.17 33.83 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.0 1.133 . . . . 0.0 111.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 2' ' ' SER . 9.2 m120 -154.06 69.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.333 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.3 m -164.06 103.16 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 64.1 t80 54.06 -176.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.568 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.552 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 76.17 -12.13 10.31 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER 46.83 28.0 0.77 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.631 -0.923 . . . . 0.0 109.727 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.4 mt 46.2 43.0 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.53 -32.88 0.84 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 170.67 162.75 23.54 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.17 165.97 18.06 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 118.355 1.077 . . . . 0.0 112.192 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.26 142.45 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.7 mt -123.61 149.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 m -127.81 137.24 52.32 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -139.17 145.07 38.91 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -111.5 145.7 38.58 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.05 147.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -120.37 129.35 53.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.73 140.01 36.4 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.25 142.13 97.17 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 120.104 1.073 . . . . 0.0 110.876 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -48.64 -41.36 30.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 111.306 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.0 111.248 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.13 -23.45 51.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.578 -1.326 . . . . 0.0 108.308 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.77 90.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.786 0.803 . . . . 0.0 109.669 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -74.13 -33.87 63.69 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.43 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -67.46 -34.79 77.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.706 -1.246 . . . . 0.0 109.25 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 81' ' ' VAL . 88.4 mt -78.82 -42.66 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 110.852 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.62 ' CD1' HH11 ' A' ' 59' ' ' ARG . 64.5 mt -69.35 -37.09 74.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.394 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.93 -171.33 42.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.96 -51.43 5.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.074 -1.251 . . . . 0.0 108.809 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 13.98 64.2 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.6 -4.48 14.15 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.688 -1.478 . . . . 0.0 109.578 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.0 mt-30 -42.69 -20.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.016 -1.285 . . . . 0.0 110.096 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 18.3 tpt180 -86.29 -39.42 16.53 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.158 -0.964 . . . . 0.0 110.862 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.34 -28.0 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.584 -1.322 . . . . 0.0 109.345 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -72.87 -49.05 32.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -56.26 -53.57 55.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.864 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.19 -31.56 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -62.88 -41.24 99.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.31 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 3.6 m80 -81.28 -38.93 26.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.38 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -65.28 -41.94 93.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.436 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -87.08 -23.14 25.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.05 . . . . 0.0 110.609 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 0.6 71.05 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.69 160.66 21.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.846 -0.796 . . . . 0.0 110.114 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.7 m -108.67 139.91 42.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.3 137.57 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 109.966 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -123.21 127.41 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.0 mt -99.57 134.11 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.938 -1.101 . . . . 0.0 108.775 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.06 152.91 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 0.0 108.503 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.6 149.64 98.02 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 120.935 -1.103 . . . . 0.0 108.606 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -61.01 143.33 99.27 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 120.57 0.847 . . . . 0.0 111.718 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.8 mt -82.75 119.43 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.266 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -49.83 129.91 20.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.88 29.29 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -153.43 123.74 7.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.53 50.25 1.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -140.07 154.11 46.97 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.844 0.83 . . . . 0.0 110.099 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.62 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.6 mtt180 -119.28 137.87 53.39 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.34 144.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.408 -0.807 . . . . 0.0 110.347 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.03 144.31 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.749 -0.594 . . . . 0.0 110.324 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.5 m -117.7 122.1 42.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.624 . . . . 0.0 109.333 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.3 mt -102.3 133.61 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.9 . . . . 0.0 109.394 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 m -131.39 129.52 41.42 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.002 -1.061 . . . . 0.0 109.146 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.79 -173.62 37.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 p -70.58 158.54 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.91 -1.347 . . . . 0.0 109.493 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -45.08 49.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.255 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -67.25 -48.42 67.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.036 -1.04 . . . . 0.0 109.502 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.96 -35.51 69.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 108.822 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.26 -46.33 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 110.076 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -59.83 -43.19 94.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.79 -1.194 . . . . 0.0 109.23 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -62.26 -32.02 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -47.32 18.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.512 -0.743 . . . . 0.0 109.541 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.86 -37.75 74.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -70.61 -34.49 72.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.668 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.31 -20.19 60.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.804 -1.185 . . . . 0.0 108.902 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.82 -46.43 21.57 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -62.68 -37.38 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.38 -24.66 46.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.209 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -64.24 -37.59 88.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 117.725 -1.59 . . . . 0.0 107.177 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 28' ' ' ILE . 18.2 t -41.65 -49.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.892 -0.505 . . . . 0.0 109.723 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 84' ' ' TYR . 49.6 mttm -48.85 -21.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.701 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' SER . 59.7 tt0 -55.84 -10.1 0.69 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.492 -1.38 . . . . 0.0 107.859 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 84.3 t80 -66.63 55.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.795 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . 5.6 p 63.54 8.27 3.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.98 -66.92 1.98 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' PHE . 16.2 mtpp -73.58 111.09 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.139 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 93.3 m-85 51.32 98.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.41 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -68.53 -43.64 31.45 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.259 -1.142 . . . . 0.0 110.269 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 2' ' ' SER . 3.9 Cg_exo -67.29 -167.32 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.765 0.977 . . . . 0.0 112.071 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -168.73 110.26 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -165.56 53.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.406 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.459 ' C ' ' N ' ' A' ' 8' ' ' ASP . 44.2 p90 -66.35 -1.68 3.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.63 -12.64 0.66 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' N ' ' C ' ' A' ' 6' ' ' TYR . 27.0 t70 49.91 60.33 3.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.402 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.0 OUTLIER 46.35 46.13 13.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.05 -41.98 0.36 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.41 162.33 23.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -65.18 171.67 8.67 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 118.423 1.111 . . . . 0.0 112.26 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.57 141.18 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.249 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.7 mt -124.83 150.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.365 -0.834 . . . . 0.0 109.702 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -128.01 137.55 52.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.62 145.87 39.05 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -111.75 145.47 39.29 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.68 155.62 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -125.37 130.11 51.27 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.28 131.16 23.85 Favored Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.19 132.81 53.5 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 CA-C-N 120.383 1.172 . . . . 0.0 111.186 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -39.54 -41.1 0.96 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.491 -0.755 . . . . 0.0 111.666 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.43 -46.51 88.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.746 -1.221 . . . . 0.0 110.702 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -76.11 -20.09 57.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.53 -1.356 . . . . 0.0 108.052 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.39 85.29 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.85 0.833 . . . . 0.0 109.439 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.16 -27.9 61.06 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.8 p -73.86 -32.02 63.45 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.257 -0.902 . . . . 0.0 109.154 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.6 mt -88.98 -43.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.0 111.099 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.66 -35.2 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.882 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 -173.12 41.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -91.81 -2.03 57.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.943 -1.328 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -152.01 18.17 0.83 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.9 -9.87 10.49 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.8 tt0 -36.24 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.707 -0.878 . . . . 0.0 111.004 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.668 HH21 HE22 ' A' ' 83' ' ' GLN . 11.8 tpp180 -88.19 -36.8 16.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.638 -1.289 . . . . 0.0 109.903 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.2 mm -73.05 -25.56 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.798 -1.189 . . . . 0.0 108.623 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -73.02 -49.95 25.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 108.837 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.53 -48.22 81.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.038 -1.039 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.62 -33.9 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.61 -54.75 43.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -70.81 -39.15 73.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.949 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -59.67 -46.04 90.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -86.5 -23.16 26.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 -0.98 85.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.46 163.13 17.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.966 . . . . 0.0 109.939 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 m -105.69 145.51 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.75 139.8 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.688 -1.257 . . . . 0.0 110.15 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.56 124.33 33.59 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.82 135.77 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 109.245 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.56 152.77 18.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.963 . . . . 0.0 108.81 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.48 153.46 94.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.002 -1.061 . . . . 0.0 108.721 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.44 157.05 56.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.874 1.049 . . . . 0.0 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.0 mt -103.11 170.68 7.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.522 -0.736 . . . . 0.0 109.146 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.3 141.61 28.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.088 -1.008 . . . . 0.0 109.45 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.26 21.74 64.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 m -163.81 94.89 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -1.155 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.2 pm0 -73.03 52.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.566 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 6.1 p30 -120.45 158.35 27.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.517 0.675 . . . . 0.0 109.27 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -119.88 138.92 53.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.6 mt -111.96 149.83 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.037 -1.04 . . . . 0.0 111.056 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.4 mt -135.04 143.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.769 -0.582 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.8 m -116.95 122.71 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -100.98 132.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -130.72 129.43 42.52 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.993 -1.067 . . . . 0.0 109.323 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -171.56 38.51 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.456 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 17.7 p -73.14 160.02 32.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.971 -1.311 . . . . 0.0 109.645 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -46.49 -47.25 19.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.22 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.52 -45.31 72.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -59.03 -36.98 75.9 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.906 -1.121 . . . . 0.0 108.787 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.1 -46.01 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.79 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.85 -43.44 94.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -61.17 -34.96 75.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 108.843 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.23 -45.76 46.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.448 -0.782 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.33 -47.35 85.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.366 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -61.32 -41.2 96.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.089 . . . . 0.0 109.943 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.59 -18.11 64.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.823 -1.173 . . . . 0.0 109.055 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -45.48 13.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 108.583 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -61.95 -38.83 89.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.688 . . . . 0.0 110.109 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -78.89 -22.53 45.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.411 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 98.8 p -63.36 -40.1 96.35 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.592 HG13 HD23 ' A' ' 24' ' ' LEU . 19.5 t -42.13 -52.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.325 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.471 ' C ' ' N ' ' A' ' 84' ' ' TYR . 41.2 mttp -46.93 -21.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.889 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.668 HE22 HH21 ' A' ' 35' ' ' ARG . 50.1 tt0 -57.95 -10.72 1.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.599 -1.313 . . . . 0.0 107.555 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 85.4 t80 -65.81 60.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.35 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . 23.9 p 54.4 8.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -70.31 -55.14 9.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' PHE . 16.2 mtpp -78.14 104.86 8.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 109.326 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 87' ' ' LYS . 45.6 t80 56.39 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.46 179.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m 52.25 70.76 1.72 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.39 -166.56 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.064 1.176 . . . . 0.0 111.892 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 52.44 51.86 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.6 p -73.7 144.32 45.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.479 ' C ' ' H ' ' A' ' 8' ' ' ASP . 25.1 m-85 55.42 22.25 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.74 13.41 2.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER 52.19 91.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 0.0 109.417 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.3 -23.15 57.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.343 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.57 38.31 80.43 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.55 164.89 15.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.03 156.15 64.27 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.895 1.063 . . . . 0.0 112.297 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.22 140.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -124.12 149.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.295 -0.878 . . . . 0.0 109.662 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -128.13 137.61 52.17 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.42 145.34 38.77 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.95 145.62 38.05 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.57 151.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.5 m -124.11 129.42 50.83 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.99 134.61 26.08 Favored Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.37 146.16 52.74 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.26 1.129 . . . . 0.0 110.917 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.23 -41.87 63.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.065 -1.022 . . . . 0.0 111.451 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.8 p-10 -63.23 -46.68 85.82 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.741 -1.224 . . . . 0.0 111.15 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 -24.16 59.78 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.536 -1.353 . . . . 0.0 108.332 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.52 83.65 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.641 0.734 . . . . 0.0 109.796 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.689 HH12 ' NH2' ' A' ' 59' ' ' ARG . 5.9 mtt-85 -74.37 -31.65 62.47 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.795 -0.762 . . . . 0.0 108.96 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -70.31 -39.07 75.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 109.327 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.5 mt -74.11 -44.76 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 110.743 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.3 mt -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.968 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.11 40.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -92.12 -40.53 10.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.334 . . . . 0.0 109.496 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.35 14.97 36.06 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 69.12 -5.79 4.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -43.42 -23.79 0.08 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.989 -1.301 . . . . 0.0 110.206 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.1 tpp180 -81.6 -39.65 24.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.045 -1.034 . . . . 0.0 110.675 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -26.93 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 109.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.63 -43.3 72.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 0.0 109.045 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.42 -49.5 76.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.937 -1.102 . . . . 0.0 109.959 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -52.58 -33.84 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.99 -1.069 . . . . 0.0 109.935 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -66.66 -35.99 81.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.78 -36.61 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 110.358 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -74.53 -41.62 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.178 -0.951 . . . . 0.0 110.503 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -87.1 -23.21 24.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 110.598 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.6 2.1 68.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.961 -2.056 . . . . 0.0 107.961 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.98 161.39 20.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.842 -0.799 . . . . 0.0 110.148 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.0 m -109.14 140.91 42.09 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.2 mt -138.03 136.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.819 -1.175 . . . . 0.0 109.974 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -121.14 127.51 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.76 132.29 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 0.0 108.484 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 60' ' ' ILE . 1.3 p30 -93.04 153.2 18.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.955 -1.09 . . . . 0.0 108.56 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -67.33 149.0 98.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 120.91 -1.119 . . . . 0.0 108.536 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.22 142.54 98.48 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 120.423 0.749 . . . . 0.0 111.696 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 mt -82.2 132.49 35.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -57.05 129.45 41.8 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 109.475 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.32 35.06 8.22 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 58' ' ' ASP . 51.0 m -163.96 102.23 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -1.109 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 6.0 mp0 -70.21 49.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 109.35 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 56' ' ' SER . 5.5 m-20 -141.12 154.01 45.69 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.994 0.902 . . . . 0.0 110.191 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.689 ' NH2' HH12 ' A' ' 26' ' ' ARG . 50.1 mtt180 -119.38 139.45 51.97 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 75.5 mt -111.07 141.07 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.348 -0.845 . . . . 0.0 110.518 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -122.41 144.98 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 110.393 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -117.78 123.53 46.21 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.68 132.6 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.424 -0.797 . . . . 0.0 109.547 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -129.58 130.07 45.22 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -173.67 38.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 p -73.63 160.45 31.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.293 . . . . 0.0 109.693 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.68 -47.1 20.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.588 -0.695 . . . . 0.0 110.017 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.9 -45.75 73.54 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.74 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.51 -38.65 81.51 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.813 -1.179 . . . . 0.0 109.183 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.32 -45.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.625 -0.672 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.36 -43.41 96.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.776 -1.202 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.54 -37.39 83.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 108.822 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.23 -46.79 48.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.716 . . . . 0.0 109.661 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -60.01 -46.63 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.243 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -61.59 -33.6 74.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.54 -24.28 58.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 108.93 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.77 -44.77 47.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 0.0 108.459 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -61.97 -38.58 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.728 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.85 -23.98 44.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -62.98 -37.86 88.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 t -42.46 -49.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.987 -0.445 . . . . 0.0 109.85 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' C ' ' N ' ' A' ' 84' ' ' TYR . 2.6 mptm? -48.06 -22.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 109.468 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' SER . 55.1 tt0 -59.93 -13.67 12.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.541 -1.349 . . . . 0.0 107.401 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.425 ' N ' ' C ' ' A' ' 82' ' ' LYS . 91.2 t80 -53.8 86.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER 69.46 10.08 7.54 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.06 160.52 29.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -55.62 143.95 28.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.375 -1.074 . . . . 0.0 108.466 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' LYS . 84.2 m-85 52.51 101.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.479 -0.763 . . . . 0.0 109.511 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.427 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.43 162.26 4.15 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 108.92 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.06 -69.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.996 1.13 . . . . 0.0 111.858 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 51.71 51.17 17.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.9 p -168.7 146.64 3.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 62.4 t80 -165.33 42.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . -65.84 4.24 2.45 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 6' ' ' TYR . 20.8 t0 58.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -1.041 . . . . 0.0 109.749 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' GLY . 31.0 mt -134.12 90.94 2.74 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.2 -18.65 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . -178.52 165.07 34.05 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.54 145.49 87.48 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 120.982 1.121 . . . . 0.0 112.064 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -74.6 140.85 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.912 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.58 148.11 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -126.95 136.94 52.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.67 144.89 37.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.49 145.21 39.45 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.06 151.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 m -124.43 129.9 51.51 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.85 140.46 37.72 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.28 146.56 88.7 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 CA-C-N 120.131 1.083 . . . . 0.0 111.107 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -53.08 -41.05 64.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.999 -1.063 . . . . 0.0 111.463 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.78 -44.82 95.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.732 -1.23 . . . . 0.0 111.355 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.37 -23.04 50.87 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.57 -1.331 . . . . 0.0 108.135 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.9 89.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.739 0.78 . . . . 0.0 109.606 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.413 HH11 ' CG ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -74.7 -30.93 61.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.52 ' O ' ' NE2' ' A' ' 83' ' ' GLN . 2.1 m -70.26 -32.23 69.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.867 -1.146 . . . . 0.0 109.286 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -82.42 -44.04 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.48 -35.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.787 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -173.36 41.07 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.73 2.0 56.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.001 -1.293 . . . . 0.0 109.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -156.01 19.58 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.08 -11.06 3.97 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 32' ' ' GLY . 59.5 mt-30 -36.26 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.708 -0.878 . . . . 0.0 110.683 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpp180 -85.13 -35.56 21.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.804 -1.185 . . . . 0.0 109.842 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -74.37 -26.45 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.961 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.7 -48.05 49.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.992 . . . . 0.0 108.912 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -57.16 -56.47 21.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.754 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.62 -32.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -62.16 -38.94 90.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -83.2 -39.37 21.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 110.602 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.8 -43.05 89.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.058 -1.026 . . . . 0.0 110.489 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 t -87.19 -23.55 24.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.191 -0.943 . . . . 0.0 110.692 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.67 1.67 72.69 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.92 161.96 19.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.852 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.48 140.72 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.6 mt -137.22 137.25 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.641 -1.287 . . . . 0.0 109.999 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -124.12 129.88 51.61 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.82 128.8 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.998 -1.063 . . . . 0.0 108.556 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 60' ' ' ILE . 20.5 p-10 -87.83 156.67 19.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.885 -1.134 . . . . 0.0 108.968 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.9 151.62 96.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.949 -1.095 . . . . 0.0 108.506 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.2 143.14 93.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.556 0.837 . . . . 0.0 111.858 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.7 mt -80.38 141.66 35.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.285 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -70.64 134.84 47.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.341 -0.85 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.01 -2.7 76.12 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.3 t -110.39 -178.95 3.63 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.467 -1.019 . . . . 0.0 109.661 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -144.02 31.07 1.27 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -135.11 159.81 40.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.889 0.852 . . . . 0.0 110.596 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -114.39 138.46 50.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 76.4 mt -112.3 141.06 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.24 -0.913 . . . . 0.0 110.802 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -125.6 145.87 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.716 -0.615 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.5 m -118.16 122.66 43.59 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.6 mt -103.91 132.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.925 . . . . 0.0 109.471 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -131.43 129.78 41.66 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.988 -1.07 . . . . 0.0 109.278 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.23 -172.38 38.33 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 p -72.33 159.63 33.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.269 . . . . 0.0 109.519 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -46.96 -46.94 21.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -68.16 -47.04 69.1 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -56.78 -34.45 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.885 -1.135 . . . . 0.0 109.369 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.9 mt -73.67 -45.35 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.499 -0.751 . . . . 0.0 110.45 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 16.2 tm0? -60.33 -43.83 96.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.717 -1.239 . . . . 0.0 109.6 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.23 -32.65 72.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 108.856 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.14 -45.87 25.37 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.456 -0.778 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.63 -48.08 80.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.05 -39.89 91.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.037 -1.04 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.52 -25.63 65.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 0.0 108.959 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.4 -46.24 41.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -61.73 -38.48 88.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.537 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -78.58 -25.06 45.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 89.1 p -62.36 -37.14 84.54 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.8 t -42.06 -48.37 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' C ' ' N ' ' A' ' 84' ' ' TYR . 39.0 pttt -50.07 -21.09 1.13 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.044 -1.035 . . . . 0.0 110.25 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.52 ' NE2' ' O ' ' A' ' 27' ' ' SER . 23.3 tt0 -57.68 -10.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 107.577 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 76.3 t80 -69.34 42.77 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.026 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 83' ' ' GLN . 8.4 p 59.02 7.58 0.84 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.364 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.0 -54.98 8.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -125.23 43.07 3.14 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.581 -0.952 . . . . 0.0 108.907 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 65.5 t80 -171.67 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.531 -0.73 . . . . 0.0 109.403 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 p90 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.469 -179.83 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.65 162.2 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -1.171 . . . . 0.0 108.966 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.78 159.82 23.45 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.974 1.116 . . . . 0.0 111.915 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 1.8 m120 -55.75 135.86 51.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.2 m -155.84 -11.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ASP . 31.9 p90 -172.0 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 9' ' ' LEU . . . -67.37 68.62 0.24 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.396 -2.281 . . . . 0.0 107.396 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' TYR . 26.5 t0 -45.49 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.928 . . . . 0.0 110.26 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLY . 14.3 mt -89.02 51.99 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 108.762 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 38.86 96.3 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.27 162.18 23.18 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -63.75 166.01 16.98 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 118.289 1.045 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -82.97 141.37 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.022 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -123.84 149.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -0.875 . . . . 0.0 109.642 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 m -127.78 137.3 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -139.24 144.91 38.64 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -110.59 145.61 37.55 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.162 -0.962 . . . . 0.0 110.008 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.63 151.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.7 129.86 52.28 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.34 136.97 29.37 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 24' ' ' LEU . 1.1 Cg_endo -60.42 137.55 75.0 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 CA-C-N 120.114 1.076 . . . . 0.0 111.082 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -43.79 -40.68 4.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.274 -0.891 . . . . 0.0 111.448 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -46.73 84.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.699 -1.25 . . . . 0.0 111.399 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 21' ' ' PRO . 74.3 mt -76.33 -19.46 58.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.375 -1.453 . . . . 0.0 108.069 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.82 88.93 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.721 0.772 . . . . 0.0 109.367 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 5.5 mtt-85 -74.57 -26.87 60.22 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.6 p -74.58 -28.84 61.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -88.28 -45.15 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.808 -1.183 . . . . 0.0 111.21 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.23 -34.7 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.91 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.05 -173.98 43.52 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -92.09 -4.97 53.65 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.997 -1.296 . . . . 0.0 109.554 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.1 1.41 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 77.34 -8.41 32.93 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLY . 12.2 pt20 -34.02 -29.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.952 -0.734 . . . . 0.0 111.235 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 mmt180 -85.88 -40.63 15.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.419 -1.426 . . . . 0.0 109.622 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -68.86 -26.62 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.009 -1.057 . . . . 0.0 109.202 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.86 -52.78 8.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.447 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -60.87 -47.8 84.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.05 . . . . 0.0 109.489 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.33 -36.01 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -55.87 -67.15 0.32 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.406 -0.809 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.78 -39.81 86.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -58.19 -45.97 86.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 110.128 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 p -86.77 -21.96 26.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.014 -1.054 . . . . 0.0 110.089 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.85 0.07 73.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.0 160.91 20.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.729 -0.865 . . . . 0.0 110.026 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.5 t -106.93 141.86 37.47 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.02 136.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.658 -1.276 . . . . 0.0 110.139 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.84 130.76 54.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.3 mt -101.01 134.16 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.644 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.28 150.48 20.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 108.598 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -66.86 149.85 98.13 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.899 -1.125 . . . . 0.0 108.437 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.98 141.6 89.83 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 119.261 0.772 . . . . 0.0 111.442 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -77.47 117.86 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.008 . . . . 0.0 109.317 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 5.6 mp0 -52.95 131.23 35.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.404 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.4 48.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.5 t -130.46 -170.4 2.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.488 -1.007 . . . . 0.0 109.295 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -144.63 33.58 1.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -138.15 157.67 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 110.706 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 26' ' ' ARG . 3.5 mtt-85 -116.87 140.53 49.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -111.93 141.63 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.288 -0.882 . . . . 0.0 110.718 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.25 144.4 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.696 -0.627 . . . . 0.0 110.47 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 m -117.57 122.3 43.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 mt -103.16 132.66 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -129.87 130.16 44.86 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.54 38.79 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 p -73.49 160.42 31.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.29 . . . . 0.0 109.662 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.14 -46.95 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.0 -47.02 69.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.07 -37.55 74.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.832 -1.167 . . . . 0.0 109.201 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.39 -45.8 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.621 -0.674 . . . . 0.0 110.316 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -60.01 -43.55 95.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.819 -1.176 . . . . 0.0 109.518 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -61.74 -33.12 73.5 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.19 -0.943 . . . . 0.0 108.75 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.12 -46.84 22.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.403 -0.811 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -58.36 -46.0 87.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -62.81 -37.06 85.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.062 . . . . 0.0 110.135 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.01 -17.71 62.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 108.971 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.34 -45.91 14.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 108.532 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.42 -38.24 88.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.621 -0.675 . . . . 0.0 110.273 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.71 -22.94 45.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 t -66.18 -36.35 82.86 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.06 -1.456 . . . . 0.0 107.369 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 81' ' ' VAL . 4.4 t -48.59 -43.26 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 110.201 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' TYR . 80.8 mttt -53.79 -22.36 9.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.284 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -57.91 -10.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.279 -1.513 . . . . 0.0 107.636 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.515 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 88.1 t80 -71.3 63.7 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m 52.37 10.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.272 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 84' ' ' TYR . . . -67.86 -65.9 2.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 16.6 mtpp -81.6 29.06 0.38 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -1.142 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 72.9 m-85 -162.0 40.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.6 t80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.414 -179.716 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.73 162.17 3.17 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.05 -36.39 96.52 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 120.928 1.085 . . . . 0.0 111.856 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.4 134.92 28.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.507 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -168.99 150.34 4.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.261 -0.899 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 50.98 22.0 1.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . -60.15 -10.37 15.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 7' ' ' GLY . 19.8 t0 60.48 143.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 11' ' ' GLY . 46.2 mt -96.54 -15.96 21.35 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.256 -0.903 . . . . 0.0 109.252 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.93 -10.02 3.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 161.75 167.63 22.48 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.3 141.66 76.1 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.077 1.184 . . . . 0.0 112.255 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -80.95 141.64 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 108.932 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -123.79 148.27 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.24 -0.913 . . . . 0.0 109.661 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -127.74 137.6 52.49 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.37 144.4 38.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.41 145.41 36.18 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.253 -0.904 . . . . 0.0 109.911 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.94 151.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -127.0 129.55 48.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.534 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.4 141.86 41.23 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.46 141.83 89.67 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 CA-C-N 120.287 1.138 . . . . 0.0 110.691 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -47.94 -41.15 24.16 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.897 -1.127 . . . . 0.0 111.451 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -61.75 -43.56 98.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.651 -1.281 . . . . 0.0 111.293 -178.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -78.92 -29.2 44.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.732 -1.23 . . . . 0.0 108.411 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -40.79 74.46 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.79 0.805 . . . . 0.0 109.311 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.78 -32.51 62.05 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.5 p -68.53 -25.24 64.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.959 -1.088 . . . . 0.0 109.046 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.55 -41.86 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.965 -1.085 . . . . 0.0 110.578 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.63 ' CD1' HH11 ' A' ' 59' ' ' ARG . 58.1 mt -68.12 -37.44 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.851 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.04 -173.72 39.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -91.27 -4.6 55.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.888 -1.36 . . . . 0.0 109.938 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.56 20.81 1.17 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.08 -11.4 2.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 32' ' ' GLY . 88.0 mt-30 -36.53 -27.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.737 -0.861 . . . . 0.0 110.624 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.6 tpp180 -86.17 -34.33 20.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.76 -1.213 . . . . 0.0 109.889 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -75.91 -27.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 109.172 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.29 -48.91 30.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -58.21 -55.13 38.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.574 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -50.41 -32.37 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 109.672 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -62.7 -37.81 87.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.045 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.79 -39.75 19.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 0.0 110.518 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.44 -41.61 93.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.984 -1.072 . . . . 0.0 110.333 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -86.96 -24.24 24.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.54 1.27 70.36 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.12 161.06 20.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.765 -0.844 . . . . 0.0 110.041 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.8 t -108.46 139.35 43.33 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.3 mt -136.76 136.75 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.822 -1.174 . . . . 0.0 109.981 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -122.28 128.83 51.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -99.05 135.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.119 . . . . 0.0 108.829 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.49 148.57 22.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.082 -1.011 . . . . 0.0 108.616 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 149.26 97.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.953 -1.092 . . . . 0.0 108.797 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.28 143.0 93.38 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.391 0.818 . . . . 0.0 111.479 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.83 133.56 39.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.07 -1.019 . . . . 0.0 109.507 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.29 134.95 57.01 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.14 39.41 7.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -159.99 174.87 13.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -1.119 . . . . 0.0 109.223 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -138.02 44.01 2.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 0.0 108.966 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -140.56 154.34 46.47 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.919 0.866 . . . . 0.0 109.831 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.63 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.4 mtt180 -118.71 140.14 50.42 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -111.26 142.16 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.16 143.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.82 -0.55 . . . . 0.0 110.384 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.3 m -117.76 122.84 44.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 0.0 109.451 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.74 133.07 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 m -130.36 130.23 44.14 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.052 -1.03 . . . . 0.0 109.221 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.33 -172.71 38.49 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 p -72.65 159.55 33.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.024 -1.28 . . . . 0.0 109.725 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -46.59 -46.94 19.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.102 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.24 -45.73 72.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -58.84 -37.35 76.27 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.85 -1.156 . . . . 0.0 109.226 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.66 -45.6 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.774 . . . . 0.0 110.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -60.53 -43.08 97.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 0.0 109.363 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -62.64 -34.58 77.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.897 . . . . 0.0 108.657 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -46.01 31.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.76 -37.16 78.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 110.142 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.79 -35.33 72.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.589 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.85 -1.156 . . . . 0.0 108.885 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -81.28 -45.31 16.42 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -61.81 -38.72 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.561 -0.712 . . . . 0.0 109.628 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -78.53 -24.69 45.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.6 p -62.14 -37.31 84.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HD23 ' A' ' 24' ' ' LEU . 39.6 t -41.56 -50.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.893 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' C ' ' N ' ' A' ' 84' ' ' TYR . 79.5 mttt -48.09 -22.55 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.609 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -58.44 -12.53 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.448 ' N ' ' C ' ' A' ' 82' ' ' LYS . 74.9 t80 -55.08 -59.38 4.83 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.929 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.1 p -171.57 58.66 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -135.74 -72.03 0.07 OUTLIER Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -81.87 18.3 1.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 108.571 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 86' ' ' GLY . 93.6 t80 -178.03 81.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.424 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.9 p 50.32 71.64 1.49 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -1.163 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.64 -46.49 6.89 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.122 1.215 . . . . 0.0 111.992 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -66.4 135.61 54.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 7' ' ' GLY . 42.3 t -158.54 169.57 24.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 8' ' ' ASP . 87.8 m-85 -74.79 33.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.892 . . . . 0.0 109.606 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -70.17 49.37 0.72 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' TYR . 7.3 p-10 -42.92 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.908 -0.76 . . . . 0.0 110.216 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.2 mt -75.36 -21.5 58.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.204 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 -40.54 0.44 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.12 165.71 28.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.84 150.13 89.12 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.972 1.114 . . . . 0.0 112.195 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -81.4 141.34 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.091 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -123.6 148.61 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.569 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 m -127.31 136.96 52.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.38 144.92 38.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.92 148.77 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.45 129.68 52.29 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.97 136.51 28.95 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.3 137.64 80.7 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 CA-C-N 120.243 1.123 . . . . 0.0 110.995 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -43.36 -40.53 3.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 111.528 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -63.02 -46.5 87.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.72 -1.237 . . . . 0.0 111.178 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.42 -20.52 57.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.58 -1.325 . . . . 0.0 108.289 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.58 89.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.702 0.763 . . . . 0.0 109.881 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 59' ' ' ARG . 3.8 mtt-85 -74.41 -32.39 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.859 -0.737 . . . . 0.0 109.265 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -69.22 -32.53 71.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.71 -1.244 . . . . 0.0 109.267 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -80.02 -44.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.025 -1.047 . . . . 0.0 110.821 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.526 ' CD1' HH11 ' A' ' 59' ' ' ARG . 54.5 mt -68.4 -36.39 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.941 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.88 -172.36 40.29 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -91.83 -24.26 19.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.992 -1.299 . . . . 0.0 109.765 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -127.41 18.26 6.09 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.12 -9.18 4.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' GLY . 36.9 mt-30 -38.93 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.991 . . . . 0.0 110.417 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 tpp180 -83.43 -37.68 22.9 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.977 -1.077 . . . . 0.0 110.244 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.0 -27.71 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.144 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.987 . . . . 0.0 109.076 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.44 -46.43 90.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.21 -33.44 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 0.0 110.078 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -67.35 -41.44 85.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HD1' ' C ' ' A' ' 41' ' ' HIS . 3.1 t-80 -78.44 -34.15 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.008 . . . . 0.0 110.221 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.27 -41.64 48.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.637 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -86.49 -23.55 25.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.939 -1.101 . . . . 0.0 110.449 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 0.69 71.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.62 161.26 20.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.738 -0.86 . . . . 0.0 109.926 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -109.1 140.05 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.44 137.34 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.728 -1.232 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -121.83 129.84 52.93 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.5 135.19 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.048 -1.033 . . . . 0.0 108.84 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -95.3 150.15 20.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 108.532 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 3.4 mp0 -66.56 149.52 98.07 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.878 -1.138 . . . . 0.0 108.586 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -61.69 141.49 90.99 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 119.363 0.808 . . . . 0.0 111.44 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.0 mt -76.38 117.73 18.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 109.4 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 13.6 mp0 -49.35 133.8 19.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.335 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.88 28.62 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -139.49 -175.98 4.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.462 -1.023 . . . . 0.0 109.232 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 11.8 mp0 -142.46 34.8 1.47 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -143.65 157.1 44.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.037 0.922 . . . . 0.0 111.033 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 26' ' ' ARG . 44.3 mtt180 -117.65 139.17 51.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -108.61 156.16 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.825 0.821 . . . . 0.0 110.541 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -138.94 142.63 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.752 -0.593 . . . . 0.0 110.07 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -116.65 123.08 46.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.695 -0.628 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.52 132.75 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.9 m -130.54 130.12 43.7 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.118 -0.989 . . . . 0.0 109.234 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.07 -173.13 39.23 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.8 p -73.49 160.23 32.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.046 -1.267 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -45.45 -48.77 13.8 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.397 0.618 . . . . 0.0 110.498 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.25 -45.43 73.24 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.946 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -58.54 -36.26 73.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 109.392 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.11 -45.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.251 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -60.62 -43.07 97.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.658 -1.276 . . . . 0.0 109.305 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.36 -36.63 82.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.59 49.42 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.517 -0.74 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.48 -45.05 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.924 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.5 mt -73.36 -16.0 61.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.867 -1.146 . . . . 0.0 108.998 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -83.36 -45.84 13.26 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.44 -38.2 88.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.78 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.3 -23.52 47.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -65.24 -35.41 80.96 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.953 -1.499 . . . . 0.0 107.392 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 81' ' ' VAL . 25.0 t -42.36 -54.24 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.661 -0.649 . . . . 0.0 110.179 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 84' ' ' TYR . 5.5 mptp? -45.0 -24.61 0.24 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 110.077 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' SER . 34.5 tt0 -55.66 -13.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.409 -1.432 . . . . 0.0 107.574 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 85' ' ' SER . 88.3 t80 -58.34 81.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER 82.68 53.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.275 0.559 . . . . 0.0 109.737 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.85 -35.24 0.49 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -158.36 -167.49 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 108.798 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' H ' ' CD ' ' A' ' 87' ' ' LYS . 73.4 t80 -52.56 -7.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 109.673 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' H ' ' C ' ' A' ' 87' ' ' LYS . 73.9 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.376 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.6 p -168.16 71.26 0.86 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -1.216 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.51 -42.13 35.57 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.12 1.213 . . . . 0.0 112.016 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 6' ' ' TYR . 28.0 t-20 -167.94 13.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 7' ' ' GLY . 8.2 m -71.37 12.54 0.32 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 57.2 t80 -73.68 35.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -65.31 4.28 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.5 ' OD1' ' CE2' ' A' ' 6' ' ' TYR . 36.6 m-20 53.04 67.78 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -1.154 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.4 mt -82.95 44.11 0.9 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.23 -34.76 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 168.96 162.08 20.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -65.63 166.67 19.23 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.32 1.06 . . . . 0.0 112.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mm -87.19 140.46 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 109.154 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.2 mt -125.31 151.47 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.341 -0.849 . . . . 0.0 109.931 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 t -129.69 142.25 50.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.254 -0.904 . . . . 0.0 108.988 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -143.24 146.75 33.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.98 146.94 39.43 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.57 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.2 150.97 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -130.44 82.28 2.05 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.56 149.61 75.17 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -57.01 169.13 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 119.418 0.828 . . . . 0.0 110.148 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -76.08 -42.33 47.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.565 -1.335 . . . . 0.0 110.949 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.06 -39.85 95.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.748 -1.22 . . . . 0.0 111.532 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 21' ' ' PRO . 21.9 mt -79.63 -27.66 40.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.779 -1.201 . . . . 0.0 108.638 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' PRO . . . -58.19 -38.64 77.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.826 0.822 . . . . 0.0 109.186 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.34 -33.81 63.25 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -67.9 -29.93 69.15 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.859 -1.15 . . . . 0.0 108.97 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -83.93 -42.99 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.926 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' CD1' HH11 ' A' ' 59' ' ' ARG . 56.4 mt -67.45 -36.24 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.961 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.02 -173.83 41.67 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 31' ' ' LYS . 1.4 mptm? -91.74 -0.02 57.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.933 -1.333 . . . . 0.0 109.651 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.13 19.4 0.64 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.18 -11.52 4.9 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 32' ' ' GLY . 14.8 pt20 -34.99 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.858 -0.789 . . . . 0.0 111.011 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.3 tpp180 -84.31 -34.62 23.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.718 -1.239 . . . . 0.0 109.89 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -74.69 -26.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.935 -1.103 . . . . 0.0 108.882 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -71.57 -47.94 51.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 108.945 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -60.09 -49.57 77.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.14 -34.71 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.112 -0.992 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 110.036 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.49 -38.1 59.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.099 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.97 -43.42 98.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 110.086 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -86.86 -22.16 25.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.991 -1.068 . . . . 0.0 110.276 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 0.19 74.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.72 161.83 19.88 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.771 -0.841 . . . . 0.0 110.042 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -107.58 142.85 36.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -138.46 136.54 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.681 -1.262 . . . . 0.0 110.027 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -121.39 130.02 53.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.8 mt -100.47 135.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.894 -1.129 . . . . 0.0 108.808 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.29 150.39 20.33 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.17 150.46 95.5 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.905 -1.122 . . . . 0.0 108.504 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.25 142.27 97.82 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 CA-C-N 119.167 0.738 . . . . 0.0 111.523 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.68 130.81 35.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.938 . . . . 0.0 109.422 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 3.0 mp0 -63.14 133.16 53.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.15 19.03 34.57 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -153.1 142.81 21.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -1.079 . . . . 0.0 109.243 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.3 pm0 -102.87 51.64 0.8 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.503 -0.748 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -143.99 154.54 43.38 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.669 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' CD1' ' A' ' 29' ' ' ILE . 40.7 mtt180 -117.69 139.81 50.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -109.08 152.09 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.759 0.79 . . . . 0.0 110.793 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.97 142.47 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.771 -0.58 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.4 m -114.61 126.61 55.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mt -107.36 130.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.396 -0.815 . . . . 0.0 109.397 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -128.63 131.11 48.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.17 -174.33 39.45 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 p -72.92 159.96 32.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.045 -1.268 . . . . 0.0 109.773 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.94 -47.41 21.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.4 -45.34 72.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -59.21 -36.22 75.0 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.904 -1.122 . . . . 0.0 109.235 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.697 ' CG2' HE22 ' A' ' 74' ' ' GLN . 86.1 mt -74.48 -45.28 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 110.454 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 13.7 tm0? -60.36 -43.22 96.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.708 -1.245 . . . . 0.0 109.188 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.92 -31.86 71.37 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.57 -42.02 53.21 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.591 -0.693 . . . . 0.0 109.913 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.697 HE22 ' CG2' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -57.79 -52.69 64.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 0.0 109.354 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.99 -38.73 70.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.96 -22.21 62.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.791 -1.193 . . . . 0.0 109.251 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.9 mt -79.44 -45.54 19.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.0 108.222 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.24 -38.48 89.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.573 -0.704 . . . . 0.0 109.846 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.62 -24.17 45.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' ' 83' ' ' GLN . 78.9 p -63.72 -37.21 86.49 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.423 ' CG1' HD13 ' A' ' 24' ' ' LEU . 3.5 t -50.11 -40.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.704 -0.623 . . . . 0.0 110.144 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' C ' ' N ' ' A' ' 84' ' ' TYR . 85.3 mttt -56.89 -24.86 55.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.951 -1.093 . . . . 0.0 110.531 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.519 ' N ' ' OE1' ' A' ' 83' ' ' GLN . 9.7 mp0 -57.76 -11.24 2.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.116 -1.615 . . . . 0.0 107.363 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 85.0 t80 -68.97 55.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.032 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 83' ' ' GLN . 7.4 m 56.8 4.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -64.91 -78.6 0.2 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 6.6 ptmm? -59.55 120.11 8.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -1.15 . . . . 0.0 109.226 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 50.95 91.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.447 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m 52.45 71.54 1.43 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.201 -1.176 . . . . 0.0 109.559 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.71 102.93 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.18 1.253 . . . . 0.0 111.97 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -165.64 79.97 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 m 51.46 68.06 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 69.5 t80 -64.43 -176.89 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.586 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 69.84 0.55 26.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' GLY . 5.1 m-20 52.91 82.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.47 -1.018 . . . . 0.0 109.484 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 mt 45.58 58.1 4.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.58 27.11 17.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' GLY . . . 79.98 163.24 27.27 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -64.63 166.46 17.74 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.956 1.104 . . . . 0.0 112.227 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.96 141.9 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 109.096 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -125.08 149.85 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.3 -0.875 . . . . 0.0 109.879 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.3 t -129.08 142.1 51.0 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.011 0.91 . . . . 0.0 108.888 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -143.07 144.59 32.32 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -110.46 145.99 36.69 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.18 148.59 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -121.78 129.65 52.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 135.21 27.07 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.531 -0.731 . . . . 0.0 109.087 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.99 136.66 78.06 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.271 1.132 . . . . 0.0 111.335 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -43.16 -41.31 3.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.219 -0.925 . . . . 0.0 111.579 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -62.25 -46.19 89.96 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.74 -1.225 . . . . 0.0 111.054 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.31 -25.47 54.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.658 -1.276 . . . . 0.0 108.02 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.59 82.33 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.785 0.803 . . . . 0.0 109.321 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.84 -29.33 61.02 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -72.08 -30.25 64.93 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.062 -1.024 . . . . 0.0 109.052 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -86.97 -43.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.007 -1.058 . . . . 0.0 110.937 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.61 -35.59 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.728 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -175.35 43.13 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -91.59 -3.38 56.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -150.03 18.71 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.31 -10.43 6.21 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 32' ' ' GLY . 18.7 mm100 -36.25 -27.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.787 -0.831 . . . . 0.0 110.594 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.92 -35.7 20.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.937 -1.102 . . . . 0.0 109.856 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -76.19 -28.04 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.961 -1.087 . . . . 0.0 109.269 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.57 -48.8 37.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.966 -1.084 . . . . 0.0 109.307 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -57.38 -42.68 82.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.0 110.057 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.12 -32.72 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 110.114 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -65.76 -49.47 68.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.002 . . . . 0.0 109.952 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 1.7 m80 -71.4 -32.27 68.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -42.7 42.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.373 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -86.58 -23.74 25.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.68 0.81 75.29 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.74 161.38 20.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.761 -0.847 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.9 140.51 42.28 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.88 137.76 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.689 -1.257 . . . . 0.0 110.013 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -122.82 129.45 51.71 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG21 ' NH2' ' A' ' 59' ' ' ARG . 68.4 mt -100.36 135.42 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 108.71 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.03 151.67 18.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.023 -1.048 . . . . 0.0 109.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.95 154.44 92.31 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.067 -1.02 . . . . 0.0 108.399 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -64.69 141.99 74.93 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.477 0.785 . . . . 0.0 111.748 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.2 mt -79.92 118.94 22.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.282 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -55.77 114.64 1.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.411 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.07 -17.0 5.2 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.0 t -122.51 -170.25 2.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.435 -1.038 . . . . 0.0 109.687 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.47 37.85 1.69 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.68 157.77 36.48 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.8 mmm180 -117.72 137.55 52.61 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.61 156.0 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.887 0.851 . . . . 0.0 111.078 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.74 142.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.139 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.8 m -116.21 123.96 49.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.643 -0.661 . . . . 0.0 109.287 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.17 -0.956 . . . . 0.0 109.572 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -130.35 130.24 44.18 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.098 -1.001 . . . . 0.0 109.06 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.46 -173.25 38.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.2 p -72.42 159.59 33.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.968 -1.313 . . . . 0.0 109.618 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -47.1 -46.97 23.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 110.162 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.12 -47.14 68.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 109.882 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.36 -36.51 71.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.79 -1.194 . . . . 0.0 109.111 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.26 -45.82 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -60.48 -42.75 96.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.818 -1.177 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -62.16 -37.74 86.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.305 -0.872 . . . . 0.0 108.875 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.92 -44.09 64.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.422 -0.798 . . . . 0.0 109.601 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -58.04 -48.93 78.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.024 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.64 -39.14 83.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.84 -18.3 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.861 -1.15 . . . . 0.0 109.194 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -45.91 12.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 108.392 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.11 -38.62 89.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.665 -0.647 . . . . 0.0 110.042 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -78.99 -23.59 44.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.925 -1.109 . . . . 0.0 109.89 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.1 p -61.94 -36.68 82.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 t -49.92 -51.12 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.89 -0.506 . . . . 0.0 110.42 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -47.85 -25.51 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.804 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.572 ' O ' ' N ' ' A' ' 85' ' ' SER . 48.5 tt0 -61.72 -10.75 9.45 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.473 -1.392 . . . . 0.0 107.694 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' O ' ' OG ' ' A' ' 85' ' ' SER . 89.2 t80 -44.76 88.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.5 p 52.45 32.43 11.33 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 61.43 150.23 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.86 57.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.134 . . . . 0.0 109.038 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 86' ' ' GLY . 61.9 t80 -172.26 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CD1' ' OXT' ' A' ' 89' ' ' PHE . 54.1 t80 . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.505 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -168.78 71.22 0.76 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.21 -1.171 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.94 101.49 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.064 1.176 . . . . 0.0 111.934 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.419 ' C ' ' N ' ' A' ' 6' ' ' TYR . 50.9 t30 -168.29 176.15 6.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.417 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 10.5 m 54.83 9.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASP . 58.7 t80 -72.23 6.86 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . -69.04 62.39 0.52 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' TYR . 5.2 m-20 -40.89 130.54 2.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.885 -0.774 . . . . 0.0 110.367 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER 53.32 29.81 9.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.237 -0.915 . . . . 0.0 108.73 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' GLY . . . 75.54 -37.72 1.2 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 176.06 164.52 30.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.83 164.12 25.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.862 1.041 . . . . 0.0 112.02 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.62 142.9 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.377 -0.827 . . . . 0.0 109.156 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.93 149.22 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.293 -0.879 . . . . 0.0 109.682 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.4 m -127.94 137.5 52.29 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.91 146.17 38.9 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -112.02 145.97 38.72 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -126.77 155.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -126.44 130.27 50.35 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -126.21 133.26 24.77 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.94 136.09 74.6 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 CA-C-N 120.356 1.163 . . . . 0.0 111.265 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -42.46 -41.28 2.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 111.515 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.88 -46.33 88.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.651 -1.28 . . . . 0.0 111.187 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 HG13 ' A' ' 81' ' ' VAL . 10.8 mp -75.65 -19.8 58.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.491 -1.381 . . . . 0.0 108.109 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.43 85.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.34 -28.66 61.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.9 p -72.89 -30.71 64.16 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.121 -0.987 . . . . 0.0 109.178 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -89.06 -43.06 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 0.0 111.014 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.5 mt -69.13 -35.98 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.061 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -170.7 38.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 15.7 ttpp -91.76 -11.76 35.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.948 -1.325 . . . . 0.0 110.007 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.17 17.99 2.51 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.55 -9.64 14.76 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 5.7 tp-100 -36.07 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.707 -0.878 . . . . 0.0 111.137 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.683 HH21 ' NE2' ' A' ' 83' ' ' GLN . 12.1 tpp180 -85.95 -35.51 20.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.536 -1.352 . . . . 0.0 109.7 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -72.55 -23.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.81 -1.182 . . . . 0.0 108.414 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -73.19 -50.23 23.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -0.976 . . . . 0.0 109.004 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -57.25 -51.42 69.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.63 -33.5 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.566 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -58.8 -64.82 0.8 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -62.29 -39.3 92.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -61.14 -44.65 96.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.255 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 p -86.71 -22.93 25.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.976 -1.078 . . . . 0.0 110.433 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.71 0.55 74.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.65 19.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.803 -0.822 . . . . 0.0 110.025 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.0 t -107.23 141.57 38.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.0 mt -137.09 138.33 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.57 -1.331 . . . . 0.0 110.265 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -124.83 129.87 51.28 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.68 136.23 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.059 . . . . 0.0 108.917 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.17 152.16 18.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -1.0 . . . . 0.0 109.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 4.0 pm0 -67.06 154.08 93.27 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 120.993 -1.067 . . . . 0.0 108.731 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.64 151.0 85.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.675 0.916 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.62 169.22 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.308 -0.87 . . . . 0.0 109.11 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.55 141.78 29.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.03 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 37.85 47.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 58' ' ' ASP . 26.0 t -174.07 90.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.164 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 11.3 mp0 -68.66 55.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' SER . 1.8 m-20 -126.39 154.46 43.56 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.96 138.35 52.23 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -111.66 147.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.196 -0.94 . . . . 0.0 110.752 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 20' ' ' ILE . 96.6 mt -132.55 144.04 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.858 -0.526 . . . . 0.0 110.445 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.9 m -118.02 122.29 42.82 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -102.22 133.33 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -131.17 129.67 42.04 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.999 -1.063 . . . . 0.0 109.145 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.62 -172.32 38.65 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -72.08 159.02 34.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.01 -1.288 . . . . 0.0 109.716 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -47.19 21.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.855 -0.528 . . . . 0.0 110.342 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -68.52 -45.55 71.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.806 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -58.24 -35.2 71.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.114 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.9 mt -73.52 -45.59 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.467 -0.77 . . . . 0.0 110.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -60.47 -42.84 97.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.754 -1.216 . . . . 0.0 109.376 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.79 -36.18 80.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.79 57.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -58.45 -48.66 80.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 110.379 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.06 -41.84 93.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.955 -1.091 . . . . 0.0 109.932 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.56 -25.29 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.798 -1.189 . . . . 0.0 108.966 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.6 -45.55 44.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.65 -38.59 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.471 -0.768 . . . . 0.0 109.385 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -78.41 -24.24 46.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.342 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.4 p -63.22 -37.61 87.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.331 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 HD23 ' A' ' 24' ' ' LEU . 22.9 t -41.26 -50.72 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' GLY . 2.6 mptm? -47.64 -22.39 0.5 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.424 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.683 ' NE2' HH21 ' A' ' 35' ' ' ARG . 53.4 tt0 -61.58 -14.66 32.0 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -53.81 85.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.782 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.0 t 65.46 33.24 8.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 108.891 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . 87.25 163.99 39.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 4.5 mtmm -76.1 31.8 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -1.124 . . . . 0.0 108.726 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.533 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 68.6 m-85 -162.38 92.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.9 t80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.362 -179.847 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.592 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -68.09 -44.02 37.37 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 110.282 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 2' ' ' SER . 3.3 Cg_exo -66.97 -176.79 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 120.81 1.007 . . . . 0.0 112.03 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.6 m-20 52.23 85.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 76.2 p -170.3 107.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -165.47 -4.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.83 -28.51 11.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 173.01 123.99 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' GLY . 19.0 mt -68.25 49.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . -55.45 87.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 137.58 -74.3 0.41 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -45.71 117.58 1.85 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.936 1.09 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.46 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.537 -0.727 . . . . 0.0 109.26 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 9' ' ' LEU . 57.7 mt -123.29 148.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 m -127.51 137.34 52.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -138.96 144.49 39.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -110.3 145.78 36.83 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.196 -0.94 . . . . 0.0 110.239 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.08 148.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -121.49 129.87 53.2 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.86 138.73 33.23 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.557 -0.715 . . . . 0.0 109.183 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -56.22 147.21 67.34 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.032 1.047 . . . . 0.0 110.992 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -54.05 -41.86 68.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.996 -1.065 . . . . 0.0 111.271 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -62.25 -42.64 99.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.749 -1.219 . . . . 0.0 111.162 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.488 HD13 ' CG1' ' A' ' 81' ' ' VAL . 27.2 mt -79.48 -26.68 41.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.63 -1.294 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -39.11 78.01 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.859 0.838 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.7 -30.51 61.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.4 p -70.67 -29.22 65.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.102 -0.999 . . . . 0.0 109.352 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.7 mt -86.65 -44.25 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.022 -1.049 . . . . 0.0 111.108 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.2 mt -64.86 -34.69 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.569 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -176.62 46.16 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -92.25 0.34 57.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.038 -1.272 . . . . 0.0 109.406 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.8 15.19 0.7 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 78.11 -8.02 40.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.1 mt-30 -34.57 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.943 -0.739 . . . . 0.0 111.023 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.5 mmp_? -87.05 -43.46 12.29 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.545 -1.347 . . . . 0.0 109.469 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.92 -26.46 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.077 -1.015 . . . . 0.0 108.951 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.75 -53.58 7.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' OE1' ' NH2' ' A' ' 35' ' ' ARG . 88.3 mt-30 -59.16 -52.48 65.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -52.93 -34.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.36 -47.71 84.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.389 -0.819 . . . . 0.0 110.576 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -75.07 -40.52 60.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.008 . . . . 0.0 110.746 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.93 -43.07 99.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 110.34 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -87.8 -22.92 24.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 110.632 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.73 0.6 74.86 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 160.74 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.768 -0.842 . . . . 0.0 110.194 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 t -108.09 142.8 37.72 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -138.51 136.88 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 110.301 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -122.06 128.54 51.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.1 mt -99.56 135.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 109.162 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -95.85 150.3 20.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.113 -0.992 . . . . 0.0 108.503 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.62 150.59 97.32 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.837 -1.164 . . . . 0.0 108.617 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.79 143.18 91.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 CA-C-N 119.133 0.726 . . . . 0.0 111.486 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.6 mt -77.39 119.93 21.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.048 -1.032 . . . . 0.0 109.368 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 55' ' ' GLY . 3.2 tm-20 -49.26 137.95 13.36 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.417 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 54' ' ' GLU . . . 86.98 33.82 11.73 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.0 t -155.62 -176.24 5.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -142.92 40.51 1.52 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.403 -0.811 . . . . 0.0 108.962 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.73 154.49 47.45 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.92 0.867 . . . . 0.0 110.102 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 46.9 mtt180 -119.74 138.87 53.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -108.07 155.58 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.441 -0.787 . . . . 0.0 110.607 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -138.54 141.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.762 -0.586 . . . . 0.0 110.021 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -115.76 122.99 47.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -102.32 133.48 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -130.57 129.68 43.09 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.086 -1.009 . . . . 0.0 109.152 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.61 -174.1 38.94 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -72.39 159.66 33.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.954 -1.321 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -46.59 -46.6 19.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.245 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -68.3 -45.96 71.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.274 -0.892 . . . . 0.0 109.946 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -58.35 -36.03 72.82 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.862 -1.149 . . . . 0.0 109.359 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.1 mt -71.91 -45.95 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.2 -43.59 95.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.768 -1.207 . . . . 0.0 109.663 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -60.98 -39.63 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.152 -0.968 . . . . 0.0 108.689 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.53 64.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.507 -0.746 . . . . 0.0 109.398 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.16 -49.86 74.63 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.494 -0.754 . . . . 0.0 110.319 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.53 -37.72 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.027 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.31 -19.78 63.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.791 -1.193 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 81' ' ' VAL . 13.7 mt -81.05 -46.24 15.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 108.624 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.45 -39.53 93.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.747 -0.595 . . . . 0.0 110.715 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -78.33 -22.34 48.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -65.25 -34.71 79.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.111 -1.436 . . . . 0.0 107.316 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' CG1' HD13 ' A' ' 24' ' ' LEU . 1.3 t -68.17 -40.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -0.818 . . . . 0.0 110.858 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -56.83 -32.0 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.999 -1.063 . . . . 0.0 111.018 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.02 -21.16 11.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.37 -1.456 . . . . 0.0 108.014 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.419 ' O ' ' OG ' ' A' ' 85' ' ' SER . 28.0 m-85 -100.48 84.93 2.85 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.448 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 85' ' ' SER . 24.9 p 56.91 77.24 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.548 -0.72 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -152.57 -70.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 12.9 mtpp -81.88 20.71 0.93 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 96.9 m-85 -161.73 -122.15 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.287 179.481 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 53.3 p 50.48 71.17 1.63 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.231 -1.158 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.44 140.26 52.0 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.095 1.197 . . . . 0.0 111.917 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 1.0 OUTLIER -55.38 131.2 45.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -95.15 58.79 2.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.209 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 75.9 t80 -170.28 3.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.31 -41.03 39.08 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' LEU . 14.6 t70 -176.34 177.98 1.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 4.0 mm? -93.78 66.14 3.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 108.414 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.49 45.8 22.92 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.58 165.87 25.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.52 163.56 23.62 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.857 1.038 . . . . 0.0 112.265 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -80.3 144.8 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.067 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -123.44 150.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.308 -0.87 . . . . 0.0 109.368 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.19 138.05 53.61 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.47 144.17 37.88 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -110.87 146.32 36.71 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.27 152.77 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -126.4 129.6 49.09 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 140.15 36.43 Favored Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.76 150.76 68.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 CA-C-N 120.019 1.042 . . . . 0.0 110.665 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -56.48 -40.85 75.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.87 -1.143 . . . . 0.0 111.2 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.18 -45.4 91.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 111.552 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.88 -26.2 53.93 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.36 -1.462 . . . . 0.0 108.466 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.06 80.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.812 0.815 . . . . 0.0 109.514 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.45 -30.82 62.03 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.79 -34.3 71.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.081 -1.012 . . . . 0.0 109.147 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -82.11 -44.37 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 111.09 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.562 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.4 mt -67.1 -35.38 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.918 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.09 -175.67 41.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -91.23 -9.58 44.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.022 -1.281 . . . . 0.0 109.967 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -144.17 20.03 2.11 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 71.39 -11.6 2.95 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 32' ' ' GLY . 5.7 pt20 -35.54 -36.12 0.07 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.77 -0.841 . . . . 0.0 110.656 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -76.71 -33.35 58.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.949 -1.094 . . . . 0.0 110.213 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -77.01 -26.36 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.62 -1.3 . . . . 0.0 109.334 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.63 -46.22 66.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 109.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -59.99 -49.9 75.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.677 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.05 -33.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -61.23 -64.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.243 -0.91 . . . . 0.0 110.047 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -64.08 -38.81 92.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 110.231 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.37 -42.15 98.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.238 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 28.0 p -87.01 -22.49 25.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.931 -1.106 . . . . 0.0 110.383 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.08 0.25 69.54 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.82 160.87 21.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.857 -0.79 . . . . 0.0 110.116 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.55 139.79 41.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.44 137.22 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.669 -1.269 . . . . 0.0 109.935 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -122.83 126.87 48.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.98 135.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.873 -1.142 . . . . 0.0 108.528 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.42 148.18 23.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.151 -0.968 . . . . 0.0 108.593 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.19 149.17 97.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.899 -1.126 . . . . 0.0 108.761 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -61.54 141.81 92.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 CA-C-N 119.344 0.802 . . . . 0.0 111.581 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.5 mt -76.09 122.65 24.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -50.41 140.06 14.3 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.208 -0.932 . . . . 0.0 109.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.63 32.22 19.4 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -157.99 173.29 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -1.148 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -133.88 42.18 2.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.455 -0.778 . . . . 0.0 109.194 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.38 154.59 49.97 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.801 0.81 . . . . 0.0 109.775 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.562 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.7 mtt180 -119.19 138.97 52.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.2 mt -110.12 147.95 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.35 -0.844 . . . . 0.0 110.645 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -130.57 143.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.758 -0.589 . . . . 0.0 110.311 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.3 m -116.51 122.68 45.41 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.58 133.1 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 m -130.98 129.41 42.08 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.018 -1.051 . . . . 0.0 109.169 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.83 -173.94 39.94 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 159.41 34.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.12 -1.224 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.06 -47.04 22.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.717 -0.614 . . . . 0.0 110.451 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -68.5 -44.57 74.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.787 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 43' ' ' SER . 24.1 mm100 -59.54 -36.68 76.62 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.916 -1.115 . . . . 0.0 109.284 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -71.19 -45.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.124 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -60.36 -43.12 96.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.804 -1.185 . . . . 0.0 109.334 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.5 -37.15 84.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 108.628 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -46.64 48.94 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.525 -0.734 . . . . 0.0 109.491 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.54 -41.34 89.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -66.91 -36.39 82.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.15 -13.95 61.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 108.943 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.59 -45.16 12.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.971 . . . . 0.0 108.454 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.02 -38.45 88.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -79.14 -24.16 43.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 109.467 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.9 p -63.78 -38.58 91.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 81' ' ' VAL . 22.1 t -40.19 -46.44 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.475 ' C ' ' N ' ' A' ' 84' ' ' TYR . 16.5 pttm -50.56 -19.49 0.91 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.876 -1.14 . . . . 0.0 109.903 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 85' ' ' SER . 52.1 tp60 -56.88 -12.38 1.93 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 79.9 t80 -71.16 45.34 0.09 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.977 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 83' ' ' GLN . 4.0 m 57.31 6.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.318 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -66.45 -45.67 83.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -133.67 44.05 2.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 108.876 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 81.2 t80 -173.3 58.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 109.248 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.449 -179.78 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.7 m -166.04 71.38 1.22 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.257 -1.143 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -61.28 129.44 28.38 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.094 1.196 . . . . 0.0 111.964 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -170.82 147.11 2.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.078 -1.014 . . . . 0.0 109.523 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.2 p -171.03 70.49 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -73.04 11.07 0.76 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 109.669 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -46.67 38.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' H ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER 169.73 15.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' GLY . 17.5 mt 43.6 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.834 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLY . . . -57.19 82.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 56.79 164.62 0.05 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.58 160.77 46.52 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 120.921 1.081 . . . . 0.0 112.017 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.59 140.92 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.069 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.11 149.53 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -125.83 137.78 53.79 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.48 144.75 38.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -111.31 146.79 36.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -125.59 154.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 130.05 49.51 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.32 138.42 32.75 Favored Pre-proline 0 N--CA 1.506 2.338 0 O-C-N 121.514 -0.741 . . . . 0.0 109.23 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.88 175.05 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.114 1.076 . . . . 0.0 110.828 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.37 -39.27 39.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.584 -1.322 . . . . 0.0 110.534 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -63.41 -39.75 95.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -0.889 . . . . 0.0 111.457 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 24' ' ' LEU . 11.2 mp -81.01 -28.66 35.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.439 -1.413 . . . . 0.0 108.311 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.039 0.923 . . . . 0.0 109.171 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -71.51 -30.87 66.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.0 p -72.28 -31.18 65.51 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.072 -1.017 . . . . 0.0 109.223 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -86.74 -44.27 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.146 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -67.21 -35.44 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.83 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.96 -173.61 41.56 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -91.67 0.55 57.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.046 -1.267 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.6 18.59 0.59 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.63 -10.35 6.95 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 33' ' ' GLY . 40.7 mt-30 -35.58 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.797 -0.825 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 tpt180 -85.68 -35.27 20.99 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.641 -1.287 . . . . 0.0 110.069 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -74.33 -27.38 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 109.019 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.62 -47.79 44.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.31 -46.49 88.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.039 -1.038 . . . . 0.0 110.031 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.92 -33.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -66.67 -40.18 88.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.015 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 18.5 t-80 -77.51 -30.42 52.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 110.248 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 42' ' ' GLU . 2.2 tm-20 -79.12 -41.58 28.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -86.59 -23.68 25.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 110.48 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.52 0.6 73.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.46 161.15 20.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.681 -0.894 . . . . 0.0 110.053 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.6 m -108.79 140.07 42.73 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.76 137.5 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.775 -1.203 . . . . 0.0 110.024 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -122.3 129.26 52.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -99.68 135.15 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.884 -1.135 . . . . 0.0 108.676 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 10.0 m-20 -95.83 150.18 20.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.158 -0.964 . . . . 0.0 108.626 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -66.4 151.12 96.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.916 -1.115 . . . . 0.0 108.609 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.01 142.18 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 120.451 0.767 . . . . 0.0 111.705 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.0 mt -79.71 137.37 37.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.41 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.32 134.51 50.42 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.3 -0.875 . . . . 0.0 109.695 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.24 -6.6 63.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.4 t -110.03 -169.15 1.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.367 -1.078 . . . . 0.0 109.58 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.58 38.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.68 162.79 34.55 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.794 0.807 . . . . 0.0 110.8 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -116.66 138.74 51.22 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.4 mt -112.4 147.24 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.193 -0.942 . . . . 0.0 110.962 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.1 mt -132.22 143.26 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.836 -0.54 . . . . 0.0 110.218 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 m -116.43 124.36 49.81 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.0 mt -103.92 132.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -131.03 130.06 42.81 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.038 -1.039 . . . . 0.0 109.104 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.1 -173.27 38.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -72.12 159.27 34.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.46 -46.55 26.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.673 -0.642 . . . . 0.0 110.392 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.08 -47.1 69.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 109.862 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 14.3 mp0 -57.91 -36.73 72.85 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.866 -1.146 . . . . 0.0 109.082 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.82 -45.79 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.511 -0.743 . . . . 0.0 110.019 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.66 -42.98 98.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.75 -1.219 . . . . 0.0 109.55 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.44 -38.37 89.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 108.817 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.1 -45.66 59.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.399 -0.813 . . . . 0.0 109.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.91 -41.24 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.134 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.492 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 57.1 t80 -66.84 -37.31 84.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 109.777 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -70.82 -26.69 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.799 -1.188 . . . . 0.0 108.836 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.78 -45.19 62.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.18 -38.89 90.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.39 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 18.2 m-20 -78.38 -26.08 46.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.605 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 p -62.46 -36.66 83.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.177 -1.409 . . . . 0.0 107.244 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.1 t -40.87 -44.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.077 0.465 . . . . 0.0 109.821 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 84' ' ' TYR . 39.3 pttt -52.54 -21.12 3.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 85' ' ' SER . 57.1 tt0 -58.62 -9.28 1.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.579 -1.325 . . . . 0.0 107.628 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 68.0 t80 -67.29 47.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.998 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 83' ' ' GLN . 11.4 p 57.3 6.59 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.325 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -72.97 -71.42 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -107.28 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.45 -1.03 . . . . 0.0 109.136 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 67.5 t80 -172.17 45.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.512 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m -165.37 71.77 1.37 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.258 -1.143 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' ASN . 3.4 Cg_exo -65.67 -176.06 0.52 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.102 1.201 . . . . 0.0 111.985 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' SER . 8.5 m120 54.21 101.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.647 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' ASN . 8.3 t 55.82 105.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.632 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -59.9 150.55 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.904 . . . . 0.0 109.11 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.45 2.5 80.07 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLY . 3.2 p30 40.93 -159.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 122.227 -0.572 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.97 68.1 1.68 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.873 . . . . 0.0 109.136 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.83 44.24 61.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.44 161.99 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.39 141.95 63.92 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 118.475 1.138 . . . . 0.0 112.072 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.27 139.49 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 108.862 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.64 149.46 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.352 -0.843 . . . . 0.0 109.792 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -127.1 137.66 53.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.8 145.34 38.06 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -110.95 144.74 39.55 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 109.938 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.88 149.04 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -122.24 129.62 52.41 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.92 138.99 33.79 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -56.87 146.12 80.58 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 CA-C-N 120.209 1.11 . . . . 0.0 110.918 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -52.7 -40.95 63.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.904 -1.122 . . . . 0.0 111.344 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -62.31 -44.25 96.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.807 -1.183 . . . . 0.0 111.231 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 mt -78.52 -26.73 45.87 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.622 -1.299 . . . . 0.0 108.209 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.45 79.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.83 0.824 . . . . 0.0 109.319 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -74.55 -30.09 61.61 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.8 p -71.12 -26.96 63.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.075 -1.016 . . . . 0.0 109.299 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -89.01 -43.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 110.999 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 52.4 mt -68.28 -36.01 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.707 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -172.72 40.37 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -91.65 -9.65 43.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 109.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -143.84 18.36 2.18 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.91 -10.44 9.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.583 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 19.7 mm100 -35.61 -29.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.866 -0.785 . . . . 0.0 110.803 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.0 tpp180 -84.32 -37.15 21.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.643 -1.286 . . . . 0.0 109.743 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -72.3 -23.39 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.802 -1.186 . . . . 0.0 108.532 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -71.72 -48.14 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 108.939 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 34' ' ' GLN . 0.8 OUTLIER -59.11 -47.72 84.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.53 -33.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' CG ' HH11 ' A' ' 40' ' ' ARG . 1.5 ttt-85 -57.88 -53.47 57.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.244 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.58 -39.57 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 0.0 110.357 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -59.07 -44.99 91.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.108 -0.995 . . . . 0.0 110.114 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t -86.93 -22.56 25.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 110.188 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.11 -0.16 80.41 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.03 162.82 18.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.707 -0.878 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.5 m -104.85 148.1 27.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -133.05 138.8 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.652 -1.28 . . . . 0.0 109.948 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.53 123.63 31.91 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.15 135.06 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 108.961 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.21 152.06 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.115 -0.991 . . . . 0.0 108.836 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 3.2 mp0 -70.7 150.2 95.34 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 120.933 -1.105 . . . . 0.0 108.396 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.49 139.62 65.39 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 CA-C-N 119.442 0.837 . . . . 0.0 111.59 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 56' ' ' SER . 15.3 mt -70.96 178.67 3.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.054 -1.029 . . . . 0.0 108.755 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 11.6 mp0 -58.17 129.53 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.9 62.69 5.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 58' ' ' ASP . 4.6 m -121.73 100.84 7.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.531 -0.982 . . . . 0.0 109.523 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -77.88 26.98 0.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 108.7 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' SER . 3.7 m-20 -142.27 155.06 45.2 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.135 0.969 . . . . 0.0 110.287 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.5 mtt180 -118.44 138.83 52.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -108.3 151.97 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.376 -0.828 . . . . 0.0 110.256 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -135.56 142.45 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.665 . . . . 0.0 110.123 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -116.48 121.12 40.89 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.717 -0.614 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.73 132.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.261 -0.899 . . . . 0.0 109.285 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -129.37 130.14 45.66 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.024 -1.047 . . . . 0.0 108.969 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.75 -172.34 38.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 p -73.26 160.0 32.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.001 -1.293 . . . . 0.0 109.619 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.14 -46.51 23.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.49 -45.22 72.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.254 -0.903 . . . . 0.0 109.857 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -59.16 -36.42 75.25 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.275 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 92.4 mt -72.33 -45.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.54 -0.725 . . . . 0.0 110.368 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -60.57 -42.95 97.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.753 -1.217 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.32 -31.63 71.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 109.005 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -43.14 36.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.502 -0.749 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.75 -48.23 75.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.177 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.21 -43.86 98.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -64.14 -24.58 67.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.905 -1.122 . . . . 0.0 109.084 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.87 -46.77 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 108.316 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.06 -38.57 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.55 -0.719 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.07 -25.45 47.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 109.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.9 p -62.79 -38.04 89.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.481 -1.387 . . . . 0.0 107.296 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.86 -50.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.028 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -48.17 -21.92 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.661 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -60.74 -24.69 65.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.669 -1.269 . . . . 0.0 107.737 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.46 ' CD2' ' OG ' ' A' ' 85' ' ' SER . 85.6 t80 -48.42 -36.04 13.99 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.857 0.836 . . . . 0.0 108.815 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.8 m -168.53 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.25 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 85' ' ' SER . 9.5 mttp -59.01 99.93 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 53.1 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.886 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.531 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.31 161.85 60.68 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.158 -1.201 . . . . 0.0 109.026 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.7 148.18 83.95 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.005 1.137 . . . . 0.0 111.904 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -171.17 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.0 p -169.96 146.22 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -164.33 149.29 10.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . 74.97 -0.33 58.5 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.256 -2.338 . . . . 0.0 107.256 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 10' ' ' GLY . 36.5 t70 55.13 167.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 122.055 -0.673 . . . . 0.0 109.638 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 mt 47.76 12.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.695 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 47.1 64.07 2.94 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.04 170.48 0.1 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -59.61 135.42 64.17 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.156 1.237 . . . . 0.0 112.369 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -82.83 144.42 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.38 148.54 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.286 -0.884 . . . . 0.0 109.53 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -126.7 137.75 53.31 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.45 144.48 38.05 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.13 146.6 36.54 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.178 -0.951 . . . . 0.0 110.302 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.39 150.79 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -124.86 130.08 51.67 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.68 138.0 31.6 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 22' ' ' LYS . 2.5 Cg_endo -57.91 134.69 64.11 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 CA-C-N 120.158 1.092 . . . . 0.0 110.384 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 21' ' ' PRO . 28.7 ttmt -39.07 -40.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.454 -0.779 . . . . 0.0 111.112 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.89 -40.2 96.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.985 -1.072 . . . . 0.0 110.868 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 81' ' ' VAL . 4.0 mm? -77.59 -26.74 50.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.661 -1.274 . . . . 0.0 108.696 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.32 79.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.774 0.797 . . . . 0.0 109.479 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -76.59 -29.11 56.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.4 p -73.59 -24.77 60.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.862 -1.149 . . . . 0.0 109.05 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -95.47 -42.6 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.961 -1.087 . . . . 0.0 110.609 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.25 -35.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.84 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.25 -172.04 39.28 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -91.57 -14.16 30.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.294 . . . . 0.0 109.957 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -139.04 18.51 3.13 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.96 -10.21 7.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.729 -1.748 . . . . 0.0 108.729 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' GLY . 70.2 mt-30 -36.03 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.777 -0.837 . . . . 0.0 110.673 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.53 -36.06 20.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.764 -1.21 . . . . 0.0 109.961 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -73.46 -24.48 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -73.04 -47.8 41.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.078 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.11 -50.24 74.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.048 -1.032 . . . . 0.0 109.867 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.4 -31.79 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.79 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -61.1 -65.12 0.74 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -64.9 -36.73 85.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.33 -42.95 92.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.056 -1.028 . . . . 0.0 110.199 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -86.99 -22.94 25.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.354 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.99 0.83 70.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.49 161.44 20.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -108.82 138.11 45.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.38 137.88 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.816 -1.178 . . . . 0.0 109.891 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -123.09 128.28 49.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.448 HG21 ' NH2' ' A' ' 59' ' ' ARG . 66.8 mt -99.85 135.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 108.541 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.57 151.59 19.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.037 -1.039 . . . . 0.0 108.939 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.02 155.38 87.25 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.342 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.95 143.02 77.77 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 120.624 0.883 . . . . 0.0 111.933 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.3 mt -83.14 119.88 25.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.48 128.67 20.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.62 20.58 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -158.04 128.06 6.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -1.109 . . . . 0.0 109.386 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -92.55 48.08 1.35 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -131.82 154.31 49.26 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.59 0.709 . . . . 0.0 109.655 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.3 mmm180 -119.41 137.37 53.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.17 153.79 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.3 -0.875 . . . . 0.0 111.052 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.92 141.93 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.765 -0.585 . . . . 0.0 110.184 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -115.91 123.96 49.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.636 -0.665 . . . . 0.0 109.341 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -104.07 132.19 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.74 46.49 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.114 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.54 38.63 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -74.72 161.69 29.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.995 -1.297 . . . . 0.0 109.532 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.8 -47.48 30.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -0.754 . . . . 0.0 110.449 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.85 -49.44 62.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.07 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.66 -36.68 69.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.854 -1.154 . . . . 0.0 109.212 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.8 mt -70.46 -45.54 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.7 -42.87 98.04 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.694 -1.254 . . . . 0.0 109.445 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.37 -37.94 87.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.276 -0.89 . . . . 0.0 108.784 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 -45.1 62.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.438 -0.789 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -58.83 -49.06 79.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.913 . . . . 0.0 109.966 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -59.39 -41.11 88.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.803 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.01 -25.9 66.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 108.947 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.01 -44.37 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.883 -1.135 . . . . 0.0 108.34 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -62.0 -38.89 90.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.581 -0.7 . . . . 0.0 109.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -78.57 -23.82 45.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.874 -1.141 . . . . 0.0 109.618 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.487 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 25.5 m -63.69 -36.46 83.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.252 -1.53 . . . . 0.0 107.013 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 24' ' ' LEU . 24.6 t -41.18 -44.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.791 -0.568 . . . . 0.0 109.872 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.466 ' C ' ' N ' ' A' ' 84' ' ' TYR . 14.3 mptt -55.74 -21.92 21.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.995 -1.065 . . . . 0.0 110.12 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -57.22 -11.72 1.89 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.304 -1.497 . . . . 0.0 107.51 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.466 ' N ' ' C ' ' A' ' 82' ' ' LYS . 80.5 t80 -58.15 -31.83 67.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.4 p -175.71 -144.37 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 57.2 -82.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 85' ' ' SER . 15.2 mtpp -63.66 76.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -1.146 . . . . 0.0 108.36 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' GLY . 5.7 t80 71.18 107.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.438 -179.584 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 174.79 -63.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.171 -1.193 . . . . 0.0 110.088 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 2' ' ' SER . 3.7 Cg_exo -48.92 168.1 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 CA-C-N 119.371 0.811 . . . . 0.0 112.145 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 2' ' ' SER . 20.7 m120 -157.26 57.05 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 p -62.5 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 62.6 t80 51.96 36.71 19.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.928 . . . . 0.0 109.567 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 4.82 3.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 19.0 t70 54.4 -161.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 109.15 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 32.6 mt -123.07 83.48 2.13 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -42.38 95.11 0.01 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 74.81 163.45 10.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.61 164.71 22.84 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.053 1.168 . . . . 0.0 112.169 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.75 142.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.1 mt -125.2 150.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.314 -0.866 . . . . 0.0 109.706 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 t -127.48 148.17 50.31 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -148.44 142.04 25.47 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -108.22 145.45 34.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.03 154.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -126.48 129.65 49.09 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.5 136.14 28.23 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.74 139.27 84.6 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 CA-C-N 120.16 1.093 . . . . 0.0 111.1 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -44.42 -40.02 5.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 0.0 111.252 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -63.24 -47.1 83.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.725 -1.235 . . . . 0.0 111.116 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.4 mt -76.86 -21.67 54.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.349 -1.469 . . . . 0.0 108.348 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.36 90.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.865 0.84 . . . . 0.0 109.443 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -75.42 -28.58 59.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.1 p -74.05 -32.73 63.43 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.191 -0.943 . . . . 0.0 108.881 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -86.84 -44.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.667 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CD1' HH11 ' A' ' 59' ' ' ARG . 68.1 mt -69.92 -35.98 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.018 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.89 -170.14 41.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -92.26 -47.2 7.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.18 -1.188 . . . . 0.0 109.421 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.67 13.21 59.54 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 67.12 -1.64 6.09 Favored Glycine 0 N--CA 1.493 2.455 0 O-C-N 120.882 -1.364 . . . . 0.0 109.812 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.7 mt-30 -45.93 -16.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 119.316 1.558 . . . . 0.0 109.862 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -82.95 -38.82 22.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.907 -1.121 . . . . 0.0 110.864 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 HD13 ' A' ' 47' ' ' ILE . 9.6 tp -74.05 -18.98 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.139 -1.601 . . . . 0.0 109.155 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -73.75 -50.43 20.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.393 -0.817 . . . . 0.0 109.088 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.18 -48.54 81.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.545 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.4 mt -58.45 -34.74 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.62 -59.51 5.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -67.78 -37.59 82.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.86 -44.47 93.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -0.985 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -86.6 -23.07 25.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 110.301 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.04 0.54 76.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.28 18.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.762 -0.846 . . . . 0.0 109.876 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -108.04 141.36 39.82 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.475 HD13 HD11 ' A' ' 36' ' ' ILE . 98.3 mt -134.2 137.22 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.765 -1.209 . . . . 0.0 110.214 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -122.77 127.41 49.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.1 134.43 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.021 -1.049 . . . . 0.0 108.584 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.9 149.48 21.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.133 -0.98 . . . . 0.0 108.559 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.92 149.22 97.8 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 120.827 -1.171 . . . . 0.0 108.568 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.52 143.96 93.81 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 119.213 0.754 . . . . 0.0 111.446 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -77.67 121.61 24.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.063 -1.023 . . . . 0.0 109.225 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.74 135.04 47.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.1 14.24 54.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 47.6 t -129.66 -164.48 1.41 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.528 -0.984 . . . . 0.0 109.384 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' N ' ' OG ' ' A' ' 56' ' ' SER . 6.2 pt-20 -153.48 34.76 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.89 156.78 44.98 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.079 0.942 . . . . 0.0 110.641 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.405 HH11 ' CD1' ' A' ' 29' ' ' ILE . 45.5 mtt180 -117.47 140.22 49.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.59 144.21 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.381 -0.824 . . . . 0.0 110.785 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.44 143.8 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.768 -0.583 . . . . 0.0 110.342 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.4 m -117.94 120.75 38.77 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.725 -0.609 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.09 133.13 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -129.33 130.59 46.29 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.06 -1.025 . . . . 0.0 109.19 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.56 -172.61 38.67 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 p -73.71 160.77 31.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.058 -1.26 . . . . 0.0 109.522 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -46.96 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -67.74 -45.88 73.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -59.93 -38.91 83.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.786 -1.196 . . . . 0.0 109.26 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.81 -45.61 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.733 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -60.7 -43.34 97.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.801 -1.187 . . . . 0.0 109.375 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -61.43 -40.17 93.45 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.4 -46.4 64.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.493 -0.754 . . . . 0.0 109.417 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -57.41 -52.61 64.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 109.945 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 63.7 t80 -57.31 -40.51 78.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.035 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.92 -27.67 66.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.863 -1.148 . . . . 0.0 108.975 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -74.74 -45.94 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.058 . . . . 0.0 108.433 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -61.28 -39.35 90.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.667 -0.645 . . . . 0.0 109.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 10.0 m-80 -78.38 -23.79 46.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.9 p -63.07 -34.54 77.8 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 83' ' ' GLN . 48.6 t -46.07 -54.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.595 . . . . 0.0 110.474 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 84' ' ' TYR . 13.2 pttm -45.03 -21.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.06 -1.025 . . . . 0.0 111.019 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' SER . 54.8 tp60 -59.04 -7.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.379 -1.451 . . . . 0.0 107.929 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 77.5 t80 -66.14 50.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.336 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' GLN . 26.2 p 48.97 14.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -69.4 -51.08 28.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.2 mtpp -98.7 118.72 36.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 87' ' ' LYS . 28.9 t80 57.56 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.326 -0.859 . . . . 0.0 109.324 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.471 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -168.23 71.08 0.84 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.239 -1.154 . . . . 0.0 109.627 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.47 -58.09 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.079 1.186 . . . . 0.0 112.008 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -165.56 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 86.7 t80 -69.39 -179.52 1.68 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.442 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.609 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 55.44 8.13 1.67 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 6' ' ' TYR . 5.4 p-10 41.59 54.34 3.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.813 -0.816 . . . . 0.0 110.165 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' GLY . 23.0 mt -75.26 -16.57 60.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.91 -35.26 0.74 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.92 169.36 34.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.73 163.19 22.41 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.106 1.204 . . . . 0.0 112.11 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.31 143.27 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 150.49 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 109.485 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 m -126.85 136.64 52.62 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.0 144.91 39.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.8 146.16 36.88 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.256 -0.902 . . . . 0.0 110.064 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.17 153.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -124.2 129.64 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.43 136.55 28.79 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 121.466 -0.771 . . . . 0.0 109.25 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.35 139.25 85.77 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.082 1.065 . . . . 0.0 110.954 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -44.26 -40.07 4.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.184 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.39 -46.58 85.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.824 -1.172 . . . . 0.0 111.43 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.84 -22.99 52.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.311 -1.493 . . . . 0.0 108.251 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.95 -38.23 85.17 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.831 0.824 . . . . 0.0 109.14 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.38 -27.25 59.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.9 p -74.54 -31.57 62.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.065 -1.022 . . . . 0.0 109.254 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.8 mt -83.89 -45.95 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 110.972 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.75 -34.28 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.798 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.52 -176.22 44.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -91.93 5.0 51.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 109.676 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -157.55 17.35 0.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.28 -9.49 13.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 62.0 mt-30 -34.65 -28.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.95 -0.735 . . . . 0.0 111.015 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.4 mmt180 -86.33 -40.16 15.74 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.484 -1.385 . . . . 0.0 109.617 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.1 mm -69.85 -27.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.047 . . . . 0.0 109.295 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -77.4 -53.55 7.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.68 -48.11 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.08 -34.5 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -59.26 -74.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -53.06 -34.8 58.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.471 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.06 -44.14 80.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.419 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -86.42 -24.57 25.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 0.0 110.538 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.77 -3.92 83.96 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.06 162.64 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -1.056 . . . . 0.0 110.098 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.4 m -107.01 142.62 36.35 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -138.06 136.78 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.665 -1.272 . . . . 0.0 110.04 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -123.0 127.29 48.61 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -98.03 135.07 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.94 -1.1 . . . . 0.0 108.636 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.69 151.27 19.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.094 -1.004 . . . . 0.0 108.766 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 mp0 -67.78 149.37 98.28 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 120.996 -1.065 . . . . 0.0 108.46 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.14 141.37 88.18 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 CA-C-N 119.445 0.837 . . . . 0.0 111.431 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.2 mt -74.83 134.54 41.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.078 -1.014 . . . . 0.0 109.377 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.02 144.37 55.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.9 36.85 27.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 42.4 t -155.08 -164.94 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.482 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' N ' ' OG ' ' A' ' 56' ' ' SER . 4.7 pt-20 -155.22 35.4 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 108.846 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -137.37 155.59 49.21 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.928 0.87 . . . . 0.0 110.239 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -120.63 140.47 51.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.3 140.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.437 -0.79 . . . . 0.0 111.239 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -120.92 144.73 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.665 -0.647 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.8 m -117.31 125.12 50.54 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.81 131.31 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.16 -0.963 . . . . 0.0 109.624 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -129.19 130.73 46.7 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.088 -1.008 . . . . 0.0 109.024 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.57 -174.42 38.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 p -73.24 160.22 32.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.266 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.25 -46.72 24.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.383 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 2.5 m-20 -68.15 -46.85 69.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.925 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -58.28 -37.33 74.8 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.898 -1.126 . . . . 0.0 109.293 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.2 mt -70.84 -45.76 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.504 -0.747 . . . . 0.0 110.212 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -60.2 -43.18 96.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.792 -1.193 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.16 -35.24 78.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 108.757 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.37 35.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.533 -0.729 . . . . 0.0 109.55 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.15 -47.09 84.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.268 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -61.52 -35.27 77.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.013 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.36 -26.93 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.82 -1.175 . . . . 0.0 109.02 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.33 -46.03 57.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.086 -1.009 . . . . 0.0 108.317 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -61.39 -37.64 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.446 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.85 -24.15 44.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -64.07 -40.11 95.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 81' ' ' VAL . 11.9 t -41.69 -47.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.933 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' C ' ' N ' ' A' ' 84' ' ' TYR . 54.8 mttm -49.71 -21.22 1.0 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.004 -1.06 . . . . 0.0 109.609 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -57.63 -11.47 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.569 -1.332 . . . . 0.0 107.481 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.469 ' N ' ' C ' ' A' ' 82' ' ' LYS . 91.2 t80 -53.54 -58.82 5.81 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.798 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.7 p -169.84 57.72 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -133.21 -63.79 0.08 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HZ2' ' HB3' ' A' ' 87' ' ' LYS . 15.0 mtpp -80.78 17.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 108.537 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 86' ' ' GLY . 24.9 t80 175.61 107.73 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.469 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t -169.38 71.47 0.69 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.136 . . . . 0.0 109.566 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.39 -49.64 1.74 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.023 1.149 . . . . 0.0 111.865 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -167.3 148.49 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 136.96 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.502 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 53.94 12.82 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.656 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.48 -50.95 34.05 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 10.2 t70 -174.82 -164.96 0.18 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.863 -0.787 . . . . 0.0 109.372 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' GLY . 16.9 mt 49.95 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.29 -15.86 0.15 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 169.44 166.41 28.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.25 136.23 46.58 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.003 1.135 . . . . 0.0 112.134 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mm -75.46 141.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -123.98 148.85 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -127.55 137.34 52.58 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.04 144.01 38.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.49 144.89 37.13 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.208 -0.933 . . . . 0.0 109.942 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.13 153.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.82 129.89 50.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.0 137.39 30.03 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.485 -0.759 . . . . 0.0 108.957 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.81 144.61 93.22 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.158 1.092 . . . . 0.0 110.958 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -50.94 -41.37 58.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 111.339 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -45.38 92.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.74 -1.225 . . . . 0.0 111.42 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.78 -25.71 53.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.448 -1.407 . . . . 0.0 108.175 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.26 79.83 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.735 0.779 . . . . 0.0 109.4 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.7 -30.11 61.43 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -71.41 -33.25 69.27 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.935 -1.103 . . . . 0.0 109.243 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.15 -45.13 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 111.016 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.21 -35.06 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.877 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 -171.9 39.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -91.79 -4.26 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.329 . . . . 0.0 109.771 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.87 19.58 1.11 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.32 -10.61 6.01 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 32' ' ' GLY . 35.3 tt0 -36.57 -26.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.792 -0.828 . . . . 0.0 111.109 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.2 tpp180 -87.12 -37.48 17.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.733 -1.229 . . . . 0.0 109.777 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.41 -23.92 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.744 -1.222 . . . . 0.0 108.571 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -72.78 -49.33 31.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.63 -47.96 80.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.706 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.06 -32.81 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.04 -47.19 86.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.109 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -80.22 -39.47 29.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.112 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.39 -44.28 97.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.016 -1.053 . . . . 0.0 110.188 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -87.14 -22.33 25.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.079 -1.013 . . . . 0.0 110.217 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.18 79.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.79 162.63 18.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.772 -0.84 . . . . 0.0 109.848 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 m -105.35 146.97 28.68 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mm -132.45 138.21 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.605 -1.309 . . . . 0.0 109.955 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -126.6 124.72 40.59 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -101.66 132.98 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 108.787 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.61 150.83 19.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.006 -1.059 . . . . 0.0 108.487 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -66.21 150.15 97.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.969 -1.082 . . . . 0.0 108.455 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -60.37 141.91 96.82 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 120.38 0.72 . . . . 0.0 111.687 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -82.52 147.17 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.382 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.42 126.61 29.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.2 -0.937 . . . . 0.0 109.417 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.36 37.53 7.04 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -167.08 102.21 0.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.144 . . . . 0.0 109.492 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 9.3 mp0 -73.43 50.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -136.41 154.61 50.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.96 0.886 . . . . 0.0 110.009 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.512 HH11 ' CG ' ' A' ' 59' ' ' ARG . 5.1 mtt-85 -118.05 139.52 51.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -111.54 141.89 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.314 -0.866 . . . . 0.0 110.845 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -124.96 143.71 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.752 -0.593 . . . . 0.0 110.484 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -118.59 118.38 31.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.718 -0.614 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -96.37 134.31 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -131.74 129.04 40.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 -171.95 37.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 p -71.71 159.31 34.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.049 -1.265 . . . . 0.0 109.536 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -46.26 46.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.675 . . . . 0.0 110.273 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -66.94 -46.53 74.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.08 -1.013 . . . . 0.0 109.494 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -57.99 -32.81 68.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.0 -1.062 . . . . 0.0 109.001 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.46 -45.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.503 -0.748 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -44.01 93.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.664 -1.272 . . . . 0.0 109.518 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -61.14 -34.1 74.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.072 -1.017 . . . . 0.0 108.729 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.55 -47.13 28.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.528 -0.732 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -58.44 -47.68 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 110.345 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 79' ' ' ASN . 56.9 t80 -61.14 -38.15 85.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.794 -1.191 . . . . 0.0 108.95 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.2 mt -74.38 -46.25 41.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 0.0 108.364 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.46 -38.54 87.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 8.5 m-80 -78.53 -23.89 46.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.569 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.9 p -63.99 -40.28 96.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 81' ' ' VAL . 5.2 t -44.41 -43.65 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.775 -0.578 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' C ' ' N ' ' A' ' 84' ' ' TYR . 49.5 mttp -54.5 -23.92 18.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.01 -1.056 . . . . 0.0 110.361 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -58.87 -12.17 4.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.245 -1.535 . . . . 0.0 107.304 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' N ' ' C ' ' A' ' 82' ' ' LYS . 85.5 t80 -54.55 -64.14 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.053 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.7 p -172.06 59.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.67 -65.88 0.07 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -86.01 23.61 1.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 108.757 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 65.9 t80 -174.52 46.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CD1' ' OXT' ' A' ' 89' ' ' PHE . 39.4 t80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -171.53 162.63 4.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 0.0 109.045 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.81 8.28 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 120.972 1.115 . . . . 0.0 111.944 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 2' ' ' SER . 19.5 t30 -158.76 125.49 4.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.0 t -171.83 57.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 77.3 t80 -167.96 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.24 -6.4 4.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 6' ' ' TYR . 28.3 m-20 53.38 -145.45 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -1.149 . . . . 0.0 109.428 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.25 -10.56 59.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.259 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.42 59.22 10.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.65 169.16 13.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -64.0 156.0 61.2 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.124 1.216 . . . . 0.0 112.23 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.15 142.73 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.079 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.97 149.97 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 109.858 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -128.72 143.56 50.96 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -144.7 144.38 31.19 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -109.82 145.53 36.57 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.293 -0.879 . . . . 0.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.3 148.96 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -124.71 129.6 50.8 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.622 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -126.18 142.7 43.41 Favored Pre-proline 0 N--CA 1.506 2.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.65 146.8 63.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 120.485 1.209 . . . . 0.0 110.605 178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -52.31 -40.28 61.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 111.168 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.21 -42.45 99.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.699 -1.25 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -79.8 -32.1 40.79 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.71 -1.244 . . . . 0.0 108.439 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.27 68.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.794 0.807 . . . . 0.0 109.305 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.99 -33.12 63.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.4 p -67.59 -27.87 67.28 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.936 -1.102 . . . . 0.0 108.948 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -85.33 -42.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.83 -37.37 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.748 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.64 -174.07 40.87 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.53 -8.31 47.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.955 -1.321 . . . . 0.0 109.831 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -145.2 20.11 1.92 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.33 -11.13 4.21 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 32' ' ' GLY . 74.1 mt-30 -36.34 -27.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.824 -0.809 . . . . 0.0 110.609 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.5 tpt180 -86.75 -35.48 19.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.818 -1.176 . . . . 0.0 109.77 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.3 mm -75.06 -26.55 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.078 . . . . 0.0 108.878 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -73.29 -48.27 35.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.164 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.52 -51.03 71.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.59 -32.98 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.044 -1.035 . . . . 0.0 109.734 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -59.51 -51.2 70.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.0 110.179 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -75.56 -38.45 59.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.32 -44.43 96.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.992 . . . . 0.0 110.194 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -86.76 -23.46 25.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.394 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.56 0.04 78.03 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.35 19.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.713 -0.875 . . . . 0.0 109.939 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -107.25 141.79 38.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -138.69 136.81 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.634 -1.291 . . . . 0.0 109.822 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -124.12 129.4 50.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -101.08 132.75 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.886 -1.134 . . . . 0.0 108.382 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -92.06 153.43 19.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 108.949 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.57 153.56 95.62 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 120.952 -1.093 . . . . 0.0 108.113 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.76 138.95 60.68 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 CA-C-N 119.42 0.829 . . . . 0.0 111.17 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.18 127.58 33.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.017 . . . . 0.0 109.52 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -46.87 141.56 3.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.384 -0.823 . . . . 0.0 109.571 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.95 22.63 63.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -150.08 177.47 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -1.035 . . . . 0.0 109.52 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -139.33 -31.92 0.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.534 -0.729 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.98 156.63 5.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.945 -1.097 . . . . 0.0 109.058 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.5 tpp180 -116.28 139.78 50.01 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.12 140.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -125.1 144.22 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.785 -0.572 . . . . 0.0 110.632 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.86 46.93 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.652 -0.655 . . . . 0.0 109.352 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.48 132.62 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -0.81 . . . . 0.0 109.528 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -130.47 130.49 44.29 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.994 -1.066 . . . . 0.0 109.203 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.89 38.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.2 p -73.22 160.25 32.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.051 -1.264 . . . . 0.0 109.844 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -45.41 -48.88 13.6 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.381 0.61 . . . . 0.0 110.562 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.937 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.37 -36.66 73.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.792 -1.192 . . . . 0.0 109.356 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -72.08 -45.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 110.354 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -60.76 -42.77 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.758 -1.214 . . . . 0.0 109.422 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -62.16 -34.52 76.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.807 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.36 45.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.46 -0.775 . . . . 0.0 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.34 -48.58 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.95 -40.08 87.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.6 mt -68.02 -30.27 69.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.801 -1.187 . . . . 0.0 109.02 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.64 -45.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.973 -1.079 . . . . 0.0 108.276 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.06 -39.43 92.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.593 -0.692 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -77.97 -25.49 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 0.0 109.872 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.9 m -61.93 -34.37 75.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG13 HD23 ' A' ' 24' ' ' LEU . 45.3 t -44.44 -52.82 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.772 -0.58 . . . . 0.0 110.122 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' C ' ' N ' ' A' ' 84' ' ' TYR . 37.6 pttt -46.38 -23.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 85' ' ' SER . 65.4 tt0 -58.32 -10.74 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.477 -1.389 . . . . 0.0 107.429 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.469 ' N ' ' C ' ' A' ' 82' ' ' LYS . 91.3 t80 -59.64 82.67 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.738 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.1 m 67.37 40.96 2.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 61.43 149.93 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 20.3 ttpt -68.27 48.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -1.207 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 86' ' ' GLY . 87.8 m-85 -156.61 42.49 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.429 -179.766 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m -165.04 71.16 1.42 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.229 -1.159 . . . . 0.0 109.521 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 5' ' ' SER . 5.1 Cg_exo -64.43 -15.2 48.53 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.088 1.192 . . . . 0.0 112.023 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' SER . 12.9 m120 -61.67 1.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.633 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 3' ' ' PRO . 8.8 t 55.05 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 8' ' ' ASP . 90.8 t80 -61.71 -3.72 1.19 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -61.94 -0.52 2.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 6' ' ' TYR . 17.7 m-20 52.59 90.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -1.094 . . . . 0.0 109.559 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.86 -7.67 59.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.354 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 11' ' ' GLY . . . 59.51 79.08 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 57.41 164.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -64.32 160.42 39.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.065 1.176 . . . . 0.0 112.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.88 139.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -123.06 150.8 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 109.335 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 m -126.91 136.41 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -139.66 145.59 38.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -110.19 145.36 37.4 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.112 -0.993 . . . . 0.0 109.925 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.11 148.52 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -122.72 129.89 52.31 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 140.6 37.91 Favored Pre-proline 0 N--CA 1.503 2.223 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.58 144.2 97.56 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.04 1.05 . . . . 0.0 110.86 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.03 -41.09 46.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.934 -1.104 . . . . 0.0 111.35 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -62.15 -45.82 91.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.651 -1.281 . . . . 0.0 111.12 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -76.88 -24.36 52.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.501 -1.374 . . . . 0.0 108.597 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.12 90.15 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.864 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -73.97 -33.68 63.96 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.388 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -68.2 -34.02 75.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.782 -1.199 . . . . 0.0 109.266 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -77.43 -44.85 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.147 -0.971 . . . . 0.0 110.991 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.22 -36.09 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.811 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.11 -171.96 39.42 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -91.74 -0.57 57.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.935 -1.333 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -153.52 19.1 0.69 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 73.48 -11.66 5.23 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 32' ' ' GLY . 28.0 pt20 -34.54 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.75 . . . . 0.0 111.19 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -82.43 -34.4 28.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.695 -1.253 . . . . 0.0 109.557 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -73.63 -25.03 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.971 -1.081 . . . . 0.0 108.815 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -72.26 -46.62 55.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.359 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -60.07 -47.29 86.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.81 -33.69 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.174 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.79 -43.58 83.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.039 -1.038 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -77.16 -32.94 56.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.095 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.38 -41.99 46.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 110.359 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 p -86.71 -23.38 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.079 -1.013 . . . . 0.0 110.53 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.17 71.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 161.06 20.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.86 -0.788 . . . . 0.0 110.161 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.4 m -108.42 138.55 44.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.9 mt -137.43 137.02 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.722 -1.237 . . . . 0.0 109.919 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -122.84 129.11 51.27 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.9 mt -100.91 132.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.855 -1.153 . . . . 0.0 108.528 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 18.5 p-10 -91.93 154.32 18.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 108.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 9.7 mp0 -67.8 149.51 98.22 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 120.817 -1.177 . . . . 0.0 108.502 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.66 141.7 97.51 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 119.298 0.785 . . . . 0.0 111.711 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 55' ' ' GLY . 36.8 mt -80.54 113.87 19.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.768 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -45.92 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . 143.53 -16.39 2.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.9 m -124.47 123.48 40.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.171 -1.193 . . . . 0.0 109.891 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.4 pm0 -79.55 44.03 0.59 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 108.877 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -132.07 156.64 45.94 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.701 0.762 . . . . 0.0 109.93 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -116.26 136.21 53.21 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 78.1 mt -109.65 147.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.162 -0.961 . . . . 0.0 110.414 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.85 143.75 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.811 -0.555 . . . . 0.0 110.334 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -117.13 123.76 47.52 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.04 132.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.295 -0.878 . . . . 0.0 109.582 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.3 m -129.71 130.73 45.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.994 -1.066 . . . . 0.0 109.102 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.13 -172.73 38.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -72.84 160.03 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.608 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -47.05 -46.84 22.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 110.151 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.97 -47.38 68.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -56.97 -35.79 69.55 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.903 -1.123 . . . . 0.0 109.198 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.41 -45.45 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.595 -0.691 . . . . 0.0 110.28 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -61.23 -42.61 98.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.893 -1.129 . . . . 0.0 109.584 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.41 -36.77 83.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.85 61.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.427 -0.796 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -59.49 -48.5 81.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.56 -35.97 75.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.61 -28.85 63.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.774 -1.204 . . . . 0.0 109.095 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.7 -44.83 66.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.121 -0.987 . . . . 0.0 108.422 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.22 -38.87 90.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -0.757 . . . . 0.0 109.845 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -24.4 46.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 109.749 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.452 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 20.8 m -64.27 -34.4 78.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.109 -1.437 . . . . 0.0 107.377 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.7 t -42.97 -46.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.74 -0.6 . . . . 0.0 109.822 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 84' ' ' TYR . 31.3 mttm -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.594 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 85' ' ' SER . 34.2 tp60 -57.1 -10.33 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.471 -1.393 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' C ' ' H ' ' A' ' 86' ' ' GLY . 83.4 t80 -65.41 63.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.123 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 83' ' ' GLN . 20.6 p 55.71 5.84 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -69.14 -50.33 34.5 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 88' ' ' PHE . 15.6 mtpp -84.97 114.06 21.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.368 -1.078 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 75.7 m-85 51.11 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.518 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.2 mm . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.7 mt -123.61 149.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 m -127.81 137.24 52.32 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -139.17 145.07 38.91 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.5 145.7 38.58 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.05 147.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -120.37 129.35 53.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.73 140.01 36.4 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.25 142.13 97.17 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 120.104 1.073 . . . . 0.0 110.876 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -48.64 -41.36 30.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 111.306 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.0 111.248 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.13 -23.45 51.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.578 -1.326 . . . . 0.0 108.308 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.77 90.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.786 0.803 . . . . 0.0 109.669 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -74.13 -33.87 63.69 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.43 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -67.46 -34.79 77.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.706 -1.246 . . . . 0.0 109.25 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 81' ' ' VAL . 88.4 mt -78.82 -42.66 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 110.852 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.62 ' CD1' HH11 ' A' ' 59' ' ' ARG . 64.5 mt -69.35 -37.09 74.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.394 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.93 -171.33 42.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.96 -51.43 5.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.074 -1.251 . . . . 0.0 108.809 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 13.98 64.2 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.6 -4.48 14.15 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.688 -1.478 . . . . 0.0 109.578 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.0 mt-30 -42.69 -20.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.016 -1.285 . . . . 0.0 110.096 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 18.3 tpt180 -86.29 -39.42 16.53 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.158 -0.964 . . . . 0.0 110.862 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.34 -28.0 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.584 -1.322 . . . . 0.0 109.345 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -72.87 -49.05 32.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -56.26 -53.57 55.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.864 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.19 -31.56 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -62.88 -41.24 99.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.31 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 3.6 m80 -81.28 -38.93 26.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.38 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -65.28 -41.94 93.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.436 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -87.08 -23.14 25.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.05 . . . . 0.0 110.609 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 0.6 71.05 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.69 160.66 21.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.846 -0.796 . . . . 0.0 110.114 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.7 m -108.67 139.91 42.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.3 137.57 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 109.966 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -123.21 127.41 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.0 mt -99.57 134.11 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.938 -1.101 . . . . 0.0 108.775 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.06 152.91 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 0.0 108.503 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.6 149.64 98.02 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 120.935 -1.103 . . . . 0.0 108.606 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.492 1.411 0 C-N-CA 120.57 0.847 . . . . 0.0 111.718 179.471 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 N--CA 1.498 1.954 0 CA-C-O 121.844 0.83 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.62 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.6 mtt180 -119.28 137.87 53.39 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.34 144.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.408 -0.807 . . . . 0.0 110.347 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.03 144.31 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.749 -0.594 . . . . 0.0 110.324 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.5 m -117.7 122.1 42.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.624 . . . . 0.0 109.333 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.3 mt -102.3 133.61 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.9 . . . . 0.0 109.394 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 m -131.39 129.52 41.42 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.002 -1.061 . . . . 0.0 109.146 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.79 -173.62 37.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 p -70.58 158.54 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.91 -1.347 . . . . 0.0 109.493 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -45.08 49.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.255 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -67.25 -48.42 67.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.036 -1.04 . . . . 0.0 109.502 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.96 -35.51 69.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 108.822 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.26 -46.33 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 110.076 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.83 -43.19 94.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.79 -1.194 . . . . 0.0 109.23 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -62.26 -32.02 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -47.32 18.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.512 -0.743 . . . . 0.0 109.541 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.86 -37.75 74.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -70.61 -34.49 72.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.668 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.31 -20.19 60.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.804 -1.185 . . . . 0.0 108.902 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.82 -46.43 21.57 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.68 -37.38 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.38 -24.66 46.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.209 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -64.24 -37.59 88.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 117.725 -1.59 . . . . 0.0 107.177 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 28' ' ' ILE . 18.2 t . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.892 -0.505 . . . . 0.0 109.723 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mm . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.7 mt -124.83 150.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.365 -0.834 . . . . 0.0 109.702 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -128.01 137.55 52.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.62 145.87 39.05 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -111.75 145.47 39.29 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.68 155.62 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -125.37 130.11 51.27 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.28 131.16 23.85 Favored Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.19 132.81 53.5 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 CA-C-N 120.383 1.172 . . . . 0.0 111.186 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -39.54 -41.1 0.96 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.491 -0.755 . . . . 0.0 111.666 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.43 -46.51 88.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.746 -1.221 . . . . 0.0 110.702 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -76.11 -20.09 57.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.53 -1.356 . . . . 0.0 108.052 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.39 85.29 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.85 0.833 . . . . 0.0 109.439 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.16 -27.9 61.06 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.8 p -73.86 -32.02 63.45 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.257 -0.902 . . . . 0.0 109.154 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.6 mt -88.98 -43.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.0 111.099 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.66 -35.2 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.882 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 -173.12 41.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -91.81 -2.03 57.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.943 -1.328 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -152.01 18.17 0.83 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.9 -9.87 10.49 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.8 tt0 -36.24 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.707 -0.878 . . . . 0.0 111.004 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.536 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.8 tpp180 -88.19 -36.8 16.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.638 -1.289 . . . . 0.0 109.903 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.2 mm -73.05 -25.56 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.798 -1.189 . . . . 0.0 108.623 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -73.02 -49.95 25.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 108.837 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.53 -48.22 81.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.038 -1.039 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.62 -33.9 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.61 -54.75 43.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -70.81 -39.15 73.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.949 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -59.67 -46.04 90.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -86.5 -23.16 26.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 -0.98 85.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.46 163.13 17.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.966 . . . . 0.0 109.939 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 m -105.69 145.51 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.75 139.8 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.688 -1.257 . . . . 0.0 110.15 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.56 124.33 33.59 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.82 135.77 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 109.245 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.56 152.77 18.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.963 . . . . 0.0 108.81 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.48 153.46 94.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.002 -1.061 . . . . 0.0 108.721 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.495 1.574 0 C-N-CA 120.874 1.049 . . . . 0.0 112.486 179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 6.1 p30 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 121.517 0.675 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -119.88 138.92 53.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.6 mt -111.96 149.83 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.037 -1.04 . . . . 0.0 111.056 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.4 mt -135.04 143.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.769 -0.582 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.8 m -116.95 122.71 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -100.98 132.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -130.72 129.43 42.52 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.993 -1.067 . . . . 0.0 109.323 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -171.56 38.51 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.456 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 17.7 p -73.14 160.02 32.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.971 -1.311 . . . . 0.0 109.645 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -46.49 -47.25 19.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.22 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.52 -45.31 72.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.529 ' N ' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -59.03 -36.98 75.9 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.906 -1.121 . . . . 0.0 108.787 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.1 -46.01 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.79 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -59.85 -43.44 94.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -61.17 -34.96 75.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 108.843 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.23 -45.76 46.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.448 -0.782 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.33 -47.35 85.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.366 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -61.32 -41.2 96.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.089 . . . . 0.0 109.943 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.59 -18.11 64.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.823 -1.173 . . . . 0.0 109.055 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -45.48 13.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 108.583 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -61.95 -38.83 89.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.688 . . . . 0.0 110.109 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -78.89 -22.53 45.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.411 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 98.8 p -63.36 -40.1 96.35 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.592 HG13 HD23 ' A' ' 24' ' ' LEU . 19.5 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.325 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -124.12 149.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.295 -0.878 . . . . 0.0 109.662 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -128.13 137.61 52.17 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.42 145.34 38.77 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.95 145.62 38.05 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.57 151.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.5 m -124.11 129.42 50.83 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.99 134.61 26.08 Favored Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.37 146.16 52.74 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.26 1.129 . . . . 0.0 110.917 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.23 -41.87 63.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.065 -1.022 . . . . 0.0 111.451 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.8 p-10 -63.23 -46.68 85.82 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.741 -1.224 . . . . 0.0 111.15 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 -24.16 59.78 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.536 -1.353 . . . . 0.0 108.332 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.52 83.65 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.641 0.734 . . . . 0.0 109.796 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.689 HH12 ' NH2' ' A' ' 59' ' ' ARG . 5.9 mtt-85 -74.37 -31.65 62.47 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.795 -0.762 . . . . 0.0 108.96 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -70.31 -39.07 75.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 109.327 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.5 mt -74.11 -44.76 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 110.743 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.3 mt -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.968 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.11 40.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -92.12 -40.53 10.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.334 . . . . 0.0 109.496 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.35 14.97 36.06 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 69.12 -5.79 4.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -43.42 -23.79 0.08 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.989 -1.301 . . . . 0.0 110.206 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.1 tpp180 -81.6 -39.65 24.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.045 -1.034 . . . . 0.0 110.675 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -26.93 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 109.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.63 -43.3 72.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 0.0 109.045 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.42 -49.5 76.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.937 -1.102 . . . . 0.0 109.959 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -52.58 -33.84 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.99 -1.069 . . . . 0.0 109.935 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -66.66 -35.99 81.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.78 -36.61 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 110.358 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -74.53 -41.62 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.178 -0.951 . . . . 0.0 110.503 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -87.1 -23.21 24.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 110.598 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.6 2.1 68.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.961 -2.056 . . . . 0.0 107.961 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.98 161.39 20.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.842 -0.799 . . . . 0.0 110.148 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.0 m -109.14 140.91 42.09 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.2 mt -138.03 136.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.819 -1.175 . . . . 0.0 109.974 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -121.14 127.51 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.76 132.29 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 0.0 108.484 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 60' ' ' ILE . 1.3 p30 -93.04 153.2 18.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.955 -1.09 . . . . 0.0 108.56 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -67.33 149.0 98.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 120.91 -1.119 . . . . 0.0 108.536 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.49 1.265 0 C-N-CA 120.423 0.749 . . . . 0.0 111.696 179.48 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.994 0.902 . . . . 0.0 110.191 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.689 ' NH2' HH12 ' A' ' 26' ' ' ARG . 50.1 mtt180 -119.38 139.45 51.97 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 75.5 mt -111.07 141.07 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.348 -0.845 . . . . 0.0 110.518 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -122.41 144.98 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 110.393 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -117.78 123.53 46.21 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.68 132.6 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.424 -0.797 . . . . 0.0 109.547 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -129.58 130.07 45.22 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -173.67 38.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 p -73.63 160.45 31.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.293 . . . . 0.0 109.693 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.68 -47.1 20.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.588 -0.695 . . . . 0.0 110.017 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.9 -45.75 73.54 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.74 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.51 -38.65 81.51 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.813 -1.179 . . . . 0.0 109.183 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.32 -45.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.625 -0.672 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.36 -43.41 96.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.776 -1.202 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.54 -37.39 83.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 108.822 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.23 -46.79 48.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.716 . . . . 0.0 109.661 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -60.01 -46.63 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.243 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -61.59 -33.6 74.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.54 -24.28 58.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 108.93 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.77 -44.77 47.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 0.0 108.459 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -61.97 -38.58 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.728 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.85 -23.98 44.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -62.98 -37.86 88.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.987 -0.445 . . . . 0.0 109.85 -179.647 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.58 148.11 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -126.95 136.94 52.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.67 144.89 37.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.49 145.21 39.45 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.06 151.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 m -124.43 129.9 51.51 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.85 140.46 37.72 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.28 146.56 88.7 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 CA-C-N 120.131 1.083 . . . . 0.0 111.107 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -53.08 -41.05 64.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.999 -1.063 . . . . 0.0 111.463 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.78 -44.82 95.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.732 -1.23 . . . . 0.0 111.355 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.37 -23.04 50.87 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.57 -1.331 . . . . 0.0 108.135 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.9 89.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.739 0.78 . . . . 0.0 109.606 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.413 HH11 ' CG ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -74.7 -30.93 61.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.26 -32.23 69.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.867 -1.146 . . . . 0.0 109.286 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -82.42 -44.04 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.48 -35.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.787 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -173.36 41.07 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.73 2.0 56.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.001 -1.293 . . . . 0.0 109.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -156.01 19.58 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.08 -11.06 3.97 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 32' ' ' GLY . 59.5 mt-30 -36.26 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.708 -0.878 . . . . 0.0 110.683 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpp180 -85.13 -35.56 21.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.804 -1.185 . . . . 0.0 109.842 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -74.37 -26.45 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.961 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.7 -48.05 49.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.992 . . . . 0.0 108.912 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -57.16 -56.47 21.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.754 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.62 -32.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -62.16 -38.94 90.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -83.2 -39.37 21.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 110.602 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.8 -43.05 89.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.058 -1.026 . . . . 0.0 110.489 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 t -87.19 -23.55 24.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.191 -0.943 . . . . 0.0 110.692 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.67 1.67 72.69 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.92 161.96 19.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.852 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.48 140.72 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.6 mt -137.22 137.25 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.641 -1.287 . . . . 0.0 109.999 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -124.12 129.88 51.61 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.82 128.8 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.998 -1.063 . . . . 0.0 108.556 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 60' ' ' ILE . 20.5 p-10 -87.83 156.67 19.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.885 -1.134 . . . . 0.0 108.968 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.9 151.62 96.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.949 -1.095 . . . . 0.0 108.506 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo . . . . . 0 N--CA 1.493 1.454 0 C-N-CA 120.556 0.837 . . . . 0.0 111.858 179.821 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.889 0.852 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -114.39 138.46 50.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 76.4 mt -112.3 141.06 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.24 -0.913 . . . . 0.0 110.802 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -125.6 145.87 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.716 -0.615 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.5 m -118.16 122.66 43.59 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.6 mt -103.91 132.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.925 . . . . 0.0 109.471 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -131.43 129.78 41.66 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.988 -1.07 . . . . 0.0 109.278 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.23 -172.38 38.33 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 p -72.33 159.63 33.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.269 . . . . 0.0 109.519 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.96 -46.94 21.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -68.16 -47.04 69.1 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -56.78 -34.45 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.885 -1.135 . . . . 0.0 109.369 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.9 mt -73.67 -45.35 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.499 -0.751 . . . . 0.0 110.45 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.33 -43.83 96.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.717 -1.239 . . . . 0.0 109.6 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.23 -32.65 72.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 108.856 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.14 -45.87 25.37 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.456 -0.778 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.63 -48.08 80.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.05 -39.89 91.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.037 -1.04 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.52 -25.63 65.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 0.0 108.959 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.4 -46.24 41.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.73 -38.48 88.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.537 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 79' ' ' ASN . 1.4 m-80 -78.58 -25.06 45.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 89.1 p -62.36 -37.14 84.54 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.725 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -123.84 149.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -0.875 . . . . 0.0 109.642 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 m -127.78 137.3 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -139.24 144.91 38.64 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.59 145.61 37.55 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.162 -0.962 . . . . 0.0 110.008 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.63 151.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.7 129.86 52.28 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.34 136.97 29.37 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 24' ' ' LEU . 1.1 Cg_endo -60.42 137.55 75.0 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 CA-C-N 120.114 1.076 . . . . 0.0 111.082 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -43.79 -40.68 4.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.274 -0.891 . . . . 0.0 111.448 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -46.73 84.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.699 -1.25 . . . . 0.0 111.399 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 21' ' ' PRO . 74.3 mt -76.33 -19.46 58.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.375 -1.453 . . . . 0.0 108.069 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.82 88.93 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.721 0.772 . . . . 0.0 109.367 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 5.5 mtt-85 -74.57 -26.87 60.22 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.6 p -74.58 -28.84 61.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -88.28 -45.15 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.808 -1.183 . . . . 0.0 111.21 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.23 -34.7 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.91 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.05 -173.98 43.52 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -92.09 -4.97 53.65 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.997 -1.296 . . . . 0.0 109.554 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.1 1.41 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 77.34 -8.41 32.93 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLY . 12.2 pt20 -34.02 -29.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.952 -0.734 . . . . 0.0 111.235 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 mmt180 -85.88 -40.63 15.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.419 -1.426 . . . . 0.0 109.622 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -68.86 -26.62 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.009 -1.057 . . . . 0.0 109.202 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.86 -52.78 8.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.447 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -60.87 -47.8 84.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.05 . . . . 0.0 109.489 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.33 -36.01 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -55.87 -67.15 0.32 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.406 -0.809 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.78 -39.81 86.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -58.19 -45.97 86.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 110.128 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 p -86.77 -21.96 26.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.014 -1.054 . . . . 0.0 110.089 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.85 0.07 73.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.0 160.91 20.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.729 -0.865 . . . . 0.0 110.026 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.5 t -106.93 141.86 37.47 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.02 136.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.658 -1.276 . . . . 0.0 110.139 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.84 130.76 54.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.3 mt -101.01 134.16 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.644 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.28 150.48 20.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 108.598 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -66.86 149.85 98.13 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.899 -1.125 . . . . 0.0 108.437 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 N--CA 1.491 1.354 0 CA-C-N 119.261 0.772 . . . . 0.0 111.442 179.455 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 26' ' ' ARG . 3.5 mtt-85 -116.87 140.53 49.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -111.93 141.63 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.288 -0.882 . . . . 0.0 110.718 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.25 144.4 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.696 -0.627 . . . . 0.0 110.47 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 m -117.57 122.3 43.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 mt -103.16 132.66 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -129.87 130.16 44.86 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.54 38.79 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.705 ' H ' HE21 ' A' ' 69' ' ' GLN . 21.1 p -73.49 160.42 31.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.29 . . . . 0.0 109.662 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -46.95 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.0 -47.02 69.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.705 HE21 ' H ' ' A' ' 66' ' ' THR . 24.8 mt-30 -58.07 -37.55 74.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.832 -1.167 . . . . 0.0 109.201 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.39 -45.8 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.621 -0.674 . . . . 0.0 110.316 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.01 -43.55 95.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.819 -1.176 . . . . 0.0 109.518 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -61.74 -33.12 73.5 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.19 -0.943 . . . . 0.0 108.75 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.12 -46.84 22.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.403 -0.811 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -58.36 -46.0 87.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -62.81 -37.06 85.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.062 . . . . 0.0 110.135 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.01 -17.71 62.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 108.971 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.34 -45.91 14.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 108.532 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.42 -38.24 88.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.621 -0.675 . . . . 0.0 110.273 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.71 -22.94 45.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 t -66.18 -36.35 82.86 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.06 -1.456 . . . . 0.0 107.369 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 81' ' ' VAL . 4.4 t . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 110.201 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -123.79 148.27 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.24 -0.913 . . . . 0.0 109.661 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -127.74 137.6 52.49 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.37 144.4 38.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.41 145.41 36.18 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.253 -0.904 . . . . 0.0 109.911 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.94 151.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -127.0 129.55 48.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.534 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.4 141.86 41.23 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.46 141.83 89.67 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 CA-C-N 120.287 1.138 . . . . 0.0 110.691 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -47.94 -41.15 24.16 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.897 -1.127 . . . . 0.0 111.451 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -61.75 -43.56 98.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.651 -1.281 . . . . 0.0 111.293 -178.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -78.92 -29.2 44.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.732 -1.23 . . . . 0.0 108.411 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -40.79 74.46 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.79 0.805 . . . . 0.0 109.311 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.78 -32.51 62.05 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.5 p -68.53 -25.24 64.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.959 -1.088 . . . . 0.0 109.046 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.55 -41.86 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.965 -1.085 . . . . 0.0 110.578 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.63 ' CD1' HH11 ' A' ' 59' ' ' ARG . 58.1 mt -68.12 -37.44 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.851 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.04 -173.72 39.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -91.27 -4.6 55.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.888 -1.36 . . . . 0.0 109.938 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.56 20.81 1.17 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.08 -11.4 2.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 32' ' ' GLY . 88.0 mt-30 -36.53 -27.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.737 -0.861 . . . . 0.0 110.624 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.6 tpp180 -86.17 -34.33 20.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.76 -1.213 . . . . 0.0 109.889 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -75.91 -27.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 109.172 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.29 -48.91 30.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -58.21 -55.13 38.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.574 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -50.41 -32.37 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 109.672 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -62.7 -37.81 87.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.045 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.79 -39.75 19.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 0.0 110.518 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.44 -41.61 93.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.984 -1.072 . . . . 0.0 110.333 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -86.96 -24.24 24.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.54 1.27 70.36 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.12 161.06 20.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.765 -0.844 . . . . 0.0 110.041 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.8 t -108.46 139.35 43.33 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.3 mt -136.76 136.75 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.822 -1.174 . . . . 0.0 109.981 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -122.28 128.83 51.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -99.05 135.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.119 . . . . 0.0 108.829 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.49 148.57 22.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.082 -1.011 . . . . 0.0 108.616 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 149.26 97.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.953 -1.092 . . . . 0.0 108.797 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.49 1.306 0 CA-C-N 119.391 0.818 . . . . 0.0 111.479 179.495 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.919 0.866 . . . . 0.0 109.831 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.63 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.4 mtt180 -118.71 140.14 50.42 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -111.26 142.16 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.16 143.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.82 -0.55 . . . . 0.0 110.384 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.3 m -117.76 122.84 44.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 0.0 109.451 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.74 133.07 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 m -130.36 130.23 44.14 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.052 -1.03 . . . . 0.0 109.221 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.33 -172.71 38.49 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 p -72.65 159.55 33.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.024 -1.28 . . . . 0.0 109.725 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.94 19.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.102 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.24 -45.73 72.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -58.84 -37.35 76.27 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.85 -1.156 . . . . 0.0 109.226 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.66 -45.6 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.774 . . . . 0.0 110.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -60.53 -43.08 97.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 0.0 109.363 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -62.64 -34.58 77.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.897 . . . . 0.0 108.657 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -46.01 31.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.76 -37.16 78.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 110.142 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.79 -35.33 72.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.589 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.85 -1.156 . . . . 0.0 108.885 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -81.28 -45.31 16.42 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -61.81 -38.72 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.561 -0.712 . . . . 0.0 109.628 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -78.53 -24.69 45.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.6 p -62.14 -37.31 84.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HD23 ' A' ' 24' ' ' LEU . 39.6 t . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.893 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -123.6 148.61 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.569 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 m -127.31 136.96 52.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.38 144.92 38.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.92 148.77 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.45 129.68 52.29 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.97 136.51 28.95 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.3 137.64 80.7 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 CA-C-N 120.243 1.123 . . . . 0.0 110.995 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -43.36 -40.53 3.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 111.528 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -63.02 -46.5 87.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.72 -1.237 . . . . 0.0 111.178 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.42 -20.52 57.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.58 -1.325 . . . . 0.0 108.289 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.58 89.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.702 0.763 . . . . 0.0 109.881 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 59' ' ' ARG . 3.8 mtt-85 -74.41 -32.39 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.859 -0.737 . . . . 0.0 109.265 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -69.22 -32.53 71.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.71 -1.244 . . . . 0.0 109.267 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -80.02 -44.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.025 -1.047 . . . . 0.0 110.821 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.526 ' CD1' HH11 ' A' ' 59' ' ' ARG . 54.5 mt -68.4 -36.39 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.941 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.88 -172.36 40.29 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -91.83 -24.26 19.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.992 -1.299 . . . . 0.0 109.765 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -127.41 18.26 6.09 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.12 -9.18 4.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' GLY . 36.9 mt-30 -38.93 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.991 . . . . 0.0 110.417 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 tpp180 -83.43 -37.68 22.9 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.977 -1.077 . . . . 0.0 110.244 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.0 -27.71 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.144 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.987 . . . . 0.0 109.076 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.44 -46.43 90.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.21 -33.44 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 0.0 110.078 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -67.35 -41.44 85.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HD1' ' C ' ' A' ' 41' ' ' HIS . 3.1 t-80 -78.44 -34.15 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.008 . . . . 0.0 110.221 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.27 -41.64 48.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.637 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -86.49 -23.55 25.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.939 -1.101 . . . . 0.0 110.449 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 0.69 71.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.62 161.26 20.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.738 -0.86 . . . . 0.0 109.926 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -109.1 140.05 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.44 137.34 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.728 -1.232 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -121.83 129.84 52.93 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.5 135.19 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.048 -1.033 . . . . 0.0 108.84 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -95.3 150.15 20.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 108.532 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 3.4 mp0 -66.56 149.52 98.07 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.878 -1.138 . . . . 0.0 108.586 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo . . . . . 0 N--CA 1.49 1.268 0 CA-C-N 119.363 0.808 . . . . 0.0 111.44 179.482 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 122.037 0.922 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 26' ' ' ARG . 44.3 mtt180 -117.65 139.17 51.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -108.61 156.16 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.825 0.821 . . . . 0.0 110.541 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -138.94 142.63 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.752 -0.593 . . . . 0.0 110.07 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -116.65 123.08 46.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.695 -0.628 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.52 132.75 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.9 m -130.54 130.12 43.7 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.118 -0.989 . . . . 0.0 109.234 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.07 -173.13 39.23 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.8 p -73.49 160.23 32.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.046 -1.267 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -45.45 -48.77 13.8 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.397 0.618 . . . . 0.0 110.498 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.25 -45.43 73.24 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.946 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -58.54 -36.26 73.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 109.392 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.11 -45.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.251 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -60.62 -43.07 97.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.658 -1.276 . . . . 0.0 109.305 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.36 -36.63 82.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.59 49.42 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.517 -0.74 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.48 -45.05 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.924 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.5 mt -73.36 -16.0 61.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.867 -1.146 . . . . 0.0 108.998 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -83.36 -45.84 13.26 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.44 -38.2 88.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.78 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.3 -23.52 47.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -65.24 -35.41 80.96 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.953 -1.499 . . . . 0.0 107.392 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 81' ' ' VAL . 25.0 t . . . . . 0 N--CA 1.495 1.823 0 O-C-N 121.661 -0.649 . . . . 0.0 110.179 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mm . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.2 mt -125.31 151.47 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.341 -0.849 . . . . 0.0 109.931 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 t -129.69 142.25 50.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.254 -0.904 . . . . 0.0 108.988 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -143.24 146.75 33.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.98 146.94 39.43 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.57 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.2 150.97 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -130.44 82.28 2.05 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.56 149.61 75.17 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -57.01 169.13 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 119.418 0.828 . . . . 0.0 110.148 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -76.08 -42.33 47.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.565 -1.335 . . . . 0.0 110.949 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.06 -39.85 95.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.748 -1.22 . . . . 0.0 111.532 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 21' ' ' PRO . 21.9 mt -79.63 -27.66 40.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.779 -1.201 . . . . 0.0 108.638 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' PRO . . . -58.19 -38.64 77.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.826 0.822 . . . . 0.0 109.186 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.34 -33.81 63.25 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -67.9 -29.93 69.15 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.859 -1.15 . . . . 0.0 108.97 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -83.93 -42.99 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.926 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' CD1' HH11 ' A' ' 59' ' ' ARG . 56.4 mt -67.45 -36.24 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.961 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.02 -173.83 41.67 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CD ' ' N ' ' A' ' 31' ' ' LYS . 1.4 mptm? -91.74 -0.02 57.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.933 -1.333 . . . . 0.0 109.651 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.13 19.4 0.64 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.18 -11.52 4.9 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 32' ' ' GLY . 14.8 pt20 -34.99 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.858 -0.789 . . . . 0.0 111.011 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.3 tpp180 -84.31 -34.62 23.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.718 -1.239 . . . . 0.0 109.89 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -74.69 -26.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.935 -1.103 . . . . 0.0 108.882 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -71.57 -47.94 51.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 108.945 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -60.09 -49.57 77.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.14 -34.71 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.112 -0.992 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 110.036 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.49 -38.1 59.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.099 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.97 -43.42 98.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 110.086 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -86.86 -22.16 25.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.991 -1.068 . . . . 0.0 110.276 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 0.19 74.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.72 161.83 19.88 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.771 -0.841 . . . . 0.0 110.042 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -107.58 142.85 36.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -138.46 136.54 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.681 -1.262 . . . . 0.0 110.027 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -121.39 130.02 53.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.8 mt -100.47 135.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.894 -1.129 . . . . 0.0 108.808 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.29 150.39 20.33 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.17 150.46 95.5 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.905 -1.122 . . . . 0.0 108.504 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.49 1.297 0 CA-C-N 119.167 0.738 . . . . 0.0 111.523 179.595 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.669 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' CD1' ' A' ' 29' ' ' ILE . 40.7 mtt180 -117.69 139.81 50.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -109.08 152.09 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.759 0.79 . . . . 0.0 110.793 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.97 142.47 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.771 -0.58 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.4 m -114.61 126.61 55.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.499 ' CD1' ' NE2' ' A' ' 74' ' ' GLN . 15.0 mt -107.36 130.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.396 -0.815 . . . . 0.0 109.397 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -128.63 131.11 48.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.17 -174.33 39.45 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 p -72.92 159.96 32.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.045 -1.268 . . . . 0.0 109.773 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.94 -47.41 21.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.4 -45.34 72.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -59.21 -36.22 75.0 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.904 -1.122 . . . . 0.0 109.235 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.1 mt -74.48 -45.28 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -43.22 96.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.708 -1.245 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.92 -31.86 71.37 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.57 -42.02 53.21 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.591 -0.693 . . . . 0.0 109.913 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.706 HE21 ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -57.79 -52.69 64.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 0.0 109.354 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.99 -38.73 70.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.96 -22.21 62.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.791 -1.193 . . . . 0.0 109.251 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.9 mt -79.44 -45.54 19.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.0 108.222 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.24 -38.48 89.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.573 -0.704 . . . . 0.0 109.846 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.62 -24.17 45.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -63.72 -37.21 86.49 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.423 ' CG1' HD13 ' A' ' 24' ' ' LEU . 3.5 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.704 -0.623 . . . . 0.0 110.144 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -125.08 149.85 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.3 -0.875 . . . . 0.0 109.879 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.3 t -129.08 142.1 51.0 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.011 0.91 . . . . 0.0 108.888 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -143.07 144.59 32.32 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -110.46 145.99 36.69 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.18 148.59 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -121.78 129.65 52.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 135.21 27.07 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.531 -0.731 . . . . 0.0 109.087 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.99 136.66 78.06 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.271 1.132 . . . . 0.0 111.335 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -43.16 -41.31 3.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.219 -0.925 . . . . 0.0 111.579 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -62.25 -46.19 89.96 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.74 -1.225 . . . . 0.0 111.054 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.31 -25.47 54.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.658 -1.276 . . . . 0.0 108.02 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.59 82.33 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.785 0.803 . . . . 0.0 109.321 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.84 -29.33 61.02 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -72.08 -30.25 64.93 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.062 -1.024 . . . . 0.0 109.052 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -86.97 -43.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.007 -1.058 . . . . 0.0 110.937 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.61 -35.59 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.728 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -175.35 43.13 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -91.59 -3.38 56.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -150.03 18.71 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.31 -10.43 6.21 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 32' ' ' GLY . 18.7 mm100 -36.25 -27.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.787 -0.831 . . . . 0.0 110.594 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.92 -35.7 20.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.937 -1.102 . . . . 0.0 109.856 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -76.19 -28.04 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.961 -1.087 . . . . 0.0 109.269 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.57 -48.8 37.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.966 -1.084 . . . . 0.0 109.307 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -57.38 -42.68 82.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.0 110.057 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.12 -32.72 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 110.114 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -65.76 -49.47 68.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.002 . . . . 0.0 109.952 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 1.7 m80 -71.4 -32.27 68.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -42.7 42.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.373 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -86.58 -23.74 25.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.68 0.81 75.29 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.74 161.38 20.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.761 -0.847 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.9 140.51 42.28 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.88 137.76 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.689 -1.257 . . . . 0.0 110.013 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -122.82 129.45 51.71 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.459 HG21 ' NH2' ' A' ' 59' ' ' ARG . 68.4 mt -100.36 135.42 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 108.71 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.03 151.67 18.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.023 -1.048 . . . . 0.0 109.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.95 154.44 92.31 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.067 -1.02 . . . . 0.0 108.399 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 N--CA 1.492 1.393 0 C-N-CA 120.477 0.785 . . . . 0.0 111.748 179.809 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.8 mmm180 -117.72 137.55 52.61 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.61 156.0 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.887 0.851 . . . . 0.0 111.078 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.74 142.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.139 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.8 m -116.21 123.96 49.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.643 -0.661 . . . . 0.0 109.287 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.17 -0.956 . . . . 0.0 109.572 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -130.35 130.24 44.18 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.098 -1.001 . . . . 0.0 109.06 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.46 -173.25 38.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.2 p -72.42 159.59 33.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.968 -1.313 . . . . 0.0 109.618 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.1 -46.97 23.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 110.162 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.12 -47.14 68.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 109.882 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.36 -36.51 71.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.79 -1.194 . . . . 0.0 109.111 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.26 -45.82 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.48 -42.75 96.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.818 -1.177 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -62.16 -37.74 86.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.305 -0.872 . . . . 0.0 108.875 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.92 -44.09 64.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.422 -0.798 . . . . 0.0 109.601 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -58.04 -48.93 78.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.024 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.64 -39.14 83.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.84 -18.3 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.861 -1.15 . . . . 0.0 109.194 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -45.91 12.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 108.392 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.11 -38.62 89.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.665 -0.647 . . . . 0.0 110.042 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -78.99 -23.59 44.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.925 -1.109 . . . . 0.0 109.89 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.1 p -61.94 -36.68 82.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.89 -0.506 . . . . 0.0 110.42 -179.686 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 mm . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.93 149.22 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.293 -0.879 . . . . 0.0 109.682 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.4 m -127.94 137.5 52.29 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.91 146.17 38.9 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -112.02 145.97 38.72 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -126.77 155.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -126.44 130.27 50.35 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -126.21 133.26 24.77 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.94 136.09 74.6 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 CA-C-N 120.356 1.163 . . . . 0.0 111.265 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -42.46 -41.28 2.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 111.515 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.88 -46.33 88.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.651 -1.28 . . . . 0.0 111.187 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 HG13 ' A' ' 81' ' ' VAL . 10.8 mp -75.65 -19.8 58.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.491 -1.381 . . . . 0.0 108.109 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.43 85.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.34 -28.66 61.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.9 p -72.89 -30.71 64.16 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.121 -0.987 . . . . 0.0 109.178 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -89.06 -43.06 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 0.0 111.014 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.5 mt -69.13 -35.98 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.061 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -170.7 38.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 15.7 ttpp -91.76 -11.76 35.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.948 -1.325 . . . . 0.0 110.007 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.17 17.99 2.51 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.55 -9.64 14.76 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 5.7 tp-100 -36.07 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.707 -0.878 . . . . 0.0 111.137 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.1 tpp180 -85.95 -35.51 20.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.536 -1.352 . . . . 0.0 109.7 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -72.55 -23.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.81 -1.182 . . . . 0.0 108.414 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -73.19 -50.23 23.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -0.976 . . . . 0.0 109.004 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -57.25 -51.42 69.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.63 -33.5 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.566 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -58.8 -64.82 0.8 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -62.29 -39.3 92.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -61.14 -44.65 96.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.255 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 p -86.71 -22.93 25.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.976 -1.078 . . . . 0.0 110.433 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.71 0.55 74.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.65 19.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.803 -0.822 . . . . 0.0 110.025 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.0 t -107.23 141.57 38.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.0 mt -137.09 138.33 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.57 -1.331 . . . . 0.0 110.265 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -124.83 129.87 51.28 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.68 136.23 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.059 . . . . 0.0 108.917 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.17 152.16 18.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -1.0 . . . . 0.0 109.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.642 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 pm0 -67.06 154.08 93.27 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 120.993 -1.067 . . . . 0.0 108.731 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo . . . . . 0 N--CA 1.494 1.549 0 C-N-CA 120.675 0.916 . . . . 0.0 112.341 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.498 1.967 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.96 138.35 52.23 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -111.66 147.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.196 -0.94 . . . . 0.0 110.752 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 20' ' ' ILE . 96.6 mt -132.55 144.04 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.858 -0.526 . . . . 0.0 110.445 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.9 m -118.02 122.29 42.82 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -102.22 133.33 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -131.17 129.67 42.04 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.999 -1.063 . . . . 0.0 109.145 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.62 -172.32 38.65 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -72.08 159.02 34.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.01 -1.288 . . . . 0.0 109.716 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -47.19 21.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.855 -0.528 . . . . 0.0 110.342 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -68.52 -45.55 71.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.806 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -58.24 -35.2 71.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.114 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.9 mt -73.52 -45.59 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.467 -0.77 . . . . 0.0 110.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -60.47 -42.84 97.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.754 -1.216 . . . . 0.0 109.376 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.79 -36.18 80.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.79 57.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -58.45 -48.66 80.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 110.379 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.06 -41.84 93.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.955 -1.091 . . . . 0.0 109.932 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.56 -25.29 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.798 -1.189 . . . . 0.0 108.966 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.6 -45.55 44.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.65 -38.59 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.471 -0.768 . . . . 0.0 109.385 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 79' ' ' ASN . 1.6 m-80 -78.41 -24.24 46.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.342 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.4 p -63.22 -37.61 87.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.331 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 HD23 ' A' ' 24' ' ' LEU . 22.9 t . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 57.7 mt -123.29 148.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 m -127.51 137.34 52.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -138.96 144.49 39.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -110.3 145.78 36.83 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.196 -0.94 . . . . 0.0 110.239 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.08 148.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -121.49 129.87 53.2 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.86 138.73 33.23 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.557 -0.715 . . . . 0.0 109.183 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -56.22 147.21 67.34 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.032 1.047 . . . . 0.0 110.992 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -54.05 -41.86 68.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.996 -1.065 . . . . 0.0 111.271 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -62.25 -42.64 99.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.749 -1.219 . . . . 0.0 111.162 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.488 HD13 ' CG1' ' A' ' 81' ' ' VAL . 27.2 mt -79.48 -26.68 41.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.63 -1.294 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -39.11 78.01 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.859 0.838 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.7 -30.51 61.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.4 p -70.67 -29.22 65.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.102 -0.999 . . . . 0.0 109.352 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.7 mt -86.65 -44.25 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.022 -1.049 . . . . 0.0 111.108 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.2 mt -64.86 -34.69 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.569 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -176.62 46.16 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -92.25 0.34 57.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.038 -1.272 . . . . 0.0 109.406 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.8 15.19 0.7 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 78.11 -8.02 40.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.1 mt-30 -34.57 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.943 -0.739 . . . . 0.0 111.023 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.5 mmp_? -87.05 -43.46 12.29 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.545 -1.347 . . . . 0.0 109.469 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.92 -26.46 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.077 -1.015 . . . . 0.0 108.951 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.75 -53.58 7.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.516 ' OE1' ' NH2' ' A' ' 35' ' ' ARG . 88.3 mt-30 -59.16 -52.48 65.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -52.93 -34.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.36 -47.71 84.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.389 -0.819 . . . . 0.0 110.576 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -75.07 -40.52 60.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.008 . . . . 0.0 110.746 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.93 -43.07 99.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 110.34 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -87.8 -22.92 24.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 110.632 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.73 0.6 74.86 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 160.74 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.768 -0.842 . . . . 0.0 110.194 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 t -108.09 142.8 37.72 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -138.51 136.88 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 110.301 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -122.06 128.54 51.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.1 mt -99.56 135.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 109.162 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -95.85 150.3 20.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.113 -0.992 . . . . 0.0 108.503 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.62 150.59 97.32 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.837 -1.164 . . . . 0.0 108.617 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 N--CA 1.49 1.308 0 CA-C-N 119.133 0.726 . . . . 0.0 111.486 179.508 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 121.92 0.867 . . . . 0.0 110.102 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 46.9 mtt180 -119.74 138.87 53.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -108.07 155.58 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.441 -0.787 . . . . 0.0 110.607 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -138.54 141.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.762 -0.586 . . . . 0.0 110.021 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -115.76 122.99 47.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -102.32 133.48 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -130.57 129.68 43.09 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.086 -1.009 . . . . 0.0 109.152 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.61 -174.1 38.94 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -72.39 159.66 33.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.954 -1.321 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.473 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.6 19.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.245 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -68.3 -45.96 71.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.274 -0.892 . . . . 0.0 109.946 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -58.35 -36.03 72.82 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.862 -1.149 . . . . 0.0 109.359 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.1 mt -71.91 -45.95 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.2 -43.59 95.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.768 -1.207 . . . . 0.0 109.663 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -60.98 -39.63 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.152 -0.968 . . . . 0.0 108.689 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.53 64.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.507 -0.746 . . . . 0.0 109.398 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.16 -49.86 74.63 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.494 -0.754 . . . . 0.0 110.319 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.53 -37.72 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.027 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.31 -19.78 63.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.791 -1.193 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 81' ' ' VAL . 13.7 mt -81.05 -46.24 15.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 108.624 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.45 -39.53 93.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.747 -0.595 . . . . 0.0 110.715 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -78.33 -22.34 48.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -65.25 -34.71 79.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.111 -1.436 . . . . 0.0 107.316 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.488 ' CG1' HD13 ' A' ' 24' ' ' LEU . 1.3 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.391 -0.818 . . . . 0.0 110.858 -178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -123.44 150.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.308 -0.87 . . . . 0.0 109.368 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.19 138.05 53.61 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.47 144.17 37.88 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -110.87 146.32 36.71 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.27 152.77 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -126.4 129.6 49.09 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 140.15 36.43 Favored Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.76 150.76 68.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 CA-C-N 120.019 1.042 . . . . 0.0 110.665 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -56.48 -40.85 75.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.87 -1.143 . . . . 0.0 111.2 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.18 -45.4 91.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 111.552 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.88 -26.2 53.93 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.36 -1.462 . . . . 0.0 108.466 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.06 80.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.812 0.815 . . . . 0.0 109.514 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.45 -30.82 62.03 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.79 -34.3 71.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.081 -1.012 . . . . 0.0 109.147 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -82.11 -44.37 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 111.09 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.562 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.4 mt -67.1 -35.38 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.918 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.09 -175.67 41.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -91.23 -9.58 44.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.022 -1.281 . . . . 0.0 109.967 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -144.17 20.03 2.11 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 71.39 -11.6 2.95 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 32' ' ' GLY . 5.7 pt20 -35.54 -36.12 0.07 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.77 -0.841 . . . . 0.0 110.656 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -76.71 -33.35 58.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.949 -1.094 . . . . 0.0 110.213 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -77.01 -26.36 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.62 -1.3 . . . . 0.0 109.334 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.63 -46.22 66.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 109.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -59.99 -49.9 75.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.677 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.05 -33.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -61.23 -64.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.243 -0.91 . . . . 0.0 110.047 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -64.08 -38.81 92.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 110.231 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.37 -42.15 98.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.238 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 28.0 p -87.01 -22.49 25.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.931 -1.106 . . . . 0.0 110.383 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.08 0.25 69.54 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.82 160.87 21.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.857 -0.79 . . . . 0.0 110.116 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.55 139.79 41.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.44 137.22 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.669 -1.269 . . . . 0.0 109.935 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -122.83 126.87 48.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.98 135.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.873 -1.142 . . . . 0.0 108.528 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.42 148.18 23.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.151 -0.968 . . . . 0.0 108.593 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.19 149.17 97.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.899 -1.126 . . . . 0.0 108.761 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo . . . . . 0 C--N 1.313 -1.297 0 CA-C-N 119.344 0.802 . . . . 0.0 111.581 179.542 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 121.801 0.81 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.562 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.7 mtt180 -119.19 138.97 52.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.2 mt -110.12 147.95 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.35 -0.844 . . . . 0.0 110.645 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -130.57 143.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.758 -0.589 . . . . 0.0 110.311 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.3 m -116.51 122.68 45.41 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.58 133.1 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 m -130.98 129.41 42.08 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.018 -1.051 . . . . 0.0 109.169 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.83 -173.94 39.94 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 159.41 34.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.12 -1.224 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.499 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -47.06 -47.04 22.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.717 -0.614 . . . . 0.0 110.451 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -68.5 -44.57 74.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.787 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 43' ' ' SER . 24.1 mm100 -59.54 -36.68 76.62 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.916 -1.115 . . . . 0.0 109.284 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -71.19 -45.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.124 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -60.36 -43.12 96.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.804 -1.185 . . . . 0.0 109.334 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.5 -37.15 84.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 108.628 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -46.64 48.94 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.525 -0.734 . . . . 0.0 109.491 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.54 -41.34 89.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -66.91 -36.39 82.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.15 -13.95 61.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 108.943 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.59 -45.16 12.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.971 . . . . 0.0 108.454 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.02 -38.45 88.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -79.14 -24.16 43.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 109.467 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.9 p -63.78 -38.58 91.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 81' ' ' VAL . 22.1 t . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.11 149.53 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -125.83 137.78 53.79 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.48 144.75 38.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -111.31 146.79 36.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -125.59 154.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 130.05 49.51 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.32 138.42 32.75 Favored Pre-proline 0 N--CA 1.506 2.338 0 O-C-N 121.514 -0.741 . . . . 0.0 109.23 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.88 175.05 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.114 1.076 . . . . 0.0 110.828 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.37 -39.27 39.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.584 -1.322 . . . . 0.0 110.534 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -63.41 -39.75 95.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -0.889 . . . . 0.0 111.457 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 24' ' ' LEU . 11.2 mp -81.01 -28.66 35.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.439 -1.413 . . . . 0.0 108.311 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.039 0.923 . . . . 0.0 109.171 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -71.51 -30.87 66.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.0 p -72.28 -31.18 65.51 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.072 -1.017 . . . . 0.0 109.223 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -86.74 -44.27 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.146 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -67.21 -35.44 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.83 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.96 -173.61 41.56 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -91.67 0.55 57.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.046 -1.267 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.6 18.59 0.59 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.63 -10.35 6.95 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 33' ' ' GLY . 40.7 mt-30 -35.58 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.797 -0.825 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 tpt180 -85.68 -35.27 20.99 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.641 -1.287 . . . . 0.0 110.069 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -74.33 -27.38 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 109.019 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.62 -47.79 44.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.31 -46.49 88.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.039 -1.038 . . . . 0.0 110.031 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.92 -33.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -66.67 -40.18 88.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.015 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 41' ' ' HIS . 18.5 t-80 -77.51 -30.42 52.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 110.248 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' O ' ' OE2' ' A' ' 42' ' ' GLU . 2.2 tm-20 -79.12 -41.58 28.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -86.59 -23.68 25.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 110.48 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.52 0.6 73.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.46 161.15 20.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.681 -0.894 . . . . 0.0 110.053 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.6 m -108.79 140.07 42.73 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.76 137.5 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.775 -1.203 . . . . 0.0 110.024 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -122.3 129.26 52.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -99.68 135.15 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.884 -1.135 . . . . 0.0 108.676 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 10.0 m-20 -95.83 150.18 20.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.158 -0.964 . . . . 0.0 108.626 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -66.4 151.12 96.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.916 -1.115 . . . . 0.0 108.609 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.491 1.377 0 C-N-CA 120.451 0.767 . . . . 0.0 111.705 179.586 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.794 0.807 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -116.66 138.74 51.22 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.4 mt -112.4 147.24 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.193 -0.942 . . . . 0.0 110.962 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.1 mt -132.22 143.26 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.836 -0.54 . . . . 0.0 110.218 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 m -116.43 124.36 49.81 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.0 mt -103.92 132.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -131.03 130.06 42.81 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.038 -1.039 . . . . 0.0 109.104 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.1 -173.27 38.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -72.12 159.27 34.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -47.46 -46.55 26.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.673 -0.642 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.08 -47.1 69.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 109.862 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 14.3 mp0 -57.91 -36.73 72.85 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.866 -1.146 . . . . 0.0 109.082 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.82 -45.79 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.511 -0.743 . . . . 0.0 110.019 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.66 -42.98 98.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.75 -1.219 . . . . 0.0 109.55 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.44 -38.37 89.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 108.817 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.1 -45.66 59.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.399 -0.813 . . . . 0.0 109.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.91 -41.24 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.134 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.84 -37.31 84.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 109.777 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -70.82 -26.69 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.799 -1.188 . . . . 0.0 108.836 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.78 -45.19 62.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -62.18 -38.89 90.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.39 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.38 -26.08 46.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.605 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 p -62.46 -36.66 83.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.177 -1.409 . . . . 0.0 107.244 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.077 0.465 . . . . 0.0 109.821 -179.812 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.64 149.46 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.352 -0.843 . . . . 0.0 109.792 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -127.1 137.66 53.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.8 145.34 38.06 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -110.95 144.74 39.55 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 109.938 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.88 149.04 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -122.24 129.62 52.41 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.92 138.99 33.79 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -56.87 146.12 80.58 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 CA-C-N 120.209 1.11 . . . . 0.0 110.918 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -52.7 -40.95 63.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.904 -1.122 . . . . 0.0 111.344 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -62.31 -44.25 96.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.807 -1.183 . . . . 0.0 111.231 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 mt -78.52 -26.73 45.87 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.622 -1.299 . . . . 0.0 108.209 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.45 79.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.83 0.824 . . . . 0.0 109.319 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -74.55 -30.09 61.61 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.8 p -71.12 -26.96 63.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.075 -1.016 . . . . 0.0 109.299 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -89.01 -43.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 110.999 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 52.4 mt -68.28 -36.01 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.707 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -172.72 40.37 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -91.65 -9.65 43.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 109.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -143.84 18.36 2.18 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.91 -10.44 9.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 19.7 mm100 -35.61 -29.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.866 -0.785 . . . . 0.0 110.803 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.0 tpp180 -84.32 -37.15 21.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.643 -1.286 . . . . 0.0 109.743 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -72.3 -23.39 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.802 -1.186 . . . . 0.0 108.532 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -71.72 -48.14 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 108.939 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -59.11 -47.72 84.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.53 -33.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.519 HH11 ' CG ' ' A' ' 40' ' ' ARG . 1.5 ttt-85 -57.88 -53.47 57.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.244 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.58 -39.57 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 0.0 110.357 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -59.07 -44.99 91.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.108 -0.995 . . . . 0.0 110.114 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t -86.93 -22.56 25.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 110.188 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.11 -0.16 80.41 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.03 162.82 18.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.707 -0.878 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.5 m -104.85 148.1 27.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -133.05 138.8 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.652 -1.28 . . . . 0.0 109.948 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.53 123.63 31.91 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.15 135.06 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 108.961 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.21 152.06 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.115 -0.991 . . . . 0.0 108.836 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 3.2 mp0 -70.7 150.2 95.34 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 120.933 -1.105 . . . . 0.0 108.396 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 N--CA 1.49 1.273 0 CA-C-N 119.442 0.837 . . . . 0.0 111.59 179.347 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 122.135 0.969 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.5 mtt180 -118.44 138.83 52.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -108.3 151.97 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.376 -0.828 . . . . 0.0 110.256 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -135.56 142.45 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.665 . . . . 0.0 110.123 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -116.48 121.12 40.89 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.717 -0.614 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.73 132.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.261 -0.899 . . . . 0.0 109.285 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -129.37 130.14 45.66 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.024 -1.047 . . . . 0.0 108.969 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.75 -172.34 38.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 p -73.26 160.0 32.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.001 -1.293 . . . . 0.0 109.619 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.14 -46.51 23.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.49 -45.22 72.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.254 -0.903 . . . . 0.0 109.857 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -59.16 -36.42 75.25 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.275 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 92.4 mt -72.33 -45.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.54 -0.725 . . . . 0.0 110.368 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.57 -42.95 97.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.753 -1.217 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.32 -31.63 71.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 109.005 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -43.14 36.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.502 -0.749 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.75 -48.23 75.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.177 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.21 -43.86 98.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -64.14 -24.58 67.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.905 -1.122 . . . . 0.0 109.084 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.87 -46.77 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 108.316 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.06 -38.57 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.55 -0.719 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.07 -25.45 47.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 109.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.9 p -62.79 -38.04 89.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.481 -1.387 . . . . 0.0 107.296 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t . . . . . 0 N--CA 1.494 1.762 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.028 -179.611 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.38 148.54 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.286 -0.884 . . . . 0.0 109.53 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -126.7 137.75 53.31 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.45 144.48 38.05 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.13 146.6 36.54 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.178 -0.951 . . . . 0.0 110.302 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.39 150.79 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -124.86 130.08 51.67 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.68 138.0 31.6 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 22' ' ' LYS . 2.5 Cg_endo -57.91 134.69 64.11 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 CA-C-N 120.158 1.092 . . . . 0.0 110.384 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 21' ' ' PRO . 28.7 ttmt -39.07 -40.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.454 -0.779 . . . . 0.0 111.112 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.89 -40.2 96.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.985 -1.072 . . . . 0.0 110.868 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 81' ' ' VAL . 4.0 mm? -77.59 -26.74 50.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.661 -1.274 . . . . 0.0 108.696 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.32 79.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.774 0.797 . . . . 0.0 109.479 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -76.59 -29.11 56.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.4 p -73.59 -24.77 60.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.862 -1.149 . . . . 0.0 109.05 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -95.47 -42.6 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.961 -1.087 . . . . 0.0 110.609 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.25 -35.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.84 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.25 -172.04 39.28 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -91.57 -14.16 30.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.294 . . . . 0.0 109.957 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -139.04 18.51 3.13 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.96 -10.21 7.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.729 -1.748 . . . . 0.0 108.729 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' GLY . 70.2 mt-30 -36.03 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.777 -0.837 . . . . 0.0 110.673 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.53 -36.06 20.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.764 -1.21 . . . . 0.0 109.961 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -73.46 -24.48 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -73.04 -47.8 41.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.078 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.11 -50.24 74.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.048 -1.032 . . . . 0.0 109.867 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.4 -31.79 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.79 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -61.1 -65.12 0.74 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -64.9 -36.73 85.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.33 -42.95 92.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.056 -1.028 . . . . 0.0 110.199 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -86.99 -22.94 25.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.354 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.99 0.83 70.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.49 161.44 20.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -108.82 138.11 45.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.38 137.88 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.816 -1.178 . . . . 0.0 109.891 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -123.09 128.28 49.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.448 HG21 ' NH2' ' A' ' 59' ' ' ARG . 66.8 mt -99.85 135.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 108.541 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.57 151.59 19.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.037 -1.039 . . . . 0.0 108.939 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.02 155.38 87.25 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.342 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 N--CA 1.492 1.404 0 C-N-CA 120.624 0.883 . . . . 0.0 111.933 179.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 . . . . . 0 N--CA 1.499 2.019 0 CA-C-O 121.59 0.709 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.3 mmm180 -119.41 137.37 53.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.17 153.79 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.3 -0.875 . . . . 0.0 111.052 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.92 141.93 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.765 -0.585 . . . . 0.0 110.184 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -115.91 123.96 49.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.636 -0.665 . . . . 0.0 109.341 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -104.07 132.19 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.74 46.49 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.114 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.54 38.63 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -74.72 161.69 29.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.995 -1.297 . . . . 0.0 109.532 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.8 -47.48 30.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -0.754 . . . . 0.0 110.449 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.85 -49.44 62.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.07 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.66 -36.68 69.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.854 -1.154 . . . . 0.0 109.212 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.8 mt -70.46 -45.54 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -60.7 -42.87 98.04 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.694 -1.254 . . . . 0.0 109.445 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.37 -37.94 87.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.276 -0.89 . . . . 0.0 108.784 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 -45.1 62.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.438 -0.789 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.83 -49.06 79.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.913 . . . . 0.0 109.966 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -59.39 -41.11 88.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.803 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.01 -25.9 66.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 108.947 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.01 -44.37 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.883 -1.135 . . . . 0.0 108.34 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -62.0 -38.89 90.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.581 -0.7 . . . . 0.0 109.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -78.57 -23.82 45.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.874 -1.141 . . . . 0.0 109.618 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.487 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 25.5 m -63.69 -36.46 83.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.252 -1.53 . . . . 0.0 107.013 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 24' ' ' LEU . 24.6 t . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.791 -0.568 . . . . 0.0 109.872 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.1 mt -125.2 150.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.314 -0.866 . . . . 0.0 109.706 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 t -127.48 148.17 50.31 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -148.44 142.04 25.47 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -108.22 145.45 34.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.03 154.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -126.48 129.65 49.09 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.5 136.14 28.23 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.74 139.27 84.6 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 CA-C-N 120.16 1.093 . . . . 0.0 111.1 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -44.42 -40.02 5.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 0.0 111.252 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -63.24 -47.1 83.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.725 -1.235 . . . . 0.0 111.116 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.4 mt -76.86 -21.67 54.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.349 -1.469 . . . . 0.0 108.348 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.36 90.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.865 0.84 . . . . 0.0 109.443 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -75.42 -28.58 59.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.1 p -74.05 -32.73 63.43 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.191 -0.943 . . . . 0.0 108.881 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -86.84 -44.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.667 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CD1' HH11 ' A' ' 59' ' ' ARG . 68.1 mt -69.92 -35.98 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.018 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.89 -170.14 41.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -92.26 -47.2 7.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.18 -1.188 . . . . 0.0 109.421 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.67 13.21 59.54 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 67.12 -1.64 6.09 Favored Glycine 0 N--CA 1.493 2.455 0 O-C-N 120.882 -1.364 . . . . 0.0 109.812 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.7 mt-30 -45.93 -16.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 119.316 1.558 . . . . 0.0 109.862 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -82.95 -38.82 22.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.907 -1.121 . . . . 0.0 110.864 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 HD13 ' A' ' 47' ' ' ILE . 9.6 tp -74.05 -18.98 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.139 -1.601 . . . . 0.0 109.155 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -73.75 -50.43 20.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.393 -0.817 . . . . 0.0 109.088 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.18 -48.54 81.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.545 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.4 mt -58.45 -34.74 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.62 -59.51 5.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -67.78 -37.59 82.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.86 -44.47 93.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -0.985 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -86.6 -23.07 25.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 110.301 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.04 0.54 76.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.28 18.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.762 -0.846 . . . . 0.0 109.876 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -108.04 141.36 39.82 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.475 HD13 HD11 ' A' ' 36' ' ' ILE . 98.3 mt -134.2 137.22 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.765 -1.209 . . . . 0.0 110.214 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -122.77 127.41 49.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.1 134.43 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.021 -1.049 . . . . 0.0 108.584 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.9 149.48 21.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.133 -0.98 . . . . 0.0 108.559 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.92 149.22 97.8 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 120.827 -1.171 . . . . 0.0 108.568 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 N--CA 1.49 1.305 0 CA-C-N 119.213 0.754 . . . . 0.0 111.446 179.552 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 122.079 0.942 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.405 HH11 ' CD1' ' A' ' 29' ' ' ILE . 45.5 mtt180 -117.47 140.22 49.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.59 144.21 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.381 -0.824 . . . . 0.0 110.785 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.44 143.8 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.768 -0.583 . . . . 0.0 110.342 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.4 m -117.94 120.75 38.77 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.725 -0.609 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.09 133.13 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -129.33 130.59 46.29 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.06 -1.025 . . . . 0.0 109.19 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.56 -172.61 38.67 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 p -73.71 160.77 31.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.058 -1.26 . . . . 0.0 109.522 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -46.84 -46.96 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -67.74 -45.88 73.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -59.93 -38.91 83.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.786 -1.196 . . . . 0.0 109.26 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.81 -45.61 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.733 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -60.7 -43.34 97.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.801 -1.187 . . . . 0.0 109.375 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -61.43 -40.17 93.45 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.4 -46.4 64.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.493 -0.754 . . . . 0.0 109.417 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -57.41 -52.61 64.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 109.945 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 63.7 t80 -57.31 -40.51 78.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.035 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.92 -27.67 66.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.863 -1.148 . . . . 0.0 108.975 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -74.74 -45.94 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.058 . . . . 0.0 108.433 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -61.28 -39.35 90.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.667 -0.645 . . . . 0.0 109.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 10.0 m-80 -78.38 -23.79 46.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.9 p -63.07 -34.54 77.8 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.595 . . . . 0.0 110.474 -179.251 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 150.49 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 109.485 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 m -126.85 136.64 52.62 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.0 144.91 39.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.8 146.16 36.88 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.256 -0.902 . . . . 0.0 110.064 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.17 153.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -124.2 129.64 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.43 136.55 28.79 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 121.466 -0.771 . . . . 0.0 109.25 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.35 139.25 85.77 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.082 1.065 . . . . 0.0 110.954 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -44.26 -40.07 4.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.184 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.39 -46.58 85.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.824 -1.172 . . . . 0.0 111.43 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.84 -22.99 52.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.311 -1.493 . . . . 0.0 108.251 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.95 -38.23 85.17 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.831 0.824 . . . . 0.0 109.14 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.38 -27.25 59.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.9 p -74.54 -31.57 62.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.065 -1.022 . . . . 0.0 109.254 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.8 mt -83.89 -45.95 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 110.972 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.75 -34.28 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.798 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.52 -176.22 44.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -91.93 5.0 51.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 109.676 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -157.55 17.35 0.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.28 -9.49 13.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 62.0 mt-30 -34.65 -28.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.95 -0.735 . . . . 0.0 111.015 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.4 mmt180 -86.33 -40.16 15.74 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.484 -1.385 . . . . 0.0 109.617 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.1 mm -69.85 -27.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.047 . . . . 0.0 109.295 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -77.4 -53.55 7.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.68 -48.11 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.08 -34.5 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -59.26 -74.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -53.06 -34.8 58.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.471 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.06 -44.14 80.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.419 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -86.42 -24.57 25.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 0.0 110.538 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.77 -3.92 83.96 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.06 162.64 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -1.056 . . . . 0.0 110.098 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.4 m -107.01 142.62 36.35 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -138.06 136.78 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.665 -1.272 . . . . 0.0 110.04 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -123.0 127.29 48.61 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -98.03 135.07 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.94 -1.1 . . . . 0.0 108.636 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.69 151.27 19.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.094 -1.004 . . . . 0.0 108.766 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 mp0 -67.78 149.37 98.28 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 120.996 -1.065 . . . . 0.0 108.46 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.314 -1.239 0 CA-C-N 119.445 0.837 . . . . 0.0 111.431 179.403 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 121.928 0.87 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -120.63 140.47 51.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.3 140.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.437 -0.79 . . . . 0.0 111.239 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -120.92 144.73 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.665 -0.647 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.8 m -117.31 125.12 50.54 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.81 131.31 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.16 -0.963 . . . . 0.0 109.624 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -129.19 130.73 46.7 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.088 -1.008 . . . . 0.0 109.024 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.57 -174.42 38.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 p -73.24 160.22 32.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.266 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -46.72 24.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.383 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 2.5 m-20 -68.15 -46.85 69.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.925 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -58.28 -37.33 74.8 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.898 -1.126 . . . . 0.0 109.293 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.2 mt -70.84 -45.76 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.504 -0.747 . . . . 0.0 110.212 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.2 -43.18 96.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.792 -1.193 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.16 -35.24 78.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 108.757 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.37 35.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.533 -0.729 . . . . 0.0 109.55 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.15 -47.09 84.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.268 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -61.52 -35.27 77.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.013 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.36 -26.93 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.82 -1.175 . . . . 0.0 109.02 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.33 -46.03 57.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.086 -1.009 . . . . 0.0 108.317 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -61.39 -37.64 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.446 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.85 -24.15 44.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -64.07 -40.11 95.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 81' ' ' VAL . 11.9 t . . . . . 0 N--CA 1.495 1.776 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.933 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -123.98 148.85 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -127.55 137.34 52.58 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.04 144.01 38.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.49 144.89 37.13 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.208 -0.933 . . . . 0.0 109.942 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.13 153.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.82 129.89 50.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.0 137.39 30.03 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.485 -0.759 . . . . 0.0 108.957 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.81 144.61 93.22 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.158 1.092 . . . . 0.0 110.958 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -50.94 -41.37 58.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 111.339 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -45.38 92.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.74 -1.225 . . . . 0.0 111.42 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.78 -25.71 53.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.448 -1.407 . . . . 0.0 108.175 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.26 79.83 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.735 0.779 . . . . 0.0 109.4 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.7 -30.11 61.43 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -71.41 -33.25 69.27 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.935 -1.103 . . . . 0.0 109.243 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.15 -45.13 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 111.016 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.21 -35.06 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.877 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 -171.9 39.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -91.79 -4.26 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.329 . . . . 0.0 109.771 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.87 19.58 1.11 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.32 -10.61 6.01 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 32' ' ' GLY . 35.3 tt0 -36.57 -26.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.792 -0.828 . . . . 0.0 111.109 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.2 tpp180 -87.12 -37.48 17.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.733 -1.229 . . . . 0.0 109.777 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.41 -23.92 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.744 -1.222 . . . . 0.0 108.571 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -72.78 -49.33 31.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.63 -47.96 80.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.706 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.06 -32.81 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.04 -47.19 86.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.109 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -80.22 -39.47 29.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.112 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.39 -44.28 97.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.016 -1.053 . . . . 0.0 110.188 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -87.14 -22.33 25.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.079 -1.013 . . . . 0.0 110.217 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.18 79.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.79 162.63 18.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.772 -0.84 . . . . 0.0 109.848 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 m -105.35 146.97 28.68 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mm -132.45 138.21 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.605 -1.309 . . . . 0.0 109.955 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -126.6 124.72 40.59 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -101.66 132.98 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 108.787 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.61 150.83 19.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.006 -1.059 . . . . 0.0 108.487 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -66.21 150.15 97.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.969 -1.082 . . . . 0.0 108.455 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo . . . . . 0 N--CA 1.49 1.286 0 C-N-CA 120.38 0.72 . . . . 0.0 111.687 179.627 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 121.96 0.886 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.512 HH11 ' CG ' ' A' ' 59' ' ' ARG . 5.1 mtt-85 -118.05 139.52 51.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -111.54 141.89 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.314 -0.866 . . . . 0.0 110.845 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -124.96 143.71 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.752 -0.593 . . . . 0.0 110.484 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -118.59 118.38 31.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.718 -0.614 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -96.37 134.31 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -131.74 129.04 40.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 -171.95 37.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 p -71.71 159.31 34.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.049 -1.265 . . . . 0.0 109.536 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -46.26 46.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.675 . . . . 0.0 110.273 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -66.94 -46.53 74.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.08 -1.013 . . . . 0.0 109.494 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -57.99 -32.81 68.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.0 -1.062 . . . . 0.0 109.001 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.46 -45.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.503 -0.748 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -44.01 93.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.664 -1.272 . . . . 0.0 109.518 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -61.14 -34.1 74.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.072 -1.017 . . . . 0.0 108.729 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.55 -47.13 28.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.528 -0.732 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -58.44 -47.68 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 110.345 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 79' ' ' ASN . 56.9 t80 -61.14 -38.15 85.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.794 -1.191 . . . . 0.0 108.95 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.2 mt -74.38 -46.25 41.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 0.0 108.364 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.46 -38.54 87.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 8.5 m-80 -78.53 -23.89 46.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.569 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.9 p -63.99 -40.28 96.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 81' ' ' VAL . 5.2 t . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.775 -0.578 . . . . 0.0 110.007 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.97 149.97 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 109.858 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -128.72 143.56 50.96 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -144.7 144.38 31.19 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -109.82 145.53 36.57 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.293 -0.879 . . . . 0.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.3 148.96 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -124.71 129.6 50.8 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.622 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -126.18 142.7 43.41 Favored Pre-proline 0 N--CA 1.506 2.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.65 146.8 63.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 120.485 1.209 . . . . 0.0 110.605 178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -52.31 -40.28 61.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 111.168 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.21 -42.45 99.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.699 -1.25 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -79.8 -32.1 40.79 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.71 -1.244 . . . . 0.0 108.439 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.27 68.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.794 0.807 . . . . 0.0 109.305 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.99 -33.12 63.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.4 p -67.59 -27.87 67.28 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.936 -1.102 . . . . 0.0 108.948 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -85.33 -42.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.83 -37.37 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.748 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.64 -174.07 40.87 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.53 -8.31 47.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.955 -1.321 . . . . 0.0 109.831 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -145.2 20.11 1.92 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.33 -11.13 4.21 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 32' ' ' GLY . 74.1 mt-30 -36.34 -27.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.824 -0.809 . . . . 0.0 110.609 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.5 tpt180 -86.75 -35.48 19.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.818 -1.176 . . . . 0.0 109.77 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.3 mm -75.06 -26.55 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.078 . . . . 0.0 108.878 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -73.29 -48.27 35.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.164 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.52 -51.03 71.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.59 -32.98 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.044 -1.035 . . . . 0.0 109.734 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -59.51 -51.2 70.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.0 110.179 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -75.56 -38.45 59.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.32 -44.43 96.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.992 . . . . 0.0 110.194 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -86.76 -23.46 25.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.394 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.56 0.04 78.03 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.35 19.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.713 -0.875 . . . . 0.0 109.939 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -107.25 141.79 38.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -138.69 136.81 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.634 -1.291 . . . . 0.0 109.822 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -124.12 129.4 50.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -101.08 132.75 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.886 -1.134 . . . . 0.0 108.382 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -92.06 153.43 19.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 108.949 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.57 153.56 95.62 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 120.952 -1.093 . . . . 0.0 108.113 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo . . . . . 0 C--N 1.311 -1.407 0 CA-C-N 119.42 0.829 . . . . 0.0 111.17 179.57 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.5 tpp180 -116.28 139.78 50.01 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.12 140.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -125.1 144.22 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.785 -0.572 . . . . 0.0 110.632 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.86 46.93 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.652 -0.655 . . . . 0.0 109.352 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.48 132.62 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -0.81 . . . . 0.0 109.528 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -130.47 130.49 44.29 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.994 -1.066 . . . . 0.0 109.203 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.89 38.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.2 p -73.22 160.25 32.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.051 -1.264 . . . . 0.0 109.844 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -45.41 -48.88 13.6 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.381 0.61 . . . . 0.0 110.562 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.937 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.37 -36.66 73.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.792 -1.192 . . . . 0.0 109.356 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -72.08 -45.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 110.354 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -60.76 -42.77 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.758 -1.214 . . . . 0.0 109.422 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -62.16 -34.52 76.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.807 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.36 45.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.46 -0.775 . . . . 0.0 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.34 -48.58 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.95 -40.08 87.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.6 mt -68.02 -30.27 69.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.801 -1.187 . . . . 0.0 109.02 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.64 -45.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.973 -1.079 . . . . 0.0 108.276 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.06 -39.43 92.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.593 -0.692 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 79' ' ' ASN . 1.1 m-80 -77.97 -25.49 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 0.0 109.872 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.9 m -61.93 -34.37 75.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.497 HG13 HD23 ' A' ' 24' ' ' LEU . 45.3 t . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.772 -0.58 . . . . 0.0 110.122 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -123.06 150.8 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 109.335 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 m -126.91 136.41 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -139.66 145.59 38.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -110.19 145.36 37.4 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.112 -0.993 . . . . 0.0 109.925 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.11 148.52 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -122.72 129.89 52.31 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 140.6 37.91 Favored Pre-proline 0 N--CA 1.503 2.223 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.58 144.2 97.56 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.04 1.05 . . . . 0.0 110.86 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.03 -41.09 46.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.934 -1.104 . . . . 0.0 111.35 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -62.15 -45.82 91.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.651 -1.281 . . . . 0.0 111.12 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -76.88 -24.36 52.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.501 -1.374 . . . . 0.0 108.597 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.12 90.15 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.864 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -73.97 -33.68 63.96 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.388 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -68.2 -34.02 75.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.782 -1.199 . . . . 0.0 109.266 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -77.43 -44.85 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.147 -0.971 . . . . 0.0 110.991 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.22 -36.09 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.811 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.11 -171.96 39.42 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -91.74 -0.57 57.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.935 -1.333 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -153.52 19.1 0.69 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 73.48 -11.66 5.23 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 32' ' ' GLY . 4.8 pt20 -34.54 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.75 . . . . 0.0 111.19 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -82.43 -34.4 28.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.695 -1.253 . . . . 0.0 109.557 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -73.63 -25.03 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.971 -1.081 . . . . 0.0 108.815 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -72.26 -46.62 55.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.359 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -60.07 -47.29 86.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.81 -33.69 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.174 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.79 -43.58 83.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.039 -1.038 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -77.16 -32.94 56.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.095 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.38 -41.99 46.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 110.359 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 p -86.71 -23.38 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.079 -1.013 . . . . 0.0 110.53 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.17 71.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 161.06 20.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.86 -0.788 . . . . 0.0 110.161 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.4 m -108.42 138.55 44.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.9 mt -137.43 137.02 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.722 -1.237 . . . . 0.0 109.919 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -122.84 129.11 51.27 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.9 mt -100.91 132.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.855 -1.153 . . . . 0.0 108.528 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 18.5 p-10 -91.93 154.32 18.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 108.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.495 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 9.7 mp0 -67.8 149.51 98.22 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 120.817 -1.177 . . . . 0.0 108.502 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 N--CA 1.49 1.322 0 CA-C-N 119.298 0.785 . . . . 0.0 111.711 179.554 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.701 0.762 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -116.26 136.21 53.21 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 78.1 mt -109.65 147.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.162 -0.961 . . . . 0.0 110.414 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.85 143.75 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.811 -0.555 . . . . 0.0 110.334 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -117.13 123.76 47.52 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.04 132.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.295 -0.878 . . . . 0.0 109.582 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.3 m -129.71 130.73 45.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.994 -1.066 . . . . 0.0 109.102 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.13 -172.73 38.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -72.84 160.03 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.608 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.504 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.05 -46.84 22.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 110.151 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.97 -47.38 68.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -56.97 -35.79 69.55 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.903 -1.123 . . . . 0.0 109.198 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.41 -45.45 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.595 -0.691 . . . . 0.0 110.28 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.23 -42.61 98.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.893 -1.129 . . . . 0.0 109.584 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.41 -36.77 83.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.85 61.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.427 -0.796 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -59.49 -48.5 81.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.56 -35.97 75.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.61 -28.85 63.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.774 -1.204 . . . . 0.0 109.095 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.7 -44.83 66.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.121 -0.987 . . . . 0.0 108.422 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.22 -38.87 90.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -0.757 . . . . 0.0 109.845 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -24.4 46.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 109.749 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.452 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 20.8 m -64.27 -34.4 78.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.109 -1.437 . . . . 0.0 107.377 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.74 -0.6 . . . . 0.0 109.822 -179.8 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.435 ' C ' ' H ' ' A' ' 4' ' ' ASN . 52.5 p 51.04 69.94 2.28 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.238 -1.154 . . . . 0.0 109.533 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -70.17 33.83 0.22 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.0 1.133 . . . . 0.0 111.828 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' H ' ' C ' ' A' ' 2' ' ' SER . 9.2 m120 -154.06 69.96 0.8 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 0.0 109.333 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.3 m -164.06 103.16 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.897 . . . . 0.0 109.604 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 64.1 t80 54.06 -176.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.568 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.552 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 76.17 -12.13 10.31 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 6' ' ' TYR . 0.9 OUTLIER 46.83 28.0 0.77 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.631 -0.923 . . . . 0.0 109.727 179.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' A' ' 11' ' ' GLY . 16.4 mt 46.2 43.0 10.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.53 -32.88 0.84 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 170.67 162.75 23.54 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.17 165.97 18.06 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 CA-C-N 118.355 1.077 . . . . 0.0 112.192 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.2 mm -82.26 142.45 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.381 -0.824 . . . . 0.0 109.182 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.7 mt -123.61 149.79 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.5 m -127.81 137.24 52.32 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -139.17 145.07 38.91 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -111.5 145.7 38.58 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.225 -0.922 . . . . 0.0 110.194 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.4 t -125.05 147.09 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -120.37 129.35 53.91 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.73 140.01 36.4 Favored Pre-proline 0 N--CA 1.502 2.168 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.25 142.13 97.17 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 CA-C-N 120.104 1.073 . . . . 0.0 110.876 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -48.64 -41.36 30.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.056 -1.028 . . . . 0.0 111.306 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 0.0 111.248 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 42.9 mt -77.13 -23.45 51.72 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.578 -1.326 . . . . 0.0 108.308 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.3 -38.77 90.65 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.786 0.803 . . . . 0.0 109.669 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.3 mtm180 -74.13 -33.87 63.69 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.43 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -67.46 -34.79 77.91 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.706 -1.246 . . . . 0.0 109.25 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.611 HD11 HG22 ' A' ' 81' ' ' VAL . 88.4 mt -78.82 -42.66 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.093 -1.005 . . . . 0.0 110.852 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.62 ' CD1' HH11 ' A' ' 59' ' ' ARG . 64.5 mt -69.35 -37.09 74.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.231 -0.987 . . . . 0.0 109.394 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.93 -171.33 42.69 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.009 -2.036 . . . . 0.0 108.009 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.96 -51.43 5.35 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.074 -1.251 . . . . 0.0 108.809 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.14 13.98 64.2 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.6 -4.48 14.15 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 120.688 -1.478 . . . . 0.0 109.578 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.0 mt-30 -42.69 -20.25 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.016 -1.285 . . . . 0.0 110.096 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 18.3 tpt180 -86.29 -39.42 16.53 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.158 -0.964 . . . . 0.0 110.862 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -76.34 -28.0 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.584 -1.322 . . . . 0.0 109.345 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -72.87 -49.05 32.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.97 -1.081 . . . . 0.0 109.191 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -56.26 -53.57 55.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.056 -1.027 . . . . 0.0 109.864 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.19 -31.56 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.823 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -62.88 -41.24 99.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.182 -0.949 . . . . 0.0 110.31 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.452 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 3.6 m80 -81.28 -38.93 26.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.38 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -65.28 -41.94 93.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.126 -0.984 . . . . 0.0 110.436 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -87.08 -23.14 25.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.021 -1.05 . . . . 0.0 110.609 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.13 0.6 71.05 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 107.926 -2.07 . . . . 0.0 107.926 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.69 160.66 21.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.846 -0.796 . . . . 0.0 110.114 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 71.7 m -108.67 139.91 42.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -137.3 137.57 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 120.7 -1.25 . . . . 0.0 109.966 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -123.21 127.41 48.59 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 71.0 mt -99.57 134.11 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.938 -1.101 . . . . 0.0 108.775 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -94.06 152.91 18.44 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.077 -1.015 . . . . 0.0 108.503 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -66.6 149.64 98.02 Favored Pre-proline 0 C--N 1.303 -1.445 0 O-C-N 120.935 -1.103 . . . . 0.0 108.606 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -61.01 143.33 99.27 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 120.57 0.847 . . . . 0.0 111.718 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 40.8 mt -82.75 119.43 24.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.238 -0.914 . . . . 0.0 109.266 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -49.83 129.91 20.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.312 -0.867 . . . . 0.0 109.363 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.75 17.88 29.29 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.8 t -153.43 123.74 7.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.283 -1.128 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.53 50.25 1.96 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.916 . . . . 0.0 109.539 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -140.07 154.11 46.97 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.844 0.83 . . . . 0.0 110.099 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.62 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.6 mtt180 -119.28 137.87 53.39 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.34 144.37 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.408 -0.807 . . . . 0.0 110.347 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -126.03 144.31 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.749 -0.594 . . . . 0.0 110.324 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.5 m -117.7 122.1 42.61 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.702 -0.624 . . . . 0.0 109.333 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.3 mt -102.3 133.61 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.259 -0.9 . . . . 0.0 109.394 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.1 m -131.39 129.52 41.42 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.002 -1.061 . . . . 0.0 109.146 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.79 -173.62 37.32 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 p -70.58 158.54 35.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.91 -1.347 . . . . 0.0 109.493 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.82 -45.08 49.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.58 -0.7 . . . . 0.0 110.255 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -67.25 -48.42 67.81 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.036 -1.04 . . . . 0.0 109.502 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -56.96 -35.51 69.21 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.901 -1.124 . . . . 0.0 108.822 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 59.9 mt -71.26 -46.33 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 110.076 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.83 -43.19 94.7 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.79 -1.194 . . . . 0.0 109.23 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -62.26 -32.02 72.67 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -47.32 18.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.512 -0.743 . . . . 0.0 109.541 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -57.86 -37.75 74.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 110.03 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -70.61 -34.49 72.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.071 -1.018 . . . . 0.0 109.668 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 27.4 mt -74.31 -20.19 60.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.804 -1.185 . . . . 0.0 108.902 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -77.82 -46.43 21.57 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -62.68 -37.38 86.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 0.0 110.228 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -78.38 -24.66 46.23 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.982 -1.074 . . . . 0.0 110.209 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.4 t -64.24 -37.59 88.01 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 117.725 -1.59 . . . . 0.0 107.177 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.611 HG22 HD11 ' A' ' 28' ' ' ILE . 18.2 t -41.65 -49.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.892 -0.505 . . . . 0.0 109.723 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 84' ' ' TYR . 49.6 mttm -48.85 -21.44 0.64 Allowed 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.701 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' SER . 59.7 tt0 -55.84 -10.1 0.69 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.492 -1.38 . . . . 0.0 107.859 177.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 84.3 t80 -66.63 55.05 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.795 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . 5.6 p 63.54 8.27 3.51 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.405 -0.81 . . . . 0.0 109.399 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.98 -66.92 1.98 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 88' ' ' PHE . 16.2 mtpp -73.58 111.09 8.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.139 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' O ' ' O ' ' A' ' 87' ' ' LYS . 93.3 m-85 51.32 98.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.9 p90 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.41 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.6 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -68.53 -43.64 31.45 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.259 -1.142 . . . . 0.0 110.269 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 2' ' ' SER . 3.9 Cg_exo -67.29 -167.32 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.765 0.977 . . . . 0.0 112.071 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -168.73 110.26 0.52 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.6 m -165.56 53.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.306 -0.871 . . . . 0.0 109.406 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.459 ' C ' ' N ' ' A' ' 8' ' ' ASP . 44.2 p90 -66.35 -1.68 3.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.63 -12.64 0.66 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' N ' ' C ' ' A' ' 6' ' ' TYR . 27.0 t70 49.91 60.33 3.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.402 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' C ' ' H ' ' A' ' 11' ' ' GLY . 1.0 OUTLIER 46.35 46.13 13.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.279 -0.888 . . . . 0.0 109.426 179.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.05 -41.98 0.36 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.41 162.33 23.53 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -65.18 171.67 8.67 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 CA-C-N 118.423 1.111 . . . . 0.0 112.26 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mm -88.57 141.18 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.358 -0.839 . . . . 0.0 109.249 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.7 mt -124.83 150.35 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.365 -0.834 . . . . 0.0 109.702 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.0 m -128.01 137.55 52.25 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.62 145.87 39.05 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -111.75 145.47 39.29 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.261 -0.9 . . . . 0.0 110.129 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -126.68 155.62 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -125.37 130.11 51.27 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.28 131.16 23.85 Favored Pre-proline 0 N--CA 1.504 2.261 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -57.19 132.81 53.5 Favored 'Trans proline' 0 N--CA 1.487 1.126 0 CA-C-N 120.383 1.172 . . . . 0.0 111.186 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.6 ttmm -39.54 -41.1 0.96 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.491 -0.755 . . . . 0.0 111.666 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -62.43 -46.51 88.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.746 -1.221 . . . . 0.0 110.702 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.592 HD23 HG13 ' A' ' 81' ' ' VAL . 10.5 mp -76.11 -20.09 57.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.53 -1.356 . . . . 0.0 108.052 178.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.31 -37.39 85.29 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.85 0.833 . . . . 0.0 109.439 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -74.16 -27.9 61.06 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 86.8 p -73.86 -32.02 63.45 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.257 -0.902 . . . . 0.0 109.154 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 83.6 mt -88.98 -43.35 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.942 -1.099 . . . . 0.0 111.099 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.1 mt -67.66 -35.2 72.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 119.399 -0.921 . . . . 0.0 109.882 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.45 -173.12 41.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 mttm -91.81 -2.03 57.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.943 -1.328 . . . . 0.0 109.817 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -152.01 18.17 0.83 Allowed Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.9 -9.87 10.49 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.8 tt0 -36.24 -26.84 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.707 -0.878 . . . . 0.0 111.004 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.668 HH21 HE22 ' A' ' 83' ' ' GLN . 11.8 tpp180 -88.19 -36.8 16.6 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.638 -1.289 . . . . 0.0 109.903 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.2 mm -73.05 -25.56 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.798 -1.189 . . . . 0.0 108.623 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -73.02 -49.95 25.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 108.837 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -58.53 -48.22 81.58 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.038 -1.039 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.62 -33.9 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.21 -0.931 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -57.61 -54.75 43.34 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.323 -0.86 . . . . 0.0 110.088 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -70.81 -39.15 73.24 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.0 109.949 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -59.67 -46.04 90.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 t -86.5 -23.16 26.03 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.213 -0.929 . . . . 0.0 110.09 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.77 -0.98 85.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 108.675 -1.77 . . . . 0.0 108.675 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.46 163.13 17.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.557 -0.966 . . . . 0.0 109.939 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.8 m -105.69 145.51 30.98 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 11.5 mm -129.75 139.8 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 120.688 -1.257 . . . . 0.0 110.15 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.56 124.33 33.59 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.82 135.77 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.097 -1.002 . . . . 0.0 109.245 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -95.56 152.77 18.14 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.158 -0.963 . . . . 0.0 108.81 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -67.48 153.46 94.85 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.002 -1.061 . . . . 0.0 108.721 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -64.44 157.05 56.92 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 120.874 1.049 . . . . 0.0 112.486 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.0 mt -103.11 170.68 7.82 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.522 -0.736 . . . . 0.0 109.146 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -88.3 141.61 28.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.088 -1.008 . . . . 0.0 109.45 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.26 21.74 64.34 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.7 m -163.81 94.89 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -1.155 . . . . 0.0 109.467 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.622 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.2 pm0 -73.03 52.74 0.34 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.566 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 58' ' ' ASP . 6.1 p30 -120.45 158.35 27.41 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.517 0.675 . . . . 0.0 109.27 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -119.88 138.92 53.12 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.6 mt -111.96 149.83 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 O-C-N 121.037 -1.04 . . . . 0.0 111.056 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.4 mt -135.04 143.29 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.769 -0.582 . . . . 0.0 110.279 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 16.8 m -116.95 122.71 45.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.6 mt -100.98 132.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.253 -0.904 . . . . 0.0 109.048 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.1 m -130.72 129.43 42.52 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.993 -1.067 . . . . 0.0 109.323 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.65 -171.56 38.51 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.456 ' OG1' ' NE2' ' A' ' 69' ' ' GLN . 17.7 p -73.14 160.02 32.63 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.971 -1.311 . . . . 0.0 109.645 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -46.49 -47.25 19.36 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.654 -0.654 . . . . 0.0 110.22 -179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.52 -45.31 72.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.321 -0.862 . . . . 0.0 109.673 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -59.03 -36.98 75.9 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.906 -1.121 . . . . 0.0 108.787 -179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.5 mt -71.1 -46.01 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.435 -0.79 . . . . 0.0 110.41 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -59.85 -43.44 94.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.745 -1.222 . . . . 0.0 109.584 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -61.17 -34.96 75.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.128 -0.983 . . . . 0.0 108.843 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.23 -45.76 46.06 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.448 -0.782 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -59.33 -47.35 85.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 110.366 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -61.32 -41.2 96.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.958 -1.089 . . . . 0.0 109.943 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.0 mt -67.59 -18.11 64.87 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.823 -1.173 . . . . 0.0 109.055 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.8 mt -83.67 -45.48 13.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.018 -1.051 . . . . 0.0 108.583 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -61.95 -38.83 89.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.6 -0.688 . . . . 0.0 110.109 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -78.89 -22.53 45.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.972 -1.08 . . . . 0.0 109.411 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 98.8 p -63.36 -40.1 96.35 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.592 HG13 HD23 ' A' ' 24' ' ' LEU . 19.5 t -42.13 -52.33 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.325 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.471 ' C ' ' N ' ' A' ' 84' ' ' TYR . 41.2 mttp -46.93 -21.73 0.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.108 -0.995 . . . . 0.0 109.889 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.668 HE22 HH21 ' A' ' 35' ' ' ARG . 50.1 tt0 -57.95 -10.72 1.91 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.599 -1.313 . . . . 0.0 107.555 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.499 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 85.4 t80 -65.81 60.76 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.35 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 83' ' ' GLN . 23.9 p 54.4 8.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 109.527 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -70.31 -55.14 9.26 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 88' ' ' PHE . 16.2 mtpp -78.14 104.86 8.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.345 -1.091 . . . . 0.0 109.326 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' O ' ' O ' ' A' ' 87' ' ' LYS . 45.6 t80 56.39 107.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.46 179.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.8 m 52.25 70.76 1.72 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.39 -166.56 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 121.064 1.176 . . . . 0.0 111.892 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m120 52.44 51.86 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.871 . . . . 0.0 109.428 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 71.6 p -73.7 144.32 45.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.479 ' C ' ' H ' ' A' ' 8' ' ' ASP . 25.1 m-85 55.42 22.25 4.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.539 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -71.74 13.41 2.37 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 6' ' ' TYR . 0.7 OUTLIER 52.19 91.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 0.0 109.417 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.1 mt -75.3 -23.15 57.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.275 -0.89 . . . . 0.0 109.343 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 56.57 38.31 80.43 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.55 164.89 15.54 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -65.03 156.15 64.27 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 120.895 1.063 . . . . 0.0 112.297 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.22 140.68 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.041 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -124.12 149.67 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.295 -0.878 . . . . 0.0 109.662 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -128.13 137.61 52.17 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.42 145.34 38.77 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -110.95 145.62 38.05 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.186 -0.946 . . . . 0.0 110.16 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.57 151.34 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.5 m -124.11 129.42 50.83 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.99 134.61 26.08 Favored Pre-proline 0 N--CA 1.504 2.255 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -54.37 146.16 52.74 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 CA-C-N 120.26 1.129 . . . . 0.0 110.917 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.23 -41.87 63.11 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.065 -1.022 . . . . 0.0 111.451 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.8 p-10 -63.23 -46.68 85.82 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.741 -1.224 . . . . 0.0 111.15 -178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.8 -24.16 59.78 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.536 -1.353 . . . . 0.0 108.332 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.91 -36.52 83.65 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.641 0.734 . . . . 0.0 109.796 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.689 HH12 ' NH2' ' A' ' 59' ' ' ARG . 5.9 mtt-85 -74.37 -31.65 62.47 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.795 -0.762 . . . . 0.0 108.96 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.7 t -70.31 -39.07 75.01 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.723 -1.236 . . . . 0.0 109.327 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 88.5 mt -74.11 -44.76 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 110.743 -177.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.3 mt -69.88 -35.9 66.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.968 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.46 -170.11 40.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -92.12 -40.53 10.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.932 -1.334 . . . . 0.0 109.496 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.35 14.97 36.06 Favored Glycine 0 N--CA 1.498 2.825 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 69.12 -5.79 4.61 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -43.42 -23.79 0.08 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.989 -1.301 . . . . 0.0 110.206 -177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 33' ' ' GLY . 7.1 tpp180 -81.6 -39.65 24.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.045 -1.034 . . . . 0.0 110.675 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.11 -26.93 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.686 -1.259 . . . . 0.0 109.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -69.63 -43.3 72.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.025 -1.047 . . . . 0.0 109.045 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -61.42 -49.5 76.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.937 -1.102 . . . . 0.0 109.959 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.8 mt -52.58 -33.84 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.99 -1.069 . . . . 0.0 109.935 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -66.66 -35.99 81.47 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.161 -0.962 . . . . 0.0 109.968 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -80.78 -36.61 31.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.0 110.358 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -74.53 -41.62 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.178 -0.951 . . . . 0.0 110.503 -179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.2 p -87.1 -23.21 24.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.18 -0.95 . . . . 0.0 110.598 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.6 2.1 68.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.961 -2.056 . . . . 0.0 107.961 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.98 161.39 20.78 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.842 -0.799 . . . . 0.0 110.148 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 65.0 m -109.14 140.91 42.09 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.2 mt -138.03 136.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.819 -1.175 . . . . 0.0 109.974 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -121.14 127.51 51.64 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 70.3 mt -98.76 132.29 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 0.0 108.484 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' ' O ' ' A' ' 60' ' ' ILE . 1.3 p30 -93.04 153.2 18.84 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.955 -1.09 . . . . 0.0 108.56 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -67.33 149.0 98.64 Favored Pre-proline 0 C--N 1.301 -1.537 0 O-C-N 120.91 -1.119 . . . . 0.0 108.536 178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.22 142.54 98.48 Favored 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 120.423 0.749 . . . . 0.0 111.696 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.4 mt -82.2 132.49 35.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.938 . . . . 0.0 109.403 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -57.05 129.45 41.8 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 109.475 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.32 35.06 8.22 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.451 ' O ' ' N ' ' A' ' 58' ' ' ASP . 51.0 m -163.96 102.23 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.315 -1.109 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 6.0 mp0 -70.21 49.67 0.11 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 109.35 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.451 ' N ' ' O ' ' A' ' 56' ' ' SER . 5.5 m-20 -141.12 154.01 45.69 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.994 0.902 . . . . 0.0 110.191 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.689 ' NH2' HH12 ' A' ' 26' ' ' ARG . 50.1 mtt180 -119.38 139.45 51.97 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.428 ' O ' ' OD2' ' A' ' 50' ' ' ASP . 75.5 mt -111.07 141.07 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 O-C-N 121.348 -0.845 . . . . 0.0 110.518 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.6 mt -122.41 144.98 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.662 -0.649 . . . . 0.0 110.393 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -117.78 123.53 46.21 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 17.4 mt -104.68 132.6 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.424 -0.797 . . . . 0.0 109.547 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 17.9 m -129.58 130.07 45.22 Favored 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.111 -0.993 . . . . 0.0 109.211 179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -173.67 38.82 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.3 p -73.63 160.45 31.59 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.293 . . . . 0.0 109.693 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.68 -47.1 20.39 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.588 -0.695 . . . . 0.0 110.017 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -67.9 -45.75 73.54 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.277 -0.889 . . . . 0.0 109.74 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -59.51 -38.65 81.51 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.813 -1.179 . . . . 0.0 109.183 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 85.6 mt -69.32 -45.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.625 -0.672 . . . . 0.0 110.273 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -60.36 -43.41 96.54 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.776 -1.202 . . . . 0.0 109.588 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -61.54 -37.39 83.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.146 -0.971 . . . . 0.0 108.822 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.23 -46.79 48.17 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.554 -0.716 . . . . 0.0 109.661 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -60.01 -46.63 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 110.243 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -61.59 -33.6 74.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.099 -1.001 . . . . 0.0 109.925 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.0 mt -74.54 -24.28 58.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.79 -1.194 . . . . 0.0 108.93 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.77 -44.77 47.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.117 -0.989 . . . . 0.0 108.459 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -61.97 -38.58 89.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.728 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -78.85 -23.98 44.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.112 -0.993 . . . . 0.0 109.534 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -62.98 -37.86 88.81 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 19.6 t -42.46 -49.88 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.987 -0.445 . . . . 0.0 109.85 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.425 ' C ' ' N ' ' A' ' 84' ' ' TYR . 2.6 mptm? -48.06 -22.65 0.65 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.039 -1.038 . . . . 0.0 109.468 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.517 ' O ' ' N ' ' A' ' 85' ' ' SER . 55.1 tt0 -59.93 -13.67 12.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.541 -1.349 . . . . 0.0 107.401 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.425 ' N ' ' C ' ' A' ' 82' ' ' LYS . 91.2 t80 -53.8 86.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER 69.46 10.08 7.54 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.06 160.52 29.28 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.346 -1.501 . . . . 0.0 109.346 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.438 ' O ' ' O ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -55.62 143.95 28.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.375 -1.074 . . . . 0.0 108.466 -179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' O ' ' O ' ' A' ' 87' ' ' LYS . 84.2 m-85 52.51 101.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.479 -0.763 . . . . 0.0 109.511 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.3 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.427 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -172.43 162.26 4.15 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.321 -1.105 . . . . 0.0 108.92 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -59.06 -69.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 120.996 1.13 . . . . 0.0 111.858 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 51.71 51.17 17.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.516 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 80.9 p -168.7 146.64 3.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 62.4 t80 -165.33 42.66 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 109.566 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.435 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . -65.84 4.24 2.45 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 6' ' ' TYR . 20.8 t0 58.86 115.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.431 -1.041 . . . . 0.0 109.749 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.527 ' O ' ' N ' ' A' ' 11' ' ' GLY . 31.0 mt -134.12 90.94 2.74 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.2 -18.65 0.06 OUTLIER Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . -178.52 165.07 34.05 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.54 145.49 87.48 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 120.982 1.121 . . . . 0.0 112.064 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.9 mm -74.6 140.85 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.824 . . . . 0.0 108.912 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.4 mt -123.58 148.11 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.319 -0.863 . . . . 0.0 109.617 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.6 m -126.95 136.94 52.96 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 t -139.67 144.89 37.82 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -111.49 145.21 39.45 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.283 -0.886 . . . . 0.0 109.858 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.8 t -125.06 151.85 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.6 m -124.43 129.9 51.51 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.85 140.46 37.72 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.28 146.56 88.7 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 CA-C-N 120.131 1.083 . . . . 0.0 111.107 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -53.08 -41.05 64.54 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.999 -1.063 . . . . 0.0 111.463 -178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.78 -44.82 95.17 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.732 -1.23 . . . . 0.0 111.355 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.37 -23.04 50.87 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.57 -1.331 . . . . 0.0 108.135 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.9 89.94 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.739 0.78 . . . . 0.0 109.606 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.413 HH11 ' CG ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -74.7 -30.93 61.72 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.26 -32.23 69.97 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.867 -1.146 . . . . 0.0 109.286 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -82.42 -44.04 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 110.998 -177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 54.7 mt -67.48 -35.8 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.787 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -173.36 41.07 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -91.73 2.0 56.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.001 -1.293 . . . . 0.0 109.926 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -156.01 19.58 0.49 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.08 -11.06 3.97 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.465 ' H ' ' C ' ' A' ' 32' ' ' GLY . 59.5 mt-30 -36.26 -28.23 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.708 -0.878 . . . . 0.0 110.683 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpp180 -85.13 -35.56 21.68 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.804 -1.185 . . . . 0.0 109.842 -178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -74.37 -26.45 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.969 -1.082 . . . . 0.0 108.961 179.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -71.7 -48.05 49.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.114 -0.992 . . . . 0.0 108.912 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -57.16 -56.47 21.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.754 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.7 mt -49.62 -32.58 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.143 -0.973 . . . . 0.0 109.885 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -62.16 -38.94 90.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.331 -0.856 . . . . 0.0 110.002 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -83.2 -39.37 21.07 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.957 . . . . 0.0 110.602 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.8 -43.05 89.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.058 -1.026 . . . . 0.0 110.489 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.6 t -87.19 -23.55 24.74 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.191 -0.943 . . . . 0.0 110.692 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.67 1.67 72.69 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.161 -1.976 . . . . 0.0 108.161 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.92 161.96 19.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.752 -0.852 . . . . 0.0 110.092 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.48 140.72 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.6 mt -137.22 137.25 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 120.641 -1.287 . . . . 0.0 109.999 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -124.12 129.88 51.61 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 mt -103.82 128.8 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 120.998 -1.063 . . . . 0.0 108.556 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 60' ' ' ILE . 20.5 p-10 -87.83 156.67 19.28 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.885 -1.134 . . . . 0.0 108.968 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -66.9 151.62 96.73 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 120.949 -1.095 . . . . 0.0 108.506 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -62.2 143.14 93.93 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 120.556 0.837 . . . . 0.0 111.858 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.7 mt -80.38 141.66 35.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.285 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -70.64 134.84 47.93 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.341 -0.85 . . . . 0.0 109.746 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.01 -2.7 76.12 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.3 t -110.39 -178.95 3.63 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.467 -1.019 . . . . 0.0 109.661 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -144.02 31.07 1.27 Allowed 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -135.11 159.81 40.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.889 0.852 . . . . 0.0 110.596 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 -114.39 138.46 50.53 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 76.4 mt -112.3 141.06 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.24 -0.913 . . . . 0.0 110.802 -178.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -125.6 145.87 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.716 -0.615 . . . . 0.0 110.695 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 58.5 m -118.16 122.66 43.59 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 9.6 mt -103.91 132.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.925 . . . . 0.0 109.471 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -131.43 129.78 41.66 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.988 -1.07 . . . . 0.0 109.278 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.23 -172.38 38.33 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.8 p -72.33 159.63 33.71 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.044 -1.269 . . . . 0.0 109.519 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.483 ' NE2' ' O ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.96 -46.94 21.87 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.747 -0.596 . . . . 0.0 110.217 -179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -68.16 -47.04 69.1 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.226 -0.921 . . . . 0.0 109.86 -179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -56.78 -34.45 67.64 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.885 -1.135 . . . . 0.0 109.369 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.9 mt -73.67 -45.35 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.499 -0.751 . . . . 0.0 110.45 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.33 -43.83 96.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.717 -1.239 . . . . 0.0 109.6 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -61.23 -32.65 72.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.155 -0.966 . . . . 0.0 108.856 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.14 -45.87 25.37 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.456 -0.778 . . . . 0.0 109.663 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -57.63 -48.08 80.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 110.242 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -61.05 -39.89 91.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.037 -1.04 . . . . 0.0 109.965 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.6 mt -68.52 -25.63 65.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 0.0 108.959 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.7 mt -74.4 -46.24 41.54 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -61.73 -38.48 88.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.537 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.44 HD22 ' N ' ' A' ' 79' ' ' ASN . 1.4 m-80 -78.58 -25.06 45.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 89.1 p -62.36 -37.14 84.54 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.8 t -42.06 -48.37 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.188 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.472 ' C ' ' N ' ' A' ' 84' ' ' TYR . 39.0 pttt -50.07 -21.09 1.13 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.044 -1.035 . . . . 0.0 110.25 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.479 ' C ' ' H ' ' A' ' 85' ' ' SER . 42.7 tt0 -57.68 -10.92 1.78 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.576 -1.328 . . . . 0.0 107.577 178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.497 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 76.3 t80 -69.34 42.77 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.026 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.479 ' H ' ' C ' ' A' ' 83' ' ' GLN . 8.4 p 59.02 7.58 0.84 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.338 -0.851 . . . . 0.0 109.364 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.0 -54.98 8.44 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -125.23 43.07 3.14 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.581 -0.952 . . . . 0.0 108.907 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 65.5 t80 -171.67 45.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.531 -0.73 . . . . 0.0 109.403 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.3 p90 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.469 -179.83 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -171.65 162.2 4.87 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -1.171 . . . . 0.0 108.966 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.78 159.82 23.45 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 120.974 1.116 . . . . 0.0 111.915 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 1.8 m120 -55.75 135.86 51.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.475 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.2 m -155.84 -11.15 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.219 -0.925 . . . . 0.0 109.37 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ASP . 31.9 p90 -172.0 3.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 9' ' ' LEU . . . -67.37 68.62 0.24 Allowed Glycine 0 N--CA 1.487 2.079 0 N-CA-C 107.396 -2.281 . . . . 0.0 107.396 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' TYR . 26.5 t0 -45.49 89.63 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.623 -0.928 . . . . 0.0 110.26 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.542 ' N ' ' O ' ' A' ' 7' ' ' GLY . 14.3 mt -89.02 51.99 2.29 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.189 -0.944 . . . . 0.0 108.762 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.13 38.86 96.3 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.27 162.18 23.18 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -63.75 166.01 16.98 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 118.289 1.045 . . . . 0.0 112.304 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -82.97 141.37 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.022 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -123.84 149.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.301 -0.875 . . . . 0.0 109.642 -178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.2 m -127.78 137.3 52.36 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.4 t -139.24 144.91 38.64 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.59 145.61 37.55 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.162 -0.962 . . . . 0.0 110.008 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.5 t -125.63 151.47 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.7 129.86 52.28 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.34 136.97 29.37 Favored Pre-proline 0 N--CA 1.505 2.301 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 24' ' ' LEU . 1.1 Cg_endo -60.42 137.55 75.0 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 CA-C-N 120.114 1.076 . . . . 0.0 111.082 178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -43.79 -40.68 4.53 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.274 -0.891 . . . . 0.0 111.448 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -63.44 -46.73 84.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.699 -1.25 . . . . 0.0 111.399 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD12 ' HG2' ' A' ' 21' ' ' PRO . 74.3 mt -76.33 -19.46 58.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.375 -1.453 . . . . 0.0 108.069 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.82 88.93 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.721 0.772 . . . . 0.0 109.367 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 59' ' ' ARG . 5.5 mtt-85 -74.57 -26.87 60.22 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 91.6 p -74.58 -28.84 61.09 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.097 -1.002 . . . . 0.0 109.386 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.9 mt -88.28 -45.15 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 120.808 -1.183 . . . . 0.0 111.21 -177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -66.23 -34.7 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.91 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.05 -173.98 43.52 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -92.09 -4.97 53.65 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.997 -1.296 . . . . 0.0 109.554 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.84 17.1 1.41 Allowed Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 77.34 -8.41 32.93 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 33' ' ' GLY . 12.2 pt20 -34.02 -29.63 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.952 -0.734 . . . . 0.0 111.235 -178.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 mmt180 -85.88 -40.63 15.74 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.419 -1.426 . . . . 0.0 109.622 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -68.86 -26.62 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.009 -1.057 . . . . 0.0 109.202 -179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -76.86 -52.78 8.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 0.0 109.447 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -60.87 -47.8 84.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.05 . . . . 0.0 109.489 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 80.1 mt -57.33 -36.01 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -55.87 -67.15 0.32 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.406 -0.809 . . . . 0.0 110.251 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -59.78 -39.81 86.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.297 -0.877 . . . . 0.0 110.359 -178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -58.19 -45.97 86.62 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.087 -1.008 . . . . 0.0 110.128 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.0 p -86.77 -21.96 26.21 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.014 -1.054 . . . . 0.0 110.089 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.85 0.07 73.68 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.188 -1.965 . . . . 0.0 108.188 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.0 160.91 20.91 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.729 -0.865 . . . . 0.0 110.026 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.5 t -106.93 141.86 37.47 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.1 mt -138.02 136.08 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.658 -1.276 . . . . 0.0 110.139 -178.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -120.84 130.76 54.08 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.3 mt -101.01 134.16 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.995 -1.066 . . . . 0.0 108.644 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.28 150.48 20.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 108.598 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -66.86 149.85 98.13 Favored Pre-proline 0 C--N 1.303 -1.417 0 O-C-N 120.899 -1.125 . . . . 0.0 108.437 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -61.98 141.6 89.83 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 119.261 0.772 . . . . 0.0 111.442 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.8 mt -77.47 117.86 19.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.088 -1.008 . . . . 0.0 109.317 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.565 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 5.6 mp0 -52.95 131.23 35.65 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.39 -0.819 . . . . 0.0 109.404 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.72 7.4 48.07 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.5 t -130.46 -170.4 2.33 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.488 -1.007 . . . . 0.0 109.295 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -144.63 33.58 1.16 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -138.15 157.67 45.84 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.0 0.905 . . . . 0.0 110.706 -178.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.615 ' NH2' ' NH2' ' A' ' 26' ' ' ARG . 3.5 mtt-85 -116.87 140.53 49.34 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -111.93 141.63 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.288 -0.882 . . . . 0.0 110.718 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -125.25 144.4 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.696 -0.627 . . . . 0.0 110.47 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 76.7 m -117.57 122.3 43.28 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 13.5 mt -103.16 132.66 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.4 m -129.87 130.16 44.86 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.071 -1.018 . . . . 0.0 108.987 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.51 -173.54 38.79 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.705 ' H ' HE21 ' A' ' 69' ' ' GLN . 21.1 p -73.49 160.42 31.73 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.29 . . . . 0.0 109.662 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.14 -46.95 23.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.725 -0.61 . . . . 0.0 110.194 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.0 -47.02 69.65 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.705 HE21 ' H ' ' A' ' 66' ' ' THR . 24.8 mt-30 -58.07 -37.55 74.66 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.832 -1.167 . . . . 0.0 109.201 -179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.39 -45.8 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.621 -0.674 . . . . 0.0 110.316 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.01 -43.55 95.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.819 -1.176 . . . . 0.0 109.518 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -61.74 -33.12 73.5 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.19 -0.943 . . . . 0.0 108.75 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.12 -46.84 22.14 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.403 -0.811 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -58.36 -46.0 87.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 110.248 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -62.81 -37.06 85.26 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.062 . . . . 0.0 110.135 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.5 mt -72.01 -17.71 62.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.796 -1.19 . . . . 0.0 108.971 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -82.34 -45.91 14.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.09 -1.006 . . . . 0.0 108.532 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.42 -38.24 88.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.621 -0.675 . . . . 0.0 110.273 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.71 -22.94 45.87 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.019 -1.05 . . . . 0.0 109.895 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.9 t -66.18 -36.35 82.86 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.06 -1.456 . . . . 0.0 107.369 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 81' ' ' VAL . 4.4 t -48.59 -43.26 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.444 -0.785 . . . . 0.0 110.201 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.48 ' C ' ' N ' ' A' ' 84' ' ' TYR . 80.8 mttt -53.79 -22.36 9.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.98 -1.075 . . . . 0.0 110.284 -178.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.474 ' NE2' ' NH1' ' A' ' 35' ' ' ARG . 53.5 mt-30 -57.91 -10.09 1.61 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.279 -1.513 . . . . 0.0 107.636 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.515 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 88.1 t80 -71.3 63.7 0.37 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.136 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m 52.37 10.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.272 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 84' ' ' TYR . . . -67.86 -65.9 2.53 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.544 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 16.6 mtpp -81.6 29.06 0.38 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -1.142 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.544 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 72.9 m-85 -162.0 40.95 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.6 t80 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.414 -179.716 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.485 ' OG ' ' ND2' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -173.73 162.17 3.17 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 108.944 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -59.05 -36.39 96.52 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 120.928 1.085 . . . . 0.0 111.856 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.764 HD22 ' H ' ' A' ' 4' ' ' ASN . 0.8 OUTLIER -51.4 134.92 28.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.507 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 t -168.99 150.34 4.51 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.261 -0.899 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 50.98 22.0 1.11 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . -60.15 -10.37 15.01 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.442 ' O ' ' O ' ' A' ' 7' ' ' GLY . 19.8 t0 60.48 143.57 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.524 -0.986 . . . . 0.0 109.807 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.444 ' C ' ' H ' ' A' ' 11' ' ' GLY . 46.2 mt -96.54 -15.96 21.35 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.256 -0.903 . . . . 0.0 109.252 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.93 -10.02 3.41 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 161.75 167.63 22.48 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -64.3 141.66 76.1 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.077 1.184 . . . . 0.0 112.255 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.2 mm -80.95 141.64 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -0.854 . . . . 0.0 108.932 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.3 mt -123.79 148.27 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.24 -0.913 . . . . 0.0 109.661 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.3 m -127.74 137.6 52.49 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.37 144.4 38.17 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.41 145.41 36.18 Favored 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.253 -0.904 . . . . 0.0 109.911 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.1 t -124.94 151.05 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -127.0 129.55 48.31 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.534 ' H ' HD12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.4 141.86 41.23 Favored Pre-proline 0 N--CA 1.505 2.309 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.46 141.83 89.67 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 CA-C-N 120.287 1.138 . . . . 0.0 110.691 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -47.94 -41.15 24.16 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.897 -1.127 . . . . 0.0 111.451 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 1.0 OUTLIER -61.75 -43.56 98.62 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.651 -1.281 . . . . 0.0 111.293 -178.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -78.92 -29.2 44.04 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.732 -1.23 . . . . 0.0 108.411 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.17 -40.79 74.46 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.79 0.805 . . . . 0.0 109.311 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -74.78 -32.51 62.05 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.5 p -68.53 -25.24 64.83 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 120.959 -1.088 . . . . 0.0 109.046 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.55 -41.86 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.965 -1.085 . . . . 0.0 110.578 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.63 ' CD1' HH11 ' A' ' 59' ' ' ARG . 58.1 mt -68.12 -37.44 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.851 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.04 -173.72 39.84 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 108.599 -1.8 . . . . 0.0 108.599 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -91.27 -4.6 55.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.888 -1.36 . . . . 0.0 109.938 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.56 20.81 1.17 Allowed Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.08 -11.4 2.71 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 32' ' ' GLY . 88.0 mt-30 -36.53 -27.11 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.737 -0.861 . . . . 0.0 110.624 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 11.6 tpp180 -86.17 -34.33 20.57 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.76 -1.213 . . . . 0.0 109.889 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -75.91 -27.41 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.994 -1.066 . . . . 0.0 109.172 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.29 -48.91 30.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.054 -1.029 . . . . 0.0 109.23 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -58.21 -55.13 38.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.574 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.5 mt -50.41 -32.37 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.028 -1.045 . . . . 0.0 109.672 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -62.7 -37.81 87.94 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.045 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.79 -39.75 19.62 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.125 -0.985 . . . . 0.0 110.518 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.44 -41.61 93.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.984 -1.072 . . . . 0.0 110.333 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -86.96 -24.24 24.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.175 -0.953 . . . . 0.0 110.707 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.54 1.27 70.36 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.12 161.06 20.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.765 -0.844 . . . . 0.0 110.041 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.8 t -108.46 139.35 43.33 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.3 mt -136.76 136.75 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.822 -1.174 . . . . 0.0 109.981 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -122.28 128.83 51.58 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.7 mt -99.05 135.54 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.909 -1.119 . . . . 0.0 108.829 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -96.49 148.57 22.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.082 -1.011 . . . . 0.0 108.616 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.72 149.26 97.59 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.953 -1.092 . . . . 0.0 108.797 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.28 143.0 93.38 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 CA-C-N 119.391 0.818 . . . . 0.0 111.479 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.5 mt -76.83 133.56 39.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.07 -1.019 . . . . 0.0 109.507 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -58.29 134.95 57.01 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.372 -0.83 . . . . 0.0 109.541 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.14 39.41 7.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.6 m -159.99 174.87 13.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.298 -1.119 . . . . 0.0 109.223 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -138.02 44.01 2.19 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.213 -0.929 . . . . 0.0 108.966 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -140.56 154.34 46.47 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.919 0.866 . . . . 0.0 109.831 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.63 HH11 ' CD1' ' A' ' 29' ' ' ILE . 52.4 mtt180 -118.71 140.14 50.42 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -111.26 142.16 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 121.325 -0.859 . . . . 0.0 110.709 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.16 143.26 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.82 -0.55 . . . . 0.0 110.384 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 53.3 m -117.76 122.84 44.51 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.663 -0.648 . . . . 0.0 109.451 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.8 mt -102.74 133.07 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.9 m -130.36 130.23 44.14 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.052 -1.03 . . . . 0.0 109.221 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.33 -172.71 38.49 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.844 -1.703 . . . . 0.0 108.844 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.1 p -72.65 159.55 33.67 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.024 -1.28 . . . . 0.0 109.725 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.478 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.94 19.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.754 -0.591 . . . . 0.0 110.102 -179.316 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -68.24 -45.73 72.4 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 109.865 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -58.84 -37.35 76.27 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.85 -1.156 . . . . 0.0 109.226 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.66 -45.6 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.461 -0.774 . . . . 0.0 110.203 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -60.53 -43.08 97.54 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 0.0 109.363 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -62.64 -34.58 77.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.897 . . . . 0.0 108.657 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.01 -46.01 31.6 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.466 -0.771 . . . . 0.0 109.534 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -59.76 -37.16 78.24 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.289 -0.882 . . . . 0.0 110.142 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -70.79 -35.33 72.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.948 -1.095 . . . . 0.0 109.589 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.4 mt -73.24 -18.19 61.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.85 -1.156 . . . . 0.0 108.885 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.3 mt -81.28 -45.31 16.42 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -61.81 -38.72 89.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.561 -0.712 . . . . 0.0 109.628 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -78.53 -24.69 45.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.167 -0.958 . . . . 0.0 109.563 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 83.6 p -62.14 -37.31 84.68 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HD23 ' A' ' 24' ' ' LEU . 39.6 t -41.56 -50.84 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.893 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' C ' ' N ' ' A' ' 84' ' ' TYR . 79.5 mttt -48.09 -22.55 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.609 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -58.44 -12.53 3.98 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.448 ' N ' ' C ' ' A' ' 82' ' ' LYS . 74.9 t80 -55.08 -59.38 4.83 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.131 -0.941 . . . . 0.0 108.929 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.1 p -171.57 58.66 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -135.74 -72.03 0.07 OUTLIER Glycine 0 N--CA 1.496 2.672 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.6 mtpp -81.87 18.3 1.33 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 108.571 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.409 ' H ' ' C ' ' A' ' 86' ' ' GLY . 93.6 t80 -178.03 81.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.299 -1.62 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.424 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.9 p 50.32 71.64 1.49 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.223 -1.163 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -64.64 -46.49 6.89 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.122 1.215 . . . . 0.0 111.992 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -66.4 135.61 54.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 7' ' ' GLY . 42.3 t -158.54 169.57 24.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.526 ' O ' ' N ' ' A' ' 8' ' ' ASP . 87.8 m-85 -74.79 33.9 0.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.892 . . . . 0.0 109.606 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -70.17 49.37 0.72 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.706 -2.158 . . . . 0.0 107.706 178.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.526 ' N ' ' O ' ' A' ' 6' ' ' TYR . 7.3 p-10 -42.92 167.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.908 -0.76 . . . . 0.0 110.216 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' A' ' 11' ' ' GLY . 24.2 mt -75.36 -21.5 58.28 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.204 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.04 -40.54 0.44 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.12 165.71 28.84 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.84 150.13 89.12 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.972 1.114 . . . . 0.0 112.195 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.9 mm -81.4 141.34 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.375 -0.828 . . . . 0.0 109.091 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -123.6 148.61 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.338 -0.851 . . . . 0.0 109.569 -178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.5 m -127.31 136.96 52.67 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.38 144.92 38.38 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -111.01 145.34 38.63 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.182 -0.949 . . . . 0.0 109.997 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.92 148.77 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -122.45 129.68 52.29 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.97 136.51 28.95 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.3 137.64 80.7 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 CA-C-N 120.243 1.123 . . . . 0.0 110.995 178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 20.5 pttm -43.36 -40.53 3.69 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.185 -0.947 . . . . 0.0 111.528 -178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -63.02 -46.5 87.34 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.72 -1.237 . . . . 0.0 111.178 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.1 mp -76.42 -20.52 57.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.58 -1.325 . . . . 0.0 108.289 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.58 89.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.702 0.763 . . . . 0.0 109.881 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.61 ' NH1' ' NH2' ' A' ' 59' ' ' ARG . 3.8 mtt-85 -74.41 -32.39 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.859 -0.737 . . . . 0.0 109.265 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.2 t -69.22 -32.53 71.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.71 -1.244 . . . . 0.0 109.267 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -80.02 -44.11 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.025 -1.047 . . . . 0.0 110.821 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.526 ' CD1' HH11 ' A' ' 59' ' ' ARG . 54.5 mt -68.4 -36.39 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.941 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.88 -172.36 40.29 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -91.83 -24.26 19.43 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.992 -1.299 . . . . 0.0 109.765 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -127.41 18.26 6.09 Favored Glycine 0 N--CA 1.5 2.964 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 71.12 -9.18 4.2 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.956 -1.658 . . . . 0.0 108.956 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.428 ' H ' ' C ' ' A' ' 32' ' ' GLY . 36.9 mt-30 -38.93 -26.95 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.515 -0.991 . . . . 0.0 110.417 -177.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.492 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.3 tpp180 -83.43 -37.68 22.9 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.977 -1.077 . . . . 0.0 110.244 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -75.0 -27.71 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.891 -1.13 . . . . 0.0 109.144 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.79 -43.97 67.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.122 -0.987 . . . . 0.0 109.076 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -61.44 -46.43 90.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.02 -1.05 . . . . 0.0 110.109 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.1 mt -57.21 -33.44 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 0.0 110.078 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -67.35 -41.44 85.14 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 110.064 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.46 ' HD1' ' C ' ' A' ' 41' ' ' HIS . 3.1 t-80 -78.44 -34.15 48.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.086 -1.008 . . . . 0.0 110.221 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -76.27 -41.64 48.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 110.637 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -86.49 -23.55 25.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.939 -1.101 . . . . 0.0 110.449 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.21 0.69 71.87 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.62 161.26 20.2 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.738 -0.86 . . . . 0.0 109.926 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.2 t -109.1 140.05 43.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.614 -1.625 . . . . 0.0 106.614 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.9 mt -137.44 137.34 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.728 -1.232 . . . . 0.0 109.953 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -121.83 129.84 52.93 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 74.8 mt -100.5 135.19 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.048 -1.033 . . . . 0.0 108.84 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -95.3 150.15 20.57 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.156 -0.965 . . . . 0.0 108.532 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 3.4 mp0 -66.56 149.52 98.07 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.878 -1.138 . . . . 0.0 108.586 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -61.69 141.49 90.99 Favored 'Trans proline' 0 N--CA 1.49 1.268 0 CA-C-N 119.363 0.808 . . . . 0.0 111.44 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 44.0 mt -76.38 117.73 18.35 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.071 -1.018 . . . . 0.0 109.4 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 13.6 mp0 -49.35 133.8 19.35 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.335 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.92 24.88 28.62 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 26.9 t -139.49 -175.98 4.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.462 -1.023 . . . . 0.0 109.232 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.478 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 11.8 mp0 -142.46 34.8 1.47 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 108.94 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -143.65 157.1 44.66 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 122.037 0.922 . . . . 0.0 111.033 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.61 ' NH2' ' NH1' ' A' ' 26' ' ' ARG . 44.3 mtt180 -117.65 139.17 51.37 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.1 mt -108.61 156.16 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 CA-C-O 121.825 0.821 . . . . 0.0 110.541 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.5 mt -138.94 142.63 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.752 -0.593 . . . . 0.0 110.07 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.5 m -116.65 123.08 46.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.695 -0.628 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.52 132.75 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.234 -0.916 . . . . 0.0 109.369 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.9 m -130.54 130.12 43.7 Favored 'General case' 0 N--CA 1.505 2.325 0 O-C-N 121.118 -0.989 . . . . 0.0 109.234 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.07 -173.13 39.23 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.8 p -73.49 160.23 32.03 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.046 -1.267 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -45.45 -48.77 13.8 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.397 0.618 . . . . 0.0 110.498 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.25 -45.43 73.24 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.946 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -58.54 -36.26 73.6 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.871 -1.143 . . . . 0.0 109.392 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 84.0 mt -72.11 -45.48 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.449 -0.782 . . . . 0.0 110.251 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -60.62 -43.07 97.89 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.658 -1.276 . . . . 0.0 109.305 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -62.36 -36.63 82.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 108.626 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.94 -45.59 49.42 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.517 -0.74 . . . . 0.0 109.473 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -58.48 -45.05 89.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.4 t80 -63.35 -35.11 79.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.063 -1.023 . . . . 0.0 109.924 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.5 mt -73.36 -16.0 61.36 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.867 -1.146 . . . . 0.0 108.998 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 mt -83.36 -45.84 13.26 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -62.44 -38.2 88.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.78 . . . . 0.0 110.144 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -78.3 -23.52 47.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.121 -0.987 . . . . 0.0 109.799 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.7 t -65.24 -35.41 80.96 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.953 -1.499 . . . . 0.0 107.392 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 81' ' ' VAL . 25.0 t -42.36 -54.24 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.661 -0.649 . . . . 0.0 110.179 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.489 ' C ' ' N ' ' A' ' 84' ' ' TYR . 5.5 mptp? -45.0 -24.61 0.24 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.164 -0.96 . . . . 0.0 110.077 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 85' ' ' SER . 34.5 tt0 -55.66 -13.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.409 -1.432 . . . . 0.0 107.574 178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 85' ' ' SER . 88.3 t80 -58.34 81.67 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.525 ' N ' ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER 82.68 53.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.275 0.559 . . . . 0.0 109.737 -179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.85 -35.24 0.49 Allowed Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -158.36 -167.49 2.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.153 -1.204 . . . . 0.0 108.798 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.481 ' H ' ' CD ' ' A' ' 87' ' ' LYS . 73.4 t80 -52.56 -7.92 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 0.0 109.673 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' H ' ' C ' ' A' ' 87' ' ' LYS . 73.9 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.376 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 80.6 p -168.16 71.26 0.86 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.134 -1.216 . . . . 0.0 109.48 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.51 -42.13 35.57 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.12 1.213 . . . . 0.0 112.016 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 6' ' ' TYR . 17.3 t30 -167.94 13.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.331 -0.856 . . . . 0.0 109.429 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 7' ' ' GLY . 8.2 m -71.37 12.54 0.32 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.508 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 57.2 t80 -73.68 35.79 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -65.31 4.28 2.0 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.5 ' OD1' ' CE2' ' A' ' 6' ' ' TYR . 36.6 m-20 53.04 67.78 0.94 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.238 -1.154 . . . . 0.0 109.549 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 11' ' ' GLY . 70.4 mt -82.95 44.11 0.9 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -0.906 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.23 -34.76 0.78 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 168.96 162.08 20.48 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -65.63 166.67 19.23 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 118.32 1.06 . . . . 0.0 112.258 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.6 mm -87.19 140.46 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.412 -0.805 . . . . 0.0 109.154 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.2 mt -125.31 151.47 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.341 -0.849 . . . . 0.0 109.931 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 12.0 t -129.69 142.25 50.75 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.254 -0.904 . . . . 0.0 108.988 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -143.24 146.75 33.92 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -113.98 146.94 39.43 Favored 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.256 -0.903 . . . . 0.0 110.57 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -122.2 150.97 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.8 m -130.44 82.28 2.05 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.413 HD12 ' HA ' ' A' ' 25' ' ' ALA . 0.1 OUTLIER -78.56 149.61 75.17 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.332 -0.855 . . . . 0.0 109.527 -179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -57.01 169.13 2.08 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 CA-C-N 119.418 0.828 . . . . 0.0 110.148 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -76.08 -42.33 47.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.565 -1.335 . . . . 0.0 110.949 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -63.06 -39.85 95.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.748 -1.22 . . . . 0.0 111.532 -178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.437 HD12 ' HG2' ' A' ' 21' ' ' PRO . 21.9 mt -79.63 -27.66 40.97 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.779 -1.201 . . . . 0.0 108.638 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 21' ' ' PRO . . . -58.19 -38.64 77.12 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.826 0.822 . . . . 0.0 109.186 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -74.34 -33.81 63.25 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.4 m -67.9 -29.93 69.15 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.859 -1.15 . . . . 0.0 108.97 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.3 mt -83.93 -42.99 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.122 -0.986 . . . . 0.0 110.926 -177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' CD1' HH11 ' A' ' 59' ' ' ARG . 56.4 mt -67.45 -36.24 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.306 -0.871 . . . . 0.0 109.961 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.02 -173.83 41.67 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' N ' ' CD ' ' A' ' 31' ' ' LYS . 1.4 mptm? -91.74 -0.02 57.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.933 -1.333 . . . . 0.0 109.651 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.13 19.4 0.64 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.18 -11.52 4.9 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 32' ' ' GLY . 14.8 pt20 -34.99 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.858 -0.789 . . . . 0.0 111.011 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.3 tpp180 -84.31 -34.62 23.69 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.718 -1.239 . . . . 0.0 109.89 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.9 OUTLIER -74.69 -26.13 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.935 -1.103 . . . . 0.0 108.882 179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -71.57 -47.94 51.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.027 -1.046 . . . . 0.0 108.945 179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -60.09 -49.57 77.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.195 -0.941 . . . . 0.0 109.649 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -58.14 -34.71 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.112 -0.992 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.34 -0.85 . . . . 0.0 110.036 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.5 t-80 -75.49 -38.1 59.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.099 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -62.97 -43.42 98.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.095 -1.003 . . . . 0.0 110.086 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -86.86 -22.16 25.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.991 -1.068 . . . . 0.0 110.276 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.9 0.19 74.45 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.219 -1.952 . . . . 0.0 108.219 -178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.72 161.83 19.88 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.771 -0.841 . . . . 0.0 110.042 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 69.5 m -107.58 142.85 36.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.6 mt -138.46 136.54 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 120.681 -1.262 . . . . 0.0 110.027 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -121.39 130.02 53.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 73.8 mt -100.47 135.14 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.894 -1.129 . . . . 0.0 108.808 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -94.29 150.39 20.33 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.17 150.46 95.5 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 120.905 -1.122 . . . . 0.0 108.504 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -60.25 142.27 97.82 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 CA-C-N 119.167 0.738 . . . . 0.0 111.523 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.4 mt -81.68 130.81 35.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.938 . . . . 0.0 109.422 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 54' ' ' GLU . 3.0 mp0 -63.14 133.16 53.94 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.15 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.15 19.03 34.57 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.9 t -153.1 142.81 21.97 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -1.079 . . . . 0.0 109.243 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.3 pm0 -102.87 51.64 0.8 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.503 -0.748 . . . . 0.0 109.483 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -143.99 154.54 43.38 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.669 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.41 HH11 ' CD1' ' A' ' 29' ' ' ILE . 40.7 mtt180 -117.69 139.81 50.52 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 79.9 mt -109.08 152.09 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.759 0.79 . . . . 0.0 110.793 -178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.97 142.47 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.771 -0.58 . . . . 0.0 110.082 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 66.4 m -114.61 126.61 55.09 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.499 ' CD1' ' NE2' ' A' ' 74' ' ' GLN . 15.0 mt -107.36 130.21 59.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.396 -0.815 . . . . 0.0 109.397 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -128.63 131.11 48.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.042 -1.036 . . . . 0.0 109.33 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.17 -174.33 39.45 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 p -72.92 159.96 32.88 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.045 -1.268 . . . . 0.0 109.773 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -46.94 -47.41 21.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 0.0 110.406 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -68.4 -45.34 72.93 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.735 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -59.21 -36.22 75.0 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.904 -1.122 . . . . 0.0 109.235 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.1 mt -74.48 -45.28 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.461 -0.774 . . . . 0.0 110.454 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -43.22 96.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.708 -1.245 . . . . 0.0 109.188 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.92 -31.86 71.37 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.57 -42.02 53.21 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.591 -0.693 . . . . 0.0 109.913 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.706 HE21 ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -57.79 -52.69 64.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 0.0 109.354 -179.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -55.99 -38.73 70.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 30.6 mt -70.96 -22.21 62.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.791 -1.193 . . . . 0.0 109.251 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 77' ' ' LEU . 18.9 mt -79.44 -45.54 19.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.959 -1.088 . . . . 0.0 108.222 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.24 -38.48 89.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.573 -0.704 . . . . 0.0 109.846 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.62 -24.17 45.49 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.119 -0.988 . . . . 0.0 109.457 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' ' 83' ' ' GLN . 78.9 p -63.72 -37.21 86.49 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.423 ' CG1' HD13 ' A' ' 24' ' ' LEU . 3.5 t -50.11 -40.58 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.704 -0.623 . . . . 0.0 110.144 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.477 ' C ' ' N ' ' A' ' 84' ' ' TYR . 85.3 mttt -56.89 -24.86 55.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.951 -1.093 . . . . 0.0 110.531 -178.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.519 ' N ' ' OE1' ' A' ' 83' ' ' GLN . 9.7 mp0 -57.76 -11.24 2.07 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.116 -1.615 . . . . 0.0 107.363 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.518 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 85.0 t80 -68.97 55.88 0.09 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.032 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 83' ' ' GLN . 7.4 m 56.8 4.38 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.444 -0.785 . . . . 0.0 109.546 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -64.91 -78.6 0.2 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.051 -1.619 . . . . 0.0 109.051 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 6.6 ptmm? -59.55 120.11 8.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.244 -1.15 . . . . 0.0 109.226 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 50.95 91.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.447 -179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m 52.45 71.54 1.43 Allowed Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.201 -1.176 . . . . 0.0 109.559 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.71 102.93 0.53 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.18 1.253 . . . . 0.0 111.97 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -165.64 79.97 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 m 51.46 68.06 0.86 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 69.5 t80 -64.43 -176.89 0.26 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.586 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 69.84 0.55 26.87 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' A' ' 11' ' ' GLY . 5.1 m-20 52.91 82.41 0.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.47 -1.018 . . . . 0.0 109.484 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.4 mt 45.58 58.1 4.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.406 -0.809 . . . . 0.0 109.648 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.58 27.11 17.55 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 7' ' ' GLY . . . 79.98 163.24 27.27 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -64.63 166.46 17.74 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 120.956 1.104 . . . . 0.0 112.227 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.96 141.9 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.385 -0.822 . . . . 0.0 109.096 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -125.08 149.85 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.3 -0.875 . . . . 0.0 109.879 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.3 t -129.08 142.1 51.0 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 122.011 0.91 . . . . 0.0 108.888 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.8 t -143.07 144.59 32.32 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -110.46 145.99 36.69 Favored 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.218 -0.926 . . . . 0.0 110.141 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.18 148.59 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -121.78 129.65 52.82 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.25 135.21 27.07 Favored Pre-proline 0 N--CA 1.502 2.139 0 O-C-N 121.531 -0.731 . . . . 0.0 109.087 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.99 136.66 78.06 Favored 'Trans proline' 0 N--CA 1.49 1.289 0 CA-C-N 120.271 1.132 . . . . 0.0 111.335 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -43.16 -41.31 3.66 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.219 -0.925 . . . . 0.0 111.579 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -62.25 -46.19 89.96 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.74 -1.225 . . . . 0.0 111.054 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 mp -76.31 -25.47 54.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.658 -1.276 . . . . 0.0 108.02 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.79 -38.59 82.33 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.785 0.803 . . . . 0.0 109.321 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -74.84 -29.33 61.02 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 95.3 p -72.08 -30.25 64.93 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.062 -1.024 . . . . 0.0 109.052 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -86.97 -43.72 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.007 -1.058 . . . . 0.0 110.937 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 51.6 mt -66.61 -35.59 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.728 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.03 -175.35 43.13 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.672 -1.771 . . . . 0.0 108.672 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -91.59 -3.38 56.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.094 -1.239 . . . . 0.0 109.757 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -150.03 18.71 1.08 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.31 -10.43 6.21 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.442 ' H ' ' C ' ' A' ' 32' ' ' GLY . 18.7 mm100 -36.25 -27.81 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.787 -0.831 . . . . 0.0 110.594 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -85.92 -35.7 20.35 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.937 -1.102 . . . . 0.0 109.856 -178.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.459 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -76.19 -28.04 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.961 -1.087 . . . . 0.0 109.269 179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -72.57 -48.8 37.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.966 -1.084 . . . . 0.0 109.307 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -57.38 -42.68 82.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.0 110.057 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.12 -32.72 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.146 -0.971 . . . . 0.0 110.114 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -65.76 -49.47 68.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.096 -1.002 . . . . 0.0 109.952 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.481 ' ND1' ' N ' ' A' ' 41' ' ' HIS . 1.7 m80 -71.4 -32.27 68.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.241 -0.912 . . . . 0.0 110.114 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -42.7 42.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.373 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -86.58 -23.74 25.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.158 -0.964 . . . . 0.0 110.477 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.68 0.81 75.29 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.74 161.38 20.03 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.761 -0.847 . . . . 0.0 110.067 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.9 t -108.9 140.51 42.28 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.88 137.76 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.689 -1.257 . . . . 0.0 110.013 -178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -122.82 129.45 51.71 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.459 HG21 ' NH2' ' A' ' 59' ' ' ARG . 68.4 mt -100.36 135.42 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.908 -1.12 . . . . 0.0 108.71 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.03 151.67 18.98 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.023 -1.048 . . . . 0.0 109.06 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -66.95 154.44 92.31 Favored Pre-proline 0 N--CA 1.487 1.425 0 O-C-N 121.067 -1.02 . . . . 0.0 108.399 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -64.69 141.99 74.93 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 120.477 0.785 . . . . 0.0 111.748 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.2 mt -79.92 118.94 22.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.156 -0.965 . . . . 0.0 109.282 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -55.77 114.64 1.97 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.411 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.07 -17.0 5.2 Favored Glycine 0 N--CA 1.499 2.881 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.0 t -122.51 -170.25 2.05 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.435 -1.038 . . . . 0.0 109.687 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -141.47 37.85 1.69 Allowed 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -125.68 157.77 36.48 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.637 0.732 . . . . 0.0 109.872 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.8 mmm180 -117.72 137.55 52.61 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.8 mt -110.61 156.0 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 CA-C-O 121.887 0.851 . . . . 0.0 111.078 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.6 mt -140.74 142.28 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.139 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.8 m -116.21 123.96 49.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.643 -0.661 . . . . 0.0 109.287 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.4 mt -104.09 132.74 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.17 -0.956 . . . . 0.0 109.572 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.5 m -130.35 130.24 44.18 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.098 -1.001 . . . . 0.0 109.06 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.46 -173.25 38.71 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.2 p -72.42 159.59 33.74 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.968 -1.313 . . . . 0.0 109.618 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.1 -46.97 23.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.717 -0.615 . . . . 0.0 110.162 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.12 -47.14 68.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.363 -0.836 . . . . 0.0 109.882 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.36 -36.51 71.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.79 -1.194 . . . . 0.0 109.111 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 77.5 mt -71.26 -45.82 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 110.226 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -60.48 -42.75 96.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.818 -1.177 . . . . 0.0 109.472 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -62.16 -37.74 86.38 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.305 -0.872 . . . . 0.0 108.875 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.92 -44.09 64.24 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.422 -0.798 . . . . 0.0 109.601 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -58.04 -48.93 78.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.268 -0.895 . . . . 0.0 110.024 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -59.64 -39.14 83.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.099 -1.0 . . . . 0.0 109.873 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.0 mt -69.84 -18.3 63.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.861 -1.15 . . . . 0.0 109.194 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -84.23 -45.91 12.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.062 -1.024 . . . . 0.0 108.392 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -62.11 -38.62 89.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.665 -0.647 . . . . 0.0 110.042 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -78.99 -23.59 44.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.925 -1.109 . . . . 0.0 109.89 -179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 81.1 p -61.94 -36.68 82.1 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.9 t -49.92 -51.12 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.89 -0.506 . . . . 0.0 110.42 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.2 mttm -47.85 -25.51 1.33 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.965 -1.084 . . . . 0.0 109.804 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.572 ' O ' ' N ' ' A' ' 85' ' ' SER . 48.5 tt0 -61.72 -10.75 9.45 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.473 -1.392 . . . . 0.0 107.694 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.416 ' O ' ' OG ' ' A' ' 85' ' ' SER . 89.2 t80 -44.76 88.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.5 p 52.45 32.43 11.33 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.556 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 61.43 150.23 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.2 mtmm -67.86 57.03 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -1.134 . . . . 0.0 109.038 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 86' ' ' GLY . 61.9 t80 -172.26 -108.25 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' OXT' ' CD1' ' A' ' 89' ' ' PHE . 54.1 t80 . . . . . 0 C--N 1.299 -1.614 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.505 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.9 p -168.78 71.22 0.76 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.21 -1.171 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.94 101.49 0.69 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 121.064 1.176 . . . . 0.0 111.934 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.419 ' C ' ' N ' ' A' ' 6' ' ' TYR . 50.9 t30 -168.29 176.15 6.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.944 . . . . 0.0 109.493 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.417 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 10.5 m 54.83 9.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASP . 58.7 t80 -72.23 6.86 1.98 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.404 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 10' ' ' GLY . . . -69.04 62.39 0.52 Allowed Glycine 0 N--CA 1.488 2.114 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 6' ' ' TYR . 5.2 m-20 -40.89 130.54 2.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.885 -0.774 . . . . 0.0 110.367 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.441 ' C ' ' H ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER 53.32 29.81 9.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.237 -0.915 . . . . 0.0 108.73 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 7' ' ' GLY . . . 75.54 -37.72 1.2 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 176.06 164.52 30.42 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -64.83 164.12 25.56 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 120.862 1.041 . . . . 0.0 112.02 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 mm -82.62 142.9 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.377 -0.827 . . . . 0.0 109.156 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.0 mt -123.93 149.22 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.293 -0.879 . . . . 0.0 109.682 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.4 m -127.94 137.5 52.29 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 t -139.91 146.17 38.9 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -112.02 145.97 38.72 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.107 -0.996 . . . . 0.0 110.102 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.6 t -126.77 155.56 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 m -126.44 130.27 50.35 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -126.21 133.26 24.77 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.94 136.09 74.6 Favored 'Trans proline' 0 N--CA 1.489 1.22 0 CA-C-N 120.356 1.163 . . . . 0.0 111.265 178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' HZ3' ' HB2' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -42.46 -41.28 2.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -0.875 . . . . 0.0 111.515 -178.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -62.88 -46.33 88.35 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.651 -1.28 . . . . 0.0 111.187 -178.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.504 HD23 HG13 ' A' ' 81' ' ' VAL . 10.8 mp -75.65 -19.8 58.93 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.491 -1.381 . . . . 0.0 108.109 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.25 -37.43 85.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.349 -0.844 . . . . 0.0 109.567 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -74.34 -28.66 61.24 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.9 p -72.89 -30.71 64.16 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.121 -0.987 . . . . 0.0 109.178 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.1 mt -89.06 -43.06 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.908 -1.12 . . . . 0.0 111.014 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.5 mt -69.13 -35.98 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.061 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.62 -170.7 38.79 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 31' ' ' LYS . 15.7 ttpp -91.76 -11.76 35.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.948 -1.325 . . . . 0.0 110.007 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.17 17.99 2.51 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.55 -9.64 14.76 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 5.7 tp-100 -36.07 -27.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.707 -0.878 . . . . 0.0 111.137 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.683 HH21 ' NE2' ' A' ' 83' ' ' GLN . 12.1 tpp180 -85.95 -35.51 20.42 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.536 -1.352 . . . . 0.0 109.7 -178.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -72.55 -23.04 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.81 -1.182 . . . . 0.0 108.414 178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -73.19 -50.23 23.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.138 -0.976 . . . . 0.0 109.004 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -57.25 -51.42 69.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.302 -0.874 . . . . 0.0 109.855 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.63 -33.5 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.176 -0.952 . . . . 0.0 109.566 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -58.8 -64.82 0.8 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.366 -0.834 . . . . 0.0 110.151 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -62.29 -39.3 92.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -61.14 -44.65 96.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 0.0 110.255 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.0 p -86.71 -22.93 25.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.976 -1.078 . . . . 0.0 110.433 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.71 0.55 74.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.65 19.63 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.803 -0.822 . . . . 0.0 110.025 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.0 t -107.23 141.57 38.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 94.0 mt -137.09 138.33 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 120.57 -1.331 . . . . 0.0 110.265 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -124.83 129.87 51.28 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.68 136.23 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.006 -1.059 . . . . 0.0 108.917 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -96.17 152.16 18.81 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.101 -1.0 . . . . 0.0 109.111 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.642 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 4.0 pm0 -67.06 154.08 93.27 Favored Pre-proline 0 C--N 1.307 -1.272 0 O-C-N 120.993 -1.067 . . . . 0.0 108.731 179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -65.64 151.0 85.9 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 120.675 0.916 . . . . 0.0 112.341 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 mt -94.62 169.22 10.33 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.308 -0.87 . . . . 0.0 109.11 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -85.55 141.78 29.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.053 -1.03 . . . . 0.0 109.424 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 37.85 47.09 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 58' ' ' ASP . 26.0 t -174.07 90.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -1.164 . . . . 0.0 109.527 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 11.3 mp0 -68.66 55.44 0.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 56' ' ' SER . 1.8 m-20 -126.39 154.46 43.56 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -117.96 138.35 52.23 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.7 mt -111.66 147.76 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.196 -0.94 . . . . 0.0 110.752 -178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.404 HD11 HD11 ' A' ' 20' ' ' ILE . 96.6 mt -132.55 144.04 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.858 -0.526 . . . . 0.0 110.445 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.9 m -118.02 122.29 42.82 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.0 mt -102.22 133.33 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.204 -0.935 . . . . 0.0 109.461 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.3 m -131.17 129.67 42.04 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.999 -1.063 . . . . 0.0 109.145 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.62 -172.32 38.65 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -72.08 159.02 34.88 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.01 -1.288 . . . . 0.0 109.716 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -46.84 -47.19 21.22 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.855 -0.528 . . . . 0.0 110.342 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -68.52 -45.55 71.94 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.806 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -58.24 -35.2 71.36 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.917 -1.114 . . . . 0.0 109.32 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.9 mt -73.52 -45.59 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.467 -0.77 . . . . 0.0 110.322 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -60.47 -42.84 97.06 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.754 -1.216 . . . . 0.0 109.376 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -61.79 -36.18 80.34 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.43 -44.79 57.45 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.574 -0.704 . . . . 0.0 109.703 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -58.45 -48.66 80.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 110.379 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -60.06 -41.84 93.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.955 -1.091 . . . . 0.0 109.932 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.1 mt -66.56 -25.29 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.798 -1.189 . . . . 0.0 108.966 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.6 -45.55 44.39 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -61.65 -38.59 88.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.471 -0.768 . . . . 0.0 109.385 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.41 HD22 ' N ' ' A' ' 79' ' ' ASN . 1.6 m-80 -78.41 -24.24 46.3 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.106 -0.996 . . . . 0.0 109.342 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 86.4 p -63.22 -37.61 87.92 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.278 -1.369 . . . . 0.0 107.331 179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.504 HG13 HD23 ' A' ' 24' ' ' LEU . 22.9 t -41.26 -50.72 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' ' 86' ' ' GLY . 2.6 mptm? -47.64 -22.39 0.5 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.111 -0.993 . . . . 0.0 109.424 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.683 ' NE2' HH21 ' A' ' 35' ' ' ARG . 53.4 tt0 -61.58 -14.66 32.0 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -53.81 85.63 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.782 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.521 ' N ' ' O ' ' A' ' 83' ' ' GLN . 2.0 t 65.46 33.24 8.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.443 -0.786 . . . . 0.0 108.891 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . 87.25 163.99 39.6 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 4.5 mtmm -76.1 31.8 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.289 -1.124 . . . . 0.0 108.726 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.533 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 68.6 m-85 -162.38 92.31 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 85.9 t80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.362 -179.847 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.592 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -68.09 -44.02 37.37 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.238 -1.154 . . . . 0.0 110.282 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 2' ' ' SER . 3.3 Cg_exo -66.97 -176.79 0.82 Allowed 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 120.81 1.007 . . . . 0.0 112.03 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.2 m120 52.23 85.79 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 76.2 p -170.3 107.32 0.33 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -165.47 -4.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.446 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.83 -28.51 11.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.156 -1.978 . . . . 0.0 108.156 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.472 ' O ' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER 173.01 123.99 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.532 ' O ' ' N ' ' A' ' 11' ' ' GLY . 19.0 mt -68.25 49.23 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.255 -0.903 . . . . 0.0 109.54 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . -55.45 87.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 137.58 -74.3 0.41 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -45.71 117.58 1.85 Allowed 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.936 1.09 . . . . 0.0 112.634 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mm -69.46 145.96 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.537 -0.727 . . . . 0.0 109.26 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.518 HD11 HD12 ' A' ' 9' ' ' LEU . 57.7 mt -123.29 148.01 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.281 -0.887 . . . . 0.0 109.58 -178.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 3.9 m -127.51 137.34 52.62 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -138.96 144.49 39.02 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -110.3 145.78 36.83 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.196 -0.94 . . . . 0.0 110.239 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.8 t -125.08 148.16 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -121.49 129.87 53.2 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.86 138.73 33.23 Favored Pre-proline 0 N--CA 1.503 2.207 0 O-C-N 121.557 -0.715 . . . . 0.0 109.183 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.407 ' HG2' HD12 ' A' ' 24' ' ' LEU . 6.3 Cg_exo -56.22 147.21 67.34 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.032 1.047 . . . . 0.0 110.992 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -54.05 -41.86 68.56 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.996 -1.065 . . . . 0.0 111.271 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -62.25 -42.64 99.51 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.749 -1.219 . . . . 0.0 111.162 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.488 HD13 ' CG1' ' A' ' 81' ' ' VAL . 27.2 mt -79.48 -26.68 41.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.63 -1.294 . . . . 0.0 108.13 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 -39.11 78.01 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.859 0.838 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -74.7 -30.51 61.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 88.4 p -70.67 -29.22 65.49 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.102 -0.999 . . . . 0.0 109.352 179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 78.7 mt -86.65 -44.25 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.022 -1.049 . . . . 0.0 111.108 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.2 mt -64.86 -34.69 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.029 -1.068 . . . . 0.0 109.569 -179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.77 -176.62 46.16 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.1 mttp -92.25 0.34 57.45 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.038 -1.272 . . . . 0.0 109.406 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -152.8 15.19 0.7 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 78.11 -8.02 40.97 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 43.1 mt-30 -34.57 -29.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.943 -0.739 . . . . 0.0 111.023 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.5 mmp_? -87.05 -43.46 12.29 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.545 -1.347 . . . . 0.0 109.469 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mm -66.92 -26.46 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.077 -1.015 . . . . 0.0 108.951 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.75 -53.58 7.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.516 ' OE1' ' NH2' ' A' ' 35' ' ' ARG . 88.3 mt-30 -59.16 -52.48 65.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.6 mt -52.93 -34.38 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 109.597 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -59.36 -47.71 84.39 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.389 -0.819 . . . . 0.0 110.576 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -75.07 -40.52 60.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.088 -1.008 . . . . 0.0 110.746 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -60.93 -43.07 99.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 110.34 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -87.8 -22.92 24.23 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.0 -1.063 . . . . 0.0 110.632 -178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.73 0.6 74.86 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.51 160.74 21.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.768 -0.842 . . . . 0.0 110.194 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 t -108.09 142.8 37.72 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -138.51 136.88 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 120.673 -1.267 . . . . 0.0 110.301 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -122.06 128.54 51.49 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 72.1 mt -99.56 135.7 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.92 -1.112 . . . . 0.0 109.162 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -95.85 150.3 20.57 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.113 -0.992 . . . . 0.0 108.503 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -66.62 150.59 97.32 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 120.837 -1.164 . . . . 0.0 108.617 179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.79 143.18 91.41 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 CA-C-N 119.133 0.726 . . . . 0.0 111.486 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 39.6 mt -77.39 119.93 21.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.048 -1.032 . . . . 0.0 109.368 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' CD ' ' N ' ' A' ' 55' ' ' GLY . 3.2 tm-20 -49.26 137.95 13.36 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.487 -0.758 . . . . 0.0 109.417 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' N ' ' CD ' ' A' ' 54' ' ' GLU . . . 86.98 33.82 11.73 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.0 t -155.62 -176.24 5.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.304 -1.115 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -142.92 40.51 1.52 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.403 -0.811 . . . . 0.0 108.962 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -139.73 154.49 47.45 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.92 0.867 . . . . 0.0 110.102 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 46.9 mtt180 -119.74 138.87 53.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.4 mt -108.07 155.58 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.441 -0.787 . . . . 0.0 110.607 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.7 mt -138.54 141.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.762 -0.586 . . . . 0.0 110.021 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.3 m -115.76 122.99 47.12 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.7 mt -102.32 133.48 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.275 -0.891 . . . . 0.0 109.372 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 11.9 m -130.57 129.68 43.09 Favored 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.086 -1.009 . . . . 0.0 109.152 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.61 -174.1 38.94 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.808 -1.717 . . . . 0.0 108.808 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -72.39 159.66 33.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.954 -1.321 . . . . 0.0 109.609 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.473 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -46.59 -46.6 19.69 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.699 -0.626 . . . . 0.0 110.245 -179.219 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -68.3 -45.96 71.58 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.274 -0.892 . . . . 0.0 109.946 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -58.35 -36.03 72.82 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.862 -1.149 . . . . 0.0 109.359 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 78.1 mt -71.91 -45.95 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -60.2 -43.59 95.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.768 -1.207 . . . . 0.0 109.663 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -60.98 -39.63 90.33 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.152 -0.968 . . . . 0.0 108.689 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.53 64.23 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.507 -0.746 . . . . 0.0 109.398 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.16 -49.86 74.63 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.494 -0.754 . . . . 0.0 110.319 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.53 -37.72 82.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.027 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.5 mt -70.31 -19.78 63.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.791 -1.193 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' O ' HG23 ' A' ' 81' ' ' VAL . 13.7 mt -81.05 -46.24 15.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -0.968 . . . . 0.0 108.624 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.45 -39.53 93.69 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.747 -0.595 . . . . 0.0 110.715 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -78.33 -22.34 48.21 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.03 -1.044 . . . . 0.0 109.794 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.9 t -65.25 -34.71 79.0 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.111 -1.436 . . . . 0.0 107.316 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.488 ' CG1' HD13 ' A' ' 24' ' ' LEU . 1.3 t -68.17 -40.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.391 -0.818 . . . . 0.0 110.858 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -56.83 -32.0 65.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.999 -1.063 . . . . 0.0 111.018 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -55.02 -21.16 11.12 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.37 -1.456 . . . . 0.0 108.014 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.419 ' O ' ' OG ' ' A' ' 85' ' ' SER . 28.0 m-85 -100.48 84.93 2.85 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.448 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.42 ' O ' ' OG ' ' A' ' 85' ' ' SER . 24.9 p 56.91 77.24 0.27 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.548 -0.72 . . . . 0.0 109.999 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -152.57 -70.74 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.089 -2.004 . . . . 0.0 108.089 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.541 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 12.9 mtpp -81.88 20.71 0.93 Allowed 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.541 ' CG ' ' O ' ' A' ' 87' ' ' LYS . 96.9 m-85 -161.73 -122.15 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.3 t80 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.287 179.481 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 53.3 p 50.48 71.17 1.63 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.231 -1.158 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.44 140.26 52.0 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 121.095 1.197 . . . . 0.0 111.917 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER -55.38 131.2 45.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.183 -0.948 . . . . 0.0 109.374 -179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -95.15 58.79 2.18 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.261 -0.899 . . . . 0.0 109.209 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.481 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 75.9 t80 -170.28 3.76 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.265 -0.897 . . . . 0.0 109.521 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.31 -41.03 39.08 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 107.803 -2.119 . . . . 0.0 107.803 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 9' ' ' LEU . 14.6 t70 -176.34 177.98 1.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' N ' ' OD1' ' A' ' 8' ' ' ASP . 4.0 mm? -93.78 66.14 3.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.164 -0.96 . . . . 0.0 108.414 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 47.49 45.8 22.92 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.58 165.87 25.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -63.52 163.56 23.62 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 120.857 1.038 . . . . 0.0 112.265 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.1 mm -80.3 144.8 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.376 -0.827 . . . . 0.0 109.067 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.5 mt -123.44 150.07 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.308 -0.87 . . . . 0.0 109.368 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 5.6 m -126.19 138.05 53.61 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.47 144.17 37.88 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -110.87 146.32 36.71 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 121.263 -0.898 . . . . 0.0 110.048 -179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.27 152.77 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -126.4 129.6 49.09 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.35 140.15 36.43 Favored Pre-proline 0 N--CA 1.505 2.276 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.76 150.76 68.65 Favored 'Trans proline' 0 N--CA 1.488 1.175 0 CA-C-N 120.019 1.042 . . . . 0.0 110.665 177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -56.48 -40.85 75.63 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.87 -1.143 . . . . 0.0 111.2 -178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -63.18 -45.4 91.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.78 -1.2 . . . . 0.0 111.552 -178.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.7 mt -76.88 -26.2 53.93 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.36 -1.462 . . . . 0.0 108.466 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -38.06 80.37 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.812 0.815 . . . . 0.0 109.514 -179.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.45 -30.82 62.03 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 m -70.79 -34.3 71.63 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.081 -1.012 . . . . 0.0 109.147 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 91.4 mt -82.11 -44.37 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 111.09 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.562 ' CD1' HH11 ' A' ' 59' ' ' ARG . 59.4 mt -67.1 -35.38 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 C-N-CA 119.349 -0.94 . . . . 0.0 109.918 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.09 -175.67 41.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 108.809 -1.717 . . . . 0.0 108.809 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -91.23 -9.58 44.76 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.022 -1.281 . . . . 0.0 109.967 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -144.17 20.03 2.11 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 71.39 -11.6 2.95 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.758 -1.737 . . . . 0.0 108.758 -179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.474 ' H ' ' C ' ' A' ' 32' ' ' GLY . 5.7 pt20 -35.54 -36.12 0.07 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.77 -0.841 . . . . 0.0 110.656 -178.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.403 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -76.71 -33.35 58.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.949 -1.094 . . . . 0.0 110.213 -178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.499 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.4 OUTLIER -77.01 -26.36 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.62 -1.3 . . . . 0.0 109.334 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.63 -46.22 66.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.983 -1.073 . . . . 0.0 109.102 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -59.99 -49.9 75.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.677 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.9 mt -58.05 -33.95 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.207 -0.933 . . . . 0.0 109.52 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -61.23 -64.71 0.86 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.243 -0.91 . . . . 0.0 110.047 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -64.08 -38.81 92.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 110.231 -179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -63.37 -42.15 98.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.157 -0.965 . . . . 0.0 110.238 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 28.0 p -87.01 -22.49 25.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.931 -1.106 . . . . 0.0 110.383 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.08 0.25 69.54 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.82 160.87 21.1 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.857 -0.79 . . . . 0.0 110.116 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 t -107.55 139.79 41.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -137.44 137.22 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.669 -1.269 . . . . 0.0 109.935 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -122.83 126.87 48.22 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.8 mt -97.98 135.63 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.873 -1.142 . . . . 0.0 108.528 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -96.42 148.18 23.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.151 -0.968 . . . . 0.0 108.593 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.19 149.17 97.3 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.899 -1.126 . . . . 0.0 108.761 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -61.54 141.81 92.85 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 CA-C-N 119.344 0.802 . . . . 0.0 111.581 179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.5 mt -76.09 122.65 24.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.425 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -50.41 140.06 14.3 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.208 -0.932 . . . . 0.0 109.512 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.63 32.22 19.4 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -157.99 173.29 16.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -1.148 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -133.88 42.18 2.95 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.455 -0.778 . . . . 0.0 109.194 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -137.38 154.59 49.97 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.801 0.81 . . . . 0.0 109.775 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.562 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.7 mtt180 -119.19 138.97 52.59 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.2 mt -110.12 147.95 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.35 -0.844 . . . . 0.0 110.645 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -130.57 143.07 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.758 -0.589 . . . . 0.0 110.311 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.3 m -116.51 122.68 45.41 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.7 mt -102.58 133.1 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.221 -0.924 . . . . 0.0 109.422 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.2 m -130.98 129.41 42.08 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.018 -1.051 . . . . 0.0 109.169 178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 163.83 -173.94 39.94 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.09 159.41 34.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.12 -1.224 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.499 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -47.06 -47.04 22.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.717 -0.614 . . . . 0.0 110.451 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -68.5 -44.57 74.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.2 -0.938 . . . . 0.0 109.787 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.517 ' NE2' ' O ' ' A' ' 43' ' ' SER . 24.1 mm100 -59.54 -36.68 76.62 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.916 -1.115 . . . . 0.0 109.284 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 80.2 mt -71.19 -45.54 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.477 -0.764 . . . . 0.0 110.124 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -60.36 -43.12 96.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.804 -1.185 . . . . 0.0 109.334 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -62.5 -37.15 84.89 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.275 -0.891 . . . . 0.0 108.628 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.24 -46.64 48.94 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.525 -0.734 . . . . 0.0 109.491 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -59.54 -41.34 89.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -66.91 -36.39 82.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.948 -1.095 . . . . 0.0 109.713 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.6 mt -72.15 -13.95 61.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.954 -1.091 . . . . 0.0 108.943 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.0 mt -85.59 -45.16 12.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.147 -0.971 . . . . 0.0 108.454 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -62.02 -38.45 88.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.484 -0.76 . . . . 0.0 109.838 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -79.14 -24.16 43.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.011 -1.055 . . . . 0.0 109.467 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 88.9 p -63.78 -38.58 91.63 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 81' ' ' VAL . 22.1 t -40.19 -46.44 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 CA-C-O 120.999 0.428 . . . . 0.0 110.066 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.475 ' C ' ' N ' ' A' ' 84' ' ' TYR . 16.5 pttm -50.56 -19.49 0.91 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.876 -1.14 . . . . 0.0 109.903 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' A' ' 85' ' ' SER . 52.1 tp60 -56.88 -12.38 1.93 Allowed 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 79.9 t80 -71.16 45.34 0.09 Allowed 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 115.292 -0.867 . . . . 0.0 108.977 179.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 83' ' ' GLN . 4.0 m 57.31 6.2 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.318 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -66.45 -45.67 83.65 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.169 -1.573 . . . . 0.0 109.169 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -133.67 44.05 2.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.517 -0.99 . . . . 0.0 108.876 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 81.2 t80 -173.3 58.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 109.248 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.449 -179.78 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 72.7 m -166.04 71.38 1.22 Allowed Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.257 -1.143 . . . . 0.0 109.487 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -61.28 129.44 28.38 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 121.094 1.196 . . . . 0.0 111.964 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -170.82 147.11 2.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.078 -1.014 . . . . 0.0 109.523 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.2 p -171.03 70.49 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.333 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -73.04 11.07 0.76 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.321 -0.862 . . . . 0.0 109.669 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -49.72 -46.67 38.98 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.44 ' H ' ' H ' ' A' ' 9' ' ' LEU . 0.6 OUTLIER 169.73 15.56 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' A' ' 11' ' ' GLY . 17.5 mt 43.6 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.641 -0.662 . . . . 0.0 109.834 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 11' ' ' GLY . . . -57.19 82.62 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 56.79 164.62 0.05 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -67.58 160.77 46.52 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 120.921 1.081 . . . . 0.0 112.017 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.59 140.92 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.069 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.5 mt -124.11 149.53 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.321 -0.862 . . . . 0.0 109.481 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -125.83 137.78 53.79 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.48 144.75 38.12 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -111.31 146.79 36.42 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.204 -0.935 . . . . 0.0 110.335 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -125.59 154.92 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 m -126.8 130.05 49.51 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.32 138.42 32.75 Favored Pre-proline 0 N--CA 1.506 2.338 0 O-C-N 121.514 -0.741 . . . . 0.0 109.23 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -55.88 175.05 0.24 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 CA-C-N 120.114 1.076 . . . . 0.0 110.828 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.37 -39.27 39.72 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.584 -1.322 . . . . 0.0 110.534 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -63.41 -39.75 95.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.278 -0.889 . . . . 0.0 111.457 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 ' N ' HD12 ' A' ' 24' ' ' LEU . 11.2 mp -81.01 -28.66 35.39 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.439 -1.413 . . . . 0.0 108.311 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.039 0.923 . . . . 0.0 109.171 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 28.0 ptt180 -71.51 -30.87 66.44 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 94.0 p -72.28 -31.18 65.51 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.072 -1.017 . . . . 0.0 109.223 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 87.6 mt -86.74 -44.27 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.009 -1.057 . . . . 0.0 111.146 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.2 mt -67.21 -35.44 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.83 -178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.96 -173.61 41.56 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.551 -1.82 . . . . 0.0 108.551 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttp -91.67 0.55 57.49 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.046 -1.267 . . . . 0.0 109.838 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -154.6 18.59 0.59 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.63 -10.35 6.95 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.7 -1.76 . . . . 0.0 108.7 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 33' ' ' GLY . 40.7 mt-30 -35.58 -28.57 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.797 -0.825 . . . . 0.0 110.738 -178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.1 tpt180 -85.68 -35.27 20.99 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.641 -1.287 . . . . 0.0 110.069 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.456 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -74.33 -27.38 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.996 -1.065 . . . . 0.0 109.019 179.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -72.62 -47.79 44.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 0.0 109.284 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.31 -46.49 88.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.039 -1.038 . . . . 0.0 110.031 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -56.92 -33.49 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.231 -0.918 . . . . 0.0 110.066 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -66.67 -40.18 88.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.015 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.482 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 18.5 t-80 -77.51 -30.42 52.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 110.248 -179.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' OE2' ' O ' ' A' ' 42' ' ' GLU . 2.2 tm-20 -79.12 -41.58 28.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.346 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -86.59 -23.68 25.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.043 . . . . 0.0 110.48 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.52 0.6 73.53 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.46 161.15 20.39 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.681 -0.894 . . . . 0.0 110.053 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.6 m -108.79 140.07 42.73 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.8 mt -137.76 137.5 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.775 -1.203 . . . . 0.0 110.024 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -122.3 129.26 52.01 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.3 mt -99.68 135.15 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.884 -1.135 . . . . 0.0 108.676 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.514 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 10.0 m-20 -95.83 150.18 20.7 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.158 -0.964 . . . . 0.0 108.626 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -66.4 151.12 96.49 Favored Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 120.916 -1.115 . . . . 0.0 108.609 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.01 142.18 91.72 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 120.451 0.767 . . . . 0.0 111.705 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.0 mt -79.71 137.37 37.02 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 109.41 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.32 134.51 50.42 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.3 -0.875 . . . . 0.0 109.695 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.24 -6.6 63.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.4 t -110.03 -169.15 1.42 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.367 -1.078 . . . . 0.0 109.58 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -150.58 38.64 0.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -142.68 162.79 34.55 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.794 0.807 . . . . 0.0 110.8 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -116.66 138.74 51.22 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.4 mt -112.4 147.24 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.21 0 O-C-N 121.193 -0.942 . . . . 0.0 110.962 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.1 mt -132.22 143.26 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.836 -0.54 . . . . 0.0 110.218 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 73.0 m -116.43 124.36 49.81 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.0 mt -103.92 132.92 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 m -131.03 130.06 42.81 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.038 -1.039 . . . . 0.0 109.104 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.1 -173.27 38.39 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.426 ' OG1' ' OE1' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -72.12 159.27 34.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.988 -1.301 . . . . 0.0 109.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -47.46 -46.55 26.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.673 -0.642 . . . . 0.0 110.392 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -68.08 -47.1 69.17 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.154 -0.966 . . . . 0.0 109.862 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 69' ' ' GLN . 14.3 mp0 -57.91 -36.73 72.85 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.866 -1.146 . . . . 0.0 109.082 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 68.4 mt -69.82 -45.79 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.511 -0.743 . . . . 0.0 110.019 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -60.66 -42.98 98.14 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.75 -1.219 . . . . 0.0 109.55 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -62.44 -38.37 89.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 108.817 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.1 -45.66 59.75 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.399 -0.813 . . . . 0.0 109.533 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -58.91 -41.24 86.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.134 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.84 -37.31 84.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.006 -1.059 . . . . 0.0 109.777 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.6 mt -70.82 -26.69 63.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.799 -1.188 . . . . 0.0 108.836 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -71.78 -45.19 62.41 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -62.18 -38.89 90.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.455 -0.778 . . . . 0.0 109.39 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -78.38 -26.08 46.44 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.251 -0.905 . . . . 0.0 109.605 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 53.8 p -62.46 -36.66 83.16 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.177 -1.409 . . . . 0.0 107.244 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 32.1 t -40.87 -44.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.077 0.465 . . . . 0.0 109.821 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' C ' ' H ' ' A' ' 84' ' ' TYR . 39.3 pttt -52.54 -21.12 3.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.022 -1.049 . . . . 0.0 109.935 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.507 ' O ' ' N ' ' A' ' 85' ' ' SER . 57.1 tt0 -58.62 -9.28 1.6 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.579 -1.325 . . . . 0.0 107.628 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 68.0 t80 -67.29 47.02 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.998 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 83' ' ' GLN . 11.4 p 57.3 6.59 0.39 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.394 -0.816 . . . . 0.0 109.325 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -72.97 -71.42 1.09 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.5 mttp -107.28 41.25 1.52 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.45 -1.03 . . . . 0.0 109.136 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.504 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 67.5 t80 -172.17 45.86 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 56.7 t80 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.512 -179.895 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m -165.37 71.77 1.37 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.258 -1.143 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.421 ' O ' ' O ' ' A' ' 4' ' ' ASN . 3.4 Cg_exo -65.67 -176.06 0.52 Allowed 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.102 1.201 . . . . 0.0 111.985 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' SER . 8.5 m120 54.21 101.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.647 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.432 ' O ' ' O ' ' A' ' 4' ' ' ASN . 8.3 t 55.82 105.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.258 -0.902 . . . . 0.0 109.632 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -59.9 150.55 28.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.904 . . . . 0.0 109.11 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' OD1' ' A' ' 8' ' ' ASP . . . 77.45 2.5 80.07 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 107.381 -2.288 . . . . 0.0 107.381 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 7' ' ' GLY . 3.2 p30 40.93 -159.69 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 122.227 -0.572 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 mt -98.97 68.1 1.68 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.302 -0.873 . . . . 0.0 109.136 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.83 44.24 61.0 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 70.44 161.99 3.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -66.39 141.95 63.92 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 118.475 1.138 . . . . 0.0 112.072 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.6 mm -78.27 139.49 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 108.862 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.64 149.46 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.352 -0.843 . . . . 0.0 109.792 -178.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.2 m -127.1 137.66 53.05 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.8 t -139.8 145.34 38.06 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -110.95 144.74 39.55 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.233 -0.917 . . . . 0.0 109.938 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.88 149.04 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -122.24 129.62 52.41 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.92 138.99 33.79 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -56.87 146.12 80.58 Favored 'Trans proline' 0 N--CA 1.489 1.222 0 CA-C-N 120.209 1.11 . . . . 0.0 110.918 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -52.7 -40.95 63.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.904 -1.122 . . . . 0.0 111.344 -178.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -62.31 -44.25 96.94 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.807 -1.183 . . . . 0.0 111.231 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 mt -78.52 -26.73 45.87 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.622 -1.299 . . . . 0.0 108.209 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.43 -39.45 79.85 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 121.83 0.824 . . . . 0.0 109.319 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -74.55 -30.09 61.61 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 96.8 p -71.12 -26.96 63.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.075 -1.016 . . . . 0.0 109.299 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.4 mt -89.01 -43.74 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 110.999 -177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.607 ' CD1' HH11 ' A' ' 59' ' ' ARG . 52.4 mt -68.28 -36.01 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.707 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.09 -172.72 40.37 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -91.65 -9.65 43.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.045 -1.267 . . . . 0.0 109.763 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -143.84 18.36 2.18 Favored Glycine 0 N--CA 1.497 2.723 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 74.91 -10.44 9.27 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.428 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 19.7 mm100 -35.61 -29.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.866 -0.785 . . . . 0.0 110.803 -178.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.0 tpp180 -84.32 -37.15 21.99 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.643 -1.286 . . . . 0.0 109.743 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -72.3 -23.39 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.802 -1.186 . . . . 0.0 108.532 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -71.72 -48.14 49.2 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 108.939 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.616 ' NE2' ' N ' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -59.11 -47.72 84.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.188 -0.945 . . . . 0.0 109.309 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -60.53 -33.76 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.188 -0.945 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.519 ' CG ' HH11 ' A' ' 40' ' ' ARG . 1.5 ttt-85 -57.88 -53.47 57.81 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.273 -0.892 . . . . 0.0 110.244 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -78.58 -39.57 37.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.208 -0.933 . . . . 0.0 110.357 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -59.07 -44.99 91.93 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.108 -0.995 . . . . 0.0 110.114 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.5 t -86.93 -22.56 25.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.045 -1.034 . . . . 0.0 110.188 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.11 -0.16 80.41 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -86.03 162.82 18.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.707 -0.878 . . . . 0.0 109.83 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 64.5 m -104.85 148.1 27.03 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 5.6 mm -133.05 138.8 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.652 -1.28 . . . . 0.0 109.948 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -129.53 123.63 31.91 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.9 mt -100.15 135.06 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 108.961 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -96.21 152.06 18.92 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.115 -0.991 . . . . 0.0 108.836 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 3.2 mp0 -70.7 150.2 95.34 Favored Pre-proline 0 N--CA 1.487 1.381 0 O-C-N 120.933 -1.105 . . . . 0.0 108.396 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -64.49 139.62 65.39 Favored 'Trans proline' 0 N--CA 1.49 1.273 0 CA-C-N 119.442 0.837 . . . . 0.0 111.59 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.426 ' O ' ' OG ' ' A' ' 56' ' ' SER . 15.3 mt -70.96 178.67 3.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.054 -1.029 . . . . 0.0 108.755 179.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 11.6 mp0 -58.17 129.53 42.44 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.081 -1.012 . . . . 0.0 109.53 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.9 62.69 5.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 58' ' ' ASP . 4.6 m -121.73 100.84 7.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.531 -0.982 . . . . 0.0 109.523 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -77.88 26.98 0.18 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.233 -0.917 . . . . 0.0 108.7 179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' SER . 3.7 m-20 -142.27 155.06 45.2 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 122.135 0.969 . . . . 0.0 110.287 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.607 HH11 ' CD1' ' A' ' 29' ' ' ILE . 51.5 mtt180 -118.44 138.83 52.2 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 83.7 mt -108.3 151.97 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.376 -0.828 . . . . 0.0 110.256 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -135.56 142.45 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.637 -0.665 . . . . 0.0 110.123 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.9 m -116.48 121.12 40.89 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.717 -0.614 . . . . 0.0 109.492 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.73 132.61 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.261 -0.899 . . . . 0.0 109.285 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -129.37 130.14 45.66 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.024 -1.047 . . . . 0.0 108.969 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.75 -172.34 38.77 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.3 p -73.26 160.0 32.56 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.001 -1.293 . . . . 0.0 109.619 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.14 -46.51 23.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.641 -0.662 . . . . 0.0 110.445 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -68.49 -45.22 72.91 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.254 -0.903 . . . . 0.0 109.857 -179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -59.16 -36.42 75.25 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.861 -1.149 . . . . 0.0 109.275 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 92.4 mt -72.33 -45.57 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.54 -0.725 . . . . 0.0 110.368 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.57 -42.95 97.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.753 -1.217 . . . . 0.0 109.491 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -61.32 -31.63 71.48 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.281 -0.887 . . . . 0.0 109.005 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -43.14 36.39 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.502 -0.749 . . . . 0.0 109.689 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -55.75 -48.23 75.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.275 -0.89 . . . . 0.0 110.177 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -61.21 -43.86 98.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.807 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -64.14 -24.58 67.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.905 -1.122 . . . . 0.0 109.084 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.3 mt -76.87 -46.77 23.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.048 -1.032 . . . . 0.0 108.316 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -62.06 -38.57 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.55 -0.719 . . . . 0.0 109.607 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.07 -25.45 47.7 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.185 -0.947 . . . . 0.0 109.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.9 p -62.79 -38.04 89.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.481 -1.387 . . . . 0.0 107.296 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.8 t -41.86 -50.78 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.028 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 42.0 mttp -48.17 -21.92 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.661 -179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -60.74 -24.69 65.91 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.669 -1.269 . . . . 0.0 107.737 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.46 ' CD2' ' OG ' ' A' ' 85' ' ' SER . 85.6 t80 -48.42 -36.04 13.99 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.857 0.836 . . . . 0.0 108.815 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.574 ' O ' ' N ' ' A' ' 87' ' ' LYS . 2.8 m -168.53 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 51.25 -88.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.569 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.574 ' N ' ' O ' ' A' ' 85' ' ' SER . 9.5 mttp -59.01 99.93 0.06 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 53.1 94.57 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.252 -0.905 . . . . 0.0 108.886 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.531 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.31 161.85 60.68 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.158 -1.201 . . . . 0.0 109.026 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -58.7 148.18 83.95 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.005 1.137 . . . . 0.0 111.904 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -171.17 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 90.0 p -169.96 146.22 3.06 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.307 -0.87 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -164.33 149.29 10.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 8' ' ' ASP . . . 74.97 -0.33 58.5 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 107.256 -2.338 . . . . 0.0 107.256 -178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 10' ' ' GLY . 36.5 t70 55.13 167.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 122.055 -0.673 . . . . 0.0 109.638 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 mt 47.76 12.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.282 -0.886 . . . . 0.0 109.695 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 8' ' ' ASP . . . 47.1 64.07 2.94 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 56.04 170.48 0.1 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -59.61 135.42 64.17 Favored 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 121.156 1.237 . . . . 0.0 112.369 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mm -82.83 144.42 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.8 mt -124.38 148.54 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.286 -0.884 . . . . 0.0 109.53 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.4 m -126.7 137.75 53.31 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -139.45 144.48 38.05 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -111.13 146.6 36.54 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.178 -0.951 . . . . 0.0 110.302 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -125.39 150.79 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -124.86 130.08 51.67 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.68 138.0 31.6 Favored Pre-proline 0 N--CA 1.505 2.284 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 22' ' ' LYS . 2.5 Cg_endo -57.91 134.69 64.11 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 CA-C-N 120.158 1.092 . . . . 0.0 110.384 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 21' ' ' PRO . 28.7 ttmt -39.07 -40.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.454 -0.779 . . . . 0.0 111.112 -178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.89 -40.2 96.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.985 -1.072 . . . . 0.0 110.868 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.529 HD12 HG13 ' A' ' 81' ' ' VAL . 4.0 mm? -77.59 -26.74 50.96 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.661 -1.274 . . . . 0.0 108.696 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.18 -38.32 79.52 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 121.774 0.797 . . . . 0.0 109.479 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -76.59 -29.11 56.45 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 85.4 p -73.59 -24.77 60.11 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.862 -1.149 . . . . 0.0 109.05 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -95.47 -42.6 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.961 -1.087 . . . . 0.0 110.609 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -69.25 -35.87 69.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.84 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.25 -172.04 39.28 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.593 -1.803 . . . . 0.0 108.593 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -91.57 -14.16 30.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.001 -1.294 . . . . 0.0 109.957 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -139.04 18.51 3.13 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.96 -10.21 7.83 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.729 -1.748 . . . . 0.0 108.729 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' A' ' 33' ' ' GLY . 70.2 mt-30 -36.03 -27.95 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.777 -0.837 . . . . 0.0 110.673 -178.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.535 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -85.53 -36.06 20.73 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.764 -1.21 . . . . 0.0 109.961 -178.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.8 OUTLIER -73.46 -24.48 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.844 -1.16 . . . . 0.0 108.532 179.195 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -73.04 -47.8 41.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.108 -0.995 . . . . 0.0 109.078 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -58.11 -50.24 74.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.048 -1.032 . . . . 0.0 109.867 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 83.9 mt -58.4 -31.79 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.161 -0.962 . . . . 0.0 109.79 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.1 ttt180 -61.1 -65.12 0.74 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.261 -0.899 . . . . 0.0 110.18 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -64.9 -36.73 85.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.206 -0.934 . . . . 0.0 110.326 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.33 -42.95 92.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.056 -1.028 . . . . 0.0 110.199 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.1 p -86.99 -22.94 25.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.05 -1.031 . . . . 0.0 110.354 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.99 0.83 70.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.947 -2.061 . . . . 0.0 107.947 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.49 161.44 20.26 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.747 -0.855 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 60.2 m -108.82 138.11 45.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.2 mt -136.38 137.88 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 120.816 -1.178 . . . . 0.0 109.891 -178.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -123.09 128.28 49.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.448 HG21 ' NH2' ' A' ' 59' ' ' ARG . 66.8 mt -99.85 135.75 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.017 -1.052 . . . . 0.0 108.541 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -95.57 151.59 19.19 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.037 -1.039 . . . . 0.0 108.939 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -66.02 155.38 87.25 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 120.964 -1.085 . . . . 0.0 108.342 179.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.95 143.02 77.77 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 120.624 0.883 . . . . 0.0 111.933 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 37.3 mt -83.14 119.88 25.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 109.354 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -50.48 128.67 20.59 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.316 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.84 21.62 20.58 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.8 t -158.04 128.06 6.08 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.314 -1.109 . . . . 0.0 109.386 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -92.55 48.08 1.35 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.218 -0.926 . . . . 0.0 109.599 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -131.82 154.31 49.26 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.59 0.709 . . . . 0.0 109.655 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' NH2' HG21 ' A' ' 49' ' ' ILE . 16.3 mmm180 -119.41 137.37 53.8 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 178.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 76.2 mt -110.17 153.79 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.3 -0.875 . . . . 0.0 111.052 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.7 mt -137.92 141.93 37.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.765 -0.585 . . . . 0.0 110.184 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.5 m -115.91 123.96 49.41 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.636 -0.665 . . . . 0.0 109.341 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.5 mt -104.07 132.19 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.271 -0.893 . . . . 0.0 109.491 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.74 46.49 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.124 -0.985 . . . . 0.0 109.114 179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.54 38.63 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 p -74.72 161.69 29.4 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.995 -1.297 . . . . 0.0 109.532 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -47.8 -47.48 30.95 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.494 -0.754 . . . . 0.0 110.449 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -67.85 -49.44 62.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 110.07 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -56.66 -36.68 69.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.854 -1.154 . . . . 0.0 109.212 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 72.8 mt -70.46 -45.54 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -60.7 -42.87 98.04 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.694 -1.254 . . . . 0.0 109.445 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.37 -37.94 87.65 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.276 -0.89 . . . . 0.0 108.784 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.99 -45.1 62.22 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.438 -0.789 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.83 -49.06 79.15 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.24 -0.913 . . . . 0.0 109.966 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -59.39 -41.11 88.65 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.099 -1.0 . . . . 0.0 109.803 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 25.7 mt -67.01 -25.9 66.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 108.947 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 mt -75.01 -44.37 48.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.883 -1.135 . . . . 0.0 108.34 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -62.0 -38.89 90.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.581 -0.7 . . . . 0.0 109.874 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -78.57 -23.82 45.87 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.874 -1.141 . . . . 0.0 109.618 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.487 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 25.5 m -63.69 -36.46 83.91 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.252 -1.53 . . . . 0.0 107.013 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.529 HG13 HD12 ' A' ' 24' ' ' LEU . 24.6 t -41.18 -44.44 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.791 -0.568 . . . . 0.0 109.872 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.466 ' C ' ' N ' ' A' ' 84' ' ' TYR . 14.3 mptt -55.74 -21.92 21.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.995 -1.065 . . . . 0.0 110.12 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -57.22 -11.72 1.89 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.304 -1.497 . . . . 0.0 107.51 178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.466 ' N ' ' C ' ' A' ' 82' ' ' LYS . 80.5 t80 -58.15 -31.83 67.6 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 87' ' ' LYS . 5.4 p -175.71 -144.37 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 57.2 -82.64 0.01 OUTLIER Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.552 ' N ' ' O ' ' A' ' 85' ' ' SER . 15.2 mtpp -63.66 76.32 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -1.146 . . . . 0.0 108.36 179.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.527 ' N ' ' O ' ' A' ' 86' ' ' GLY . 5.7 t80 71.18 107.7 0.06 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.438 -179.584 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.437 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.4 OUTLIER 174.79 -63.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.171 -1.193 . . . . 0.0 110.088 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 2' ' ' SER . 3.7 Cg_exo -48.92 168.1 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.303 0 CA-C-N 119.371 0.811 . . . . 0.0 112.145 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 2' ' ' SER . 20.7 m120 -157.26 57.05 0.51 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.2 p -62.5 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.328 -0.858 . . . . 0.0 109.597 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 6' ' ' TYR . 62.6 t80 51.96 36.71 19.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.928 . . . . 0.0 109.567 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.39 4.82 3.42 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 19.0 t70 54.4 -161.0 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.269 -1.136 . . . . 0.0 109.15 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 8' ' ' ASP . 32.6 mt -123.07 83.48 2.13 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -42.38 95.11 0.01 OUTLIER Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 74.81 163.45 10.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -64.61 164.71 22.84 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.053 1.168 . . . . 0.0 112.169 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -77.75 142.48 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.393 -0.817 . . . . 0.0 109.04 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.1 mt -125.2 150.22 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.314 -0.866 . . . . 0.0 109.706 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 t -127.48 148.17 50.31 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 t -148.44 142.04 25.47 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -108.22 145.45 34.25 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.245 -0.909 . . . . 0.0 110.162 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 t -125.03 154.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.9 m -126.48 129.65 49.09 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -126.5 136.14 28.23 Favored Pre-proline 0 N--CA 1.505 2.297 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -60.74 139.27 84.6 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 CA-C-N 120.16 1.093 . . . . 0.0 111.1 178.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -44.42 -40.02 5.15 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.096 -1.002 . . . . 0.0 111.252 -178.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -63.24 -47.1 83.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.725 -1.235 . . . . 0.0 111.116 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.4 mt -76.86 -21.67 54.63 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.349 -1.469 . . . . 0.0 108.348 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.92 -38.36 90.67 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.865 0.84 . . . . 0.0 109.443 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -75.42 -28.58 59.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 93.1 p -74.05 -32.73 63.43 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.191 -0.943 . . . . 0.0 108.881 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 89.2 mt -86.84 -44.25 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.667 -177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CD1' HH11 ' A' ' 59' ' ' ARG . 68.1 mt -69.92 -35.98 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.018 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.89 -170.14 41.33 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.194 -1.963 . . . . 0.0 108.194 -178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.7 mtmm -92.26 -47.2 7.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.18 -1.188 . . . . 0.0 109.421 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.67 13.21 59.54 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.681 -0.968 . . . . 0.0 110.681 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 67.12 -1.64 6.09 Favored Glycine 0 N--CA 1.493 2.455 0 O-C-N 120.882 -1.364 . . . . 0.0 109.812 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 33' ' ' GLY . 36.7 mt-30 -45.93 -16.86 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 119.316 1.558 . . . . 0.0 109.862 -178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.0 tpp180 -82.95 -38.82 22.23 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.907 -1.121 . . . . 0.0 110.864 -178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.475 HD11 HD13 ' A' ' 47' ' ' ILE . 9.6 tp -74.05 -18.98 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.139 -1.601 . . . . 0.0 109.155 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -73.75 -50.43 20.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.393 -0.817 . . . . 0.0 109.088 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.18 -48.54 81.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.545 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.4 mt -58.45 -34.74 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.17 -0.956 . . . . 0.0 109.341 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -59.62 -59.51 5.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.0 110.028 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -67.78 -37.59 82.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.275 -0.891 . . . . 0.0 110.155 -179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -63.86 -44.47 93.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.123 -0.985 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.4 t -86.6 -23.07 25.89 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.08 -1.012 . . . . 0.0 110.301 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.04 0.54 76.63 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 -178.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.66 162.28 18.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.762 -0.846 . . . . 0.0 109.876 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.9 t -108.04 141.36 39.82 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.475 HD13 HD11 ' A' ' 36' ' ' ILE . 98.3 mt -134.2 137.22 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.765 -1.209 . . . . 0.0 110.214 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -122.77 127.41 49.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 67.0 mt -100.1 134.43 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.021 -1.049 . . . . 0.0 108.584 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.9 149.48 21.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.133 -0.98 . . . . 0.0 108.559 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.92 149.22 97.8 Favored Pre-proline 0 C--N 1.304 -1.391 0 O-C-N 120.827 -1.171 . . . . 0.0 108.568 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.52 143.96 93.81 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 CA-C-N 119.213 0.754 . . . . 0.0 111.446 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 46.6 mt -77.67 121.61 24.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.063 -1.023 . . . . 0.0 109.225 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -54.74 135.04 47.7 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.304 -0.872 . . . . 0.0 109.326 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.1 14.24 54.84 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 47.6 t -129.66 -164.48 1.41 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.528 -0.984 . . . . 0.0 109.384 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.409 ' N ' ' OG ' ' A' ' 56' ' ' SER . 6.2 pt-20 -153.48 34.76 0.45 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.89 156.78 44.98 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 122.079 0.942 . . . . 0.0 110.641 -178.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.405 HH11 ' CD1' ' A' ' 29' ' ' ILE . 45.5 mtt180 -117.47 140.22 49.89 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.7 mt -111.59 144.21 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.381 -0.824 . . . . 0.0 110.785 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.2 mt -127.44 143.8 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.768 -0.583 . . . . 0.0 110.342 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.4 m -117.94 120.75 38.77 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.725 -0.609 . . . . 0.0 109.404 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 8.4 mt -101.09 133.13 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.129 -0.982 . . . . 0.0 109.324 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 19.0 m -129.33 130.59 46.29 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.06 -1.025 . . . . 0.0 109.19 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.56 -172.61 38.67 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 p -73.71 160.77 31.05 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.058 -1.26 . . . . 0.0 109.522 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -46.84 -46.96 21.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.496 -0.752 . . . . 0.0 110.066 -179.448 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.7 OUTLIER -67.74 -45.88 73.73 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 110.06 -179.283 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -59.93 -38.91 83.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.786 -1.196 . . . . 0.0 109.26 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 96.4 mt -69.81 -45.61 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.526 -0.733 . . . . 0.0 110.19 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -60.7 -43.34 97.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.801 -1.187 . . . . 0.0 109.375 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -61.43 -40.17 93.45 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.4 -46.4 64.05 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.493 -0.754 . . . . 0.0 109.417 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -57.41 -52.61 64.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.715 . . . . 0.0 109.945 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CE2' ' ND2' ' A' ' 79' ' ' ASN . 63.7 t80 -57.31 -40.51 78.02 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 110.035 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 22.4 mt -67.92 -27.67 66.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.863 -1.148 . . . . 0.0 108.975 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 mt -74.74 -45.94 40.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.058 . . . . 0.0 108.433 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -61.28 -39.35 90.08 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.667 -0.645 . . . . 0.0 109.486 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.433 ' ND2' ' CE2' ' A' ' 75' ' ' TYR . 10.0 m-80 -78.38 -23.79 46.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.385 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 85.9 p -63.07 -34.54 77.8 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 83' ' ' GLN . 48.6 t -46.07 -54.01 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.748 -0.595 . . . . 0.0 110.474 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' A' ' 84' ' ' TYR . 13.2 pttm -45.03 -21.64 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.06 -1.025 . . . . 0.0 111.019 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 85' ' ' SER . 54.8 tp60 -59.04 -7.5 1.12 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.379 -1.451 . . . . 0.0 107.929 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 77.5 t80 -66.14 50.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.336 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 83' ' ' GLN . 26.2 p 48.97 14.96 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 84' ' ' TYR . . . -69.4 -51.08 28.45 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.417 ' O ' ' O ' ' A' ' 88' ' ' PHE . 17.2 mtpp -98.7 118.72 36.07 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.301 -1.117 . . . . 0.0 109.461 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' O ' ' O ' ' A' ' 87' ' ' LYS . 28.9 t80 57.56 107.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.326 -0.859 . . . . 0.0 109.324 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.471 -179.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 78.0 p -168.23 71.08 0.84 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.239 -1.154 . . . . 0.0 109.627 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.47 -58.09 0.48 Allowed 'Trans proline' 0 N--CA 1.491 1.343 0 C-N-CA 121.079 1.186 . . . . 0.0 112.008 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.95 0.63 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.256 -0.903 . . . . 0.0 109.383 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.4 m -165.56 96.51 0.66 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 109.454 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.609 ' CD2' ' N ' ' A' ' 7' ' ' GLY . 86.7 t80 -69.39 -179.52 1.68 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.264 -0.897 . . . . 0.0 109.442 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.609 ' N ' ' CD2' ' A' ' 6' ' ' TYR . . . 55.44 8.13 1.67 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 6' ' ' TYR . 5.4 p-10 41.59 54.34 3.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.813 -0.816 . . . . 0.0 110.165 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 11' ' ' GLY . 23.0 mt -75.26 -16.57 60.44 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.431 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.91 -35.26 0.74 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 9' ' ' LEU . . . 171.92 169.36 34.61 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -62.73 163.19 22.41 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.106 1.204 . . . . 0.0 112.11 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.3 mp -102.31 143.27 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.8 mt -123.16 150.49 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.499 -0.751 . . . . 0.0 109.485 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.4 m -126.85 136.64 52.62 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -139.0 144.91 39.1 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -110.8 146.16 36.88 Favored 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.256 -0.902 . . . . 0.0 110.064 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.17 153.09 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 m -124.2 129.64 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.43 136.55 28.79 Favored Pre-proline 0 N--CA 1.504 2.232 0 O-C-N 121.466 -0.771 . . . . 0.0 109.25 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.35 139.25 85.77 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 CA-C-N 120.082 1.065 . . . . 0.0 110.954 177.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -44.26 -40.07 4.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 111.184 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -63.39 -46.58 85.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.824 -1.172 . . . . 0.0 111.43 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.84 -22.99 52.73 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 120.311 -1.493 . . . . 0.0 108.251 178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.95 -38.23 85.17 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.831 0.824 . . . . 0.0 109.14 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -75.38 -27.25 59.04 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 92.9 p -74.54 -31.57 62.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.065 -1.022 . . . . 0.0 109.254 179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 84.8 mt -83.89 -45.95 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.027 -1.045 . . . . 0.0 110.972 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 48.1 mt -65.75 -34.28 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.798 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.52 -176.22 44.62 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 108.475 -1.85 . . . . 0.0 108.475 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.6 mtpt -91.93 5.0 51.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.024 -1.28 . . . . 0.0 109.676 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -157.55 17.35 0.35 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 75.28 -9.49 13.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.621 -1.792 . . . . 0.0 108.621 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.435 ' C ' ' O ' ' A' ' 33' ' ' GLY . 62.0 mt-30 -34.65 -28.95 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.175 0 O-C-N 121.95 -0.735 . . . . 0.0 111.015 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 33' ' ' GLY . 13.4 mmt180 -86.33 -40.16 15.74 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.484 -1.385 . . . . 0.0 109.617 -179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.1 mm -69.85 -27.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.025 -1.047 . . . . 0.0 109.295 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -77.4 -53.55 7.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.521 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -58.68 -48.11 82.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.151 -0.968 . . . . 0.0 109.639 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.0 mt -58.08 -34.5 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.3 -0.875 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 57.1 ttt180 -59.26 -74.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -53.06 -34.8 58.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 0.0 110.471 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -67.06 -44.14 80.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.0 110.419 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -86.42 -24.57 25.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.127 -0.983 . . . . 0.0 110.538 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.77 -3.92 83.96 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.06 162.64 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.404 -1.056 . . . . 0.0 110.098 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 59.4 m -107.01 142.62 36.35 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.8 mt -138.06 136.78 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 120.665 -1.272 . . . . 0.0 110.04 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -123.0 127.29 48.61 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.5 mt -98.03 135.07 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.94 -1.1 . . . . 0.0 108.636 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -94.69 151.27 19.42 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.094 -1.004 . . . . 0.0 108.766 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 51' ' ' GLU . 4.0 mp0 -67.78 149.37 98.28 Favored Pre-proline 0 C--N 1.304 -1.405 0 O-C-N 120.996 -1.065 . . . . 0.0 108.46 178.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -62.14 141.37 88.18 Favored 'Trans proline' 0 C--N 1.314 -1.239 0 CA-C-N 119.445 0.837 . . . . 0.0 111.431 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.2 mt -74.83 134.54 41.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.078 -1.014 . . . . 0.0 109.377 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -62.02 144.37 55.25 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.266 -0.896 . . . . 0.0 109.454 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.9 36.85 27.37 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 57' ' ' GLU . 42.4 t -155.08 -164.94 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -1.124 . . . . 0.0 109.482 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.438 ' N ' ' OG ' ' A' ' 56' ' ' SER . 4.7 pt-20 -155.22 35.4 0.38 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 108.846 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -137.37 155.59 49.21 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.928 0.87 . . . . 0.0 110.239 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -120.63 140.47 51.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 70.6 mt -111.3 140.79 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.437 -0.79 . . . . 0.0 111.239 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -120.92 144.73 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.665 -0.647 . . . . 0.0 110.239 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.8 m -117.31 125.12 50.54 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.81 131.31 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.16 -0.963 . . . . 0.0 109.624 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.5 m -129.19 130.73 46.7 Favored 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.088 -1.008 . . . . 0.0 109.024 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.57 -174.42 38.95 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.889 -1.684 . . . . 0.0 108.889 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.5 p -73.24 160.22 32.24 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.048 -1.266 . . . . 0.0 109.714 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.25 -46.72 24.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.726 -0.609 . . . . 0.0 110.383 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 2.5 m-20 -68.15 -46.85 69.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.22 -0.925 . . . . 0.0 109.925 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -58.28 -37.33 74.8 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.898 -1.126 . . . . 0.0 109.293 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 76.2 mt -70.84 -45.76 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.504 -0.747 . . . . 0.0 110.212 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -60.2 -43.18 96.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.792 -1.193 . . . . 0.0 109.358 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.16 -35.24 78.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.317 -0.864 . . . . 0.0 108.757 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.37 35.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.533 -0.729 . . . . 0.0 109.55 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.15 -47.09 84.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.328 -0.858 . . . . 0.0 110.268 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -61.52 -35.27 77.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.053 -1.03 . . . . 0.0 110.013 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 mt -73.36 -26.93 61.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.82 -1.175 . . . . 0.0 109.02 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.0 mt -72.33 -46.03 57.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.086 -1.009 . . . . 0.0 108.317 178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -61.39 -37.64 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.483 -0.761 . . . . 0.0 109.446 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -78.85 -24.15 44.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 90.2 p -64.07 -40.11 95.54 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.404 ' H ' HG23 ' A' ' 81' ' ' VAL . 11.9 t -41.69 -47.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.933 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' C ' ' N ' ' A' ' 84' ' ' TYR . 54.8 mttm -49.71 -21.22 1.0 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.004 -1.06 . . . . 0.0 109.609 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 62.0 tp60 -57.63 -11.47 2.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.569 -1.332 . . . . 0.0 107.481 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.469 ' N ' ' C ' ' A' ' 82' ' ' LYS . 91.2 t80 -53.54 -58.82 5.81 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.798 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.7 p -169.84 57.72 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 88' ' ' PHE . . . -133.21 -63.79 0.08 OUTLIER Glycine 0 N--CA 1.497 2.745 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.413 ' HZ2' ' HB3' ' A' ' 87' ' ' LYS . 15.0 mtpp -80.78 17.94 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.219 -1.165 . . . . 0.0 108.537 179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' H ' ' C ' ' A' ' 86' ' ' GLY . 24.9 t80 175.61 107.73 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.469 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.4 t -169.38 71.47 0.69 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.136 . . . . 0.0 109.566 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -66.39 -49.64 1.74 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.023 1.149 . . . . 0.0 111.865 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -167.3 148.49 5.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.445 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.9 m -67.42 136.96 55.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.502 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 53.94 12.82 0.48 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 109.656 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -50.48 -50.95 34.05 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.492 ' CG ' ' H ' ' A' ' 9' ' ' LEU . 10.2 t70 -174.82 -164.96 0.18 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.863 -0.787 . . . . 0.0 109.372 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' O ' ' N ' ' A' ' 11' ' ' GLY . 16.9 mt 49.95 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.323 -0.86 . . . . 0.0 109.579 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.29 -15.86 0.15 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 9' ' ' LEU . . . 169.44 166.41 28.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -65.25 136.23 46.58 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 121.003 1.135 . . . . 0.0 112.134 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.7 mm -75.46 141.67 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 108.812 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -123.98 148.85 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.277 -0.89 . . . . 0.0 109.627 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 4.1 m -127.55 137.34 52.58 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -139.04 144.01 38.64 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.49 144.89 37.13 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.208 -0.933 . . . . 0.0 109.942 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.7 t -125.13 153.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.7 m -125.82 129.89 50.32 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.0 137.39 30.03 Favored Pre-proline 0 N--CA 1.504 2.27 0 O-C-N 121.485 -0.759 . . . . 0.0 108.957 -179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.81 144.61 93.22 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 CA-C-N 120.158 1.092 . . . . 0.0 110.958 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -50.94 -41.37 58.96 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.049 -1.032 . . . . 0.0 111.339 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.95 -45.38 92.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.74 -1.225 . . . . 0.0 111.42 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.8 mt -76.78 -25.71 53.67 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.448 -1.407 . . . . 0.0 108.175 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -38.26 79.83 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 121.735 0.779 . . . . 0.0 109.4 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -74.7 -30.11 61.43 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.8 m -71.41 -33.25 69.27 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.935 -1.103 . . . . 0.0 109.243 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.15 -45.13 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 111.016 -177.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.21 -35.06 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.877 -178.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.06 -171.9 39.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -91.79 -4.26 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.329 . . . . 0.0 109.771 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -149.87 19.58 1.11 Allowed Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 73.32 -10.61 6.01 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 32' ' ' GLY . 35.3 tt0 -36.57 -26.57 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.792 -0.828 . . . . 0.0 111.109 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.2 tpp180 -87.12 -37.48 17.34 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.733 -1.229 . . . . 0.0 109.777 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mm -72.41 -23.92 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 120.744 -1.222 . . . . 0.0 108.571 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -72.78 -49.33 31.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 108.938 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -57.63 -47.96 80.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.15 -0.969 . . . . 0.0 109.706 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.06 -32.81 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.153 -0.967 . . . . 0.0 109.703 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 55.7 ttt180 -60.04 -47.19 86.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 110.109 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -80.22 -39.47 29.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.198 -0.939 . . . . 0.0 110.112 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -61.39 -44.28 97.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.016 -1.053 . . . . 0.0 110.188 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.3 t -87.14 -22.33 25.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.079 -1.013 . . . . 0.0 110.217 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.71 0.18 79.45 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.79 162.63 18.59 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.772 -0.84 . . . . 0.0 109.848 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.9 m -105.35 146.97 28.68 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.4 mm -132.45 138.21 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.605 -1.309 . . . . 0.0 109.955 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -126.6 124.72 40.59 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.6 mt -101.66 132.98 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 108.787 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -94.61 150.83 19.83 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.006 -1.059 . . . . 0.0 108.487 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -66.21 150.15 97.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.969 -1.082 . . . . 0.0 108.455 179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -60.37 141.91 96.82 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 C-N-CA 120.38 0.72 . . . . 0.0 111.687 179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.4 mt -82.52 147.17 28.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.382 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.42 126.61 29.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.2 -0.937 . . . . 0.0 109.417 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.36 37.53 7.04 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.9 m -167.08 102.21 0.54 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.256 -1.144 . . . . 0.0 109.492 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 9.3 mp0 -73.43 50.82 0.32 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.431 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -136.41 154.61 50.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.96 0.886 . . . . 0.0 110.009 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.512 HH11 ' CG ' ' A' ' 59' ' ' ARG . 5.1 mtt-85 -118.05 139.52 51.09 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.9 mt -111.54 141.89 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.314 -0.866 . . . . 0.0 110.845 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.8 mt -124.96 143.71 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.752 -0.593 . . . . 0.0 110.484 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 m -118.59 118.38 31.51 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.718 -0.614 . . . . 0.0 109.556 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.0 mt -96.37 134.31 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 109.258 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.7 m -131.74 129.04 40.1 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.075 -1.016 . . . . 0.0 109.202 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.13 -171.95 37.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 p -71.71 159.31 34.6 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.049 -1.265 . . . . 0.0 109.536 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -49.37 -46.26 46.93 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.619 -0.675 . . . . 0.0 110.273 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -66.94 -46.53 74.46 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.08 -1.013 . . . . 0.0 109.494 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -57.99 -32.81 68.24 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.0 -1.062 . . . . 0.0 109.001 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.46 -45.92 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.503 -0.748 . . . . 0.0 110.527 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.62 -44.01 93.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.664 -1.272 . . . . 0.0 109.518 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -61.14 -34.1 74.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.072 -1.017 . . . . 0.0 108.729 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.55 -47.13 28.18 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.528 -0.732 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -58.44 -47.68 83.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.377 -0.827 . . . . 0.0 110.345 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CE1' ' ND2' ' A' ' 79' ' ' ASN . 56.9 t80 -61.14 -38.15 85.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.025 -1.047 . . . . 0.0 109.958 -179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 29.5 mt -70.16 -25.4 63.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.794 -1.191 . . . . 0.0 108.95 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.2 mt -74.38 -46.25 41.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 0.0 108.364 178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -61.46 -38.54 87.6 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.617 -0.677 . . . . 0.0 109.576 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' ND2' ' CE1' ' A' ' 75' ' ' TYR . 8.5 m-80 -78.53 -23.89 46.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.569 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.9 p -63.99 -40.28 96.01 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 81' ' ' VAL . 5.2 t -44.41 -43.65 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.775 -0.578 . . . . 0.0 110.007 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' C ' ' N ' ' A' ' 84' ' ' TYR . 49.5 mttp -54.5 -23.92 18.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.01 -1.056 . . . . 0.0 110.361 -178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -58.87 -12.17 4.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.245 -1.535 . . . . 0.0 107.304 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.447 ' N ' ' C ' ' A' ' 82' ' ' LYS . 85.5 t80 -54.55 -64.14 0.93 Allowed 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.053 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.7 p -172.06 59.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.67 -65.88 0.07 OUTLIER Glycine 0 N--CA 1.497 2.72 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -86.01 23.61 1.46 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.264 -1.139 . . . . 0.0 108.757 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.497 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 65.9 t80 -174.52 46.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CD1' ' OXT' ' A' ' 89' ' ' PHE . 39.4 t80 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.471 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -171.53 162.63 4.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.299 -1.118 . . . . 0.0 109.045 179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -61.81 8.28 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 120.972 1.115 . . . . 0.0 111.944 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 2' ' ' SER . 19.5 t30 -158.76 125.49 4.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.464 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.0 t -171.83 57.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.505 ' O ' ' CD2' ' A' ' 6' ' ' TYR . 77.3 t80 -167.96 21.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.506 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -59.24 -6.4 4.21 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 6' ' ' TYR . 28.3 m-20 53.38 -145.45 0.59 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -1.149 . . . . 0.0 109.428 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.3 mt -70.25 -10.56 59.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.202 -0.936 . . . . 0.0 109.259 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.42 59.22 10.69 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 72.65 169.16 13.2 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -64.0 156.0 61.2 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.124 1.216 . . . . 0.0 112.23 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 mm -84.15 142.73 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.432 -0.792 . . . . 0.0 109.079 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.97 149.97 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.309 -0.869 . . . . 0.0 109.858 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 8.9 t -128.72 143.56 50.96 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -144.7 144.38 31.19 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -109.82 145.53 36.57 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.293 -0.879 . . . . 0.0 109.748 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.3 148.96 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -124.71 129.6 50.8 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.622 HD12 ' H ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -126.18 142.7 43.41 Favored Pre-proline 0 N--CA 1.506 2.348 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.461 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.65 146.8 63.2 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 CA-C-N 120.485 1.209 . . . . 0.0 110.605 178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -52.31 -40.28 61.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.786 -1.196 . . . . 0.0 111.168 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -62.21 -42.45 99.3 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.699 -1.25 . . . . 0.0 111.446 -178.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD23 HG13 ' A' ' 81' ' ' VAL . 11.1 mp -79.8 -32.1 40.79 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.71 -1.244 . . . . 0.0 108.439 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.27 68.23 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.794 0.807 . . . . 0.0 109.305 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.99 -33.12 63.7 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 98.4 p -67.59 -27.87 67.28 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.936 -1.102 . . . . 0.0 108.948 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 82.2 mt -85.33 -42.07 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.011 -1.056 . . . . 0.0 110.559 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 55.3 mt -67.83 -37.37 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 119.322 -0.951 . . . . 0.0 109.748 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.64 -174.07 40.87 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.549 -1.82 . . . . 0.0 108.549 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -91.53 -8.31 47.89 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.955 -1.321 . . . . 0.0 109.831 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -145.2 20.11 1.92 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' A' ' 35' ' ' ARG . . . 72.33 -11.13 4.21 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' H ' ' C ' ' A' ' 32' ' ' GLY . 74.1 mt-30 -36.34 -27.35 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.824 -0.809 . . . . 0.0 110.609 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 33' ' ' GLY . 15.5 tpt180 -86.75 -35.48 19.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.818 -1.176 . . . . 0.0 109.77 -178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.3 mm -75.06 -26.55 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.976 -1.078 . . . . 0.0 108.878 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -73.29 -48.27 35.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.164 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.52 -51.03 71.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.885 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -56.59 -32.98 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.044 -1.035 . . . . 0.0 109.734 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -59.51 -51.2 70.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.252 -0.905 . . . . 0.0 110.179 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -75.56 -38.45 59.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.207 -0.933 . . . . 0.0 110.259 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -62.32 -44.43 96.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.112 -0.992 . . . . 0.0 110.194 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -86.76 -23.46 25.45 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.132 -0.98 . . . . 0.0 110.394 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.56 0.04 78.03 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 -178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.05 161.35 19.75 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.713 -0.875 . . . . 0.0 109.939 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 55.2 m -107.25 141.79 38.01 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.5 mt -138.69 136.81 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.634 -1.291 . . . . 0.0 109.822 -178.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -124.12 129.4 50.79 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mt -101.08 132.75 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 120.886 -1.134 . . . . 0.0 108.382 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -92.06 153.43 19.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.055 -1.028 . . . . 0.0 108.949 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -68.57 153.56 95.62 Favored Pre-proline 0 N--CA 1.486 1.372 0 O-C-N 120.952 -1.093 . . . . 0.0 108.113 178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -64.76 138.95 60.68 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 CA-C-N 119.42 0.829 . . . . 0.0 111.17 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.9 mt -74.18 127.58 33.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.073 -1.017 . . . . 0.0 109.52 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -46.87 141.56 3.94 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.384 -0.823 . . . . 0.0 109.571 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.95 22.63 63.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.0 t -150.08 177.47 9.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -1.035 . . . . 0.0 109.52 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -139.33 -31.92 0.67 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.534 -0.729 . . . . 0.0 110.464 -179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -55.98 156.63 5.14 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.945 -1.097 . . . . 0.0 109.058 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.525 ' O ' HD12 ' A' ' 20' ' ' ILE . 2.5 tpp180 -116.28 139.78 50.01 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.12 140.54 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.172 0 O-C-N 121.331 -0.856 . . . . 0.0 110.971 -178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.8 mt -125.1 144.22 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.785 -0.572 . . . . 0.0 110.632 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.2 m -117.85 123.86 46.93 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.652 -0.655 . . . . 0.0 109.352 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 12.2 mt -104.48 132.62 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.404 -0.81 . . . . 0.0 109.528 -179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 9.3 m -130.47 130.49 44.29 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.994 -1.066 . . . . 0.0 109.203 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.53 -172.89 38.72 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.831 -1.708 . . . . 0.0 108.831 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.2 p -73.22 160.25 32.2 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.051 -1.264 . . . . 0.0 109.844 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.2 tp60 -45.41 -48.88 13.6 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.381 0.61 . . . . 0.0 110.562 -179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -68.18 -45.67 72.8 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.937 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -58.37 -36.66 73.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.792 -1.192 . . . . 0.0 109.356 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 81.9 mt -72.08 -45.45 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.538 -0.726 . . . . 0.0 110.354 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -60.76 -42.77 98.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.758 -1.214 . . . . 0.0 109.422 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -62.16 -34.52 76.56 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.276 -0.89 . . . . 0.0 108.807 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.34 -44.36 45.68 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.46 -0.775 . . . . 0.0 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -58.34 -48.58 80.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -59.95 -40.08 87.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 109.87 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.6 mt -68.02 -30.27 69.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.801 -1.187 . . . . 0.0 109.02 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.64 -45.6 68.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.973 -1.079 . . . . 0.0 108.276 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -62.06 -39.43 92.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.593 -0.692 . . . . 0.0 109.576 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.508 HD22 ' N ' ' A' ' 79' ' ' ASN . 1.1 m-80 -77.97 -25.49 48.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 0.0 109.872 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.9 m -61.93 -34.37 75.97 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.497 HG13 HD23 ' A' ' 24' ' ' LEU . 45.3 t -44.44 -52.82 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.772 -0.58 . . . . 0.0 110.122 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.469 ' C ' ' N ' ' A' ' 84' ' ' TYR . 37.6 pttt -46.38 -23.05 0.31 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.112 -0.993 . . . . 0.0 110.44 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 85' ' ' SER . 65.4 tt0 -58.32 -10.74 2.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.477 -1.389 . . . . 0.0 107.429 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.469 ' N ' ' C ' ' A' ' 82' ' ' LYS . 91.3 t80 -59.64 82.67 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.738 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 83' ' ' GLN . 1.1 m 67.37 40.96 2.56 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 88' ' ' PHE . . . 61.43 149.93 0.02 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.993 -1.643 . . . . 0.0 108.993 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 88' ' ' PHE . 20.3 ttpt -68.27 48.25 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.147 -1.207 . . . . 0.0 109.301 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 86' ' ' GLY . 87.8 m-85 -156.61 42.49 0.37 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.0 p90 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.429 -179.766 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.0 m -165.04 71.16 1.42 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.229 -1.159 . . . . 0.0 109.521 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.47 ' C ' ' H ' ' A' ' 5' ' ' SER . 5.1 Cg_exo -64.43 -15.2 48.53 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 121.088 1.192 . . . . 0.0 112.023 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 5' ' ' SER . 12.9 m120 -61.67 1.04 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.633 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 3' ' ' PRO . 8.8 t 55.05 102.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 8' ' ' ASP . 90.8 t80 -61.71 -3.72 1.19 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.166 -0.959 . . . . 0.0 109.507 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 5' ' ' SER . . . -61.94 -0.52 2.26 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 6' ' ' TYR . 17.7 m-20 52.59 90.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -1.094 . . . . 0.0 109.559 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.6 mt -80.86 -7.67 59.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.354 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 11' ' ' GLY . . . 59.51 79.08 0.12 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 10' ' ' GLY . . . 57.41 164.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -64.32 160.42 39.02 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 121.065 1.176 . . . . 0.0 112.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.88 139.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.5 mt -123.06 150.8 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.507 -0.746 . . . . 0.0 109.335 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.0 m -126.91 136.41 52.26 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.0 t -139.66 145.59 38.64 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -110.19 145.36 37.4 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.112 -0.993 . . . . 0.0 109.925 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.11 148.52 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.2 m -122.72 129.89 52.31 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.66 140.6 37.91 Favored Pre-proline 0 N--CA 1.503 2.223 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -58.58 144.2 97.56 Favored 'Trans proline' 0 N--CA 1.488 1.201 0 CA-C-N 120.04 1.05 . . . . 0.0 110.86 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -50.03 -41.09 46.77 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.934 -1.104 . . . . 0.0 111.35 -178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -62.15 -45.82 91.73 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.651 -1.281 . . . . 0.0 111.12 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 mt -76.88 -24.36 52.58 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.501 -1.374 . . . . 0.0 108.597 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.62 -39.12 90.15 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.756 0.789 . . . . 0.0 109.864 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -73.97 -33.68 63.96 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.929 -0.708 . . . . 0.0 109.388 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.1 t -68.2 -34.02 75.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.782 -1.199 . . . . 0.0 109.266 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.3 mt -77.43 -44.85 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.147 -0.971 . . . . 0.0 110.991 -177.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.22 -36.09 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.811 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.11 -171.96 39.42 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 -178.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -91.74 -0.57 57.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.935 -1.333 . . . . 0.0 109.855 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' A' ' 34' ' ' GLN . . . -153.52 19.1 0.69 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 36' ' ' ILE . . . 73.48 -11.66 5.23 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.603 -1.799 . . . . 0.0 108.603 -179.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 32' ' ' GLY . 4.8 pt20 -34.54 -31.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.925 -0.75 . . . . 0.0 111.19 -178.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -82.43 -34.4 28.21 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.695 -1.253 . . . . 0.0 109.557 -179.038 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.0 OUTLIER -73.63 -25.03 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.971 -1.081 . . . . 0.0 108.815 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -72.26 -46.62 55.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.359 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -60.07 -47.29 86.47 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.173 -0.954 . . . . 0.0 110.033 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 93.9 mt -57.81 -33.69 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.968 . . . . 0.0 110.174 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -66.79 -43.58 83.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.039 -1.038 . . . . 0.0 109.861 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -77.16 -32.94 56.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 110.095 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -76.38 -41.99 46.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.162 -0.961 . . . . 0.0 110.359 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 p -86.71 -23.38 25.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.079 -1.013 . . . . 0.0 110.53 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.17 71.09 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 107.941 -2.063 . . . . 0.0 107.941 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.25 161.06 20.63 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.86 -0.788 . . . . 0.0 110.161 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.4 m -108.42 138.55 44.53 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 90.9 mt -137.43 137.02 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.722 -1.237 . . . . 0.0 109.919 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -122.84 129.11 51.27 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.9 mt -100.91 132.05 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.855 -1.153 . . . . 0.0 108.528 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' O ' ' NH2' ' A' ' 59' ' ' ARG . 18.5 p-10 -91.93 154.32 18.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 108.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.495 ' CD ' ' H ' ' A' ' 51' ' ' GLU . 9.7 mp0 -67.8 149.51 98.22 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 120.817 -1.177 . . . . 0.0 108.502 178.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -59.66 141.7 97.51 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 CA-C-N 119.298 0.785 . . . . 0.0 111.711 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 55' ' ' GLY . 36.8 mt -80.54 113.87 19.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.209 -0.932 . . . . 0.0 109.768 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -45.92 94.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.478 -0.764 . . . . 0.0 109.441 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 53' ' ' LEU . . . 143.53 -16.39 2.25 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.9 m -124.47 123.48 40.23 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.171 -1.193 . . . . 0.0 109.891 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.4 pm0 -79.55 44.03 0.59 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 108.877 179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -132.07 156.64 45.94 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.701 0.762 . . . . 0.0 109.93 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.481 ' NH2' ' O ' ' A' ' 50' ' ' ASP . 0.7 OUTLIER -116.26 136.21 53.21 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.403 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 78.1 mt -109.65 147.42 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 O-C-N 121.162 -0.961 . . . . 0.0 110.414 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.0 mt -130.85 143.75 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 O-C-N 121.811 -0.555 . . . . 0.0 110.334 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 88.9 m -117.13 123.76 47.52 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.666 -0.646 . . . . 0.0 109.363 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 14.9 mt -105.04 132.13 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.295 -0.878 . . . . 0.0 109.582 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.3 m -129.71 130.73 45.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.994 -1.066 . . . . 0.0 109.102 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 162.13 -172.73 38.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -72.84 160.03 32.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.266 . . . . 0.0 109.608 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.504 ' O ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -47.05 -46.84 22.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.633 -0.667 . . . . 0.0 110.151 -179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.97 -47.38 68.73 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.31 -0.869 . . . . 0.0 109.867 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -56.97 -35.79 69.55 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.903 -1.123 . . . . 0.0 109.198 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 86.8 mt -72.41 -45.45 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.595 -0.691 . . . . 0.0 110.28 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.23 -42.61 98.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.893 -1.129 . . . . 0.0 109.584 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -62.41 -36.77 83.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -0.881 . . . . 0.0 108.956 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.37 -42.85 61.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.427 -0.796 . . . . 0.0 109.614 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -59.49 -48.5 81.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.074 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -59.56 -35.97 75.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.065 -1.022 . . . . 0.0 110.091 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 24.2 mt -72.61 -28.85 63.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.774 -1.204 . . . . 0.0 109.095 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 mt -70.7 -44.83 66.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.121 -0.987 . . . . 0.0 108.422 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.22 -38.87 90.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.49 -0.757 . . . . 0.0 109.845 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -78.27 -24.4 46.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.133 -0.979 . . . . 0.0 109.749 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.452 ' OG ' ' NH1' ' A' ' 35' ' ' ARG . 20.8 m -64.27 -34.4 78.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.109 -1.437 . . . . 0.0 107.377 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 35.7 t -42.97 -46.5 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.74 -0.6 . . . . 0.0 109.822 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.484 ' C ' ' H ' ' A' ' 84' ' ' TYR . 31.3 mttm -51.07 -20.4 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.594 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.531 ' O ' ' N ' ' A' ' 85' ' ' SER . 34.2 tp60 -57.1 -10.33 1.15 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.471 -1.393 . . . . 0.0 107.746 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' C ' ' H ' ' A' ' 86' ' ' GLY . 83.4 t80 -65.41 63.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.123 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 83' ' ' GLN . 20.6 p 55.71 5.84 0.17 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.385 -0.822 . . . . 0.0 109.508 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 84' ' ' TYR . . . -69.14 -50.33 34.5 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 88' ' ' PHE . 15.6 mtpp -84.97 114.06 21.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.368 -1.078 . . . . 0.0 109.113 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.424 ' O ' ' O ' ' A' ' 87' ' ' LYS . 75.7 m-85 51.11 96.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.32 -0.863 . . . . 0.0 109.441 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.518 -179.958 . . . . . . . . 0 0 . 1 stop_ save_